reference_id,authors,title,journal,year,volume,citation_footer,citation_type,citation,urls,pubmed_id,doi,header,reference_type,study_id,exclusion_reason
CD009925-bib-0001,"Anandakumar C, Chew S, Wong YC, Goh VH, Tain CF, Ratnam SS. ","The sensitivity of the trivariate analysis using maternal serum alpha‐feto protein, human chorionic gonadotrophin and maternal age in screening for fetal aneuploidy in mothers above the age of 35", Journal of Perinatal Medicine ,1999,27,    ,['citation-journal']," Anandakumar C, Chew S, Wong YC, Goh VH, Tain CF, Ratnam SS. The sensitivity of the trivariate analysis using maternal serum alpha‐feto protein, human chorionic gonadotrophin and maternal age in screening for fetal aneuploidy in mothers above the age of 35.  Journal of Perinatal Medicine 1999;27(3):178‐82.    Link to article     Google Scholar     ","['https://doi.org/10.1515/JPM.1999.024', 'https://scholar.google.com/scholar_lookup?title=The+sensitivity+of+the+trivariate+analysis+using+maternal+serum+alpha‐feto+protein,+human+chorionic+gonadotrophin+and+maternal+age+in+screening+for+fetal+aneuploidy+in+mothers+above+the+age+of+35+&author=C+Anandakumar&author=S+Chew&author=YC+Wong&author=VH+Goh&author=CF+Tain&author=SS+Ratnam&publication_year=1999&hl=en']",,https://doi.org/10.1515/JPM.1999.024, Anandakumar 1999 {published data only}  ,included,CD009925-bbs2-0001,
CD009925-bib-0002,"Audibert F, Dommergues M, Benattar C, Taieb J, Thalabard JC, Frydman R. ",Screening for Down syndrome using first‐trimester ultrasound and second‐trimester maternal serum markers in a low‐risk population: a prospective longitudinal study, Ultrasound in Obstetrics & Gynecology ,2001,18,    ,['citation-journal']," Audibert F, Dommergues M, Benattar C, Taieb J, Thalabard JC, Frydman R. Screening for Down syndrome using first‐trimester ultrasound and second‐trimester maternal serum markers in a low‐risk population: a prospective longitudinal study.  Ultrasound in Obstetrics & Gynecology 2001;18(1):26‐31.    Link to article     Google Scholar     ","['https://doi.org/10.1046/j.1469-0705.2001.00457.x', 'https://scholar.google.com/scholar_lookup?title=Screening+for+Down+syndrome+using+first‐trimester+ultrasound+and+second‐trimester+maternal+serum+markers+in+a+low‐risk+population:+a+prospective+longitudinal+study+&author=F+Audibert&author=M+Dommergues&author=C+Benattar&author=J+Taieb&author=JC+Thalabard&author=R+Frydman&publication_year=2001&hl=en']",,https://doi.org/10.1046/j.1469-0705.2001.00457.x, Audibert 2001a {published data only}  ,included,CD009925-bbs2-0002,
CD009925-bib-0003,"Bahado Singh, Oz U, Rinne K, Hunter D, Cole L, Mahoney MJ, et al. ",Elevated maternal urine level of ß‐core fragment of human chorionic gonadotropin versus serum triple test in the second‐trimester detection of Down syndrome, American Journal of Obstetrics and Gynecology ,1999,181,    ,['citation-journal']," Bahado Singh, Oz U, Rinne K, Hunter D, Cole L, Mahoney MJ, et al. Elevated maternal urine level of ß‐core fragment of human chorionic gonadotropin versus serum triple test in the second‐trimester detection of Down syndrome.  American Journal of Obstetrics and Gynecology 1999;181(4):929‐33.    Link to article     Google Scholar     ","['https://doi.org/10.1016/S0002-9378(99)70327-3', 'https://scholar.google.com/scholar_lookup?title=Elevated+maternal+urine+level+of+ß‐core+fragment+of+human+chorionic+gonadotropin+versus+serum+triple+test+in+the+second‐trimester+detection+of+Down+syndrome+&author=Singh+Bahado&author=U+Oz&author=K+Rinne&author=D+Hunter&author=L+Cole&author=MJ+Mahoney&publication_year=1999&hl=en']",,https://doi.org/10.1016/S0002-9378(99)70327-3, Bahado‐Singh 1999a {published data only}  ,included,CD009925-bbs2-0003,
CD009925-bib-0004,"Bahado Singh, Oz AU, Gomez K, Hunter D, Copel J, Baumgarten A, et al. ","Combined ultrasound biometry, serum markers and age for Down syndrome risk estimation", Ultrasound in Obstetrics and Gynecology ,2000,15,    ,['citation-journal']," Bahado Singh, Oz AU, Gomez K, Hunter D, Copel J, Baumgarten A, et al. Combined ultrasound biometry, serum markers and age for Down syndrome risk estimation.  Ultrasound in Obstetrics and Gynecology 2000;15(3):199‐204.    Link to article     Google Scholar     ","['https://doi.org/10.1046/j.1469-0705.2000.00071.x', 'https://scholar.google.com/scholar_lookup?title=Combined+ultrasound+biometry,+serum+markers+and+age+for+Down+syndrome+risk+estimation&author=Singh+Bahado&author=AU+Oz&author=K+Gomez&author=D+Hunter&author=J+Copel&author=A+Baumgarten&publication_year=2000&hl=en']",,https://doi.org/10.1046/j.1469-0705.2000.00071.x, Bahado‐Singh 2000 {published data only}  ,included,CD009925-bbs2-0004,
CD009925-bib-0005,"Bahado‐Singh, Oz AU, Kovanci E, Deren O, Copel J, Baumgarten A, et al. ",New Down syndrome screening algorithm: Ultrasonographic biometry and multiple serum markers combined with maternal age, American Journal of Obstetrics and Gynecology ,1998,179,    ,['citation-journal']," Bahado‐Singh, Oz AU, Kovanci E, Deren O, Copel J, Baumgarten A, et al. New Down syndrome screening algorithm: Ultrasonographic biometry and multiple serum markers combined with maternal age.  American Journal of Obstetrics and Gynecology 1998;179(6 I):1627‐31.    Link to article     Google Scholar     ","['https://doi.org/10.1016/S0002-9378(98)70036-5', 'https://scholar.google.com/scholar_lookup?title=New+Down+syndrome+screening+algorithm:+Ultrasonographic+biometry+and+multiple+serum+markers+combined+with+maternal+age+&author=+Bahado‐Singh&author=AU+Oz&author=E+Kovanci&author=O+Deren&author=J+Copel&author=A+Baumgarten&publication_year=1998&hl=en']",,https://doi.org/10.1016/S0002-9378(98)70036-5, Bahado‐Singh 2000 {published data only}  ,included,CD009925-bbs2-0004,
CD009925-bib-0006,"Bartels I, Thiele M, Bogart MH. ",Maternal serum hCG and SP1 in pregnancies with fetal aneuploidy, American Journal of Medical Genetics ,1990,37,    ,['citation-journal']," Bartels I, Thiele M, Bogart MH. Maternal serum hCG and SP1 in pregnancies with fetal aneuploidy.  American Journal of Medical Genetics 1990;37(2):261‐4.    Link to article     Google Scholar     ","['https://doi.org/10.1002/ajmg.1320370220', 'https://scholar.google.com/scholar_lookup?title=Maternal+serum+hCG+and+SP1+in+pregnancies+with+fetal+aneuploidy&author=I+Bartels&author=M+Thiele&author=MH+Bogart&publication_year=1990&hl=en']",,https://doi.org/10.1002/ajmg.1320370220, Bartels 1990 {published data only}  ,included,CD009925-bbs2-0005,
CD009925-bib-0007,"Bogart MH, Golbus MS, Sorg ND, Jones OW. ",Human chorionic gonadotropin levels in pregnancies with aneuploid fetuses, Prenatal Diagnosis ,1989,9,    ,['citation-journal']," Bogart MH, Golbus MS, Sorg ND, Jones OW. Human chorionic gonadotropin levels in pregnancies with aneuploid fetuses.  Prenatal Diagnosis 1989;9(6):379‐84.    Link to article     Google Scholar     ","['https://doi.org/10.1002/pd.1970090602', 'https://scholar.google.com/scholar_lookup?title=Human+chorionic+gonadotropin+levels+in+pregnancies+with+aneuploid+fetuses&author=MH+Bogart&author=MS+Golbus&author=ND+Sorg&author=OW+Jones&publication_year=1989&hl=en']",,https://doi.org/10.1002/pd.1970090602, Bartels 1990 {published data only}  ,included,CD009925-bbs2-0005,
CD009925-bib-0008,"Bogart MH, Pandian MR, Jones OW. ",Abnormal maternal serum chorionic gonadotropin levels in pregnancies with fetal chromosome abnormalities, Prenatal Diagnosis ,1987,7,    ,['citation-journal']," Bogart MH, Pandian MR, Jones OW. Abnormal maternal serum chorionic gonadotropin levels in pregnancies with fetal chromosome abnormalities.  Prenatal Diagnosis 1987;7(9):623‐30.    Link to article     Google Scholar     ","['https://doi.org/10.1002/pd.1970070904', 'https://scholar.google.com/scholar_lookup?title=Abnormal+maternal+serum+chorionic+gonadotropin+levels+in+pregnancies+with+fetal+chromosome+abnormalities+&author=MH+Bogart&author=MR+Pandian&author=OW+Jones&publication_year=1987&hl=en']",,https://doi.org/10.1002/pd.1970070904, Bartels 1990 {published data only}  ,included,CD009925-bbs2-0005,
CD009925-bib-0009,"Bartels I, Bockel B, Caesar J, Krawczak M, Thiele M, Rauskolb R. ",Risk of fetal Down's syndrome based on maternal age and varying combinations of maternal serum markers, Archives of Gynecology & Obstetrics ,1994,255,    ,['citation-journal']," Bartels I, Bockel B, Caesar J, Krawczak M, Thiele M, Rauskolb R. Risk of fetal Down's syndrome based on maternal age and varying combinations of maternal serum markers.  Archives of Gynecology & Obstetrics 1994;255(2):57‐64.    Link to article     Google Scholar     ","['https://doi.org/10.1007/BF02391798', ""https://scholar.google.com/scholar_lookup?title=Risk+of+fetal+Down's+syndrome+based+on+maternal+age+and+varying+combinations+of+maternal+serum+markers+&author=I+Bartels&author=B+Bockel&author=J+Caesar&author=M+Krawczak&author=M+Thiele&author=R+Rauskolb&publication_year=1994&hl=en""]",,https://doi.org/10.1007/BF02391798, Bartels 1994a {published data only}  ,included,CD009925-bbs2-0006,
CD009925-bib-0010,"Bartels I, Bockel B, Caesar J, Krawczak M, Thiele M, Rauskolb R. ",Risk of fetal Down's syndrome based on maternal age and varying combinations of maternal serum markers, Archives of Gynecology & Obstetrics ,1994,255,    ,['citation-journal']," Bartels I, Bockel B, Caesar J, Krawczak M, Thiele M, Rauskolb R. Risk of fetal Down's syndrome based on maternal age and varying combinations of maternal serum markers.  Archives of Gynecology & Obstetrics 1994;255(2):57‐64.    Link to article     Google Scholar     ","['https://doi.org/10.1007/BF02391798', ""https://scholar.google.com/scholar_lookup?title=Risk+of+fetal+Down's+syndrome+based+on+maternal+age+and+varying+combinations+of+maternal+serum+markers+&author=I+Bartels&author=B+Bockel&author=J+Caesar&author=M+Krawczak&author=M+Thiele&author=R+Rauskolb&publication_year=1994&hl=en""]",,https://doi.org/10.1007/BF02391798, Bartels 1994b {published data only}  ,included,CD009925-bbs2-0007,
CD009925-bib-0011,"Beekhuis JR, Mantingh A, De Wolf BT, Van Lith JM, Breed AS. ",[Serum screening of pregnant women for fetal neural tube defects and Down syndrome; initial experiences in The Netherlands]. [Dutch], Nederlands Tijdschrift voor Geneeskunde ,1993,137,    ,['citation-journal']," Beekhuis JR, Mantingh A, De Wolf BT, Van Lith JM, Breed AS. [Serum screening of pregnant women for fetal neural tube defects and Down syndrome; initial experiences in The Netherlands]. [Dutch].  Nederlands Tijdschrift voor Geneeskunde 1993;137(26):1303‐7.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=[Serum+screening+of+pregnant+women+for+fetal+neural+tube+defects+and+Down+syndrome;+initial+experiences+in+The+Netherlands].+[Dutch]+&author=JR+Beekhuis&author=A+Mantingh&author=BT+Wolf&author=JM+Lith&author=AS+Breed&publication_year=1993&hl=en'],,, Beekhuis 1993 {published data only}  ,included,CD009925-bbs2-0008,
CD009925-bib-0012,"Benattar C, Audibert F, Taieb J, Ville Y, Roberto A, Lindenbaum A, et al. ",Efficiency of ultrasound and biochemical markers for Down's syndrome risk screening. A prospective study, Fetal Diagnosis & Therapy ,1999,14,    ,['citation-journal']," Benattar C, Audibert F, Taieb J, Ville Y, Roberto A, Lindenbaum A, et al. Efficiency of ultrasound and biochemical markers for Down's syndrome risk screening. A prospective study.  Fetal Diagnosis & Therapy 1999;14(2):112‐7.    Link to article     Google Scholar     ","['https://doi.org/10.1159/000020900', ""https://scholar.google.com/scholar_lookup?title=Efficiency+of+ultrasound+and+biochemical+markers+for+Down's+syndrome+risk+screening.+A+prospective+study+&author=C+Benattar&author=F+Audibert&author=J+Taieb&author=Y+Ville&author=A+Roberto&author=A+Lindenbaum&publication_year=1999&hl=en""]",,https://doi.org/10.1159/000020900, Benattar 1999 {published data only}  ,included,CD009925-bbs2-0009,
CD009925-bib-0013,"Brajenovic Milic, Tislaric D, Bacic J, Paravic J, Slivar A, Kapovic M, et al. ",Screening for Down's syndrome and neural tube defect in Croatia. A regional prospective study, Fetal Diagnosis and Therapy ,1998,13,    ,['citation-journal']," Brajenovic Milic, Tislaric D, Bacic J, Paravic J, Slivar A, Kapovic M, et al. Screening for Down's syndrome and neural tube defect in Croatia. A regional prospective study.  Fetal Diagnosis and Therapy 1998;13(6):367‐71.    Link to article     Google Scholar     ","['https://doi.org/10.1159/000020871', ""https://scholar.google.com/scholar_lookup?title=Screening+for+Down's+syndrome+and+neural+tube+defect+in+Croatia.+A+regional+prospective+study+&author=Milic+Brajenovic&author=D+Tislaric&author=J+Bacic&author=J+Paravic&author=A+Slivar&author=M+Kapovic&publication_year=1998&hl=en""]",,https://doi.org/10.1159/000020871, Brajenovic 1998 {published data only}  ,included,CD009925-bbs2-0010,
CD009925-bib-0014,"Brizzi L, Cariati E, Periti E, Nannini R, Torricelli F, Cappelli G, et al. ",Evaluation of maternal serum alpha‐fetoprotein and ultrasound examination to screen fetal chromosomal abnormalities, Journal of Nuclear Medicine & Allied Sciences ,1989,33,    ,['citation-journal']," Brizzi L, Cariati E, Periti E, Nannini R, Torricelli F, Cappelli G, et al. Evaluation of maternal serum alpha‐fetoprotein and ultrasound examination to screen fetal chromosomal abnormalities.  Journal of Nuclear Medicine & Allied Sciences 1989;33(3 Suppl):85‐8.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=Evaluation+of+maternal+serum+alpha‐fetoprotein+and+ultrasound+examination+to+screen+fetal+chromosomal+abnormalities+&author=L+Brizzi&author=E+Cariati&author=E+Periti&author=R+Nannini&author=F+Torricelli&author=G+Cappelli&publication_year=1989&hl=en'],,, Brizzi 1989a {published data only}  ,included,CD009925-bbs2-0011,
CD009925-bib-0015,"Chao AS, Chung CL, Wu CD, Chang SD, Cheng PJ, Lin YT, et al. ","Second trimester maternal serum screening using alpha fetoprotein, free ß human chorionic gonadotropin and maternal age specific risk: result of chromosomal abnormalities detected in screen positive for Down syndrome in an Asian population", Acta Obstetricia et Gynecologica Scandinavica ,1999,78,    ,['citation-journal']," Chao AS, Chung CL, Wu CD, Chang SD, Cheng PJ, Lin YT, et al. Second trimester maternal serum screening using alpha fetoprotein, free ß human chorionic gonadotropin and maternal age specific risk: result of chromosomal abnormalities detected in screen positive for Down syndrome in an Asian population.  Acta Obstetricia et Gynecologica Scandinavica 1999;78(5):393‐7.    Google Scholar     ","['https://scholar.google.com/scholar_lookup?title=Second+trimester+maternal+serum+screening+using+alpha+fetoprotein,+free+ß+human+chorionic+gonadotropin+and+maternal+age+specific+risk:+result+of+chromosomal+abnormalities+detected+in+screen+positive+for+Down+syndrome+in+an+Asian+population+&author=AS+Chao&author=CL+Chung&author=CD+Wu&author=SD+Chang&author=PJ+Cheng&author=YT+Lin&publication_year=1999&hl=en']",,, Chao 1999 {published data only}  ,included,CD009925-bbs2-0012,
CD009925-bib-0016,"Christiansen M, Oxvig C, Wagner JM, Qin QP, Nguyen TH, Overgaard MT, et al. ",The proform of eosinophil major basic protein: a new maternal serum marker for Down syndrome, Prenatal Diagnosis. ,1999,19,    ,['citation-journal']," Christiansen M, Oxvig C, Wagner JM, Qin QP, Nguyen TH, Overgaard MT, et al. The proform of eosinophil major basic protein: a new maternal serum marker for Down syndrome.  Prenatal Diagnosis. 1999;19(10):905‐10.    Link to article     Google Scholar     ","['https://doi.org/10.1002/(SICI)1097-0223(199910)19:10<905::AID-PD658>3.0.CO;2-Q', 'https://scholar.google.com/scholar_lookup?title=The+proform+of+eosinophil+major+basic+protein:+a+new+maternal+serum+marker+for+Down+syndrome+&author=M+Christiansen&author=C+Oxvig&author=JM+Wagner&author=QP+Qin&author=TH+Nguyen&author=MT+Overgaard&publication_year=1999&hl=en']",,https://doi.org/10.1002/(SICI)1097-0223(199910)19:10<905::AID-PD658>3.0.CO;2-Q, Christiansen 1999 {published data only}  ,included,CD009925-bbs2-0013,
CD009925-bib-0017,"Christiansen M, Larsen SO, Oxvig C, Qin QP, Wagner JM, Overgaard MT, et al. ",Screening for Down's syndrome in early and late first and second trimester using six maternal serum markers, Clinical Genetics ,2004,65,    ,['citation-journal']," Christiansen M, Larsen SO, Oxvig C, Qin QP, Wagner JM, Overgaard MT, et al. Screening for Down's syndrome in early and late first and second trimester using six maternal serum markers.  Clinical Genetics 2004;65(1):11‐6.    Link to article     Google Scholar     ","['https://doi.org/10.1111/j..2004.00177.x', ""https://scholar.google.com/scholar_lookup?title=Screening+for+Down's+syndrome+in+early+and+late+first+and+second+trimester+using+six+maternal+serum+markers+&author=M+Christiansen&author=SO+Larsen&author=C+Oxvig&author=QP+Qin&author=JM+Wagner&author=MT+Overgaard&publication_year=2004&hl=en""]",,https://doi.org/10.1111/j..2004.00177.x, Christiansen 2004 {published data only}  ,included,CD009925-bbs2-0014,
CD009925-bib-0018,"Cioffi M, Gazzerro P, Di MacChia, Vietri MT, Contursi A, Magnetta R, et al. ",Screening of maternal serum for prenatal Down's syndrome and neural tube defects: An Italian experience, Immuno‐Analyse et Biologie Specialisee ,2000,15,    ,['citation-journal']," Cioffi M, Gazzerro P, Di MacChia, Vietri MT, Contursi A, Magnetta R, et al. Screening of maternal serum for prenatal Down's syndrome and neural tube defects: An Italian experience.  Immuno‐Analyse et Biologie Specialisee 2000;15(3):177‐81.    Link to article     Google Scholar     ","['https://doi.org/10.1016/S0923-2532(00)80005-8', ""https://scholar.google.com/scholar_lookup?title=Screening+of+maternal+serum+for+prenatal+Down's+syndrome+and+neural+tube+defects:+An+Italian+experience+&author=M+Cioffi&author=P+Gazzerro&author=MacChia+Di&author=MT+Vietri&author=A+Contursi&author=R+Magnetta&publication_year=2000&hl=en""]",,https://doi.org/10.1016/S0923-2532(00)80005-8, Cioffi 2000 {published data only}  ,included,CD009925-bbs2-0015,
CD009925-bib-0019,"Crossley JA, Aitken DA, Berry E, Connor JM. ",Impact of a regional screening programme using maternal serum alpha fetoprotein (AFP) and human chorionic gonadotrophin (hCG) on the birth incidence of Down's syndrome in the west of Scotland, Journal of Medical Screening ,1994,1,    ,['citation-journal']," Crossley JA, Aitken DA, Berry E, Connor JM. Impact of a regional screening programme using maternal serum alpha fetoprotein (AFP) and human chorionic gonadotrophin (hCG) on the birth incidence of Down's syndrome in the west of Scotland.  Journal of Medical Screening 1994;1(3):180‐3.    Link to article     Google Scholar     ","['https://doi.org/10.1177/096914139400100309', ""https://scholar.google.com/scholar_lookup?title=Impact+of+a+regional+screening+programme+using+maternal+serum+alpha+fetoprotein+(AFP)+and+human+chorionic+gonadotrophin+(hCG)+on+the+birth+incidence+of+Down's+syndrome+in+the+west+of+Scotland+&author=JA+Crossley&author=DA+Aitken&author=E+Berry&author=JM+Connor&publication_year=1994&hl=en""]",,https://doi.org/10.1177/096914139400100309, Crossley 1994 {published data only}  ,included,CD009925-bbs2-0016,
CD009925-bib-0020,"David M, Merksamer R, Israel N, Dar H. ",Unconjugated estriol as maternal serum marker for the detection of Down syndrome pregnancies, Fetal Diagnosis & Therapy ,1996,11,    ,['citation-journal']," David M, Merksamer R, Israel N, Dar H. Unconjugated estriol as maternal serum marker for the detection of Down syndrome pregnancies.  Fetal Diagnosis & Therapy 1996;11(2):99‐105.    Link to article     Google Scholar     ","['https://doi.org/10.1159/000264287', 'https://scholar.google.com/scholar_lookup?title=Unconjugated+estriol+as+maternal+serum+marker+for+the+detection+of+Down+syndrome+pregnancies&author=M+David&author=R+Merksamer&author=N+Israel&author=H+Dar&publication_year=1996&hl=en']",,https://doi.org/10.1159/000264287, David 1996 {published data only}  ,included,CD009925-bbs2-0017,
CD009925-bib-0021,"Debieve F, Bouckaert A, Hubinont C, Thomas K. ","Multiple screening for fetal Down's syndrome with the classic triple test, dimeric Inhibin A and ultrasound", Gynecologic & Obstetric Investigation ,2000,49,    ,['citation-journal']," Debieve F, Bouckaert A, Hubinont C, Thomas K. Multiple screening for fetal Down's syndrome with the classic triple test, dimeric Inhibin A and ultrasound.  Gynecologic & Obstetric Investigation 2000;49(4):221‐6.    Link to article     Google Scholar     ","['https://doi.org/10.1159/000010263', ""https://scholar.google.com/scholar_lookup?title=Multiple+screening+for+fetal+Down's+syndrome+with+the+classic+triple+test,+dimeric+Inhibin+A+and+ultrasound+&author=F+Debieve&author=A+Bouckaert&author=C+Hubinont&author=K+Thomas&publication_year=2000&hl=en""]",,https://doi.org/10.1159/000010263, Debieve 2000 {published data only}  ,included,CD009925-bbs2-0018,
CD009925-bib-0022,"Extermann P, Bischof P, Marguerat P, Mermillod B. ","Second‐trimester maternal serum screening for Down's syndrome: free ß‐human chorionic gonadotrophin (HCG) and alpha‐fetoprotein, with or without unconjugated oestriol, compared with total HCG, alpha‐fetoprotein and unconjugated oestriol", Human Reproduction ,1998,13,    ,['citation-journal']," Extermann P, Bischof P, Marguerat P, Mermillod B. Second‐trimester maternal serum screening for Down's syndrome: free ß‐human chorionic gonadotrophin (HCG) and alpha‐fetoprotein, with or without unconjugated oestriol, compared with total HCG, alpha‐fetoprotein and unconjugated oestriol.  Human Reproduction 1998;13(1):220‐3.    Link to article     Google Scholar     ","['https://doi.org/10.1093/humrep/13.1.220', ""https://scholar.google.com/scholar_lookup?title=Second‐trimester+maternal+serum+screening+for+Down's+syndrome:+free+ß‐human+chorionic+gonadotrophin+(HCG)+and+alpha‐fetoprotein,+with+or+without+unconjugated+oestriol,+compared+with+total+HCG,+alpha‐fetoprotein+and+unconjugated+oestriol+&author=P+Extermann&author=P+Bischof&author=P+Marguerat&author=B+Mermillod&publication_year=1998&hl=en""]",,https://doi.org/10.1093/humrep/13.1.220, Extermann 1998 {published data only}  ,included,CD009925-bbs2-0019,
CD009925-bib-0023,"Forest JC, Masse J, Rousseau F, Moutquin JM, Brideau NA, Belanger M. ",Screening for Down syndrome during the first and second trimesters: impact of risk estimation parameters, Clinical Biochemistry ,1995,28,    ,['citation-journal']," Forest JC, Masse J, Rousseau F, Moutquin JM, Brideau NA, Belanger M. Screening for Down syndrome during the first and second trimesters: impact of risk estimation parameters.  Clinical Biochemistry 1995;28(4):443‐9.    Link to article     Google Scholar     ","['https://doi.org/10.1016/0009-9120(95)00021-Z', 'https://scholar.google.com/scholar_lookup?title=Screening+for+Down+syndrome+during+the+first+and+second+trimesters:+impact+of+risk+estimation+parameters+&author=JC+Forest&author=J+Masse&author=F+Rousseau&author=JM+Moutquin&author=NA+Brideau&author=M+Belanger&publication_year=1995&hl=en']",,https://doi.org/10.1016/0009-9120(95)00021-Z, Forest 1995 {published data only}  ,included,CD009925-bbs2-0020,
CD009925-bib-0024,"Greenberg F, Del Junco D, Weyland B, Faucett WA, Schmidt D, Rose E, et al. ",The effect of gestational age on the detection rate of Down's syndrome by maternal serum alpha‐fetoprotein screening, American Journal of Obstetrics & Gynecology ,1991,165,    ,['citation-journal']," Greenberg F, Del Junco D, Weyland B, Faucett WA, Schmidt D, Rose E, et al. The effect of gestational age on the detection rate of Down's syndrome by maternal serum alpha‐fetoprotein screening.  American Journal of Obstetrics & Gynecology 1991;165(5 Pt 1):1391‐3.    Google Scholar     ","[""https://scholar.google.com/scholar_lookup?title=The+effect+of+gestational+age+on+the+detection+rate+of+Down's+syndrome+by+maternal+serum+alpha‐fetoprotein+screening+&author=F+Greenberg&author=D+Junco&author=B+Weyland&author=WA+Faucett&author=D+Schmidt&author=E+Rose&publication_year=1991&hl=en""]",,, Greenberg 1991 {published data only}  ,included,CD009925-bbs2-0021,
CD009925-bib-0025,"Haddow JE, Palomaki GE, Knight GJ, Cunningham GC, Lustig LS, Boyd PA. ",Reducing the need for amniocentesis in women 35 years of age or older with serum markers for screening, New England Journal of Medicine ,1994,330,    ,['citation-journal']," Haddow JE, Palomaki GE, Knight GJ, Cunningham GC, Lustig LS, Boyd PA. Reducing the need for amniocentesis in women 35 years of age or older with serum markers for screening.  New England Journal of Medicine 1994;330(16):1114‐8.    Link to article     Google Scholar     ","['https://doi.org/10.1056/NEJM199404213301603', 'https://scholar.google.com/scholar_lookup?title=Reducing+the+need+for+amniocentesis+in+women+35+years+of+age+or+older+with+serum+markers+for+screening+&author=JE+Haddow&author=GE+Palomaki&author=GJ+Knight&author=GC+Cunningham&author=LS+Lustig&author=PA+Boyd&publication_year=1994&hl=en']",,https://doi.org/10.1056/NEJM199404213301603, Haddow 1994 {published data only}  ,included,CD009925-bbs2-0022,
CD009925-bib-0026,"Haddow JE, Palomaki GE, Knight GJ, Foster DL, Neveux LM. ",Second trimester screening for Down's syndrome using maternal serum dimeric Inhibin A, Journal of Medical Screening ,1998,5,    ,['citation-journal']," Haddow JE, Palomaki GE, Knight GJ, Foster DL, Neveux LM. Second trimester screening for Down's syndrome using maternal serum dimeric Inhibin A.  Journal of Medical Screening 1998;5(3):115‐9.    Link to article     Google Scholar     ","['https://doi.org/10.1136/jms.5.3.115', ""https://scholar.google.com/scholar_lookup?title=Second+trimester+screening+for+Down's+syndrome+using+maternal+serum+dimeric+Inhibin+A+&author=JE+Haddow&author=GE+Palomaki&author=GJ+Knight&author=DL+Foster&author=LM+Neveux&publication_year=1998&hl=en""]",,https://doi.org/10.1136/jms.5.3.115, Haddow 1998 {published data only}  ,included,CD009925-bbs2-0023,
CD009925-bib-0027,"Heyl PS, Miller W, Canick JA. ","Maternal serum screening for aneuploid pregnancy by alpha‐fetoprotein, hCG, and unconjugated estriol", Obstetrics & Gynecology ,1990,76,    ,['citation-journal']," Heyl PS, Miller W, Canick JA. Maternal serum screening for aneuploid pregnancy by alpha‐fetoprotein, hCG, and unconjugated estriol.  Obstetrics & Gynecology 1990;76(6):1025‐31.    Google Scholar     ","['https://scholar.google.com/scholar_lookup?title=Maternal+serum+screening+for+aneuploid+pregnancy+by+alpha‐fetoprotein,+hCG,+and+unconjugated+estriol+&author=PS+Heyl&author=W+Miller&author=JA+Canick&publication_year=1990&hl=en']",,, Heyl 1990 {published data only}  ,included,CD009925-bbs2-0024,
CD009925-bib-0028,"Hsu JJ, Hsieh TT, Soong YK, Spencer K. ",Comparison of Down's syndrome screening strategies in Asians combining serum free ß‐hCG and alpha‐fetoprotein with maternal age, Prenatal Diagnosis ,1997,17,    ,['citation-journal']," Hsu JJ, Hsieh TT, Soong YK, Spencer K. Comparison of Down's syndrome screening strategies in Asians combining serum free ß‐hCG and alpha‐fetoprotein with maternal age.  Prenatal Diagnosis 1997;17(8):707‐16.    Link to article     Google Scholar     ","['https://doi.org/10.1002/(SICI)1097-0223(199708)17:8<707::AID-PD142>3.0.CO;2-H', ""https://scholar.google.com/scholar_lookup?title=Comparison+of+Down's+syndrome+screening+strategies+in+Asians+combining+serum+free+ß‐hCG+and+alpha‐fetoprotein+with+maternal+age+&author=JJ+Hsu&author=TT+Hsieh&author=YK+Soong&author=K+Spencer&publication_year=1997&hl=en""]",,https://doi.org/10.1002/(SICI)1097-0223(199708)17:8<707::AID-PD142>3.0.CO;2-H, Hsu 1997a {published data only}  ,included,CD009925-bbs2-0025,
CD009925-bib-0029,"Huderer‐Duric K, Skrablin S, Kuvacic I, Sonicki Z, Rubala D, Suchanek E. ",The triple‐marker test in predicting fetal aneuploidy: a compromise between sensitivity and specificity," European Journal of Obstetrics, Gynecology, & Reproductive Biology ",2000,88,    ,['citation-journal']," Huderer‐Duric K, Skrablin S, Kuvacic I, Sonicki Z, Rubala D, Suchanek E. The triple‐marker test in predicting fetal aneuploidy: a compromise between sensitivity and specificity.  European Journal of Obstetrics, Gynecology, & Reproductive Biology 2000;88(1):49‐55.    Link to article     Google Scholar     ","['https://doi.org/10.1016/S0301-2115(99)00121-9', 'https://scholar.google.com/scholar_lookup?title=The+triple‐marker+test+in+predicting+fetal+aneuploidy:+a+compromise+between+sensitivity+and+specificity+&author=K+Huderer‐Duric&author=S+Skrablin&author=I+Kuvacic&author=Z+Sonicki&author=D+Rubala&author=E+Suchanek&publication_year=2000&hl=en']",,https://doi.org/10.1016/S0301-2115(99)00121-9, Huderer‐Duric 2000 {published data only}  ,included,CD009925-bbs2-0026,
CD009925-bib-0030,"Jou HJ, Shyu MK, Chen SM, Shih JC, Hsu JJ, Hsieh FJ. ",Maternal serum screening for down syndrome by using alpha‐fetoprotein and human chorionic gonadotropin in an asian population. a prospective study," Fetal Diagnosis & Therapy.15(2):108‐11, ",2000,15,    ,['citation-journal']," Jou HJ, Shyu MK, Chen SM, Shih JC, Hsu JJ, Hsieh FJ. Maternal serum screening for down syndrome by using alpha‐fetoprotein and human chorionic gonadotropin in an asian population. a prospective study.  Fetal Diagnosis & Therapy.15(2):108‐11, 2000;15(2):108‐11.    Link to article     Google Scholar     ","['https://doi.org/10.1159/000020986', 'https://scholar.google.com/scholar_lookup?title=Maternal+serum+screening+for+down+syndrome+by+using+alpha‐fetoprotein+and+human+chorionic+gonadotropin+in+an+asian+population.+a+prospective+study+&author=HJ+Jou&author=MK+Shyu&author=SM+Chen&author=JC+Shih&author=JJ+Hsu&author=FJ+Hsieh&publication_year=2000&hl=en']",,https://doi.org/10.1159/000020986, Jou 2000 {published data only}  ,included,CD009925-bbs2-0027,
CD009925-bib-0031,"Kadir RA, Economides DL. ",The effect of nuchal translucency measurement on second‐trimester biochemical screening for Down's syndrome, Ultrasound in Obstetrics and Gynecology ,1997,9,    ,['citation-journal']," Kadir RA, Economides DL. The effect of nuchal translucency measurement on second‐trimester biochemical screening for Down's syndrome.  Ultrasound in Obstetrics and Gynecology 1997;9(4):244‐7.    Link to article     Google Scholar     ","['https://doi.org/10.1046/j.1469-0705.1997.09040244.x', ""https://scholar.google.com/scholar_lookup?title=The+effect+of+nuchal+translucency+measurement+on+second‐trimester+biochemical+screening+for+Down's+syndrome+&author=RA+Kadir&author=DL+Economides&publication_year=1997&hl=en""]",,https://doi.org/10.1046/j.1469-0705.1997.09040244.x, Kadir 1999 {published data only}  ,included,CD009925-bbs2-0028,
CD009925-bib-0032,"Kadir RA, Pepera T, Economides DL. ",Second trimester maternal serum biochemical screening for Down's syndrome: Experience of a single obstetric unit, Journal of Obstetrics and Gynaecology ,1999,19,    ,['citation-journal']," Kadir RA, Pepera T, Economides DL. Second trimester maternal serum biochemical screening for Down's syndrome: Experience of a single obstetric unit.  Journal of Obstetrics and Gynaecology 1999;19(4):373‐6.    Google Scholar     ","[""https://scholar.google.com/scholar_lookup?title=Second+trimester+maternal+serum+biochemical+screening+for+Down's+syndrome:+Experience+of+a+single+obstetric+unit+&author=RA+Kadir&author=T+Pepera&author=DL+Economides&publication_year=1999&hl=en""]",,, Kadir 1999 {published data only}  ,included,CD009925-bbs2-0028,
CD009925-bib-0033,"Kishida T, Hoshi N, Hattori R, Negishi H, Yamada H, Okuyama K, et al. ",Efficacy of maternal serum screening in the prenatal detection of fetal chromosome abnormalities in Japanese women, Fetal Diagnosis & Therapy ,2000,15,    ,['citation-journal']," Kishida T, Hoshi N, Hattori R, Negishi H, Yamada H, Okuyama K, et al. Efficacy of maternal serum screening in the prenatal detection of fetal chromosome abnormalities in Japanese women.  Fetal Diagnosis & Therapy 2000;15(2):112‐7.    Link to article     Google Scholar     ","['https://doi.org/10.1159/000020987', 'https://scholar.google.com/scholar_lookup?title=Efficacy+of+maternal+serum+screening+in+the+prenatal+detection+of+fetal+chromosome+abnormalities+in+Japanese+women+&author=T+Kishida&author=N+Hoshi&author=R+Hattori&author=H+Negishi&author=H+Yamada&author=K+Okuyama&publication_year=2000&hl=en']",,https://doi.org/10.1159/000020987, Kishida 2000 {published data only}  ,included,CD009925-bbs2-0029,
CD009925-bib-0034,"Knight GJ, Palomaki GE, Neveux LM, Fodor KK, Haddow JE. ",hCG and the free ß‐subunit as screening tests for Down syndrome, Prenatal Diagnosis ,1998,18,    ,['citation-journal']," Knight GJ, Palomaki GE, Neveux LM, Fodor KK, Haddow JE. hCG and the free ß‐subunit as screening tests for Down syndrome.  Prenatal Diagnosis 1998;18(3):235‐45.    Link to article     Google Scholar     ","['https://doi.org/10.1002/(SICI)1097-0223(199803)18:3<235::AID-PD248>3.0.CO;2-A', 'https://scholar.google.com/scholar_lookup?title=hCG+and+the+free+ß‐subunit+as+screening+tests+for+Down+syndrome&author=GJ+Knight&author=GE+Palomaki&author=LM+Neveux&author=KK+Fodor&author=JE+Haddow&publication_year=1998&hl=en']",,https://doi.org/10.1002/(SICI)1097-0223(199803)18:3<235::AID-PD248>3.0.CO;2-A, Knight 1998 {published data only}  ,included,CD009925-bbs2-0030,
CD009925-bib-0035,"Lam YH, Lee CP, Sin SY, Tang R, Wong HS, Wong SF, et al. ",Comparison and integration of first trimester fetal nuchal translucency and second trimester maternal serum screening for fetal Down syndrome, Prenatal Diagnosis ,2002,22,    ,['citation-journal']," Lam YH, Lee CP, Sin SY, Tang R, Wong HS, Wong SF, et al. Comparison and integration of first trimester fetal nuchal translucency and second trimester maternal serum screening for fetal Down syndrome.  Prenatal Diagnosis 2002;22(8):730‐5.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=Comparison+and+integration+of+first+trimester+fetal+nuchal+translucency+and+second+trimester+maternal+serum+screening+for+fetal+Down+syndrome+&author=YH+Lam&author=CP+Lee&author=SY+Sin&author=R+Tang&author=HS+Wong&author=SF+Wong&publication_year=2002&hl=en'],,, Lam 2002 {published data only}  ,included,CD009925-bbs2-0031,
CD009925-bib-0036,"Lemay C, Roussel‐Mizon N, Thepot F, Desmet G. ","Maternal serum screening for fetal Down's syndrome, a retrospective study", Clinica Chimica Acta ,1995,238,    ,['citation-journal']," Lemay C, Roussel‐Mizon N, Thepot F, Desmet G. Maternal serum screening for fetal Down's syndrome, a retrospective study.  Clinica Chimica Acta 1995;238(2):151‐62.    Link to article     Google Scholar     ","['https://doi.org/10.1016/0009-8981(95)06084-Q', ""https://scholar.google.com/scholar_lookup?title=Maternal+serum+screening+for+fetal+Down's+syndrome,+a+retrospective+study&author=C+Lemay&author=N+Roussel‐Mizon&author=F+Thepot&author=G+Desmet&publication_year=1995&hl=en""]",,https://doi.org/10.1016/0009-8981(95)06084-Q, Lemay 1995 {published data only}  ,included,CD009925-bbs2-0032,
CD009925-bib-0037,"Canick JA, Lambert‐Messerlian GM, Palomaki GE, Neveux LM, Malone FD, Ball RH, et al. for the First and Second Trimester Evaluation of Risk (FASTER) Trial Research Consortium. ",Comparison of serum markers in first‐trimester down syndrome screening, Obstetrics & Gynecology ,2006,108,    ,['citation-journal']," Canick JA, Lambert‐Messerlian GM, Palomaki GE, Neveux LM, Malone FD, Ball RH, et al. for the First and Second Trimester Evaluation of Risk (FASTER) Trial Research Consortium. Comparison of serum markers in first‐trimester down syndrome screening.  Obstetrics & Gynecology 2006;108(5):1192‐9.    Link to article     Google Scholar     ","['https://doi.org/10.1097/01.AOG.0000241095.19638.f2', 'https://scholar.google.com/scholar_lookup?title=Comparison+of+serum+markers+in+first‐trimester+down+syndrome+screening&author=JA+Canick&author=GM+Lambert‐Messerlian&author=GE+Palomaki&author=LM+Neveux&author=FD+Malone&author=RH+Ball&publication_year=2006&hl=en']",,https://doi.org/10.1097/01.AOG.0000241095.19638.f2, Malone 2005 {published data only}  ,included,CD009925-bbs2-0033,
CD009925-bib-0038,"Malone FD, Canick JA, Ball RH, Nyberg DA, Comstock CH, Bukowski R, et al. for the First‐ and Second‐Trimester Evaluation of Risk (FASTER) Research Consortium. ","First‐trimester or second‐trimester screening, or both, for Down's syndrome", New England Journal of Medicine ,2005,353,    ,['citation-journal']," Malone FD, Canick JA, Ball RH, Nyberg DA, Comstock CH, Bukowski R, et al. for the First‐ and Second‐Trimester Evaluation of Risk (FASTER) Research Consortium. First‐trimester or second‐trimester screening, or both, for Down's syndrome.  New England Journal of Medicine 2005;353(19):2001‐11.    Link to article     Google Scholar     ","['https://doi.org/10.1056/NEJMoa043693', ""https://scholar.google.com/scholar_lookup?title=First‐trimester+or+second‐trimester+screening,+or+both,+for+Down's+syndrome&author=FD+Malone&author=JA+Canick&author=RH+Ball&author=DA+Nyberg&author=CH+Comstock&author=R+Bukowski&publication_year=2005&hl=en""]",,https://doi.org/10.1056/NEJMoa043693, Malone 2005 {published data only}  ,included,CD009925-bbs2-0033,
CD009925-bib-0039,"Mancini G, Perona M, Dall'Amico D, Bollati C, Albano F, Mazzone R, et al. ",Screening for fetal Down's syndrome with maternal serum markers‐‐an experience in Italy, Prenatal Diagnosis ,1991,11,    ,['citation-journal']," Mancini G, Perona M, Dall'Amico D, Bollati C, Albano F, Mazzone R, et al. Screening for fetal Down's syndrome with maternal serum markers‐‐an experience in Italy.  Prenatal Diagnosis 1991;11(4):245‐52.    Link to article     Google Scholar     ","['https://doi.org/10.1002/pd.1970110406', ""https://scholar.google.com/scholar_lookup?title=Screening+for+fetal+Down's+syndrome+with+maternal+serum+markers‐‐an+experience+in+Italy+&author=G+Mancini&author=M+Perona&author=D+Dall'Amico&author=C+Bollati&author=F+Albano&author=R+Mazzone&publication_year=1991&hl=en""]",,https://doi.org/10.1002/pd.1970110406, Mancini 1991 {published data only}  ,included,CD009925-bbs2-0034,
CD009925-bib-0040,"Milunsky A, Nebiolo LM, Bellet D. ",Maternal serum screening for chromosome defects: human chorionic gonadotropin versus its free‐ß subunit, Fetal Diagnosis & Therapy ,1993,8,    ,['citation-journal']," Milunsky A, Nebiolo LM, Bellet D. Maternal serum screening for chromosome defects: human chorionic gonadotropin versus its free‐ß subunit.  Fetal Diagnosis & Therapy 1993;8(4):221‐4.    Link to article     Google Scholar     ","['https://doi.org/10.1159/000263830', 'https://scholar.google.com/scholar_lookup?title=Maternal+serum+screening+for+chromosome+defects:+human+chorionic+gonadotropin+versus+its+free‐ß+subunit+&author=A+Milunsky&author=LM+Nebiolo&author=D+Bellet&publication_year=1993&hl=en']",,https://doi.org/10.1159/000263830, Milunsky 1993 {published data only}  ,included,CD009925-bbs2-0035,
CD009925-bib-0041,"Muller F, Aegerter P, Boue A. ",Prospective maternal serum human chorionic gonadotropin screening for the risk of fetal chromosome anomalies and of subsequent fetal and neonatal deaths, Prenatal Diagnosis ,1993,13,    ,['citation-journal']," Muller F, Aegerter P, Boue A. Prospective maternal serum human chorionic gonadotropin screening for the risk of fetal chromosome anomalies and of subsequent fetal and neonatal deaths.  Prenatal Diagnosis 1993;13(1):29‐43.    Link to article     Google Scholar     ","['https://doi.org/10.1002/pd.1970130106', 'https://scholar.google.com/scholar_lookup?title=Prospective+maternal+serum+human+chorionic+gonadotropin+screening+for+the+risk+of+fetal+chromosome+anomalies+and+of+subsequent+fetal+and+neonatal+deaths+&author=F+Muller&author=P+Aegerter&author=A+Boue&publication_year=1993&hl=en']",,https://doi.org/10.1002/pd.1970130106, Muller 1996a {published data only}  ,included,CD009925-bbs2-0036,
CD009925-bib-0042,"Muller F, Boue A. ",A single chorionic gonadotropin assay for maternal serum screening for Down's syndrome, Prenatal Diagnosis ,1990,10,    ,['citation-journal']," Muller F, Boue A. A single chorionic gonadotropin assay for maternal serum screening for Down's syndrome.  Prenatal Diagnosis 1990;10(6):389‐98.    Link to article     Google Scholar     ","['https://doi.org/10.1002/pd.1970100606', ""https://scholar.google.com/scholar_lookup?title=A+single+chorionic+gonadotropin+assay+for+maternal+serum+screening+for+Down's+syndrome&author=F+Muller&author=A+Boue&publication_year=1990&hl=en""]",,https://doi.org/10.1002/pd.1970100606, Muller 1996a {published data only}  ,included,CD009925-bbs2-0036,
CD009925-bib-0043,"Muller F, Bussieres L. ",Maternal serum markers for fetal trisomy 21 screening. [Review]," European Journal of Obstetrics, Gynecology, & Reproductive Biology ",1996,65,    ,['citation-journal']," Muller F, Bussieres L. Maternal serum markers for fetal trisomy 21 screening. [Review].  European Journal of Obstetrics, Gynecology, & Reproductive Biology 1996;65(1):3‐6.    Link to article     Google Scholar     ","['https://doi.org/10.1016/0028-2243(95)02293-2', 'https://scholar.google.com/scholar_lookup?title=Maternal+serum+markers+for+fetal+trisomy+21+screening.+[Review]&author=F+Muller&author=L+Bussieres&publication_year=1996&hl=en']",,https://doi.org/10.1016/0028-2243(95)02293-2, Muller 1996a {published data only}  ,included,CD009925-bbs2-0036,
CD009925-bib-0044,"Palomaki GE, Neveux LM, Knight GJ, Haddow JE, Pandian R. ",Maternal serum invasive trophoblast antigen (hyperglycosylated hCG) as a screening marker for Down syndrome during the second trimester, Clinical Chemistry ,2004,50,    ,['citation-journal']," Palomaki GE, Neveux LM, Knight GJ, Haddow JE, Pandian R. Maternal serum invasive trophoblast antigen (hyperglycosylated hCG) as a screening marker for Down syndrome during the second trimester.  Clinical Chemistry 2004;50(10):1804‐8.    Link to article     Google Scholar     ","['https://doi.org/10.1373/clinchem.2004.038059', 'https://scholar.google.com/scholar_lookup?title=Maternal+serum+invasive+trophoblast+antigen+(hyperglycosylated+hCG)+as+a+screening+marker+for+Down+syndrome+during+the+second+trimester+&author=GE+Palomaki&author=LM+Neveux&author=GJ+Knight&author=JE+Haddow&author=R+Pandian&publication_year=2004&hl=en']",,https://doi.org/10.1373/clinchem.2004.038059, Palomaki 2004 {published data only}  ,included,CD009925-bbs2-0037,
CD009925-bib-0045,"Palomaki GE, Wright DE, Summers AM, Neveux LM, Meier C, O'donnell A, et al. ",Repeated measurement of pregnancy‐associated plasma protein‐A (PAPP‐A) in Down syndrome screening: a validation study, Prenatal Diagnosis ,2006,26,    ,['citation-journal']," Palomaki GE, Wright DE, Summers AM, Neveux LM, Meier C, O'donnell A, et al. Repeated measurement of pregnancy‐associated plasma protein‐A (PAPP‐A) in Down syndrome screening: a validation study.  Prenatal Diagnosis 2006;26(8):730‐9.    Link to article     Google Scholar     ","['https://doi.org/10.1002/pd.1497', ""https://scholar.google.com/scholar_lookup?title=Repeated+measurement+of+pregnancy‐associated+plasma+protein‐A+(PAPP‐A)+in+Down+syndrome+screening:+a+validation+study+&author=GE+Palomaki&author=DE+Wright&author=AM+Summers&author=LM+Neveux&author=C+Meier&author=A+O'donnell&publication_year=2006&hl=en""]",,https://doi.org/10.1002/pd.1497, Palomaki 2006 {published data only}  ,included,CD009925-bbs2-0038,
CD009925-bib-0046,"Pandian R, Cole LA, Palomaki GE. ",Second‐trimester maternal serum invasive trophoblast antigen: a marker for Down syndrome screening, Clinical Chemistry ,2004,50,    ,['citation-journal']," Pandian R, Cole LA, Palomaki GE. Second‐trimester maternal serum invasive trophoblast antigen: a marker for Down syndrome screening.  Clinical Chemistry 2004;50(8):1433‐5.    Link to article     Google Scholar     ","['https://doi.org/10.1373/clinchem.2004.032839', 'https://scholar.google.com/scholar_lookup?title=Second‐trimester+maternal+serum+invasive+trophoblast+antigen:+a+marker+for+Down+syndrome+screening+&author=R+Pandian&author=LA+Cole&author=GE+Palomaki&publication_year=2004&hl=en']",,https://doi.org/10.1373/clinchem.2004.032839, Pandian 2004 {published data only}  ,included,CD009925-bbs2-0039,
CD009925-bib-0047,"Mancini G, Perona M, Dall'Amico D, Bollati C, Albano F, Mazzone R, et al. ",Maternal serum markers. Estimation of the risk of Down's syndrome: a prospective study, International Journal of Clinical & Laboratory Research ,1994,24,    ,['citation-journal']," Mancini G, Perona M, Dall'Amico D, Bollati C, Albano F, Mazzone R, et al. Maternal serum markers. Estimation of the risk of Down's syndrome: a prospective study.  International Journal of Clinical & Laboratory Research 1994;24(1):49‐53.    Link to article     Google Scholar     ","['https://doi.org/10.1007/BF02592410', ""https://scholar.google.com/scholar_lookup?title=Maternal+serum+markers.+Estimation+of+the+risk+of+Down's+syndrome:+a+prospective+study&author=G+Mancini&author=M+Perona&author=D+Dall'Amico&author=C+Bollati&author=F+Albano&author=R+Mazzone&publication_year=1994&hl=en""]",,https://doi.org/10.1007/BF02592410, Perona 1997 {published data only}  ,included,CD009925-bbs2-0040,
CD009925-bib-0048,"Perona M, Mancini G, Dall'Amico D, Guaraldo V, Carbonara A. ",Repeat testing of mothers with high human chorionic gonadotrophin levels in Down's syndrome screening, International Journal of Clinical & Laboratory Research ,1997,27,    ,['citation-journal']," Perona M, Mancini G, Dall'Amico D, Guaraldo V, Carbonara A. Repeat testing of mothers with high human chorionic gonadotrophin levels in Down's syndrome screening.  International Journal of Clinical & Laboratory Research 1997;27(4):253‐6.    Link to article     Google Scholar     ","['https://doi.org/10.1007/s005990050007', ""https://scholar.google.com/scholar_lookup?title=Repeat+testing+of+mothers+with+high+human+chorionic+gonadotrophin+levels+in+Down's+syndrome+screening+&author=M+Perona&author=G+Mancini&author=D+Dall'Amico&author=V+Guaraldo&author=A+Carbonara&publication_year=1997&hl=en""]",,https://doi.org/10.1007/s005990050007, Perona 1997 {published data only}  ,included,CD009925-bbs2-0040,
CD009925-bib-0049,"Piggott M, Wilkinson P, Bennett J. ",Implementation of an antenatal serum screening programme for Down's syndrome in two districts (Brighton and Eastbourne). The Brighton and Eastbourne Down's Syndrome Screening Group, Journal of Medical Screening ,1994,1,    ,['citation-journal']," Piggott M, Wilkinson P, Bennett J. Implementation of an antenatal serum screening programme for Down's syndrome in two districts (Brighton and Eastbourne). The Brighton and Eastbourne Down's Syndrome Screening Group.  Journal of Medical Screening 1994;1(1):45‐9.    Link to article     Google Scholar     ","['https://doi.org/10.1177/096914139400100109', ""https://scholar.google.com/scholar_lookup?title=Implementation+of+an+antenatal+serum+screening+programme+for+Down's+syndrome+in+two+districts+(Brighton+and+Eastbourne).+The+Brighton+and+Eastbourne+Down's+Syndrome+Screening+Group+&author=M+Piggott&author=P+Wilkinson&author=J+Bennett&publication_year=1994&hl=en""]",,https://doi.org/10.1177/096914139400100109, Piggott 1994 {published data only}  ,included,CD009925-bbs2-0041,
CD009925-bib-0050,"Qin QP, Christiansen M, Nguyen TH, Sorensen S, Larsen SO, Norgaard‐Pedersen B. ",Schwangerschaftsprotein 1 (SP1) as a maternal serum marker for Down syndrome in the first and second trimesters, Prenatal Diagnosis ,1997,17,    ,['citation-journal']," Qin QP, Christiansen M, Nguyen TH, Sorensen S, Larsen SO, Norgaard‐Pedersen B. Schwangerschaftsprotein 1 (SP1) as a maternal serum marker for Down syndrome in the first and second trimesters.  Prenatal Diagnosis 1997;17(2):101‐8.    Link to article     Google Scholar     ","['https://doi.org/10.1002/(SICI)1097-0223(199702)17:2<101::AID-PD4>3.0.CO;2-H', 'https://scholar.google.com/scholar_lookup?title=Schwangerschaftsprotein+1+(SP1)+as+a+maternal+serum+marker+for+Down+syndrome+in+the+first+and+second+trimesters+&author=QP+Qin&author=M+Christiansen&author=TH+Nguyen&author=S+Sorensen&author=SO+Larsen&author=B+Norgaard‐Pedersen&publication_year=1997&hl=en']",,https://doi.org/10.1002/(SICI)1097-0223(199702)17:2<101::AID-PD4>3.0.CO;2-H, Qin 1997 {published data only}  ,included,CD009925-bbs2-0042,
CD009925-bib-0051,"Roberts D, Walkinshaw SA, McCormack MJ, Ellis J. ",Prenatal detection of trisomy 21: combined experience of two British hospitals, Prenatal Diagnosis. ,2000,20,    ,['citation-journal']," Roberts D, Walkinshaw SA, McCormack MJ, Ellis J. Prenatal detection of trisomy 21: combined experience of two British hospitals.  Prenatal Diagnosis. 2000;20(1):17‐22.    Link to article     Google Scholar     ","['https://doi.org/10.1002/(SICI)1097-0223(200001)20:1<17::AID-PD744>3.0.CO;2-Y', 'https://scholar.google.com/scholar_lookup?title=Prenatal+detection+of+trisomy+21:+combined+experience+of+two+British+hospitals&author=D+Roberts&author=SA+Walkinshaw&author=MJ+McCormack&author=J+Ellis&publication_year=2000&hl=en']",,https://doi.org/10.1002/(SICI)1097-0223(200001)20:1<17::AID-PD744>3.0.CO;2-Y, Roberts 2000 {published data only}  ,included,CD009925-bbs2-0043,
CD009925-bib-0052,"Rose NC, Palomaki GE, Haddow JE, Goodman DBP, Mennuti MT. ",Maternal serum alpha‐fetoprotein screening for chromosomal abnormalities: A prospective study in women aged 35 and older, American Journal of Obstetrics and Gynecology ,1994,170,    ,['citation-journal']," Rose NC, Palomaki GE, Haddow JE, Goodman DBP, Mennuti MT. Maternal serum alpha‐fetoprotein screening for chromosomal abnormalities: A prospective study in women aged 35 and older.  American Journal of Obstetrics and Gynecology 1994;170(4):1073‐8.    Link to article     Google Scholar     ","['https://doi.org/10.1016/S0002-9378(94)70100-8', 'https://scholar.google.com/scholar_lookup?title=Maternal+serum+alpha‐fetoprotein+screening+for+chromosomal+abnormalities:+A+prospective+study+in+women+aged+35+and+older+&author=NC+Rose&author=GE+Palomaki&author=JE+Haddow&author=DBP+Goodman&author=MT+Mennuti&publication_year=1994&hl=en']",,https://doi.org/10.1016/S0002-9378(94)70100-8, Rose 1994 {published data only}  ,included,CD009925-bbs2-0044,
CD009925-bib-0053,"Rosen DJ, Kedar I, Amiel A, Ben‐Tovim T, Petel Y, Kaneti H, et al. ",A negative second trimester triple test and absence of specific ultrasonographic markers may decrease the need for genetic amniocentesis in advanced maternal age by 60%, Prenatal Diagnosis ,2002,22,    ,['citation-journal']," Rosen DJ, Kedar I, Amiel A, Ben‐Tovim T, Petel Y, Kaneti H, et al. A negative second trimester triple test and absence of specific ultrasonographic markers may decrease the need for genetic amniocentesis in advanced maternal age by 60%.  Prenatal Diagnosis 2002;22(1):59‐63.    Link to article     Google Scholar     ","['https://doi.org/10.1002/pd.238', 'https://scholar.google.com/scholar_lookup?title=A+negative+second+trimester+triple+test+and+absence+of+specific+ultrasonographic+markers+may+decrease+the+need+for+genetic+amniocentesis+in+advanced+maternal+age+by+60%+&author=DJ+Rosen&author=I+Kedar&author=A+Amiel&author=T+Ben‐Tovim&author=Y+Petel&author=H+Kaneti&publication_year=2002&hl=en']",,https://doi.org/10.1002/pd.238, Rosen 2002 {published data only}  ,included,CD009925-bbs2-0045,
CD009925-bib-0054,"Rozenberg P, Malagrida L, Cuckle H, Durand‐Zaleski I, Nisand I, Audibert F, et al. ",Down's syndrome screening with nuchal translucency at 12(+0)‐14(+0) weeks and maternal serum markers at 14(+1)‐17(+0) weeks: a prospective study, Human Reproduction ,2002,17,    ,['citation-journal']," Rozenberg P, Malagrida L, Cuckle H, Durand‐Zaleski I, Nisand I, Audibert F, et al. Down's syndrome screening with nuchal translucency at 12(+0)‐14(+0) weeks and maternal serum markers at 14(+1)‐17(+0) weeks: a prospective study.  Human Reproduction 2002;17(4):1093‐8.    Link to article     Google Scholar     ","['https://doi.org/10.1093/humrep/17.4.1093', ""https://scholar.google.com/scholar_lookup?title=Down's+syndrome+screening+with+nuchal+translucency+at+12(+0)‐14(+0)+weeks+and+maternal+serum+markers+at+14(+1)‐17(+0)+weeks:+a+prospective+study+&author=P+Rozenberg&author=L+Malagrida&author=H+Cuckle&author=I+Durand‐Zaleski&author=I+Nisand&author=F+Audibert&publication_year=2002&hl=en""]",,https://doi.org/10.1093/humrep/17.4.1093, Rozenberg 2002 {published data only}  ,included,CD009925-bbs2-0046,
CD009925-bib-0055,"Sancken U, Bahner D. ",Comparison of triple‐risk assessment of fetal trisomy 21 including total human choriogonadotropin (hCG) or its free ß‐subunit (free ß hCG), Fetal Diagnosis & Therapy ,2003,18,    ,['citation-journal']," Sancken U, Bahner D. Comparison of triple‐risk assessment of fetal trisomy 21 including total human choriogonadotropin (hCG) or its free ß‐subunit (free ß hCG).  Fetal Diagnosis & Therapy 2003;18(2):122‐7.    Link to article     Google Scholar     ","['https://doi.org/10.1159/000068073', 'https://scholar.google.com/scholar_lookup?title=Comparison+of+triple‐risk+assessment+of+fetal+trisomy+21+including+total+human+choriogonadotropin+(hCG)+or+its+free+ß‐subunit+(free+ß+hCG)+&author=U+Sancken&author=D+Bahner&publication_year=2003&hl=en']",,https://doi.org/10.1159/000068073, Sancken 2003 {published data only}  ,included,CD009925-bbs2-0047,
CD009925-bib-0056,"Su YN, Hsu JJ, Lee CN, Cheng WF, Kung CC, Hsieh FJ. ",Raised maternal serum placenta growth factor concentration during the second trimester is associated with Down syndrome, Prenatal Diagnosis ,2002,22,    ,['citation-journal']," Su YN, Hsu JJ, Lee CN, Cheng WF, Kung CC, Hsieh FJ. Raised maternal serum placenta growth factor concentration during the second trimester is associated with Down syndrome.  Prenatal Diagnosis 2002;22(1):8‐12.    Link to article     Google Scholar     ","['https://doi.org/10.1002/pd.218', 'https://scholar.google.com/scholar_lookup?title=Raised+maternal+serum+placenta+growth+factor+concentration+during+the+second+trimester+is+associated+with+Down+syndrome+&author=YN+Su&author=JJ+Hsu&author=CN+Lee&author=WF+Cheng&author=CC+Kung&author=FJ+Hsieh&publication_year=2002&hl=en']",,https://doi.org/10.1002/pd.218, Su 2002 {published data only}  ,included,CD009925-bbs2-0048,
CD009925-bib-0057,"Suzumori K, Tanemura M, Murakami I, Okada S, Natori M, Tanaka M, et al. ",A retrospective evaluation of maternal serum screening for the detection of fetal aneuploidy, Prenatal Diagnosis ,1997,17,    ,['citation-journal']," Suzumori K, Tanemura M, Murakami I, Okada S, Natori M, Tanaka M, et al. A retrospective evaluation of maternal serum screening for the detection of fetal aneuploidy.  Prenatal Diagnosis 1997;17(9):861‐6.    Link to article     Google Scholar     ","['https://doi.org/10.1002/(SICI)1097-0223(199709)17:9<861::AID-PD169>3.0.CO;2-E', 'https://scholar.google.com/scholar_lookup?title=A+retrospective+evaluation+of+maternal+serum+screening+for+the+detection+of+fetal+aneuploidy+&author=K+Suzumori&author=M+Tanemura&author=I+Murakami&author=S+Okada&author=M+Natori&author=M+Tanaka&publication_year=1997&hl=en']",,https://doi.org/10.1002/(SICI)1097-0223(199709)17:9<861::AID-PD169>3.0.CO;2-E, Suzumori 1997 {published data only}  ,included,CD009925-bbs2-0049,
CD009925-bib-0058,"Talbot JA, Spencer K, Abushoufa RA. ",Detection of maternal serum hCG glycoform variants in the second trimester of pregnancies affected by Down syndrome using a lectin immunoassay, Prenatal Diagnosis ,2003,23,    ,['citation-journal']," Talbot JA, Spencer K, Abushoufa RA. Detection of maternal serum hCG glycoform variants in the second trimester of pregnancies affected by Down syndrome using a lectin immunoassay.  Prenatal Diagnosis 2003;23(1):1‐5.    Link to article     Google Scholar     ","['https://doi.org/10.1002/pd.507', 'https://scholar.google.com/scholar_lookup?title=Detection+of+maternal+serum+hCG+glycoform+variants+in+the+second+trimester+of+pregnancies+affected+by+Down+syndrome+using+a+lectin+immunoassay+&author=JA+Talbot&author=K+Spencer&author=RA+Abushoufa&publication_year=2003&hl=en']",,https://doi.org/10.1002/pd.507, Talbot 2003 {published data only}  ,included,CD009925-bbs2-0050,
CD009925-bib-0059,"Van Lith JM, Pratt JJ, Beekhuis JR, Mantingh A. ",Second‐trimester maternal serum immunoreactive Inhibin Aas a marker for fetal Down's syndrome, Prenatal Diagnosis ,1992,12,    ,['citation-journal']," Van Lith JM, Pratt JJ, Beekhuis JR, Mantingh A. Second‐trimester maternal serum immunoreactive Inhibin Aas a marker for fetal Down's syndrome.  Prenatal Diagnosis 1992;12(10):801‐6.    Link to article     Google Scholar     ","['https://doi.org/10.1002/pd.1970121005', ""https://scholar.google.com/scholar_lookup?title=Second‐trimester+maternal+serum+immunoreactive+Inhibin+Aas+a+marker+for+fetal+Down's+syndrome+&author=JM+Lith&author=JJ+Pratt&author=JR+Beekhuis&author=A+Mantingh&publication_year=1992&hl=en""]",,https://doi.org/10.1002/pd.1970121005, Van Lith 1992 {published data only}  ,included,CD009925-bbs2-0051,
CD009925-bib-0060,"Verloes A, Schoos R, Herens C, Vintens A, Koulischer L. ","A prenatal trisomy 21 screening program using alpha‐fetoprotein, human chorionic gonadotropin, and free estriol assays on maternal dried blood", American Journal of Obstetrics & Gynecology ,1995,172,    ,['citation-journal']," Verloes A, Schoos R, Herens C, Vintens A, Koulischer L. A prenatal trisomy 21 screening program using alpha‐fetoprotein, human chorionic gonadotropin, and free estriol assays on maternal dried blood.  American Journal of Obstetrics & Gynecology 1995;172(1 pt 1):167‐74.    Google Scholar     ","['https://scholar.google.com/scholar_lookup?title=A+prenatal+trisomy+21+screening+program+using+alpha‐fetoprotein,+human+chorionic+gonadotropin,+and+free+estriol+assays+on+maternal+dried+blood+&author=A+Verloes&author=R+Schoos&author=C+Herens&author=A+Vintens&author=L+Koulischer&publication_year=1995&hl=en']",,, Verloes 1995 {published data only}  ,included,CD009925-bbs2-0052,
CD009925-bib-0061,"Wald NJ, Huttly WJ, Hackshaw AK. ",Antenatal screening for Down's syndrome with the quadruple test, Lancet ,2003,361,    ,['citation-journal']," Wald NJ, Huttly WJ, Hackshaw AK. Antenatal screening for Down's syndrome with the quadruple test.  Lancet 2003;361(9360):835‐6.    Link to article     Google Scholar     ","['https://doi.org/10.1016/S0140-6736(03)12680-3', ""https://scholar.google.com/scholar_lookup?title=Antenatal+screening+for+Down's+syndrome+with+the+quadruple+test&author=NJ+Wald&author=WJ+Huttly&author=AK+Hackshaw&publication_year=2003&hl=en""]",,https://doi.org/10.1016/S0140-6736(03)12680-3, Wald 2003a {published data only}  ,included,CD009925-bbs2-0053,
CD009925-bib-0062,"Wald NJ, Rodeck C, Hackshaw AK, Rudnicka A. ",SURUSS in perspective, BJOG: An International Journal of Obstetrics & Gynaecology ,2004,111,    ,['citation-journal']," Wald NJ, Rodeck C, Hackshaw AK, Rudnicka A. SURUSS in perspective.  BJOG: An International Journal of Obstetrics & Gynaecology 2004;111(6):521‐31.    Link to article     Google Scholar     ","['https://doi.org/10.1111/j.1471-0528.2004.00193.x', 'https://scholar.google.com/scholar_lookup?title=SURUSS+in+perspective&author=NJ+Wald&author=C+Rodeck&author=AK+Hackshaw&author=A+Rudnicka&publication_year=2004&hl=en']",,https://doi.org/10.1111/j.1471-0528.2004.00193.x, Wald 2003a {published data only}  ,included,CD009925-bbs2-0053,
CD009925-bib-0063,"Wald NJ, Rodeck C, Hackshaw AK, Rudnicka A. ",SURUSS in perspective, Seminars in Perinatology ,2005,29,    ,['citation-journal']," Wald NJ, Rodeck C, Hackshaw AK, Rudnicka A. SURUSS in perspective.  Seminars in Perinatology 2005;29(4):225‐35.    Link to article     Google Scholar     ","['https://doi.org/10.1053/j.semperi.2005.05.006', 'https://scholar.google.com/scholar_lookup?title=SURUSS+in+perspective&author=NJ+Wald&author=C+Rodeck&author=AK+Hackshaw&author=A+Rudnicka&publication_year=2005&hl=en']",,https://doi.org/10.1053/j.semperi.2005.05.006, Wald 2003a {published data only}  ,included,CD009925-bbs2-0053,
CD009925-bib-0065,"Wald NJ, Rodeck C, Hackshaw AK, Walters J, Chitty L, Mackinson AM. ","First and second trimester antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS)", Journal of Medical Screening ,2003,10,    ,['citation-journal']," Wald NJ, Rodeck C, Hackshaw AK, Walters J, Chitty L, Mackinson AM. First and second trimester antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS).  Journal of Medical Screening 2003;10(2):56‐104.    Google Scholar     ","[""https://scholar.google.com/scholar_lookup?title=First+and+second+trimester+antenatal+screening+for+Down's+syndrome:+the+results+of+the+Serum,+Urine+and+Ultrasound+Screening+Study+(SURUSS)+&author=NJ+Wald&author=C+Rodeck&author=AK+Hackshaw&author=J+Walters&author=L+Chitty&author=AM+Mackinson&publication_year=2003&hl=en""]",,, Wald 2003a {published data only}  ,included,CD009925-bbs2-0053,
CD009925-bib-0064,"Wald NJ, Rodeck C, Hackshaw AK, Walters J, Chitty L, Mackinson AM, SURUSS Research Group. ","First and second trimester antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS)", Health Technology Assessment ,2003,7,    ,['citation-journal']," Wald NJ, Rodeck C, Hackshaw AK, Walters J, Chitty L, Mackinson AM, SURUSS Research Group. First and second trimester antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS).  Health Technology Assessment 2003;7(11):1‐77.    Link to article     Google Scholar     ","['https://doi.org/10.3310/hta7110', ""https://scholar.google.com/scholar_lookup?title=First+and+second+trimester+antenatal+screening+for+Down's+syndrome:+the+results+of+the+Serum,+Urine+and+Ultrasound+Screening+Study+(SURUSS)+&author=NJ+Wald&author=C+Rodeck&author=AK+Hackshaw&author=J+Walters&author=L+Chitty&author=AM+Mackinson&publication_year=2003&hl=en""]",,https://doi.org/10.3310/hta7110, Wald 2003a {published data only}  ,included,CD009925-bbs2-0053,
CD009925-bib-0066,"Marcus SF, Ward PA, Wood PL. ",Maternal serum screening for Down syndrome in women aged 40 years and over, Journal of Obstetrics and Gynaecology ,1999,19,    ,['citation-journal']," Marcus SF, Ward PA, Wood PL. Maternal serum screening for Down syndrome in women aged 40 years and over.  Journal of Obstetrics and Gynaecology 1999;19(6):604‐8.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=Maternal+serum+screening+for+Down+syndrome+in+women+aged+40+years+and+over&author=SF+Marcus&author=PA+Ward&author=PL+Wood&publication_year=1999&hl=en'],,, Ward 1999 {published data only}  ,included,CD009925-bbs2-0054,
CD009925-bib-0067,"Ward PA, Wilson H, Wood PL. ",The outcome of five years' implementation of maternal serum screening for Down's syndrome comparing actual age risks and mode of delivery, Journal of Obstetrics and Gynaecology ,1999,19,    ,['citation-journal']," Ward PA, Wilson H, Wood PL. The outcome of five years' implementation of maternal serum screening for Down's syndrome comparing actual age risks and mode of delivery.  Journal of Obstetrics and Gynaecology 1999;19(3):257‐61.    Google Scholar     ","[""https://scholar.google.com/scholar_lookup?title=The+outcome+of+five+years'+implementation+of+maternal+serum+screening+for+Down's+syndrome+comparing+actual+age+risks+and+mode+of+delivery+&author=PA+Ward&author=H+Wilson&author=PL+Wood&publication_year=1999&hl=en""]",,, Ward 1999 {published data only}  ,included,CD009925-bbs2-0054,
CD009925-bib-0068,"Watanabe H, Hamada H, Yamada N, Ogura T, Yasuoka MO, Okuno S, et al. ",Second‐trimester maternal pregnancy‐associated plasma protein a and Inhibin Aa levels in fetal trisomies, Fetal Diagnosis & Therapy ,2002,17,    ,['citation-journal']," Watanabe H, Hamada H, Yamada N, Ogura T, Yasuoka MO, Okuno S, et al. Second‐trimester maternal pregnancy‐associated plasma protein a and Inhibin Aa levels in fetal trisomies.  Fetal Diagnosis & Therapy 2002;17(3):137‐41.    Link to article     Google Scholar     ","['https://doi.org/10.1159/000048026', 'https://scholar.google.com/scholar_lookup?title=Second‐trimester+maternal+pregnancy‐associated+plasma+protein+a+and+Inhibin+Aa+levels+in+fetal+trisomies+&author=H+Watanabe&author=H+Hamada&author=N+Yamada&author=T+Ogura&author=MO+Yasuoka&author=S+Okuno&publication_year=2002&hl=en']",,https://doi.org/10.1159/000048026, Watanabe 2002 {published data only}  ,included,CD009925-bbs2-0055,
CD009925-bib-0069,"Wenstrom KD, Owen J, Chu DC, Boots L. ",Elevated second‐trimester dimeric Inhibin A levels identify Down syndrome pregnancies, American Journal of Obstetrics & Gynecology ,1997,177,    ,['citation-journal']," Wenstrom KD, Owen J, Chu DC, Boots L. Elevated second‐trimester dimeric Inhibin A levels identify Down syndrome pregnancies.  American Journal of Obstetrics & Gynecology 1997;177(5):992‐6.    Link to article     Google Scholar     ","['https://doi.org/10.1016/S0002-9378(97)70002-4', 'https://scholar.google.com/scholar_lookup?title=Elevated+second‐trimester+dimeric+Inhibin+A+levels+identify+Down+syndrome+pregnancies&author=KD+Wenstrom&author=J+Owen&author=DC+Chu&author=L+Boots&publication_year=1997&hl=en']",,https://doi.org/10.1016/S0002-9378(97)70002-4, Wenstrom 1997 {published data only}  ,included,CD009925-bbs2-0056,
CD009925-bib-0070,"Wenstrom KD, Owen J, Chu DC, Boots L. ",Free ß‐hCG subunit versus intact hCG in Down syndrome screening, Obstetrics & Gynecology ,1997,90,    ,['citation-journal']," Wenstrom KD, Owen J, Chu DC, Boots L. Free ß‐hCG subunit versus intact hCG in Down syndrome screening.  Obstetrics & Gynecology 1997;90(3):370‐4.    Link to article     Google Scholar     ","['https://doi.org/10.1016/S0029-7844(97)00250-0', 'https://scholar.google.com/scholar_lookup?title=Free+ß‐hCG+subunit+versus+intact+hCG+in+Down+syndrome+screening&author=KD+Wenstrom&author=J+Owen&author=DC+Chu&author=L+Boots&publication_year=1997&hl=en']",,https://doi.org/10.1016/S0029-7844(97)00250-0, Wenstrom 1997a {published data only}  ,included,CD009925-bbs2-0057,
CD009925-bib-0071,"Wenstrom KD, Owen J, Boots L. ",Second‐trimester maternal serum CA‐125 versus estriol in the multiple‐marker screening test for Down syndrome," Obstetrics & Gynecology.89(3):359‐63, ",1997,89,    ,['citation-journal']," Wenstrom KD, Owen J, Boots L. Second‐trimester maternal serum CA‐125 versus estriol in the multiple‐marker screening test for Down syndrome.  Obstetrics & Gynecology.89(3):359‐63, 1997;89(3):359‐63.    Link to article     Google Scholar     ","['https://doi.org/10.1016/S0029-7844(96)00519-4', 'https://scholar.google.com/scholar_lookup?title=Second‐trimester+maternal+serum+CA‐125+versus+estriol+in+the+multiple‐marker+screening+test+for+Down+syndrome+&author=KD+Wenstrom&author=J+Owen&author=L+Boots&publication_year=1997&hl=en']",,https://doi.org/10.1016/S0029-7844(96)00519-4, Wenstrom 1997b {published data only}  ,included,CD009925-bbs2-0058,
CD009925-bib-0072,"Wenstrom KD, Owen J, Chu D, Boots L. ",Prospective evaluation of free ß‐subunit of human chorionic gonadotropin and dimeric Inhibin A for aneuploidy detection, American Journal of Obstetrics & Gynecology ,1999,181,    ,['citation-journal']," Wenstrom KD, Owen J, Chu D, Boots L. Prospective evaluation of free ß‐subunit of human chorionic gonadotropin and dimeric Inhibin A for aneuploidy detection.  American Journal of Obstetrics & Gynecology 1999;181(4):887‐92.    Link to article     Google Scholar     ","['https://doi.org/10.1016/S0002-9378(99)70320-0', 'https://scholar.google.com/scholar_lookup?title=Prospective+evaluation+of+free+ß‐subunit+of+human+chorionic+gonadotropin+and+dimeric+Inhibin+A+for+aneuploidy+detection+&author=KD+Wenstrom&author=J+Owen&author=D+Chu&author=L+Boots&publication_year=1999&hl=en']",,https://doi.org/10.1016/S0002-9378(99)70320-0, Wenstrom 1999 {published data only}  ,included,CD009925-bbs2-0059,
CD009925-bib-0073,"Abbas A, Chard T, Nicolaides K. ",Fetal and maternal hCG concentration in aneuploid pregnancies, British Journal of Obstetrics and Gynaecology ,1995,102,    ,['citation-journal']," Abbas A, Chard T, Nicolaides K. Fetal and maternal hCG concentration in aneuploid pregnancies.  British Journal of Obstetrics and Gynaecology 1995;102(7):561‐3.    Link to article     Google Scholar     ","['https://doi.org/10.1111/j.1471-0528.1995.tb11362.x', 'https://scholar.google.com/scholar_lookup?title=Fetal+and+maternal+hCG+concentration+in+aneuploid+pregnancies&author=A+Abbas&author=T+Chard&author=K+Nicolaides&publication_year=1995&hl=en']",,https://doi.org/10.1111/j.1471-0528.1995.tb11362.x, Abbas 1995 {published data only}  ,excluded,CD009925-bbs2-0060, Unable to extract useful data. 
CD009925-bib-0074,"Abdul‐Hamid S, Fox R, Martin I. ",Maternal serum screening for trisomy 21 in women with a false positive result in last pregnancy, Journal of Obstetrics & Gynaecology ,2004,24,    ,['citation-journal']," Abdul‐Hamid S, Fox R, Martin I. Maternal serum screening for trisomy 21 in women with a false positive result in last pregnancy.  Journal of Obstetrics & Gynaecology 2004;24(4):374‐6.    Link to article     Google Scholar     ","['https://doi.org/10.1080/01443610410001685475', 'https://scholar.google.com/scholar_lookup?title=Maternal+serum+screening+for+trisomy+21+in+women+with+a+false+positive+result+in+last+pregnancy+&author=S+Abdul‐Hamid&author=R+Fox&author=I+Martin&publication_year=2004&hl=en']",,https://doi.org/10.1080/01443610410001685475, Abdul‐Hamid 2004 {published data only}  ,excluded,CD009925-bbs2-0061, No Down's syndrome pregnancies. 
CD009925-bib-0075,"Abraha HD, Noble PL, Nicolaides KH, Sherwood RA. ",Maternal serum S100 protein in normal and Down syndrome pregnancies, Prenatal Diagnosis. ,1999,19,    ,['citation-journal']," Abraha HD, Noble PL, Nicolaides KH, Sherwood RA. Maternal serum S100 protein in normal and Down syndrome pregnancies.  Prenatal Diagnosis. 1999;19(4):334‐6.    Link to article     Google Scholar     ","['https://doi.org/10.1002/(SICI)1097-0223(199904)19:4<334::AID-PD541>3.0.CO;2-E', 'https://scholar.google.com/scholar_lookup?title=Maternal+serum+S100+protein+in+normal+and+Down+syndrome+pregnancies&author=HD+Abraha&author=PL+Noble&author=KH+Nicolaides&author=RA+Sherwood&publication_year=1999&hl=en']",,https://doi.org/10.1002/(SICI)1097-0223(199904)19:4<334::AID-PD541>3.0.CO;2-E, Abraha 1999 {published data only}  ,excluded,CD009925-bbs2-0062, Unable to extract useful data. 
CD009925-bib-0076,"Adekunle O, Gopee A, el‐Sayed M, Thilaganathan B. ",Increased first trimester nuchal translucency: pregnancy and infant outcomes after routine screening for Down's syndrome in an unselected antenatal population, British Journal of Radiology ,1999,72,    ,['citation-journal']," Adekunle O, Gopee A, el‐Sayed M, Thilaganathan B. Increased first trimester nuchal translucency: pregnancy and infant outcomes after routine screening for Down's syndrome in an unselected antenatal population.  British Journal of Radiology 1999;72(857):457‐60.    Link to article     Google Scholar     ","['https://doi.org/10.1259/bjr.72.857.10505009', ""https://scholar.google.com/scholar_lookup?title=Increased+first+trimester+nuchal+translucency:+pregnancy+and+infant+outcomes+after+routine+screening+for+Down's+syndrome+in+an+unselected+antenatal+population+&author=O+Adekunle&author=A+Gopee&author=M+el‐Sayed&author=B+Thilaganathan&publication_year=1999&hl=en""]",,https://doi.org/10.1259/bjr.72.857.10505009, Adekunle 1999 {published data only}  ,excluded,CD009925-bbs2-0063, Unable to extract useful information. 
CD009925-bib-0077,"Aitken DA, McCaw G, Crossley JA, Berry E, Connor JM, Spencer K, et al. ",First‐trimester biochemical screening for fetal chromosome abnormalities and neural tube defects, Prenatal Diagnosis ,1993,13,    ,['citation-journal']," Aitken DA, McCaw G, Crossley JA, Berry E, Connor JM, Spencer K, et al. First‐trimester biochemical screening for fetal chromosome abnormalities and neural tube defects.  Prenatal Diagnosis 1993;13(8):681‐9.    Link to article     Google Scholar     ","['https://doi.org/10.1002/pd.1970130804', 'https://scholar.google.com/scholar_lookup?title=First‐trimester+biochemical+screening+for+fetal+chromosome+abnormalities+and+neural+tube+defects+&author=DA+Aitken&author=G+McCaw&author=JA+Crossley&author=E+Berry&author=JM+Connor&author=K+Spencer&publication_year=1993&hl=en']",,https://doi.org/10.1002/pd.1970130804, Aitken 1993 {published data only}  ,excluded,CD009925-bbs2-0064, Unable to extract useful data. 
CD009925-bib-0078,"Aitken DA, Syvertsen BS, Crossley JA, Berry E, Connor JM. ",Heat‐stable and immunoreactive placental alkaline phosphatase in maternal serum from Down's syndrome and trisomy 18 pregnancies.[see comment], Prenatal Diagnosis ,1996,16,    ,['citation-journal']," Aitken DA, Syvertsen BS, Crossley JA, Berry E, Connor JM. Heat‐stable and immunoreactive placental alkaline phosphatase in maternal serum from Down's syndrome and trisomy 18 pregnancies.[see comment].  Prenatal Diagnosis 1996;16(11):1051‐4.    Link to article     Google Scholar     ","['https://doi.org/10.1002/(SICI)1097-0223(199611)16:11<1051::AID-PD988>3.0.CO;2-T', ""https://scholar.google.com/scholar_lookup?title=Heat‐stable+and+immunoreactive+placental+alkaline+phosphatase+in+maternal+serum+from+Down's+syndrome+and+trisomy+18+pregnancies.[see+comment]+&author=DA+Aitken&author=BS+Syvertsen&author=JA+Crossley&author=E+Berry&author=JM+Connor&publication_year=1996&hl=en""]",,https://doi.org/10.1002/(SICI)1097-0223(199611)16:11<1051::AID-PD988>3.0.CO;2-T, Aitken 1996a {published data only}  ,excluded,CD009925-bbs2-0065, Fewer than 80% of pregnancies had gestational age confirmed by USS. 
CD009925-bib-0079,"Aitken DA, Wallace EM, Crossley JA, Swanston IA, Van Pareren Y, Van Maarle M, et al. ",Dimeric Inhibin A as a marker for Down's syndrome in early pregnancy, New England Journal of Medicine ,1996,334,    ,['citation-journal']," Aitken DA, Wallace EM, Crossley JA, Swanston IA, Van Pareren Y, Van Maarle M, et al. Dimeric Inhibin A as a marker for Down's syndrome in early pregnancy.  New England Journal of Medicine 1996;334(19):1231‐6.    Link to article     Google Scholar     ","['https://doi.org/10.1056/NEJM199605093341904', ""https://scholar.google.com/scholar_lookup?title=Dimeric+Inhibin+A+as+a+marker+for+Down's+syndrome+in+early+pregnancy&author=DA+Aitken&author=EM+Wallace&author=JA+Crossley&author=IA+Swanston&author=Y+Pareren&author=M+Maarle&publication_year=1996&hl=en""]",,https://doi.org/10.1056/NEJM199605093341904, Aitken 1996b {published data only}  ,excluded,CD009925-bbs2-0066, Fewer than 80% of pregnancies had gestational age confirmed by USS. 
CD009925-bib-0080,"Akbas SH, Ozben T, Alper O, Ugur A, Yucel G, Luleci G. ","Maternal serum screening for Down's syndrome, open neural tube defects and trisomy 18", Clinical Chemistry & Laboratory Medicine ,2001,39,    ,['citation-journal']," Akbas SH, Ozben T, Alper O, Ugur A, Yucel G, Luleci G. Maternal serum screening for Down's syndrome, open neural tube defects and trisomy 18.  Clinical Chemistry & Laboratory Medicine 2001;39(6):487‐90.    Link to article     Google Scholar     ","['https://doi.org/10.1515/CCLM.2001.080', ""https://scholar.google.com/scholar_lookup?title=Maternal+serum+screening+for+Down's+syndrome,+open+neural+tube+defects+and+trisomy+18+&author=SH+Akbas&author=T+Ozben&author=O+Alper&author=A+Ugur&author=G+Yucel&author=G+Luleci&publication_year=2001&hl=en""]",,https://doi.org/10.1515/CCLM.2001.080, Akbas 2001 {published data only}  ,excluded,CD009925-bbs2-0067, Less than 5 Down's syndrome pregnancies. 
CD009925-bib-0081,"Antona D, Wallace EM, Shearing C, Ashby JP, Groome NP. ",Inhibin A and pro‐alphaC Inhibin Ain Down syndrome and normal pregnancies, Prenatal Diagnosis ,1998,18,    ,['citation-journal']," Antona D, Wallace EM, Shearing C, Ashby JP, Groome NP. Inhibin A and pro‐alphaC Inhibin Ain Down syndrome and normal pregnancies.  Prenatal Diagnosis 1998;18(11):1122‐6.    Link to article     Google Scholar     ","['https://doi.org/10.1002/(SICI)1097-0223(199811)18:11<1122::AID-PD414>3.0.CO;2-P', 'https://scholar.google.com/scholar_lookup?title=Inhibin+A+and+pro‐alphaC+Inhibin+Ain+Down+syndrome+and+normal+pregnancies&author=D+Antona&author=EM+Wallace&author=C+Shearing&author=JP+Ashby&author=NP+Groome&publication_year=1998&hl=en']",,https://doi.org/10.1002/(SICI)1097-0223(199811)18:11<1122::AID-PD414>3.0.CO;2-P, Antona 1998 {published data only}  ,excluded,CD009925-bbs2-0068, Likely fewer than 80% of pregnancies dated by USS. 
CD009925-bib-0082,"Antsaklis A, Papantoniou N, Mesogitis S, Michalas S, Aravantinos D. ",Pregnant women of 35 years of age or more: Maternal serum markers or amniocentesis?, Journal of Obstetrics and Gynaecology ,1999,19,    ,['citation-journal']," Antsaklis A, Papantoniou N, Mesogitis S, Michalas S, Aravantinos D. Pregnant women of 35 years of age or more: Maternal serum markers or amniocentesis?.  Journal of Obstetrics and Gynaecology 1999;19(3):253‐6.    Link to article     Google Scholar     ","['https://doi.org/10.1080/01443619965002', 'https://scholar.google.com/scholar_lookup?title=Pregnant+women+of+35+years+of+age+or+more:+Maternal+serum+markers+or+amniocentesis?&author=A+Antsaklis&author=N+Papantoniou&author=S+Mesogitis&author=S+Michalas&author=D+Aravantinos&publication_year=1999&hl=en']",,https://doi.org/10.1080/01443619965002, Antsaklis 1999 {published data only}  ,excluded,CD009925-bbs2-0069, Women screened at greater than 24 weeks gestation. 
CD009925-bib-0083,"Ashwood ER, Cheng E, Luthy DA. ",Maternal serum alpha‐fetoprotein and fetal trisomy‐21 in women 35 years and older: implications for alpha‐fetoprotein screening programs, American Journal of Medical Genetics ,1987,26,    ,['citation-journal']," Ashwood ER, Cheng E, Luthy DA. Maternal serum alpha‐fetoprotein and fetal trisomy‐21 in women 35 years and older: implications for alpha‐fetoprotein screening programs.  American Journal of Medical Genetics 1987;26(3):531‐9.    Link to article     Google Scholar     ","['https://doi.org/10.1002/ajmg.1320260304', 'https://scholar.google.com/scholar_lookup?title=Maternal+serum+alpha‐fetoprotein+and+fetal+trisomy‐21+in+women+35+years+and+older:+implications+for+alpha‐fetoprotein+screening+programs+&author=ER+Ashwood&author=E+Cheng&author=DA+Luthy&publication_year=1987&hl=en']",,https://doi.org/10.1002/ajmg.1320260304, Ashwood 1987 {published data only}  ,excluded,CD009925-bbs2-0070, Unable to extract useful data. 
CD009925-bib-0084,Asrani CH. ,Triple marker, National Journal of Homoeopathy ,2005,7,    ,['citation-journal'], Asrani CH. Triple marker.  National Journal of Homoeopathy 2005;7(3):174.    Google Scholar     ,['https://scholar.google.com/scholar_lookup?title=Triple+marker&author=CH+Asrani&publication_year=2005&hl=en'],,, Asrani 2005 {published data only}  ,excluded,CD009925-bbs2-0071, Review article. 
CD009925-bib-0085,"Audibert F, Dommergues M, Benattar C, Taieb J, Thalabard JC, Frydman R. ",Screening for Down syndrome using first‐trimester ultrasound and second‐trimester maternal serum markers in a low‐risk population: a prospective longitudinal study, Ultrasound in Obstetrics & Gynecology ,2001,18,    ,['citation-journal']," Audibert F, Dommergues M, Benattar C, Taieb J, Thalabard JC, Frydman R. Screening for Down syndrome using first‐trimester ultrasound and second‐trimester maternal serum markers in a low‐risk population: a prospective longitudinal study.  Ultrasound in Obstetrics & Gynecology 2001;18(1):26‐31.    Link to article     Google Scholar     ","['https://doi.org/10.1046/j.1469-0705.2001.00457.x', 'https://scholar.google.com/scholar_lookup?title=Screening+for+Down+syndrome+using+first‐trimester+ultrasound+and+second‐trimester+maternal+serum+markers+in+a+low‐risk+population:+a+prospective+longitudinal+study+&author=F+Audibert&author=M+Dommergues&author=C+Benattar&author=J+Taieb&author=JC+Thalabard&author=R+Frydman&publication_year=2001&hl=en']",,https://doi.org/10.1046/j.1469-0705.2001.00457.x, Audibert 2001b {published data only}  ,excluded,CD009925-bbs2-0072, Unable to ascertain whether part of screening population in Rozenberg et al. No response from authors therefore excluded to reduce risk of data replication.  
CD009925-bib-0086,"Axt Fliedner, Schwarze A, Kreiselmaier P, Krapp M, Smrcek J, Diedrich K. ","Umbilical cord diameter at 11‐14 weeks of gestation: Relationship to nuchal translucency, ductus venous blood flow and chromosomal defects", Fetal Diagnosis and Therapy ,2006,21,    ,['citation-journal']," Axt Fliedner, Schwarze A, Kreiselmaier P, Krapp M, Smrcek J, Diedrich K. Umbilical cord diameter at 11‐14 weeks of gestation: Relationship to nuchal translucency, ductus venous blood flow and chromosomal defects.  Fetal Diagnosis and Therapy 2006;21(4):390‐5.    Google Scholar     ","['https://scholar.google.com/scholar_lookup?title=Umbilical+cord+diameter+at+11‐14+weeks+of+gestation:+Relationship+to+nuchal+translucency,+ductus+venous+blood+flow+and+chromosomal+defects+&author=Fliedner+Axt&author=A+Schwarze&author=P+Kreiselmaier&author=M+Krapp&author=J+Smrcek&author=K+Diedrich&publication_year=2006&hl=en']",,, Axt‐Fleidner 2006 {published data only}  ,excluded,CD009925-bbs2-0073, Unable to extract useful data. 
CD009925-bib-0087,"Azuma M, Yamamoto R, Wakui Y, Minobe S, Satomura S, Fujimoto S. ",A novel method for the detection of Down syndrome with the use of four serum markers, American Journal of Obstetrics & Gynecology ,2002,187,    ,['citation-journal']," Azuma M, Yamamoto R, Wakui Y, Minobe S, Satomura S, Fujimoto S. A novel method for the detection of Down syndrome with the use of four serum markers.  American Journal of Obstetrics & Gynecology 2002;187(1):197‐201.    Link to article     Google Scholar     ","['https://doi.org/10.1067/mob.2002.123201', 'https://scholar.google.com/scholar_lookup?title=A+novel+method+for+the+detection+of+Down+syndrome+with+the+use+of+four+serum+markers&author=M+Azuma&author=R+Yamamoto&author=Y+Wakui&author=S+Minobe&author=S+Satomura&author=S+Fujimoto&publication_year=2002&hl=en']",,https://doi.org/10.1067/mob.2002.123201, Azuma 2002 {published data only}  ,excluded,CD009925-bbs2-0074, Unable to extract useful data. 
CD009925-bib-0088,"Baghagho EE, Kharboush IF, El‐Kaffash DM, KarKour TA, Ismail SR, Mortada MM. ",Maternal serum alpha fetoprotein among pregnant females in Alexandria, Journal of the Egyptian Public Health Association ,2004,79,    ,['citation-journal']," Baghagho EE, Kharboush IF, El‐Kaffash DM, KarKour TA, Ismail SR, Mortada MM. Maternal serum alpha fetoprotein among pregnant females in Alexandria.  Journal of the Egyptian Public Health Association 2004;79(1‐2):59‐81.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=Maternal+serum+alpha+fetoprotein+among+pregnant+females+in+Alexandria&author=EE+Baghagho&author=IF+Kharboush&author=DM+El‐Kaffash&author=TA+KarKour&author=SR+Ismail&author=MM+Mortada&publication_year=2004&hl=en'],,, Baghagho 2004 {published data only}  ,excluded,CD009925-bbs2-0075, Unable to obtain paper. 
CD009925-bib-0089,"Bahado Singh, Goldstein I, Uerpairojkit B, Copel JA, Mahoney MJ, Baumgarten A. ",Normal nuchal thickness in the midtrimester indicates reduced risk of Down syndrome in pregnancies with abnormal triple‐screen results, American Journal of Obstetrics and Gynecology ,1995,173,    ,['citation-journal']," Bahado Singh, Goldstein I, Uerpairojkit B, Copel JA, Mahoney MJ, Baumgarten A. Normal nuchal thickness in the midtrimester indicates reduced risk of Down syndrome in pregnancies with abnormal triple‐screen results.  American Journal of Obstetrics and Gynecology 1995;173(4):1106‐0.    Link to article     Google Scholar     ","['https://doi.org/10.1016/0002-9378(95)91334-3', 'https://scholar.google.com/scholar_lookup?title=Normal+nuchal+thickness+in+the+midtrimester+indicates+reduced+risk+of+Down+syndrome+in+pregnancies+with+abnormal+triple‐screen+results+&author=Singh+Bahado&author=I+Goldstein&author=B+Uerpairojkit&author=JA+Copel&author=MJ+Mahoney&author=A+Baumgarten&publication_year=1995&hl=en']",,https://doi.org/10.1016/0002-9378(95)91334-3, Bahado‐Singh 1995 {published data only}  ,excluded,CD009925-bbs2-0076, USS markers greater than 14 weeks gestation. 
CD009925-bib-0090,"Bahado Singh, Tan A, Deren O, Hunter D, Copel J, Mahoney MJ. ",Risk of Down syndrome and any clinically significant chromosome defect in pregnancies with abnormal triple‐screen and normal targeted ultrasonographic results, American Journal of Obstetrics and Gynecology ,1996,175,    ,['citation-journal']," Bahado Singh, Tan A, Deren O, Hunter D, Copel J, Mahoney MJ. Risk of Down syndrome and any clinically significant chromosome defect in pregnancies with abnormal triple‐screen and normal targeted ultrasonographic results.  American Journal of Obstetrics and Gynecology 1996;175(4 I):824‐9.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=Risk+of+Down+syndrome+and+any+clinically+significant+chromosome+defect+in+pregnancies+with+abnormal+triple‐screen+and+normal+targeted+ultrasonographic+results+&author=Singh+Bahado&author=A+Tan&author=O+Deren&author=D+Hunter&author=J+Copel&author=MJ+Mahoney&publication_year=1996&hl=en'],,, Bahado‐Singh 1996 {published data only}  ,excluded,CD009925-bbs2-0077, USS markers greater than 14 weeks gestation. 
CD009925-bib-0091,"Bahado Singh, Oz AU, Flores D, Cermik D, Acuna E, Mahoney MJ, et al. ","Nuchal thickness, urine ß‐core fragment level, and maternal age for down syndrome screening", American Journal of Obstetrics and Gynecology ,1999,180,    ,['citation-journal']," Bahado Singh, Oz AU, Flores D, Cermik D, Acuna E, Mahoney MJ, et al. Nuchal thickness, urine ß‐core fragment level, and maternal age for down syndrome screening.  American Journal of Obstetrics and Gynecology 1999;180(2 I):491‐5.    Google Scholar     ","['https://scholar.google.com/scholar_lookup?title=Nuchal+thickness,+urine+ß‐core+fragment+level,+and+maternal+age+for+down+syndrome+screening+&author=Singh+Bahado&author=AU+Oz&author=D+Flores&author=D+Cermik&author=E+Acuna&author=MJ+Mahoney&publication_year=1999&hl=en']",,, Bahado‐Singh 1999b {published data only}  ,excluded,CD009925-bbs2-0078, USS markers greater than 14 weeks gestation. 
CD009925-bib-0092,"Bahado Singh, Shahabi S, Karaca M, Mahoney MJ, Cole L, Oz UA. ",The comprehensive midtrimester test: High‐sensitivity Down syndrome test, American Journal of Obstetrics and Gynecology ,2002,186,    ,['citation-journal']," Bahado Singh, Shahabi S, Karaca M, Mahoney MJ, Cole L, Oz UA. The comprehensive midtrimester test: High‐sensitivity Down syndrome test.  American Journal of Obstetrics and Gynecology 2002;186(4):803‐8.    Link to article     Google Scholar     ","['https://doi.org/10.1067/mob.2002.121651', 'https://scholar.google.com/scholar_lookup?title=The+comprehensive+midtrimester+test:+High‐sensitivity+Down+syndrome+test&author=Singh+Bahado&author=S+Shahabi&author=M+Karaca&author=MJ+Mahoney&author=L+Cole&author=UA+Oz&publication_year=2002&hl=en']",,https://doi.org/10.1067/mob.2002.121651, Bahado‐Singh 2002 {published data only}  ,excluded,CD009925-bbs2-0079, USS markers greater than 14 weeks gestation. 
CD009925-bib-0093,"Bahado Singh, Cheng CC, Matta P, Small M, Mahoney MJ. ",Combined serum and ultrasound screening for detection of fetal aneuploidy, Seminars in Perinatology ,2003,27,    ,['citation-journal']," Bahado Singh, Cheng CC, Matta P, Small M, Mahoney MJ. Combined serum and ultrasound screening for detection of fetal aneuploidy.  Seminars in Perinatology 2003;27(2):145‐51.    Link to article     Google Scholar     ","['https://doi.org/10.1053/sper.2003.50013', 'https://scholar.google.com/scholar_lookup?title=Combined+serum+and+ultrasound+screening+for+detection+of+fetal+aneuploidy&author=Singh+Bahado&author=CC+Cheng&author=P+Matta&author=M+Small&author=MJ+Mahoney&publication_year=2003&hl=en']",,https://doi.org/10.1053/sper.2003.50013, Bahado‐Singh 2003 {published data only}  ,excluded,CD009925-bbs2-0080, Review article. 
CD009925-bib-0094,"Bar‐Hava I, Yitzhak M, Krissi H, Shohat M, Shalev J, Czitron B, et al. ",Triple‐test screening in in vitro fertilization pregnancies, Journal of Assisted Reproduction and Genetics ,2001,18,    ,['citation-journal']," Bar‐Hava I, Yitzhak M, Krissi H, Shohat M, Shalev J, Czitron B, et al. Triple‐test screening in in vitro fertilization pregnancies.  Journal of Assisted Reproduction and Genetics 2001;18(4):226‐9.    Link to article     Google Scholar     ","['https://doi.org/10.1023/A:1009455912670', 'https://scholar.google.com/scholar_lookup?title=Triple‐test+screening+in+in+vitro+fertilization+pregnancies&author=I+Bar‐Hava&author=M+Yitzhak&author=H+Krissi&author=M+Shohat&author=J+Shalev&author=B+Czitron&publication_year=2001&hl=en']",,https://doi.org/10.1023/A:1009455912670, Bar‐Hava 2001 {published data only}  ,excluded,CD009925-bbs2-0081, No Down's pregnancies in study population. 
CD009925-bib-0095,"Barkai G, Goldman B, Ries L, Chaki R, Dor J, Cuckle H. ",Down's syndrome screening marker levels following assisted reproduction, Prenatal Diagnosis ,1996,16,    ,['citation-journal']," Barkai G, Goldman B, Ries L, Chaki R, Dor J, Cuckle H. Down's syndrome screening marker levels following assisted reproduction.  Prenatal Diagnosis 1996;16(12):1111‐4.    Link to article     Google Scholar     ","['https://doi.org/10.1002/(SICI)1097-0223(199612)16:12<1111::AID-PD998>3.0.CO;2-X', ""https://scholar.google.com/scholar_lookup?title=Down's+syndrome+screening+marker+levels+following+assisted+reproduction&author=G+Barkai&author=B+Goldman&author=L+Ries&author=R+Chaki&author=J+Dor&author=H+Cuckle&publication_year=1996&hl=en""]",,https://doi.org/10.1002/(SICI)1097-0223(199612)16:12<1111::AID-PD998>3.0.CO;2-X, Barkai 1996 {published data only}  ,excluded,CD009925-bbs2-0082, No Down's pregnancies in study population. 
CD009925-bib-0096,"Barnabei VM, Krantz DA, Macri JN, Larsen JW. ",Enhanced twin pregnancy detection within an open neural tube defect and Down syndrome screening protocol using free‐ß hCG and AFP, Prenatal Diagnosis ,1995,15,    ,['citation-journal']," Barnabei VM, Krantz DA, Macri JN, Larsen JW. Enhanced twin pregnancy detection within an open neural tube defect and Down syndrome screening protocol using free‐ß hCG and AFP.  Prenatal Diagnosis 1995;15(12):1131‐4.    Link to article     Google Scholar     ","['https://doi.org/10.1002/pd.1970151209', 'https://scholar.google.com/scholar_lookup?title=Enhanced+twin+pregnancy+detection+within+an+open+neural+tube+defect+and+Down+syndrome+screening+protocol+using+free‐ß+hCG+and+AFP+&author=VM+Barnabei&author=DA+Krantz&author=JN+Macri&author=JW+Larsen&publication_year=1995&hl=en']",,https://doi.org/10.1002/pd.1970151209, Barnabei 1995 {published data only}  ,excluded,CD009925-bbs2-0083, No Down's pregnancies in study population. 
CD009925-bib-0097,"Bartels I, Lindemann A. ",Maternal levels of pregnancy‐specific ß 1‐glycoprotein (SP‐1) are elevated in pregnancies affected by Down's syndrome, Human Genetics ,1988,80,    ,['citation-journal']," Bartels I, Lindemann A. Maternal levels of pregnancy‐specific ß 1‐glycoprotein (SP‐1) are elevated in pregnancies affected by Down's syndrome.  Human Genetics 1988;80(1):46‐8.    Link to article     Google Scholar     ","['https://doi.org/10.1007/BF00451454', ""https://scholar.google.com/scholar_lookup?title=Maternal+levels+of+pregnancy‐specific+ß+1‐glycoprotein+(SP‐1)+are+elevated+in+pregnancies+affected+by+Down's+syndrome+&author=I+Bartels&author=A+Lindemann&publication_year=1988&hl=en""]",,https://doi.org/10.1007/BF00451454, Bartels 1988 {published data only}  ,excluded,CD009925-bbs2-0084, Unable to extract useful data. 
CD009925-bib-0098,"Bartels I, Hoppe‐Sievert B, Bockel B, Herold S, Caesar J. ","Adjustment formulae for maternal serum alpha‐fetoprotein, human chorionic gonadotropin, and unconjugated oestriol to maternal weight and smoking", Prenatal Diagnosis ,1993,13,    ,['citation-journal']," Bartels I, Hoppe‐Sievert B, Bockel B, Herold S, Caesar J. Adjustment formulae for maternal serum alpha‐fetoprotein, human chorionic gonadotropin, and unconjugated oestriol to maternal weight and smoking.  Prenatal Diagnosis 1993;13(2):123‐30.    Link to article     Google Scholar     ","['https://doi.org/10.1002/pd.1970130207', 'https://scholar.google.com/scholar_lookup?title=Adjustment+formulae+for+maternal+serum+alpha‐fetoprotein,+human+chorionic+gonadotropin,+and+unconjugated+oestriol+to+maternal+weight+and+smoking+&author=I+Bartels&author=B+Hoppe‐Sievert&author=B+Bockel&author=S+Herold&author=J+Caesar&publication_year=1993&hl=en']",,https://doi.org/10.1002/pd.1970130207, Bartels 1993 {published data only}  ,excluded,CD009925-bbs2-0085, No Down's pregnancies in study population. 
CD009925-bib-0099,"Barth WH, Frigoletto FD, Krauss CM, MacMillin MD, Stryker JM, Benacerraf BR. ",Ultrasound detection of fetal aneuploidy in women with elevated maternal serum alpha‐fetoprotein, Obstetrics & Gynecology ,1991,77,    ,['citation-journal']," Barth WH, Frigoletto FD, Krauss CM, MacMillin MD, Stryker JM, Benacerraf BR. Ultrasound detection of fetal aneuploidy in women with elevated maternal serum alpha‐fetoprotein.  Obstetrics & Gynecology 1991;77(6):897‐900.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=Ultrasound+detection+of+fetal+aneuploidy+in+women+with+elevated+maternal+serum+alpha‐fetoprotein&author=WH+Barth&author=FD+Frigoletto&author=CM+Krauss&author=MD+MacMillin&author=JM+Stryker&author=BR+Benacerraf&publication_year=1991&hl=en'],,, Barth 1991 {published data only}  ,excluded,CD009925-bbs2-0086, Second trimester ultrasound study. 
CD009925-bib-0100,"Baviera G, Carbone C, Corrado F, Mastrantonio P. ",Placental growth hormone in Down's syndrome screening, Journal of Maternal‐Fetal & Neonatal Medicine ,2004,16,    ,['citation-journal']," Baviera G, Carbone C, Corrado F, Mastrantonio P. Placental growth hormone in Down's syndrome screening.  Journal of Maternal‐Fetal & Neonatal Medicine 2004;16(4):241‐3.    Link to article     Google Scholar     ","['https://doi.org/10.1080/jmf.16.4.241.243-26', ""https://scholar.google.com/scholar_lookup?title=Placental+growth+hormone+in+Down's+syndrome+screening&author=G+Baviera&author=C+Carbone&author=F+Corrado&author=P+Mastrantonio&publication_year=2004&hl=en""]",,https://doi.org/10.1080/jmf.16.4.241.243-26, Baviera 2004 {published data only}  ,excluded,CD009925-bbs2-0087, Unclear method of confirmation of gestational age. 
CD009925-bib-0101,"Bazzett LB, Yaron Y, O'Brien JE, Critchfield G, Kramer RL, Ayoub M, et al. ",Fetal gender impact on multiple‐marker screening results, American Journal of Medical Genetics ,1998,76,    ,['citation-journal']," Bazzett LB, Yaron Y, O'Brien JE, Critchfield G, Kramer RL, Ayoub M, et al. Fetal gender impact on multiple‐marker screening results.  American Journal of Medical Genetics 1998;76(5):369‐71.    Link to article     Google Scholar     ","['https://doi.org/10.1002/(SICI)1096-8628(19980413)76:5<369::AID-AJMG1>3.0.CO;2-I', ""https://scholar.google.com/scholar_lookup?title=Fetal+gender+impact+on+multiple‐marker+screening+results&author=LB+Bazzett&author=Y+Yaron&author=JE+O'Brien&author=G+Critchfield&author=RL+Kramer&author=M+Ayoub&publication_year=1998&hl=en""]",,https://doi.org/10.1002/(SICI)1096-8628(19980413)76:5<369::AID-AJMG1>3.0.CO;2-I, Bazzett 1998 {published data only}  ,excluded,CD009925-bbs2-0088, Male versus female fetuses. 
CD009925-bib-0102,"Bellver J, Lara C, Soares SR, Ramirez A, Pellicer A, Remohi J, et al. ",First trimester biochemical screening for Down's syndrome in singleton pregnancies conceived by assisted reproduction, Human Reproduction. ,2005,20,    ,['citation-journal']," Bellver J, Lara C, Soares SR, Ramirez A, Pellicer A, Remohi J, et al. First trimester biochemical screening for Down's syndrome in singleton pregnancies conceived by assisted reproduction.  Human Reproduction. 2005;20(9):2623‐7.    Link to article     Google Scholar     ","['https://doi.org/10.1093/humrep/dei107', ""https://scholar.google.com/scholar_lookup?title=First+trimester+biochemical+screening+for+Down's+syndrome+in+singleton+pregnancies+conceived+by+assisted+reproduction+&author=J+Bellver&author=C+Lara&author=SR+Soares&author=A+Ramirez&author=A+Pellicer&author=J+Remohi&publication_year=2005&hl=en""]",,https://doi.org/10.1093/humrep/dei107, Bellver 2005 {published data only}  ,excluded,CD009925-bbs2-0089, No Down's syndrome pregnancies in study. 
CD009925-bib-0103,"Benn PA, Horne D, Briganti S, Greenstein RM. ",Prenatal diagnosis of diverse chromosome abnormalities in a population of women identified by triple‐marker testing as screen positive for Down syndrome, American Journal of Obstetrics & Gynecology ,1995,173,    ,['citation-journal']," Benn PA, Horne D, Briganti S, Greenstein RM. Prenatal diagnosis of diverse chromosome abnormalities in a population of women identified by triple‐marker testing as screen positive for Down syndrome.  American Journal of Obstetrics & Gynecology 1995;173(2):496‐501.    Link to article     Google Scholar     ","['https://doi.org/10.1016/0002-9378(95)90272-4', 'https://scholar.google.com/scholar_lookup?title=Prenatal+diagnosis+of+diverse+chromosome+abnormalities+in+a+population+of+women+identified+by+triple‐marker+testing+as+screen+positive+for+Down+syndrome+&author=PA+Benn&author=D+Horne&author=S+Briganti&author=RM+Greenstein&publication_year=1995&hl=en']",,https://doi.org/10.1016/0002-9378(95)90272-4, Benn 1995 {published data only}  ,excluded,CD009925-bbs2-0090, Less than 80% follow‐up. 
CD009925-bib-0104,"Benn PA, Horne D, Craffey A, Collins R, Ramsdell L, Greenstein R. ",Maternal serum screening for birth defects: results of a Connecticut regional program, Connecticut Medicine ,1996,60,    ,['citation-journal']," Benn PA, Horne D, Craffey A, Collins R, Ramsdell L, Greenstein R. Maternal serum screening for birth defects: results of a Connecticut regional program.  Connecticut Medicine 1996;60(6):323‐7.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=Maternal+serum+screening+for+birth+defects:+results+of+a+Connecticut+regional+program&author=PA+Benn&author=D+Horne&author=A+Craffey&author=R+Collins&author=L+Ramsdell&author=R+Greenstein&publication_year=1996&hl=en'],,, Benn 1996 {published data only}  ,excluded,CD009925-bbs2-0091, Less than 80% follow‐up. 
CD009925-bib-0105,"Benn PA, Clive JM, Collins R. ","Medians for second‐trimester maternal serum alpha‐fetoprotein, human chorionic gonadotropin, and unconjugated estriol; differences between races or ethnic groups", Clinical Chemistry ,1997,43,    ,['citation-journal']," Benn PA, Clive JM, Collins R. Medians for second‐trimester maternal serum alpha‐fetoprotein, human chorionic gonadotropin, and unconjugated estriol; differences between races or ethnic groups.  Clinical Chemistry 1997;43(2):333‐7.    Link to article     Google Scholar     ","['https://doi.org/10.1093/clinchem/43.2.333', 'https://scholar.google.com/scholar_lookup?title=Medians+for+second‐trimester+maternal+serum+alpha‐fetoprotein,+human+chorionic+gonadotropin,+and+unconjugated+estriol;+differences+between+races+or+ethnic+groups+&author=PA+Benn&author=JM+Clive&author=R+Collins&publication_year=1997&hl=en']",,https://doi.org/10.1093/clinchem/43.2.333, Benn 1997 {published data only}  ,excluded,CD009925-bbs2-0092, No Down's pregnancies in study population. 
CD009925-bib-0106,Benn PA. ,Preliminary evidence for associations between second‐trimester human chorionic gonadotropin and unconjugated oestriol levels with pregnancy outcome in Down syndrome pregnancies, Prenatal Diagnosis ,1998,18,    ,['citation-journal'], Benn PA. Preliminary evidence for associations between second‐trimester human chorionic gonadotropin and unconjugated oestriol levels with pregnancy outcome in Down syndrome pregnancies.  Prenatal Diagnosis 1998;18(4):319‐24.    Link to article     Google Scholar     ,"['https://doi.org/10.1002/(SICI)1097-0223(199804)18:4<319::AID-PD261>3.0.CO;2-Q', 'https://scholar.google.com/scholar_lookup?title=Preliminary+evidence+for+associations+between+second‐trimester+human+chorionic+gonadotropin+and+unconjugated+oestriol+levels+with+pregnancy+outcome+in+Down+syndrome+pregnancies+&author=PA+Benn&publication_year=1998&hl=en']",,https://doi.org/10.1002/(SICI)1097-0223(199804)18:4<319::AID-PD261>3.0.CO;2-Q, Benn 1998 {published data only}  ,excluded,CD009925-bbs2-0093, Less than 80% follow‐up. 
CD009925-bib-0107,"Benn PA, Ying J, Beazoglou T, Egan JF. ",Estimates for the sensitivity and false‐positive rates for second trimester serum screening for Down syndrome and trisomy 18 with adjustment for cross‐identification and double‐positive results, Prenatal Diagnosis ,2001,21,    ,['citation-journal']," Benn PA, Ying J, Beazoglou T, Egan JF. Estimates for the sensitivity and false‐positive rates for second trimester serum screening for Down syndrome and trisomy 18 with adjustment for cross‐identification and double‐positive results.  Prenatal Diagnosis 2001;21(1):46‐51.    Link to article     Google Scholar     ","['https://doi.org/10.1002/1097-0223(200101)21:1<46::AID-PD984>3.0.CO;2-C', 'https://scholar.google.com/scholar_lookup?title=Estimates+for+the+sensitivity+and+false‐positive+rates+for+second+trimester+serum+screening+for+Down+syndrome+and+trisomy+18+with+adjustment+for+cross‐identification+and+double‐positive+results+&author=PA+Benn&author=J+Ying&author=T+Beazoglou&author=JF+Egan&publication_year=2001&hl=en']",,https://doi.org/10.1002/1097-0223(200101)21:1<46::AID-PD984>3.0.CO;2-C, Benn 2001 {published data only}  ,excluded,CD009925-bbs2-0094, Statistical modelling (computer simulation). 
CD009925-bib-0108,"Benn PA, Kaminsky LM, Ying J, Borgida AF, Egan JF. ",Combined second‐trimester biochemical and ultrasound screening for Down syndrome, Obstetrics & Gynecology ,2002,100,    ,['citation-journal']," Benn PA, Kaminsky LM, Ying J, Borgida AF, Egan JF. Combined second‐trimester biochemical and ultrasound screening for Down syndrome.  Obstetrics & Gynecology 2002;100(6):1168‐76.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=Combined+second‐trimester+biochemical+and+ultrasound+screening+for+Down+syndrome&author=PA+Benn&author=LM+Kaminsky&author=J+Ying&author=AF+Borgida&author=JF+Egan&publication_year=2002&hl=en'],,, Benn 2002 {published data only}  ,excluded,CD009925-bbs2-0095, Modelled data. 
CD009925-bib-0109,"Benn PA, Fang M, Egan JFX, Horne D, Collins R. ",Incorporation of inhibin‐A in second‐trimester screening for Down syndrome, Obstetrics and Gynecology ,2003,101,    ,['citation-journal']," Benn PA, Fang M, Egan JFX, Horne D, Collins R. Incorporation of inhibin‐A in second‐trimester screening for Down syndrome.  Obstetrics and Gynecology 2003;101(3):451‐4.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=Incorporation+of+inhibin‐A+in+second‐trimester+screening+for+Down+syndrome&author=PA+Benn&author=M+Fang&author=JFX+Egan&author=D+Horne&author=R+Collins&publication_year=2003&hl=en'],,, Benn 2003a {published data only}  ,excluded,CD009925-bbs2-0096, Less than 80% of pregnancies dated by USS. 
CD009925-bib-0110,Benn P. ,Improved antenatal screening for Down's syndrome, Lancet ,2003,361,    ,['citation-journal'], Benn P. Improved antenatal screening for Down's syndrome.  Lancet 2003;361(9360):794‐5.    Link to article     Google Scholar     ,"['https://doi.org/10.1016/S0140-6736(03)12718-3', ""https://scholar.google.com/scholar_lookup?title=Improved+antenatal+screening+for+Down's+syndrome&author=P+Benn&publication_year=2003&hl=en""]",,https://doi.org/10.1016/S0140-6736(03)12718-3, Benn 2003b {published data only}  ,excluded,CD009925-bbs2-0097, Editorial. 
CD009925-bib-0111,"Benn P, Wright D, Cuckle H. ",Practical strategies in contingent sequential screening for Down syndrome, Prenatal Diagnosis ,2005,25,    ,['citation-journal']," Benn P, Wright D, Cuckle H. Practical strategies in contingent sequential screening for Down syndrome.  Prenatal Diagnosis 2005;25(8):645‐52.    Link to article     Google Scholar     ","['https://doi.org/10.1002/pd.1215', 'https://scholar.google.com/scholar_lookup?title=Practical+strategies+in+contingent+sequential+screening+for+Down+syndrome&author=P+Benn&author=D+Wright&author=H+Cuckle&publication_year=2005&hl=en']",,https://doi.org/10.1002/pd.1215, Benn 2005a {published data only}  ,excluded,CD009925-bbs2-0098, No Down's pregnancies included. 
CD009925-bib-0112,"Benn P, Donnenfeld AE. ",Sequential Down syndrome screening: the importance of first and second trimester test correlations when calculating risk, Journal of Genetic Counseling ,2005,14,    ,['citation-journal']," Benn P, Donnenfeld AE. Sequential Down syndrome screening: the importance of first and second trimester test correlations when calculating risk.  Journal of Genetic Counseling 2005;14(6):409‐13.    Link to article     Google Scholar     ","['https://doi.org/10.1007/s10897-005-6390-7', 'https://scholar.google.com/scholar_lookup?title=Sequential+Down+syndrome+screening:+the+importance+of+first+and+second+trimester+test+correlations+when+calculating+risk+&author=P+Benn&author=AE+Donnenfeld&publication_year=2005&hl=en']",,https://doi.org/10.1007/s10897-005-6390-7, Benn 2005b {published data only}  ,excluded,CD009925-bbs2-0099, Mathematical model. 
CD009925-bib-0113,"Berry E, Aitken DA, Crossley JA, Macri JN, Connor JM. ",Analysis of maternal serum alpha‐fetoprotein and free ß human chorionic gonadotrophin in the first trimester: implications for Down's syndrome screening, Prenatal Diagnosis ,1995,15,    ,['citation-journal']," Berry E, Aitken DA, Crossley JA, Macri JN, Connor JM. Analysis of maternal serum alpha‐fetoprotein and free ß human chorionic gonadotrophin in the first trimester: implications for Down's syndrome screening.  Prenatal Diagnosis 1995;15(6):555‐65.    Link to article     Google Scholar     ","['https://doi.org/10.1002/pd.1970150609', ""https://scholar.google.com/scholar_lookup?title=Analysis+of+maternal+serum+alpha‐fetoprotein+and+free+ß+human+chorionic+gonadotrophin+in+the+first+trimester:+implications+for+Down's+syndrome+screening+&author=E+Berry&author=DA+Aitken&author=JA+Crossley&author=JN+Macri&author=JM+Connor&publication_year=1995&hl=en""]",,https://doi.org/10.1002/pd.1970150609, Berry 1995 {published data only}  ,excluded,CD009925-bbs2-0100, Less than 80% of pregnancies USS dated. 
CD009925-bib-0114,"Berry E, Aitken DA, Crossley JA, Macri JN, Connor JM. ",Screening for Down's syndrome: changes in marker levels and detection rates between first and second trimesters, British Journal of Obstetrics & Gynaecology ,1997,104,    ,['citation-journal']," Berry E, Aitken DA, Crossley JA, Macri JN, Connor JM. Screening for Down's syndrome: changes in marker levels and detection rates between first and second trimesters.  British Journal of Obstetrics & Gynaecology 1997;104(7):811‐7.    Link to article     Google Scholar     ","['https://doi.org/10.1111/j.1471-0528.1997.tb12025.x', ""https://scholar.google.com/scholar_lookup?title=Screening+for+Down's+syndrome:+changes+in+marker+levels+and+detection+rates+between+first+and+second+trimesters+&author=E+Berry&author=DA+Aitken&author=JA+Crossley&author=JN+Macri&author=JM+Connor&publication_year=1997&hl=en""]",,https://doi.org/10.1111/j.1471-0528.1997.tb12025.x, Berry 1997 {published data only}  ,excluded,CD009925-bbs2-0101, Less than 80% of pregnancies USS dated. 
CD009925-bib-0115,"Bersinger NA, Brizot ML, Johnson A, Snijders RJ, Abbott J, Schneider H, et al. ",First trimester maternal serum pregnancy‐associated plasma protein A and pregnancy‐specific ß 1‐glycoprotein in fetal trisomies, British Journal of Obstetrics & Gynaecology ,1994,101,    ,['citation-journal']," Bersinger NA, Brizot ML, Johnson A, Snijders RJ, Abbott J, Schneider H, et al. First trimester maternal serum pregnancy‐associated plasma protein A and pregnancy‐specific ß 1‐glycoprotein in fetal trisomies.  British Journal of Obstetrics & Gynaecology 1994;101(11):970‐4.    Link to article     Google Scholar     ","['https://doi.org/10.1111/j.1471-0528.1994.tb13042.x', 'https://scholar.google.com/scholar_lookup?title=First+trimester+maternal+serum+pregnancy‐associated+plasma+protein+A+and+pregnancy‐specific+ß+1‐glycoprotein+in+fetal+trisomies+&author=NA+Bersinger&author=ML+Brizot&author=A+Johnson&author=RJ+Snijders&author=J+Abbott&author=H+Schneider&publication_year=1994&hl=en']",,https://doi.org/10.1111/j.1471-0528.1994.tb13042.x, Bersinger 1994 {published data only}  ,excluded,CD009925-bbs2-0102, Gestational age not USS estimated. 
CD009925-bib-0116,"Bersinger NA, Xin WZ. ",Glycosylation of pregnancy‐associated plasma protein a (PAPP‐A) and pregnancy‐specific (ß)(1)‐glycoprotein (SP1): Relevance for fetal down syndrome screening and for placental function studies, Immuno‐Analyse et Biologie Specialisee ,2000,15,    ,['citation-journal']," Bersinger NA, Xin WZ. Glycosylation of pregnancy‐associated plasma protein a (PAPP‐A) and pregnancy‐specific (ß)(1)‐glycoprotein (SP1): Relevance for fetal down syndrome screening and for placental function studies.  Immuno‐Analyse et Biologie Specialisee 2000;15(6):402‐8.    Link to article     Google Scholar     ","['https://doi.org/10.1016/S0923-2532(00)80038-1', 'https://scholar.google.com/scholar_lookup?title=Glycosylation+of+pregnancy‐associated+plasma+protein+a+(PAPP‐A)+and+pregnancy‐specific+(ß)(1)‐glycoprotein+(SP1):+Relevance+for+fetal+down+syndrome+screening+and+for+placental+function+studies+&author=NA+Bersinger&author=WZ+Xin&publication_year=2000&hl=en']",,https://doi.org/10.1016/S0923-2532(00)80038-1, Bersinger 2000 {published data only}  ,excluded,CD009925-bbs2-0103, Unable to extract useful data. 
CD009925-bib-0117,"Bersinger NA, Chanson A, Crazzolara S, Hänggi W, Pescia G, Scheier M, et al. ",Serum levels of placenta protein markers: The relevance of differences between spontaneous and after in vitro fertilization pregnancies for fetal trisomy screening, Journal fur Fertilitat und Reproduktion ,2001,11,    ,['citation-journal']," Bersinger NA, Chanson A, Crazzolara S, Hänggi W, Pescia G, Scheier M, et al. Serum levels of placenta protein markers: The relevance of differences between spontaneous and after in vitro fertilization pregnancies for fetal trisomy screening.  Journal fur Fertilitat und Reproduktion 2001;11(3):7‐13.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=Serum+levels+of+placenta+protein+markers:+The+relevance+of+differences+between+spontaneous+and+after+in+vitro+fertilization+pregnancies+for+fetal+trisomy+screening+&author=NA+Bersinger&author=A+Chanson&author=S+Crazzolara&author=W+Hänggi&author=G+Pescia&author=M+Scheier&publication_year=2001&hl=en'],,, Bersinger 2001 {published data only}  ,excluded,CD009925-bbs2-0104, No Down's syndrome pregnancies in study population. 
CD009925-bib-0118,"Bersinger NA, Noble P, Nicolaides KH. ","First‐trimester maternal serum PAPP‐A, SP1 and M‐CSF levels in normal and trisomic twin pregnancies", Prenatal Diagnosis ,2003,23,    ,['citation-journal']," Bersinger NA, Noble P, Nicolaides KH. First‐trimester maternal serum PAPP‐A, SP1 and M‐CSF levels in normal and trisomic twin pregnancies.  Prenatal Diagnosis 2003;23(2):157‐62.    Link to article     Google Scholar     ","['https://doi.org/10.1002/pd.547', 'https://scholar.google.com/scholar_lookup?title=First‐trimester+maternal+serum+PAPP‐A,+SP1+and+M‐CSF+levels+in+normal+and+trisomic+twin+pregnancies+&author=NA+Bersinger&author=P+Noble&author=KH+Nicolaides&publication_year=2003&hl=en']",,https://doi.org/10.1002/pd.547, Bersinger 2003 {published data only}  ,excluded,CD009925-bbs2-0105, Unable to extract useful data. 
CD009925-bib-0119,"Bersinger NA, Wunder D, Vanderlick F, Chanson A, Pescia G, Janecek P, et al. ",Maternal serum levels of placental proteins after in vitro fertilisation and their implications for prenatal screening, Prenatal Diagnosis ,2004,24,    ,['citation-journal']," Bersinger NA, Wunder D, Vanderlick F, Chanson A, Pescia G, Janecek P, et al. Maternal serum levels of placental proteins after in vitro fertilisation and their implications for prenatal screening.  Prenatal Diagnosis 2004;24(6):471‐7.    Link to article     Google Scholar     ","['https://doi.org/10.1002/pd.910', 'https://scholar.google.com/scholar_lookup?title=Maternal+serum+levels+of+placental+proteins+after+in+vitro+fertilisation+and+their+implications+for+prenatal+screening+&author=NA+Bersinger&author=D+Wunder&author=F+Vanderlick&author=A+Chanson&author=G+Pescia&author=P+Janecek&publication_year=2004&hl=en']",,https://doi.org/10.1002/pd.910, Bersinger 2004 {published data only}  ,excluded,CD009925-bbs2-0106, No Down's syndrome pregnancies in study population. 
CD009925-bib-0120,"Bersinger NA, Vanderlick F, Birkhäuser MH, Janecek P, Wunder D. ",First trimester serum concentrations of placental proteins in singleton and multiple IVF pregnancies: Implications for Down syndrome screening, Immuno‐Analyse et Biologie Specialisee ,2005,20,    ,['citation-journal']," Bersinger NA, Vanderlick F, Birkhäuser MH, Janecek P, Wunder D. First trimester serum concentrations of placental proteins in singleton and multiple IVF pregnancies: Implications for Down syndrome screening.  Immuno‐Analyse et Biologie Specialisee 2005;20(1):21‐7.    Link to article     Google Scholar     ","['https://doi.org/10.1016/j.immbio.2004.11.006', 'https://scholar.google.com/scholar_lookup?title=First+trimester+serum+concentrations+of+placental+proteins+in+singleton+and+multiple+IVF+pregnancies:+Implications+for+Down+syndrome+screening+&author=NA+Bersinger&author=F+Vanderlick&author=MH+Birkhäuser&author=P+Janecek&author=D+Wunder&publication_year=2005&hl=en']",,https://doi.org/10.1016/j.immbio.2004.11.006, Bersinger 2005 {published data only}  ,excluded,CD009925-bbs2-0107, No Down's syndrome pregnancies in study population. 
CD009925-bib-0121,"Biggio Jr, Morris TC, Owen J, Stringer JSA. ",An outcomes analysis of five prenatal screening strategies for trisomy 21 in women younger than 35 years, American Journal of Obstetrics and Gynecology ,2004,190,    ,['citation-journal']," Biggio Jr, Morris TC, Owen J, Stringer JSA. An outcomes analysis of five prenatal screening strategies for trisomy 21 in women younger than 35 years.  American Journal of Obstetrics and Gynecology 2004;190(3):721‐9.    Link to article     Google Scholar     ","['https://doi.org/10.1016/j.ajog.2003.09.028', 'https://scholar.google.com/scholar_lookup?title=An+outcomes+analysis+of+five+prenatal+screening+strategies+for+trisomy+21+in+women+younger+than+35+years+&author=Jr+Biggio&author=TC+Morris&author=J+Owen&author=JSA+Stringer&publication_year=2004&hl=en']",,https://doi.org/10.1016/j.ajog.2003.09.028, Biggio 2004 {published data only}  ,excluded,CD009925-bbs2-0108, Cost‐effectiveness analysis. 
CD009925-bib-0122,"Bindra R, Heath V, Nicolaides KH. ",Screening for chromosomal defects by fetal nuchal translucency at 11 to 14 weeks, Clinical Obstetrics and Gynecology ,2002,45,    ,['citation-journal']," Bindra R, Heath V, Nicolaides KH. Screening for chromosomal defects by fetal nuchal translucency at 11 to 14 weeks.  Clinical Obstetrics and Gynecology 2002;45(3):661‐70.    Link to article     Google Scholar     ","['https://doi.org/10.1097/00003081-200209000-00010', 'https://scholar.google.com/scholar_lookup?title=Screening+for+chromosomal+defects+by+fetal+nuchal+translucency+at+11+to+14+weeks&author=R+Bindra&author=V+Heath&author=KH+Nicolaides&publication_year=2002&hl=en']",,https://doi.org/10.1097/00003081-200209000-00010, Bindra 2002 {published data only}  ,excluded,CD009925-bbs2-0109, Review article. 
CD009925-bib-0123,"Blundell G, Ashby JP, Martin C, Shearing CH, Langdale‐Brown B, Keeling J, et al. ",Clinical follow‐up of high mid‐trimester maternal serum intact human chorionic gonadotrophin concentrations in singleton pregnancies, Prenatal Diagnosis. ,1999,19,    ,['citation-journal']," Blundell G, Ashby JP, Martin C, Shearing CH, Langdale‐Brown B, Keeling J, et al. Clinical follow‐up of high mid‐trimester maternal serum intact human chorionic gonadotrophin concentrations in singleton pregnancies.  Prenatal Diagnosis. 1999;19(3):219‐23.    Link to article     Google Scholar     ","['https://doi.org/10.1002/(SICI)1097-0223(199903)19:3<219::AID-PD512>3.0.CO;2-K', 'https://scholar.google.com/scholar_lookup?title=Clinical+follow‐up+of+high+mid‐trimester+maternal+serum+intact+human+chorionic+gonadotrophin+concentrations+in+singleton+pregnancies+&author=G+Blundell&author=JP+Ashby&author=C+Martin&author=CH+Shearing&author=B+Langdale‐Brown&author=J+Keeling&publication_year=1999&hl=en']",,https://doi.org/10.1002/(SICI)1097-0223(199903)19:3<219::AID-PD512>3.0.CO;2-K, Blundell 1999 {published data only}  ,excluded,CD009925-bbs2-0110, Unable to extract useful data. 
CD009925-bib-0124,"Boots LR, Davis RO, Foster JM, Goldenberg RL. ",Maternal serum alpha‐fetoprotein prenatal screening for Down syndrome, Alabama Medicine ,1989,59,    ,['citation-journal']," Boots LR, Davis RO, Foster JM, Goldenberg RL. Maternal serum alpha‐fetoprotein prenatal screening for Down syndrome.  Alabama Medicine 1989;59(1):25‐7.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=Maternal+serum+alpha‐fetoprotein+prenatal+screening+for+Down+syndrome&author=LR+Boots&author=RO+Davis&author=JM+Foster&author=RL+Goldenberg&publication_year=1989&hl=en'],,, Boots 1989 {published data only}  ,excluded,CD009925-bbs2-0111, Population risk factor calculations. 
CD009925-bib-0125,"Borruto F, Comparetto C, Acanfora L, Bertini G, Rubaltelli FF. ",Role of ultrasound evaluation of nuchal translucency in prenatal diagnosis, Clinical & Experimental Obstetrics & Gynecology ,2002,29,    ,['citation-journal']," Borruto F, Comparetto C, Acanfora L, Bertini G, Rubaltelli FF. Role of ultrasound evaluation of nuchal translucency in prenatal diagnosis.  Clinical & Experimental Obstetrics & Gynecology 2002;29(4):235‐41.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=Role+of+ultrasound+evaluation+of+nuchal+translucency+in+prenatal+diagnosis&author=F+Borruto&author=C+Comparetto&author=L+Acanfora&author=G+Bertini&author=FF+Rubaltelli&publication_year=2002&hl=en'],,, Borruto 2002 {published data only}  ,excluded,CD009925-bbs2-0112, Unable to extract useful data. 
CD009925-bib-0126,"Boue A, Muller F. ",Screening for Down's syndrome with maternal serum human chorionic gonadotropin at midtrimester, Current Opinion in Pediatrics ,1990,2,    ,['citation-journal']," Boue A, Muller F. Screening for Down's syndrome with maternal serum human chorionic gonadotropin at midtrimester.  Current Opinion in Pediatrics 1990;2(6):1157‐60.    Google Scholar     ","[""https://scholar.google.com/scholar_lookup?title=Screening+for+Down's+syndrome+with+maternal+serum+human+chorionic+gonadotropin+at+midtrimester+&author=A+Boue&author=F+Muller&publication_year=1990&hl=en""]",,, Boue 1990 {published data only}  ,excluded,CD009925-bbs2-0113, Review article. 
CD009925-bib-0127,"Bradley LA, Horwitz JA, Dowman AC, Ponting NR, Peterson LM. ",Triple marker screening for fetal Down syndrome, International Pediatrics ,1994,9,    ,['citation-journal']," Bradley LA, Horwitz JA, Dowman AC, Ponting NR, Peterson LM. Triple marker screening for fetal Down syndrome.  International Pediatrics 1994;9(3):168‐74.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=Triple+marker+screening+for+fetal+Down+syndrome&author=LA+Bradley&author=JA+Horwitz&author=AC+Dowman&author=NR+Ponting&author=LM+Peterson&publication_year=1994&hl=en'],,, Bradley 1994 {published data only}  ,excluded,CD009925-bbs2-0114, Screen negative population gestations not confirmed by ultrasound. 
CD009925-bib-0128,"Braithwaite JM, Economides DL. ",Nuchal translucency and screening for Down's syndrome, Contemporary Reviews in Obstetrics and Gynaecology ,1996,8,    ,['citation-journal']," Braithwaite JM, Economides DL. Nuchal translucency and screening for Down's syndrome.  Contemporary Reviews in Obstetrics and Gynaecology 1996;8(2):75‐81.    Google Scholar     ","[""https://scholar.google.com/scholar_lookup?title=Nuchal+translucency+and+screening+for+Down's+syndrome&author=JM+Braithwaite&author=DL+Economides&publication_year=1996&hl=en""]",,, Braithwaite 1996 {published data only}  ,excluded,CD009925-bbs2-0115, Review article. 
CD009925-bib-0129,"Brambati B, Cislaghi C, Tului L, Alberti E, Amidani M, Colombo U, et al. ",First‐trimester Down's syndrome screening using nuchal translucency: a prospective study in women undergoing chorionic villus sampling, Ultrasound in Obstetrics & Gynecology ,1995,5,    ,['citation-journal']," Brambati B, Cislaghi C, Tului L, Alberti E, Amidani M, Colombo U, et al. First‐trimester Down's syndrome screening using nuchal translucency: a prospective study in women undergoing chorionic villus sampling.  Ultrasound in Obstetrics & Gynecology 1995;5(1):9‐14.    Link to article     Google Scholar     ","['https://doi.org/10.1046/j.1469-0705.1995.05010009.x', ""https://scholar.google.com/scholar_lookup?title=First‐trimester+Down's+syndrome+screening+using+nuchal+translucency:+a+prospective+study+in+women+undergoing+chorionic+villus+sampling+&author=B+Brambati&author=C+Cislaghi&author=L+Tului&author=E+Alberti&author=M+Amidani&author=U+Colombo&publication_year=1995&hl=en""]",,https://doi.org/10.1046/j.1469-0705.1995.05010009.x, Brambati 1995 {published data only}  ,excluded,CD009925-bbs2-0116, USS screening inclusive of women greater than 14 weeks gestation. 
CD009925-bib-0130,"Brambati B, Tului L, Alberti E. ",Sonography in the first trimester screening of trisomy 21 and other fetal aneuploidies. [Review] [73 refs], Early Pregnancy ,1996,2,    ,['citation-journal']," Brambati B, Tului L, Alberti E. Sonography in the first trimester screening of trisomy 21 and other fetal aneuploidies. [Review] [73 refs].  Early Pregnancy 1996;2(3):155‐67.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=Sonography+in+the+first+trimester+screening+of+trisomy+21+and+other+fetal+aneuploidies.+[Review]+[73+refs]+&author=B+Brambati&author=L+Tului&author=E+Alberti&publication_year=1996&hl=en'],,, Brambati 1996 {published data only}  ,excluded,CD009925-bbs2-0117, Review article. 
CD009925-bib-0131,"Brizot ML, Bersinger NA, Xydias G, Snijders RJ, Nicolaides KH. ",Maternal serum Schwangerschafts protein‐1 (SP1) and fetal chromosomal abnormalities at 10‐13 weeks' gestation, Early Human Development. ,1995,43,    ,['citation-journal']," Brizot ML, Bersinger NA, Xydias G, Snijders RJ, Nicolaides KH. Maternal serum Schwangerschafts protein‐1 (SP1) and fetal chromosomal abnormalities at 10‐13 weeks' gestation.  Early Human Development. 1995;43(1):31‐6.    Link to article     Google Scholar     ","['https://doi.org/10.1016/0378-3782(95)01658-P', ""https://scholar.google.com/scholar_lookup?title=Maternal+serum+Schwangerschafts+protein‐1+(SP1)+and+fetal+chromosomal+abnormalities+at+10‐13+weeks'+gestation+&author=ML+Brizot&author=NA+Bersinger&author=G+Xydias&author=RJ+Snijders&author=KH+Nicolaides&publication_year=1995&hl=en""]",,https://doi.org/10.1016/0378-3782(95)01658-P, Brizot 1995a {published data only}  ,excluded,CD009925-bbs2-0118, Unable to extract useful data. 
CD009925-bib-0132,"Brizot ML, Kuhn P, Bersinger NA, Snijders RJ, Nicolaides KH. ",First trimester maternal serum alpha‐fetoprotein in fetal trisomies, British Journal of Obstetrics & Gynaecology ,1995,102,    ,['citation-journal']," Brizot ML, Kuhn P, Bersinger NA, Snijders RJ, Nicolaides KH. First trimester maternal serum alpha‐fetoprotein in fetal trisomies.  British Journal of Obstetrics & Gynaecology 1995;102(1):31‐4.    Link to article     Google Scholar     ","['https://doi.org/10.1111/j.1471-0528.1995.tb09022.x', 'https://scholar.google.com/scholar_lookup?title=First+trimester+maternal+serum+alpha‐fetoprotein+in+fetal+trisomies&author=ML+Brizot&author=P+Kuhn&author=NA+Bersinger&author=RJ+Snijders&author=KH+Nicolaides&publication_year=1995&hl=en']",,https://doi.org/10.1111/j.1471-0528.1995.tb09022.x, Brizot 1995b {published data only}  ,excluded,CD009925-bbs2-0119, Unable to extract useful data. 
CD009925-bib-0133,"Brizzi L, Cariati E, Periti E, Nannini R, Torricelli F, Cappelli G, et al. ",Evaluation of maternal serum alpha‐fetoprotein and ultrasound examination to screen fetal chromosomal abnormalities, Journal of Nuclear Medicine & Allied Sciences ,1989,33,    ,['citation-journal']," Brizzi L, Cariati E, Periti E, Nannini R, Torricelli F, Cappelli G, et al. Evaluation of maternal serum alpha‐fetoprotein and ultrasound examination to screen fetal chromosomal abnormalities.  Journal of Nuclear Medicine & Allied Sciences 1989;33(3 Suppl):85‐8.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=Evaluation+of+maternal+serum+alpha‐fetoprotein+and+ultrasound+examination+to+screen+fetal+chromosomal+abnormalities+&author=L+Brizzi&author=E+Cariati&author=E+Periti&author=R+Nannini&author=F+Torricelli&author=G+Cappelli&publication_year=1989&hl=en'],,, Brizzi 1989b {published data only}  ,excluded,CD009925-bbs2-0120, Second trimester ultrasound. 
CD009925-bib-0134,"Brock DJ, Barron L, Holloway S, Liston WA, Hillier SG, Seppala M. ",First‐trimester maternal serum biochemical indicators in Down syndrome, Prenatal Diagnosis ,1990,10,    ,['citation-journal']," Brock DJ, Barron L, Holloway S, Liston WA, Hillier SG, Seppala M. First‐trimester maternal serum biochemical indicators in Down syndrome.  Prenatal Diagnosis 1990;10(4):245‐51.    Link to article     Google Scholar     ","['https://doi.org/10.1002/pd.1970100406', 'https://scholar.google.com/scholar_lookup?title=First‐trimester+maternal+serum+biochemical+indicators+in+Down+syndrome&author=DJ+Brock&author=L+Barron&author=S+Holloway&author=WA+Liston&author=SG+Hillier&author=M+Seppala&publication_year=1990&hl=en']",,https://doi.org/10.1002/pd.1970100406, Brock 1990 {published data only}  ,excluded,CD009925-bbs2-0121, Unable to extract useful data. 
CD009925-bib-0135,"Campogrande M, Viora E, Errante G, Bastonero S, Sciarrone A, Grassi Pirrone P, et al. ",Correlations between first and second trimester markers for Down's syndrome screening, Journal of Medical Screening ,2001,8,    ,['citation-journal']," Campogrande M, Viora E, Errante G, Bastonero S, Sciarrone A, Grassi Pirrone P, et al. Correlations between first and second trimester markers for Down's syndrome screening.  Journal of Medical Screening 2001;8(3):163‐4.    Link to article     Google Scholar     ","['https://doi.org/10.1136/jms.8.3.163', ""https://scholar.google.com/scholar_lookup?title=Correlations+between+first+and+second+trimester+markers+for+Down's+syndrome+screening&author=M+Campogrande&author=E+Viora&author=G+Errante&author=S+Bastonero&author=A+Sciarrone&author=P+GrassiPirrone&publication_year=2001&hl=en""]",,https://doi.org/10.1136/jms.8.3.163, Campogrande 2001 {published data only}  ,excluded,CD009925-bbs2-0122, Unable to extract useful data. 
CD009925-bib-0136,"Canick JA, Knight GJ, Palomaki GE, Haddow JE, Cuckle HS, Wald NJ. ",Low second trimester maternal serum unconjugated oestriol in pregnancies with Down's syndrome, British Journal of Obstetrics & Gynaecology ,1988,95,    ,['citation-journal']," Canick JA, Knight GJ, Palomaki GE, Haddow JE, Cuckle HS, Wald NJ. Low second trimester maternal serum unconjugated oestriol in pregnancies with Down's syndrome.  British Journal of Obstetrics & Gynaecology 1988;95(4):330‐3.    Link to article     Google Scholar     ","['https://doi.org/10.1111/j.1471-0528.1988.tb06601.x', ""https://scholar.google.com/scholar_lookup?title=Low+second+trimester+maternal+serum+unconjugated+oestriol+in+pregnancies+with+Down's+syndrome+&author=JA+Canick&author=GJ+Knight&author=GE+Palomaki&author=JE+Haddow&author=HS+Cuckle&author=NJ+Wald&publication_year=1988&hl=en""]",,https://doi.org/10.1111/j.1471-0528.1988.tb06601.x, Canick 1988 {published data only}  ,excluded,CD009925-bbs2-0123, Unable to extract useful data. 
CD009925-bib-0137,"Canick JA, Kellner LH, Saller Jr, Palomaki GE, Walker RP, Osathanondh R. ",Second‐trimester levels of maternal urinary gonadotropin peptide in down syndrome pregnancy, Prenatal Diagnosis ,1995,15,    ,['citation-journal']," Canick JA, Kellner LH, Saller Jr, Palomaki GE, Walker RP, Osathanondh R. Second‐trimester levels of maternal urinary gonadotropin peptide in down syndrome pregnancy.  Prenatal Diagnosis 1995;15(8):739‐44.    Link to article     Google Scholar     ","['https://doi.org/10.1002/pd.1970150809', 'https://scholar.google.com/scholar_lookup?title=Second‐trimester+levels+of+maternal+urinary+gonadotropin+peptide+in+down+syndrome+pregnancy+&author=JA+Canick&author=LH+Kellner&author=Jr+Saller&author=GE+Palomaki&author=RP+Walker&author=R+Osathanondh&publication_year=1995&hl=en']",,https://doi.org/10.1002/pd.1970150809, Canick 1995b {published data only}  ,excluded,CD009925-bbs2-0124, Unable to extract useful data. 
CD009925-bib-0138,"Canini S, Prefumo F, Famularo L, Venturini PL, Palazzese V, De Biasio P. ","Comparison of first trimester, second trimester and integrated Down's syndrome screening results in unaffected pregnancies", Clinical Chemistry & Laboratory Medicine ,2002,40,    ,['citation-journal']," Canini S, Prefumo F, Famularo L, Venturini PL, Palazzese V, De Biasio P. Comparison of first trimester, second trimester and integrated Down's syndrome screening results in unaffected pregnancies.  Clinical Chemistry & Laboratory Medicine 2002;40(6):600‐3.    Link to article     Google Scholar     ","['https://doi.org/10.1515/CCLM.2002.103', ""https://scholar.google.com/scholar_lookup?title=Comparison+of+first+trimester,+second+trimester+and+integrated+Down's+syndrome+screening+results+in+unaffected+pregnancies+&author=S+Canini&author=F+Prefumo&author=L+Famularo&author=PL+Venturini&author=V+Palazzese&author=P+Biasio&publication_year=2002&hl=en""]",,https://doi.org/10.1515/CCLM.2002.103, Canini 2002 {published data only}  ,excluded,CD009925-bbs2-0125, No Down's syndrome pregnancies in study population. 
CD009925-bib-0139,"Cans C, Amblard F, Devillard F, Pison H, Jalbert P, Jouk PS. ",Population screening for aneuploidy using maternal age and ultrasound, Prenatal Diagnosis ,1998,18,    ,['citation-journal']," Cans C, Amblard F, Devillard F, Pison H, Jalbert P, Jouk PS. Population screening for aneuploidy using maternal age and ultrasound.  Prenatal Diagnosis 1998;18(7):683‐92.    Link to article     Google Scholar     ","['https://doi.org/10.1002/(SICI)1097-0223(199807)18:7<683::AID-PD327>3.0.CO;2-G', 'https://scholar.google.com/scholar_lookup?title=Population+screening+for+aneuploidy+using+maternal+age+and+ultrasound&author=C+Cans&author=F+Amblard&author=F+Devillard&author=H+Pison&author=P+Jalbert&author=PS+Jouk&publication_year=1998&hl=en']",,https://doi.org/10.1002/(SICI)1097-0223(199807)18:7<683::AID-PD327>3.0.CO;2-G, Cans 1998 {published data only}  ,excluded,CD009925-bbs2-0126, Second trimester ultrasound. 
CD009925-bib-0140,"Carreras de Paz JJ, Silva Mendoza JM, Violante Diaz M, Cerrillo Hinojosa M, hued Ahued JR. ",[Proposed normal values for alpha fetoprotein in maternal serum for the detection of neural tube closure defects and Down syndrome. Preliminary study]. [Spanish], Ginecologia y Obstetricia de Mexico ,1991,59,    ,['citation-journal']," Carreras de Paz JJ, Silva Mendoza JM, Violante Diaz M, Cerrillo Hinojosa M, hued Ahued JR. [Proposed normal values for alpha fetoprotein in maternal serum for the detection of neural tube closure defects and Down syndrome. Preliminary study]. [Spanish].  Ginecologia y Obstetricia de Mexico 1991;59:261‐4.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=[Proposed+normal+values+for+alpha+fetoprotein+in+maternal+serum+for+the+detection+of+neural+tube+closure+defects+and+Down+syndrome.+Preliminary+study].+[Spanish]+&author=JJ+CarrerasdePaz&author=JM+SilvaMendoza&author=M+ViolanteDiaz&author=M+CerrilloHinojosa&author=JR+huedAhued&publication_year=1991&hl=en'],,, Carreras 1991 {published data only}  ,excluded,CD009925-bbs2-0127, Second trimester ultrasound. 
CD009925-bib-0141,Chen FM. ,Integrated screening for Down's syndrome, Journal of Family Practice ,1999,48,    ,['citation-journal'], Chen FM. Integrated screening for Down's syndrome.  Journal of Family Practice 1999;48(11):846‐7.    Google Scholar     ,"[""https://scholar.google.com/scholar_lookup?title=Integrated+screening+for+Down's+syndrome&author=FM+Chen&publication_year=1999&hl=en""]",,, Chen 1999 {published data only}  ,excluded,CD009925-bbs2-0128, Review article. 
CD009925-bib-0142,"Chen M, Lam YH, Tang MH, Lee CP, Sin SY, Tang R, et al. ",The effect of ethnic origin on nuchal translucency at 10‐14 weeks of gestation, Prenatal Diagnosis ,2002,22,    ,['citation-journal']," Chen M, Lam YH, Tang MH, Lee CP, Sin SY, Tang R, et al. The effect of ethnic origin on nuchal translucency at 10‐14 weeks of gestation.  Prenatal Diagnosis 2002;22(7):576‐8.    Link to article     Google Scholar     ","['https://doi.org/10.1002/pd.363', 'https://scholar.google.com/scholar_lookup?title=The+effect+of+ethnic+origin+on+nuchal+translucency+at+10‐14+weeks+of+gestation&author=M+Chen&author=YH+Lam&author=MH+Tang&author=CP+Lee&author=SY+Sin&author=R+Tang&publication_year=2002&hl=en']",,https://doi.org/10.1002/pd.363, Chen 2002 {published data only}  ,excluded,CD009925-bbs2-0129, No Down's syndrome pregnancies in study population. 
CD009925-bib-0143,"Chen M, Lam YH, Lee CP, Tang MHY. ",Ultrasound screening of fetal structural abnormalities at 12 to 14 weeks in Hong Kong, Prenatal Diagnosis ,2004,24,    ,['citation-journal']," Chen M, Lam YH, Lee CP, Tang MHY. Ultrasound screening of fetal structural abnormalities at 12 to 14 weeks in Hong Kong.  Prenatal Diagnosis 2004;24(2):92‐7.    Link to article     Google Scholar     ","['https://doi.org/10.1002/pd.798', 'https://scholar.google.com/scholar_lookup?title=Ultrasound+screening+of+fetal+structural+abnormalities+at+12+to+14+weeks+in+Hong+Kong&author=M+Chen&author=YH+Lam&author=CP+Lee&author=MHY+Tang&publication_year=2004&hl=en']",,https://doi.org/10.1002/pd.798, Chen 2004 {published data only}  ,excluded,CD009925-bbs2-0130, Less than 5 Down's cases in study population. 
CD009925-bib-0144,"Chen CP, Lin CJ, Wang W. ",Impact of second‐trimester maternal serum screening on prenatal diagnosis of Down syndrome and the use of amniocentesis in the Taiwanese population, Taiwanese Journal of Obstetrics and Gynecology ,2005,44,    ,['citation-journal']," Chen CP, Lin CJ, Wang W. Impact of second‐trimester maternal serum screening on prenatal diagnosis of Down syndrome and the use of amniocentesis in the Taiwanese population.  Taiwanese Journal of Obstetrics and Gynecology 2005;44(1):31‐5.    Link to article     Google Scholar     ","['https://doi.org/10.1016/S1028-4559(09)60103-0', 'https://scholar.google.com/scholar_lookup?title=Impact+of+second‐trimester+maternal+serum+screening+on+prenatal+diagnosis+of+Down+syndrome+and+the+use+of+amniocentesis+in+the+Taiwanese+population+&author=CP+Chen&author=CJ+Lin&author=W+Wang&publication_year=2005&hl=en']",,https://doi.org/10.1016/S1028-4559(09)60103-0, Chen 2005 {published data only}  ,excluded,CD009925-bbs2-0131, Unable to extract useful data. 
CD009925-bib-0145,"Cheng EY, Luthy DA, Zebelman AM, Williams MA, Lieppman RE, Hickok DE. ","A prospective evaluation of a second‐trimester screening test for fetal Down syndrome using maternal serum alpha‐fetoprotein, hCG, and unconjugated estriol", Obstetrics & Gynecology ,1993,81,    ,['citation-journal']," Cheng EY, Luthy DA, Zebelman AM, Williams MA, Lieppman RE, Hickok DE. A prospective evaluation of a second‐trimester screening test for fetal Down syndrome using maternal serum alpha‐fetoprotein, hCG, and unconjugated estriol.  Obstetrics & Gynecology 1993;81(1):72‐7.    Google Scholar     ","['https://scholar.google.com/scholar_lookup?title=A+prospective+evaluation+of+a+second‐trimester+screening+test+for+fetal+Down+syndrome+using+maternal+serum+alpha‐fetoprotein,+hCG,+and+unconjugated+estriol+&author=EY+Cheng&author=DA+Luthy&author=AM+Zebelman&author=MA+Williams&author=RE+Lieppman&author=DE+Hickok&publication_year=1993&hl=en']",,, Cheng 1993 {published data only}  ,excluded,CD009925-bbs2-0132, Likely that fewer than 80% of gestational age confirmed by USS. 
CD009925-bib-0146,"Cheng PJ, Liu CM, Chang SD, Lin YT, Soong YK. ",Elevated second‐trimester maternal serum hCG in women undergoing haemodialysis, Prenatal Diagnosis. ,1999,19,    ,['citation-journal']," Cheng PJ, Liu CM, Chang SD, Lin YT, Soong YK. Elevated second‐trimester maternal serum hCG in women undergoing haemodialysis.  Prenatal Diagnosis. 1999;19(10):955‐8.    Link to article     Google Scholar     ","['https://doi.org/10.1002/(SICI)1097-0223(199910)19:10<955::AID-PD670>3.0.CO;2-X', 'https://scholar.google.com/scholar_lookup?title=Elevated+second‐trimester+maternal+serum+hCG+in+women+undergoing+haemodialysis&author=PJ+Cheng&author=CM+Liu&author=SD+Chang&author=YT+Lin&author=YK+Soong&publication_year=1999&hl=en']",,https://doi.org/10.1002/(SICI)1097-0223(199910)19:10<955::AID-PD670>3.0.CO;2-X, Cheng 1999 {published data only}  ,excluded,CD009925-bbs2-0133, Case series. No Down's syndrome pregnancies in study population. 
CD009925-bib-0147,"Cheng CC, Bahado‐Singh RO, Chen SC, Tsai MS. ",Pregnancy outcomes with increased nuchal translucency after routine Down syndrome screening, International Journal of Gynaecology & Obstetrics ,2004,84,    ,['citation-journal']," Cheng CC, Bahado‐Singh RO, Chen SC, Tsai MS. Pregnancy outcomes with increased nuchal translucency after routine Down syndrome screening.  International Journal of Gynaecology & Obstetrics 2004;84(1):5‐9.    Link to article     Google Scholar     ","['https://doi.org/10.1016/S0020-7292(03)00206-6', 'https://scholar.google.com/scholar_lookup?title=Pregnancy+outcomes+with+increased+nuchal+translucency+after+routine+Down+syndrome+screening+&author=CC+Cheng&author=RO+Bahado‐Singh&author=SC+Chen&author=MS+Tsai&publication_year=2004&hl=en']",,https://doi.org/10.1016/S0020-7292(03)00206-6, Cheng 2004a {published data only}  ,excluded,CD009925-bbs2-0134, No Down's syndrome pregnancies in study population. 
CD009925-bib-0148,"Cheng PJ, Chu DC, Chueh HY, See LC, Chang HC, Weng DR. ",Elevated maternal midtrimester serum free ß‐human chorionic gonadotropin levels in vegetarian pregnancies that cause increased false‐positive Down syndrome screening results, American Journal of Obstetrics & Gynecology. ,2004,190,    ,['citation-journal']," Cheng PJ, Chu DC, Chueh HY, See LC, Chang HC, Weng DR. Elevated maternal midtrimester serum free ß‐human chorionic gonadotropin levels in vegetarian pregnancies that cause increased false‐positive Down syndrome screening results.  American Journal of Obstetrics & Gynecology. 2004;190(2):442‐7.    Link to article     Google Scholar     ","['https://doi.org/10.1016/S0002-9378(03)00948-7', 'https://scholar.google.com/scholar_lookup?title=Elevated+maternal+midtrimester+serum+free+ß‐human+chorionic+gonadotropin+levels+in+vegetarian+pregnancies+that+cause+increased+false‐positive+Down+syndrome+screening+results+&author=PJ+Cheng&author=DC+Chu&author=HY+Chueh&author=LC+See&author=HC+Chang&author=DR+Weng&publication_year=2004&hl=en']",,https://doi.org/10.1016/S0002-9378(03)00948-7, Cheng 2004b {published data only}  ,excluded,CD009925-bbs2-0135, No Down's syndrome pregnancies in study population. 
CD009925-bib-0149,"Chitayat D, Farrell SA, Huang T, Meier C, Wyatt PR, Summers AM. ",Double‐positive maternal serum screening results for down syndrome and open neural tube defects: An indicator for fetal structural or chromosomal abnormalities and adverse obstetric outcomes, American Journal of Obstetrics & Gynecology ,2002,187,    ,['citation-journal']," Chitayat D, Farrell SA, Huang T, Meier C, Wyatt PR, Summers AM. Double‐positive maternal serum screening results for down syndrome and open neural tube defects: An indicator for fetal structural or chromosomal abnormalities and adverse obstetric outcomes.  American Journal of Obstetrics & Gynecology 2002;187(3):758‐63.    Link to article     Google Scholar     ","['https://doi.org/10.1067/mob.2002.125240', 'https://scholar.google.com/scholar_lookup?title=Double‐positive+maternal+serum+screening+results+for+down+syndrome+and+open+neural+tube+defects:+An+indicator+for+fetal+structural+or+chromosomal+abnormalities+and+adverse+obstetric+outcomes+&author=D+Chitayat&author=SA+Farrell&author=T+Huang&author=C+Meier&author=PR+Wyatt&author=AM+Summers&publication_year=2002&hl=en']",,https://doi.org/10.1067/mob.2002.125240, Chitayat 2002 {published data only}  ,excluded,CD009925-bbs2-0136, Less than 5 Down's cases in study population. 
CD009925-bib-0150,"Christiansen M, Hogdall EV, Larsen SO, Hogdall C. ",The variation of risk estimates through pregnancy in second trimester maternal serum screening for Down syndrome, Prenatal Diagnosis ,2002,22,    ,['citation-journal']," Christiansen M, Hogdall EV, Larsen SO, Hogdall C. The variation of risk estimates through pregnancy in second trimester maternal serum screening for Down syndrome.  Prenatal Diagnosis 2002;22(5):385‐7.    Link to article     Google Scholar     ","['https://doi.org/10.1002/pd.297', 'https://scholar.google.com/scholar_lookup?title=The+variation+of+risk+estimates+through+pregnancy+in+second+trimester+maternal+serum+screening+for+Down+syndrome+&author=M+Christiansen&author=EV+Hogdall&author=SO+Larsen&author=C+Hogdall&publication_year=2002&hl=en']",,https://doi.org/10.1002/pd.297, Christiansen 2002 {published data only}  ,excluded,CD009925-bbs2-0137, Unable to extract useful data. 
CD009925-bib-0151,"Christiansen M, Sorensen TL, Norgaard‐Pedersen B. ",Human placental lactogen is a first‐trimester maternal serum marker of Down syndrome, Prenatal Diagnosis ,2007,27,    ,['citation-journal']," Christiansen M, Sorensen TL, Norgaard‐Pedersen B. Human placental lactogen is a first‐trimester maternal serum marker of Down syndrome.  Prenatal Diagnosis 2007;27(1):1‐5.    Link to article     Google Scholar     ","['https://doi.org/10.1002/pd.1600', 'https://scholar.google.com/scholar_lookup?title=Human+placental+lactogen+is+a+first‐trimester+maternal+serum+marker+of+Down+syndrome&author=M+Christiansen&author=TL+Sorensen&author=B+Norgaard‐Pedersen&publication_year=2007&hl=en']",,https://doi.org/10.1002/pd.1600, Christiansen 2007 {published data only}  ,excluded,CD009925-bbs2-0138, Unable to extract useful data. 
CD009925-bib-0152,"Chung BL, Kim YP, Nam MH. ",The application of three‐dimensional ultrasound to nuchal translucency thickness measurement at 10‐14 weeks of gestation, Prenatal and Neonatal Medicine ,2000,5,    ,['citation-journal']," Chung BL, Kim YP, Nam MH. The application of three‐dimensional ultrasound to nuchal translucency thickness measurement at 10‐14 weeks of gestation.  Prenatal and Neonatal Medicine 2000;5(1):17‐21.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=The+application+of+three‐dimensional+ultrasound+to+nuchal+translucency+thickness+measurement+at+10‐14+weeks+of+gestation+&author=BL+Chung&author=YP+Kim&author=MH+Nam&publication_year=2000&hl=en'],,, Chung 2000 {published data only}  ,excluded,CD009925-bbs2-0139, Less than 5 Down's syndrome pregnancies in study population. 
CD009925-bib-0153,Anon. ,Blood screening of Down's syndrome (Trisomy 21) and reimbursement of karyotype for women under 38, Revue Francaise de Gynecologie et d'Obstetrique ,1996,91,    ,['citation-journal'], Anon. Blood screening of Down's syndrome (Trisomy 21) and reimbursement of karyotype for women under 38.  Revue Francaise de Gynecologie et d'Obstetrique 1996;91(11):575‐7.    Google Scholar     ,"[""https://scholar.google.com/scholar_lookup?title=Blood+screening+of+Down's+syndrome+(Trisomy+21)+and+reimbursement+of+karyotype+for+women+under+38+&author=+Anon&publication_year=1996&hl=en""]",,, CNGOF 1996 {published data only}  ,excluded,CD009925-bbs2-0140, Unable to obtain translation. 
CD009925-bib-0154,"Cole L, Isozaki T, Palomaki G, Canick J, Iles R, Kellner L, et al. ",Detection of ß‐core fragment in second trimester Down's syndrome pregnancies. [Review], Early Human Development ,1996,47 Suppl,    ,['citation-journal']," Cole L, Isozaki T, Palomaki G, Canick J, Iles R, Kellner L, et al. Detection of ß‐core fragment in second trimester Down's syndrome pregnancies. [Review].  Early Human Development 1996;47 Suppl:S47‐S8.    Google Scholar     ","[""https://scholar.google.com/scholar_lookup?title=Detection+of+ß‐core+fragment+in+second+trimester+Down's+syndrome+pregnancies.+[Review]&author=L+Cole&author=T+Isozaki&author=G+Palomaki&author=J+Canick&author=R+Iles&author=L+Kellner&publication_year=1996&hl=en""]",,, Cole 1996 {published data only}  ,excluded,CD009925-bbs2-0141, Review article. 
CD009925-bib-0155,"Comas C, Antolín E, Torrents M, Muñoz A, Figueras F, Echevarría M, et al. ","Early screening for chromosomal abnormalities: New strategies combining biochemical, sonographic and doppler parameters", Prenatal and Neonatal Medicine ,2001,6,    ,['citation-journal']," Comas C, Antolín E, Torrents M, Muñoz A, Figueras F, Echevarría M, et al. Early screening for chromosomal abnormalities: New strategies combining biochemical, sonographic and doppler parameters.  Prenatal and Neonatal Medicine 2001;6(2):95‐102.    Google Scholar     ","['https://scholar.google.com/scholar_lookup?title=Early+screening+for+chromosomal+abnormalities:+New+strategies+combining+biochemical,+sonographic+and+doppler+parameters+&author=C+Comas&author=E+Antolín&author=M+Torrents&author=A+Muñoz&author=F+Figueras&author=M+Echevarría&publication_year=2001&hl=en']",,, Comas 2001 {published data only}  ,excluded,CD009925-bbs2-0142, USS at greater than 14 weeks. 
CD009925-bib-0156,"Comas C, Torrents M, Munoz A, Antolin E, Figueras F, Echevarria M. ",Measurement of nuchal translucency as a single strategy in trisomy 21 screening: should we use any other marker?, Obstetrics & Gynecology ,2002,100,    ,['citation-journal']," Comas C, Torrents M, Munoz A, Antolin E, Figueras F, Echevarria M. Measurement of nuchal translucency as a single strategy in trisomy 21 screening: should we use any other marker?.  Obstetrics & Gynecology 2002;100(4):648‐54.    Link to article     Google Scholar     ","['https://doi.org/10.1097/00006250-200210000-00006', 'https://scholar.google.com/scholar_lookup?title=Measurement+of+nuchal+translucency+as+a+single+strategy+in+trisomy+21+screening:+should+we+use+any+other+marker?+&author=C+Comas&author=M+Torrents&author=A+Munoz&author=E+Antolin&author=F+Figueras&author=M+Echevarria&publication_year=2002&hl=en']",,https://doi.org/10.1097/00006250-200210000-00006, Comas 2002a {published data only}  ,excluded,CD009925-bbs2-0143, USS at greater than 14 weeks. 
CD009925-bib-0157,"Comas C, Carrera JM. ",Early sonographic screening for chromosomal abnormalities, Ultrasound Review of Obstetrics and Gynecology ,2002,2,    ,['citation-journal']," Comas C, Carrera JM. Early sonographic screening for chromosomal abnormalities.  Ultrasound Review of Obstetrics and Gynecology 2002;2(2):88‐91.    Link to article     Google Scholar     ","['https://doi.org/10.3109/14722240208500465', 'https://scholar.google.com/scholar_lookup?title=Early+sonographic+screening+for+chromosomal+abnormalities&author=C+Comas&author=JM+Carrera&publication_year=2002&hl=en']",,https://doi.org/10.3109/14722240208500465, Comas 2002b {published data only}  ,excluded,CD009925-bbs2-0144, USS at greater than 14 weeks. 
CD009925-bib-0158,"Comstock CH, Malone FD, Ball RH, Nyberg DA, Saade GR, Berkowitz RL, et al. FASTER Research Consortium. ",Is there a nuchal translucency millimeter measurement above which there is no added benefit from first trimester serum screening?, American Journal of Obstetrics & Gynecology. ,2006,195,    ,['citation-journal']," Comstock CH, Malone FD, Ball RH, Nyberg DA, Saade GR, Berkowitz RL, et al. FASTER Research Consortium. Is there a nuchal translucency millimeter measurement above which there is no added benefit from first trimester serum screening?.  American Journal of Obstetrics & Gynecology. 2006;195(3):843‐7.    Link to article     Google Scholar     ","['https://doi.org/10.1016/j.ajog.2006.06.006', 'https://scholar.google.com/scholar_lookup?title=Is+there+a+nuchal+translucency+millimeter+measurement+above+which+there+is+no+added+benefit+from+first+trimester+serum+screening?+&author=CH+Comstock&author=FD+Malone&author=RH+Ball&author=DA+Nyberg&author=GR+Saade&author=RL+Berkowitz&publication_year=2006&hl=en']",,https://doi.org/10.1016/j.ajog.2006.06.006, Comstock 2006 {published data only}  ,excluded,CD009925-bbs2-0145, Unable to extract useful data. 
CD009925-bib-0159,"Conde Agudelo, Kafury Goeta. ",Triple‐marker test as screening for down syndrome: A meta‐analysis, Obstetrical and Gynecological Survey ,1998,53,    ,['citation-journal']," Conde Agudelo, Kafury Goeta. Triple‐marker test as screening for down syndrome: A meta‐analysis.  Obstetrical and Gynecological Survey 1998;53(6):369‐76.    Link to article     Google Scholar     ","['https://doi.org/10.1097/00006254-199806000-00022', 'https://scholar.google.com/scholar_lookup?title=Triple‐marker+test+as+screening+for+down+syndrome:+A+meta‐analysis&author=Agudelo+Conde&author=Goeta+Kafury&publication_year=1998&hl=en']",,https://doi.org/10.1097/00006254-199806000-00022, Conde 1998 {published data only}  ,excluded,CD009925-bbs2-0146, Review article. 
CD009925-bib-0160,"Crossley JA, Aitken DA, Connor JM. ","Prenatal screening for chromosome abnormalities using maternal serum chorionic gonadotrophin, alpha‐fetoprotein, and age", Prenatal Diagnosis ,1991,11,    ,['citation-journal']," Crossley JA, Aitken DA, Connor JM. Prenatal screening for chromosome abnormalities using maternal serum chorionic gonadotrophin, alpha‐fetoprotein, and age.  Prenatal Diagnosis 1991;11(2):83‐101.    Link to article     Google Scholar     ","['https://doi.org/10.1002/pd.1970110204', 'https://scholar.google.com/scholar_lookup?title=Prenatal+screening+for+chromosome+abnormalities+using+maternal+serum+chorionic+gonadotrophin,+alpha‐fetoprotein,+and+age+&author=JA+Crossley&author=DA+Aitken&author=JM+Connor&publication_year=1991&hl=en']",,https://doi.org/10.1002/pd.1970110204, Crossley 1991 {published data only}  ,excluded,CD009925-bbs2-0147, Less than 80% of pregnancies had gestational age confirmation by ultrasound. 
CD009925-bib-0161,"Crossley JA, Aitken DA, Connor JM. ",Second‐trimester unconjugated oestriol levels in maternal serum from chromosomally abnormal pregnancies using an optimized assay.[see comment], Prenatal Diagnosis ,1993,13,    ,['citation-journal']," Crossley JA, Aitken DA, Connor JM. Second‐trimester unconjugated oestriol levels in maternal serum from chromosomally abnormal pregnancies using an optimized assay.[see comment].  Prenatal Diagnosis 1993;13(4):271‐80.    Link to article     Google Scholar     ","['https://doi.org/10.1002/pd.1970130406', 'https://scholar.google.com/scholar_lookup?title=Second‐trimester+unconjugated+oestriol+levels+in+maternal+serum+from+chromosomally+abnormal+pregnancies+using+an+optimized+assay.[see+comment]+&author=JA+Crossley&author=DA+Aitken&author=JM+Connor&publication_year=1993&hl=en']",,https://doi.org/10.1002/pd.1970130406, Crossley 1993 {published data only}  ,excluded,CD009925-bbs2-0148, Less than 80% of pregnancies had gestational age confirmation by ultrasound. 
CD009925-bib-0162,"Crossley JA, Berry E, Aitken DA, Connor JM. ",Insulin‐dependent diabetes mellitus and prenatal screening results: current experience from a regional screening programme, Prenatal Diagnosis ,1996,16,    ,['citation-journal']," Crossley JA, Berry E, Aitken DA, Connor JM. Insulin‐dependent diabetes mellitus and prenatal screening results: current experience from a regional screening programme.  Prenatal Diagnosis 1996;16(11):1039‐42.    Link to article     Google Scholar     ","['https://doi.org/10.1002/(SICI)1097-0223(199611)16:11<1039::AID-PD985>3.0.CO;2-#', 'https://scholar.google.com/scholar_lookup?title=Insulin‐dependent+diabetes+mellitus+and+prenatal+screening+results:+current+experience+from+a+regional+screening+programme+&author=JA+Crossley&author=E+Berry&author=DA+Aitken&author=JM+Connor&publication_year=1996&hl=en']",,https://doi.org/10.1002/(SICI)1097-0223(199611)16:11<1039::AID-PD985>3.0.CO;2-#, Crossley 1996 {published data only}  ,excluded,CD009925-bbs2-0149, No Down's syndrome pregnancies in study population. 
CD009925-bib-0163,"Crossley JA, Aitken DA, Waugh SM, Kelly T, Connor JM. ","Maternal smoking: age distribution, levels of alpha‐fetoprotein and human chorionic gonadotrophin, and effect on detection of Down syndrome pregnancies in second‐trimester screening", Prenatal Diagnosis ,2002,22,    ,['citation-journal']," Crossley JA, Aitken DA, Waugh SM, Kelly T, Connor JM. Maternal smoking: age distribution, levels of alpha‐fetoprotein and human chorionic gonadotrophin, and effect on detection of Down syndrome pregnancies in second‐trimester screening.  Prenatal Diagnosis 2002;22(3):247‐55.    Link to article     Google Scholar     ","['https://doi.org/10.1002/pd.313', 'https://scholar.google.com/scholar_lookup?title=Maternal+smoking:+age+distribution,+levels+of+alpha‐fetoprotein+and+human+chorionic+gonadotrophin,+and+effect+on+detection+of+Down+syndrome+pregnancies+in+second‐trimester+screening+&author=JA+Crossley&author=DA+Aitken&author=SM+Waugh&author=T+Kelly&author=JM+Connor&publication_year=2002&hl=en']",,https://doi.org/10.1002/pd.313, Crossley 2002a {published data only}  ,excluded,CD009925-bbs2-0150, Adjustment factors for smokers. 
CD009925-bib-0164,"Cuckle HS, Wald NJ, Lindenbaum RH. ",Maternal serum alpha‐fetoprotein measurement: a screening test for Down syndrome, Lancet ,1984,i,    ,['citation-journal']," Cuckle HS, Wald NJ, Lindenbaum RH. Maternal serum alpha‐fetoprotein measurement: a screening test for Down syndrome.  Lancet 1984;i(8383):926‐9.    Link to article     Google Scholar     ","['https://doi.org/10.1016/S0140-6736(84)92389-4', 'https://scholar.google.com/scholar_lookup?title=Maternal+serum+alpha‐fetoprotein+measurement:+a+screening+test+for+Down+syndrome&author=HS+Cuckle&author=NJ+Wald&author=RH+Lindenbaum&publication_year=1984&hl=en']",,https://doi.org/10.1016/S0140-6736(84)92389-4, Cuckle 1984 {published data only}  ,excluded,CD009925-bbs2-0151, Gestational age not confirmed by USS. 
CD009925-bib-0165,"Cuckle HS, Wald NJ, Thompson SG. ",Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum alpha‐fetoprotein level, British Journal of Obstetrics & Gynaecology ,1987,94,    ,['citation-journal']," Cuckle HS, Wald NJ, Thompson SG. Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum alpha‐fetoprotein level.  British Journal of Obstetrics & Gynaecology 1987;94(5):387‐402.    Link to article     Google Scholar     ","['https://doi.org/10.1111/j.1471-0528.1987.tb03115.x', ""https://scholar.google.com/scholar_lookup?title=Estimating+a+woman's+risk+of+having+a+pregnancy+associated+with+Down's+syndrome+using+her+age+and+serum+alpha‐fetoprotein+level+&author=HS+Cuckle&author=NJ+Wald&author=SG+Thompson&publication_year=1987&hl=en""]",,https://doi.org/10.1111/j.1471-0528.1987.tb03115.x, Cuckle 1987a {published data only}  ,excluded,CD009925-bbs2-0152, Gestational age not confirmed by USS. 
CD009925-bib-0166,"Cuckle HS, Nanchahal K, Wald NJ. ",Maternal serum alpha‐fetoprotein and ethnic origin, British Journal of Obstetrics and Gynaecology ,1987,94,    ,['citation-journal']," Cuckle HS, Nanchahal K, Wald NJ. Maternal serum alpha‐fetoprotein and ethnic origin.  British Journal of Obstetrics and Gynaecology 1987;94(11):1111‐2.    Link to article     Google Scholar     ","['https://doi.org/10.1111/j.1471-0528.1987.tb02301.x', 'https://scholar.google.com/scholar_lookup?title=Maternal+serum+alpha‐fetoprotein+and+ethnic+origin&author=HS+Cuckle&author=K+Nanchahal&author=NJ+Wald&publication_year=1987&hl=en']",,https://doi.org/10.1111/j.1471-0528.1987.tb02301.x, Cuckle 1987b {published data only}  ,excluded,CD009925-bbs2-0153, No gestational age limits given. 
CD009925-bib-0167,"Cuckle HS, Wald NJ, Densem JW, Royston P, Knight GJ, Haddow JE, et al. ","The effect of smoking in pregnancy on maternal serum alpha‐fetoprotein, unconjugated oestriol, human chorionic gonadotrophin, progesterone and dehydroepiandrosterone sulphate levels", British Journal of Obstetrics & Gynaecology ,1990,97,    ,['citation-journal']," Cuckle HS, Wald NJ, Densem JW, Royston P, Knight GJ, Haddow JE, et al. The effect of smoking in pregnancy on maternal serum alpha‐fetoprotein, unconjugated oestriol, human chorionic gonadotrophin, progesterone and dehydroepiandrosterone sulphate levels.  British Journal of Obstetrics & Gynaecology 1990;97(3):272‐4.    Link to article     Google Scholar     ","['https://doi.org/10.1111/j.1471-0528.1990.tb01794.x', 'https://scholar.google.com/scholar_lookup?title=The+effect+of+smoking+in+pregnancy+on+maternal+serum+alpha‐fetoprotein,+unconjugated+oestriol,+human+chorionic+gonadotrophin,+progesterone+and+dehydroepiandrosterone+sulphate+levels+&author=HS+Cuckle&author=NJ+Wald&author=JW+Densem&author=P+Royston&author=GJ+Knight&author=JE+Haddow&publication_year=1990&hl=en']",,https://doi.org/10.1111/j.1471-0528.1990.tb01794.x, Cuckle 1990 {published data only}  ,excluded,CD009925-bbs2-0154, Paper presenting adjustment factors. 
CD009925-bib-0168,"Cuckle HS, Holding S, Jones R, Groome NP, Wallace EM. ",Combining Inhibin A with existing second‐trimester markers in maternal serum screening for Down's syndrome, Prenatal Diagnosis ,1996,16,    ,['citation-journal']," Cuckle HS, Holding S, Jones R, Groome NP, Wallace EM. Combining Inhibin A with existing second‐trimester markers in maternal serum screening for Down's syndrome.  Prenatal Diagnosis 1996;16(12):1095‐100.    Link to article     Google Scholar     ","['https://doi.org/10.1002/(SICI)1097-0223(199612)16:12<1095::AID-PD997>3.0.CO;2-9', ""https://scholar.google.com/scholar_lookup?title=Combining+Inhibin+A+with+existing+second‐trimester+markers+in+maternal+serum+screening+for+Down's+syndrome+&author=HS+Cuckle&author=S+Holding&author=R+Jones&author=NP+Groome&author=EM+Wallace&publication_year=1996&hl=en""]",,https://doi.org/10.1002/(SICI)1097-0223(199612)16:12<1095::AID-PD997>3.0.CO;2-9, Cuckle 1996 {published data only}  ,excluded,CD009925-bbs2-0155, Data modelled on 4 meta‐analysed studies. 
CD009925-bib-0169,"Cuckle HS, Sehmi I, Jones R, Evans LW. ",Maternal serum activin A and follistatin levels in pregnancies with Down syndrome, Prenatal Diagnosis. ,1999,19,    ,['citation-journal']," Cuckle HS, Sehmi I, Jones R, Evans LW. Maternal serum activin A and follistatin levels in pregnancies with Down syndrome.  Prenatal Diagnosis. 1999;19(6):513‐6.    Link to article     Google Scholar     ","['https://doi.org/10.1002/(SICI)1097-0223(199906)19:6<513::AID-PD579>3.0.CO;2-L', 'https://scholar.google.com/scholar_lookup?title=Maternal+serum+activin+A+and+follistatin+levels+in+pregnancies+with+Down+syndrome&author=HS+Cuckle&author=I+Sehmi&author=R+Jones&author=LW+Evans&publication_year=1999&hl=en']",,https://doi.org/10.1002/(SICI)1097-0223(199906)19:6<513::AID-PD579>3.0.CO;2-L, Cuckle 1999a {published data only}  ,excluded,CD009925-bbs2-0156, Unable to extract useful data. 
CD009925-bib-0170,"Cuckle HS, Van Lith JM. ",Appropriate biochemical parameters in first‐trimester screening for Down syndrome.[see comment], Prenatal Diagnosis. ,1999,19,    ,['citation-journal']," Cuckle HS, Van Lith JM. Appropriate biochemical parameters in first‐trimester screening for Down syndrome.[see comment].  Prenatal Diagnosis. 1999;19(6):505‐12.    Link to article     Google Scholar     ","['https://doi.org/10.1002/(SICI)1097-0223(199906)19:6<505::AID-PD572>3.0.CO;2-6', 'https://scholar.google.com/scholar_lookup?title=Appropriate+biochemical+parameters+in+first‐trimester+screening+for+Down+syndrome.[see+comment]+&author=HS+Cuckle&author=JM+Lith&publication_year=1999&hl=en']",,https://doi.org/10.1002/(SICI)1097-0223(199906)19:6<505::AID-PD572>3.0.CO;2-6, Cuckle 1999b {published data only}  ,excluded,CD009925-bbs2-0157, Review article. 
CD009925-bib-0171,"Cullen MT, Gabrielli S, Green JJ, Rizzo N, Mahoney MJ, Salafia C, et al. ",Diagnosis and significance of cystic hygroma in the first trimester, Prenatal Diagnosis ,1990,10,    ,['citation-journal']," Cullen MT, Gabrielli S, Green JJ, Rizzo N, Mahoney MJ, Salafia C, et al. Diagnosis and significance of cystic hygroma in the first trimester.  Prenatal Diagnosis 1990;10(10):643‐51.    Link to article     Google Scholar     ","['https://doi.org/10.1002/pd.1970101004', 'https://scholar.google.com/scholar_lookup?title=Diagnosis+and+significance+of+cystic+hygroma+in+the+first+trimester&author=MT+Cullen&author=S+Gabrielli&author=JJ+Green&author=N+Rizzo&author=MJ+Mahoney&author=C+Salafia&publication_year=1990&hl=en']",,https://doi.org/10.1002/pd.1970101004, Cullen 1990 {published data only}  ,excluded,CD009925-bbs2-0158, Abnormal scans only in study population. 
CD009925-bib-0172,"Cusick W, Provenzano J, Sullivan CA, Gallousis FM, Rodis JF. ",Fetal nasal bone length in euploid and aneuploid fetuses between 11 and 20 weeks' gestation: a prospective study, Journal of Ultrasound in Medicine ,2004,23,    ,['citation-journal']," Cusick W, Provenzano J, Sullivan CA, Gallousis FM, Rodis JF. Fetal nasal bone length in euploid and aneuploid fetuses between 11 and 20 weeks' gestation: a prospective study.  Journal of Ultrasound in Medicine 2004;23(10):1327‐33.    Link to article     Google Scholar     ","['https://doi.org/10.7863/jum.2004.23.10.1327', ""https://scholar.google.com/scholar_lookup?title=Fetal+nasal+bone+length+in+euploid+and+aneuploid+fetuses+between+11+and+20+weeks'+gestation:+a+prospective+study+&author=W+Cusick&author=J+Provenzano&author=CA+Sullivan&author=FM+Gallousis&author=JF+Rodis&publication_year=2004&hl=en""]",,https://doi.org/10.7863/jum.2004.23.10.1327, Cusick 2004 {published data only}  ,excluded,CD009925-bbs2-0159, Less than 5 Down's syndrome pregnancies in study population. 
CD009925-bib-0173,"D'Ottavio G, Meir YJ, Rustico MA, Pecile V, Fischer‐Tamaro L, Conoscenti G, et al. ",Screening for fetal anomalies by ultrasound at 14 and 21 weeks, Ultrasound in Obstetrics and Gynecology ,1997,10,    ,['citation-journal']," D'Ottavio G, Meir YJ, Rustico MA, Pecile V, Fischer‐Tamaro L, Conoscenti G, et al. Screening for fetal anomalies by ultrasound at 14 and 21 weeks.  Ultrasound in Obstetrics and Gynecology 1997;10(6):375‐80.    Link to article     Google Scholar     ","['https://doi.org/10.1046/j.1469-0705.1997.10060375.x', ""https://scholar.google.com/scholar_lookup?title=Screening+for+fetal+anomalies+by+ultrasound+at+14+and+21+weeks&author=G+D'Ottavio&author=YJ+Meir&author=MA+Rustico&author=V+Pecile&author=L+Fischer‐Tamaro&author=G+Conoscenti&publication_year=1997&hl=en""]",,https://doi.org/10.1046/j.1469-0705.1997.10060375.x, D'Ottavio 1997 {published data only}  ,excluded,CD009925-bbs2-0160, Second trimester USS. 
CD009925-bib-0174,"Dancoine F, Couplet G, Mainardi A, Sukno F, Jaumain P, Nowak E, et al. ","Antenatal screening for Dawn's syndrome with serum markers: Influence of maternal weight, smoking habits and diabetes", Immuno‐Analyse et Biologie Specialisee ,2001,16,    ,['citation-journal']," Dancoine F, Couplet G, Mainardi A, Sukno F, Jaumain P, Nowak E, et al. Antenatal screening for Dawn's syndrome with serum markers: Influence of maternal weight, smoking habits and diabetes.  Immuno‐Analyse et Biologie Specialisee 2001;16(6):381‐9.    Link to article     Google Scholar     ","['https://doi.org/10.1016/S0923-2532(01)80075-2', ""https://scholar.google.com/scholar_lookup?title=Antenatal+screening+for+Dawn's+syndrome+with+serum+markers:+Influence+of+maternal+weight,+smoking+habits+and+diabetes+&author=F+Dancoine&author=G+Couplet&author=A+Mainardi&author=F+Sukno&author=P+Jaumain&author=E+Nowak&publication_year=2001&hl=en""]",,https://doi.org/10.1016/S0923-2532(01)80075-2, Dancoine 2001 {published data only}  ,excluded,CD009925-bbs2-0161, No Down's syndrome pregnancies in study population. 
CD009925-bib-0175,"De Biasio, Siccardi M, Volpe G, Famularo L, Santi F, Canini S. ",First‐trimester screening for down syndrome using nuchal translucency measurement with free ß‐hCG and PAPP‐A between 10 and 13 weeks of pregnancy ‐ The combined test, Prenatal Diagnosis ,1999,19,    ,['citation-journal']," De Biasio, Siccardi M, Volpe G, Famularo L, Santi F, Canini S. First‐trimester screening for down syndrome using nuchal translucency measurement with free ß‐hCG and PAPP‐A between 10 and 13 weeks of pregnancy ‐ The combined test.  Prenatal Diagnosis 1999;19(4):360‐3.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=First‐trimester+screening+for+down+syndrome+using+nuchal+translucency+measurement+with+free+ß‐hCG+and+PAPP‐A+between+10+and+13+weeks+of+pregnancy+‐+The+combined+test+&author=Biasio+De&author=M+Siccardi&author=G+Volpe&author=L+Famularo&author=F+Santi&author=S+Canini&publication_year=1999&hl=en'],,," De Biasio, 1999 {published data only}  ",excluded,CD009925-bbs2-0162, Unable to ascertain whether overlapping populations between several papers ‐ attempted to contact author with no response.  
CD009925-bib-0176,"De Biasio, Ferrero S, Prefumo F, Canini S, Marchini P, Bruzzone I, et al. ",Down's syndrome: First trimester approach, Italian Journal of Gynaecology and Obstetrics ,2001,13,    ,['citation-journal']," De Biasio, Ferrero S, Prefumo F, Canini S, Marchini P, Bruzzone I, et al. Down's syndrome: First trimester approach.  Italian Journal of Gynaecology and Obstetrics 2001;13(1):22‐6.    Google Scholar     ","[""https://scholar.google.com/scholar_lookup?title=Down's+syndrome:+First+trimester+approach&author=Biasio+De&author=S+Ferrero&author=F+Prefumo&author=S+Canini&author=P+Marchini&author=I+Bruzzone&publication_year=2001&hl=en""]",,," De Biasio, 2001 {published data only}  ",excluded,CD009925-bbs2-0163, Unable to ascertain whether overlapping populations between several papers ‐ attempted to contact author with no response.  
CD009925-bib-0177,"De Biasio P, Canini S, Prefumo F, Famularo L, Venturini PL. ",Extent of correlation between first and second trimester markers for Down's syndrome screening, Journal of Medical Screening ,2000,7,    ,['citation-journal']," De Biasio P, Canini S, Prefumo F, Famularo L, Venturini PL. Extent of correlation between first and second trimester markers for Down's syndrome screening.  Journal of Medical Screening 2000;7(3):163.    Link to article     Google Scholar     ","['https://doi.org/10.1136/jms.7.3.163', ""https://scholar.google.com/scholar_lookup?title=Extent+of+correlation+between+first+and+second+trimester+markers+for+Down's+syndrome+screening+&author=P+Biasio&author=S+Canini&author=F+Prefumo&author=L+Famularo&author=PL+Venturini&publication_year=2000&hl=en""]",,https://doi.org/10.1136/jms.7.3.163, De Biasio 2000 {published data only}  ,excluded,CD009925-bbs2-0164, Unable to extract useful information. 
CD009925-bib-0178,"De Graaf I, Cuckle HS, Pajkrt E, Leschot NJ, Bleker OP, Van Lith JM. ",Co‐variables in first trimester maternal serum screening, Prenatal Diagnosis. ,1991,20,    ,['citation-journal']," De Graaf I, Cuckle HS, Pajkrt E, Leschot NJ, Bleker OP, Van Lith JM. Co‐variables in first trimester maternal serum screening.  Prenatal Diagnosis. 1991;20(3):186‐9.    Link to article     Google Scholar     ","['https://doi.org/10.1002/(SICI)1097-0223(200003)20:3<186::AID-PD776>3.0.CO;2-A', 'https://scholar.google.com/scholar_lookup?title=Co‐variables+in+first+trimester+maternal+serum+screening&author=I+Graaf&author=HS+Cuckle&author=E+Pajkrt&author=NJ+Leschot&author=OP+Bleker&author=JM+Lith&publication_year=1991&hl=en']",,https://doi.org/10.1002/(SICI)1097-0223(200003)20:3<186::AID-PD776>3.0.CO;2-A, De Graaf 1991 {published data only}  ,excluded,CD009925-bbs2-0165, Unable to extract useful data. 
CD009925-bib-0179,"De Graaf I, Pajkrt E, Bilardo CM, Leschot NJ, Cuckle HS, Van Lith JM. ",Early pregnancy screening for fetal aneuploidy with serum markers and nuchal translucency, Prenatal Diagnosis. ,1999,19,    ,['citation-journal']," De Graaf I, Pajkrt E, Bilardo CM, Leschot NJ, Cuckle HS, Van Lith JM. Early pregnancy screening for fetal aneuploidy with serum markers and nuchal translucency.  Prenatal Diagnosis. 1999;19(5):458‐62.    Link to article     Google Scholar     ","['https://doi.org/10.1002/(SICI)1097-0223(199905)19:5<458::AID-PD569>3.0.CO;2-A', 'https://scholar.google.com/scholar_lookup?title=Early+pregnancy+screening+for+fetal+aneuploidy+with+serum+markers+and+nuchal+translucency&author=I+Graaf&author=E+Pajkrt&author=CM+Bilardo&author=NJ+Leschot&author=HS+Cuckle&author=JM+Lith&publication_year=1999&hl=en']",,https://doi.org/10.1002/(SICI)1097-0223(199905)19:5<458::AID-PD569>3.0.CO;2-A, De Graaf 1999 {published data only}  ,excluded,CD009925-bbs2-0166, Modelled data. 
CD009925-bib-0180,"DeVore GR, Romero R. ",Combined use of genetic sonography and maternal serum triple‐marker screening: an effective method for increasing the detection of trisomy 21 in women younger than 35 years.[see comment], Journal of Ultrasound in Medicine. ,2001,20,    ,['citation-journal']," DeVore GR, Romero R. Combined use of genetic sonography and maternal serum triple‐marker screening: an effective method for increasing the detection of trisomy 21 in women younger than 35 years.[see comment].  Journal of Ultrasound in Medicine. 2001;20(6):645‐54.    Link to article     Google Scholar     ","['https://doi.org/10.7863/jum.2001.20.6.645', 'https://scholar.google.com/scholar_lookup?title=Combined+use+of+genetic+sonography+and+maternal+serum+triple‐marker+screening:+an+effective+method+for+increasing+the+detection+of+trisomy+21+in+women+younger+than+35+years.[see+comment]+&author=GR+DeVore&author=R+Romero&publication_year=2001&hl=en']",,https://doi.org/10.7863/jum.2001.20.6.645, DeVore 2001 {published data only}  ,excluded,CD009925-bbs2-0167, Second trimester ultrasound. 
CD009925-bib-0181,Dickerson VM. ,Multiple marker screening, Western Journal of Medicine ,1994,161,    ,['citation-journal'], Dickerson VM. Multiple marker screening.  Western Journal of Medicine 1994;161(2):161.    Google Scholar     ,['https://scholar.google.com/scholar_lookup?title=Multiple+marker+screening&author=VM+Dickerson&publication_year=1994&hl=en'],,, Dickerson 1994 {published data only}  ,excluded,CD009925-bbs2-0168, Comment. 
CD009925-bib-0182,"Dimaio MS, Baumgarten A, Greenstein RM, Saal HM, Mahoney MJ. ",Screening for fetal Down's syndrome in pregnancy by measuring maternal serum alpha‐fetoprotein levels, New England Journal of Medicine ,1987,317,    ,['citation-journal']," Dimaio MS, Baumgarten A, Greenstein RM, Saal HM, Mahoney MJ. Screening for fetal Down's syndrome in pregnancy by measuring maternal serum alpha‐fetoprotein levels.  New England Journal of Medicine 1987;317(6):342‐6.    Link to article     Google Scholar     ","['https://doi.org/10.1056/NEJM198708063170603', ""https://scholar.google.com/scholar_lookup?title=Screening+for+fetal+Down's+syndrome+in+pregnancy+by+measuring+maternal+serum+alpha‐fetoprotein+levels+&author=MS+Dimaio&author=A+Baumgarten&author=RM+Greenstein&author=HM+Saal&author=MJ+Mahoney&publication_year=1987&hl=en""]",,https://doi.org/10.1056/NEJM198708063170603, Dimaio 1987 {published data only}  ,excluded,CD009925-bbs2-0169, Gestational age by USS only in screen positive population. 
CD009925-bib-0183,"Doran TA, Cadesky K, Wong PY, Mastrogiacomo C, Capello T. ",Maternal serum alpha‐fetoprotein and fetal autosomal trisomies, American Journal of Obstetrics & Gynecology ,1986,154,    ,['citation-journal']," Doran TA, Cadesky K, Wong PY, Mastrogiacomo C, Capello T. Maternal serum alpha‐fetoprotein and fetal autosomal trisomies.  American Journal of Obstetrics & Gynecology 1986;154(2):277‐81.    Link to article     Google Scholar     ","['https://doi.org/10.1016/0002-9378(86)90655-1', 'https://scholar.google.com/scholar_lookup?title=Maternal+serum+alpha‐fetoprotein+and+fetal+autosomal+trisomies&author=TA+Doran&author=K+Cadesky&author=PY+Wong&author=C+Mastrogiacomo&author=T+Capello&publication_year=1986&hl=en']",,https://doi.org/10.1016/0002-9378(86)90655-1, Doran 1986 {published data only}  ,excluded,CD009925-bbs2-0170, Ultrasound confirmation of gestational age performed in screen positive women only. 
CD009925-bib-0184,"Drugan A, Reichler A, Bronstein M, Johnson MP, Sokol RJ, Evans MI. ",Abnormal biochemical serum screening versus 2nd‐trimester ultrasound‐detected minor anomalies as predictors of aneuploidy in low‐risk women, Fetal Diagnosis & Therapy ,1996,11,    ,['citation-journal']," Drugan A, Reichler A, Bronstein M, Johnson MP, Sokol RJ, Evans MI. Abnormal biochemical serum screening versus 2nd‐trimester ultrasound‐detected minor anomalies as predictors of aneuploidy in low‐risk women.  Fetal Diagnosis & Therapy 1996;11(5):301‐5.    Link to article     Google Scholar     ","['https://doi.org/10.1159/000264328', 'https://scholar.google.com/scholar_lookup?title=Abnormal+biochemical+serum+screening+versus+2nd‐trimester+ultrasound‐detected+minor+anomalies+as+predictors+of+aneuploidy+in+low‐risk+women+&author=A+Drugan&author=A+Reichler&author=M+Bronstein&author=MP+Johnson&author=RJ+Sokol&author=MI+Evans&publication_year=1996&hl=en']",,https://doi.org/10.1159/000264328, Drugan 1996a {published data only}  ,excluded,CD009925-bbs2-0171, Second trimester ultrasound. 
CD009925-bib-0185,"Drugan A, O'Brien JE, Dvorin E, Krivchenia EL, Johnson MP, Sokol RJ, et al. ",Multiple marker screening in multifetal gestations: failure to predict adverse pregnancy outcomes, Fetal Diagnosis & Therapy ,1996,11,    ,['citation-journal']," Drugan A, O'Brien JE, Dvorin E, Krivchenia EL, Johnson MP, Sokol RJ, et al. Multiple marker screening in multifetal gestations: failure to predict adverse pregnancy outcomes.  Fetal Diagnosis & Therapy 1996;11(1):16‐9.    Link to article     Google Scholar     ","['https://doi.org/10.1159/000264273', ""https://scholar.google.com/scholar_lookup?title=Multiple+marker+screening+in+multifetal+gestations:+failure+to+predict+adverse+pregnancy+outcomes+&author=A+Drugan&author=JE+O'Brien&author=E+Dvorin&author=EL+Krivchenia&author=MP+Johnson&author=RJ+Sokol&publication_year=1996&hl=en""]",,https://doi.org/10.1159/000264273, Drugan 1996b {published data only}  ,excluded,CD009925-bbs2-0172, Unable to extract useful data. 
CD009925-bib-0186,"Drysdale K, Ridley D, Walker K, Higgins B, Dean T. ",First‐trimester pregnancy scanning as a screening tool for high‐risk and abnormal pregnancies in a district general hospital setting, Journal of Obstetrics & Gynaecology ,2002,22,    ,['citation-journal']," Drysdale K, Ridley D, Walker K, Higgins B, Dean T. First‐trimester pregnancy scanning as a screening tool for high‐risk and abnormal pregnancies in a district general hospital setting.  Journal of Obstetrics & Gynaecology 2002;22(2):159‐65.    Link to article     Google Scholar     ","['https://doi.org/10.1080/01443610120113300', 'https://scholar.google.com/scholar_lookup?title=First‐trimester+pregnancy+scanning+as+a+screening+tool+for+high‐risk+and+abnormal+pregnancies+in+a+district+general+hospital+setting+&author=K+Drysdale&author=D+Ridley&author=K+Walker&author=B+Higgins&author=T+Dean&publication_year=2002&hl=en']",,https://doi.org/10.1080/01443610120113300, Drysdale 2002 {published data only}  ,excluded,CD009925-bbs2-0173, Fewer than 5 Down's syndrome pregnancies in population. 
CD009925-bib-0187,Ebell M. ,Is the integrated test better for screening for Down's syndrome than the traditional triple test?, Evidence‐Based Practice ,1999,2,    ,['citation-journal'], Ebell M. Is the integrated test better for screening for Down's syndrome than the traditional triple test?.  Evidence‐Based Practice 1999;2(11):4‐5.    Google Scholar     ,"[""https://scholar.google.com/scholar_lookup?title=Is+the+integrated+test+better+for+screening+for+Down's+syndrome+than+the+traditional+triple+test?+&author=M+Ebell&publication_year=1999&hl=en""]",,, Ebell 1999 {published data only}  ,excluded,CD009925-bbs2-0174, Review article. 
CD009925-bib-0188,"Economides DL, Whitlow BJ, Kadir R, Lazanakis M, Verdin SM. ",First trimester sonographic detection of chromosomal abnormalities in an unselected population, British Journal of Obstetrics & Gynaecology ,1998,105,    ,['citation-journal']," Economides DL, Whitlow BJ, Kadir R, Lazanakis M, Verdin SM. First trimester sonographic detection of chromosomal abnormalities in an unselected population.  British Journal of Obstetrics & Gynaecology 1998;105(1):58‐62.    Link to article     Google Scholar     ","['https://doi.org/10.1111/j.1471-0528.1998.tb09351.x', 'https://scholar.google.com/scholar_lookup?title=First+trimester+sonographic+detection+of+chromosomal+abnormalities+in+an+unselected+population+&author=DL+Economides&author=BJ+Whitlow&author=R+Kadir&author=M+Lazanakis&author=SM+Verdin&publication_year=1998&hl=en']",,https://doi.org/10.1111/j.1471-0528.1998.tb09351.x, Economides 1998 {published data only}  ,excluded,CD009925-bbs2-0175, Unable to extract useful data. 
CD009925-bib-0189,"Erickson JA, Ashwood ER, Gin CA. ","Evaluation of a dimeric inhibin‐A assay for assessing fetal Down syndrome: establishment, comparison, and monitoring of median concentrations for normal pregnancies", Archives of Pathology & Laboratory Medicine ,2004,128,    ,['citation-journal']," Erickson JA, Ashwood ER, Gin CA. Evaluation of a dimeric inhibin‐A assay for assessing fetal Down syndrome: establishment, comparison, and monitoring of median concentrations for normal pregnancies.  Archives of Pathology & Laboratory Medicine 2004;128(4):415‐20.    Link to article     Google Scholar     ","['https://doi.org/10.5858/2004-128-415-EOADIA', 'https://scholar.google.com/scholar_lookup?title=Evaluation+of+a+dimeric+inhibin‐A+assay+for+assessing+fetal+Down+syndrome:+establishment,+comparison,+and+monitoring+of+median+concentrations+for+normal+pregnancies+&author=JA+Erickson&author=ER+Ashwood&author=CA+Gin&publication_year=2004&hl=en']",,https://doi.org/10.5858/2004-128-415-EOADIA, Erickson 2004 {published data only}  ,excluded,CD009925-bbs2-0176, No Down's syndrome pregnancies in population. 
CD009925-bib-0190,"Evans MI, O'Brien JE, Dvorin E, Krivchenia EL, Drugan A, Hume RF, et al. ",Similarity of insulin‐dependent diabetics' and non‐insulin‐dependent diabetics' levels of ß‐hCG and unconjugated estriol with controls: no need to adjust as with alpha‐fetoprotein, Journal of the Society for Gynecologic Investigation ,1996,3,    ,['citation-journal']," Evans MI, O'Brien JE, Dvorin E, Krivchenia EL, Drugan A, Hume RF, et al. Similarity of insulin‐dependent diabetics' and non‐insulin‐dependent diabetics' levels of ß‐hCG and unconjugated estriol with controls: no need to adjust as with alpha‐fetoprotein.  Journal of the Society for Gynecologic Investigation 1996;3(1):20‐2.    Google Scholar     ","[""https://scholar.google.com/scholar_lookup?title=Similarity+of+insulin‐dependent+diabetics'+and+non‐insulin‐dependent+diabetics'+levels+of+ß‐hCG+and+unconjugated+estriol+with+controls:+no+need+to+adjust+as+with+alpha‐fetoprotein+&author=MI+Evans&author=JE+O'Brien&author=E+Dvorin&author=EL+Krivchenia&author=A+Drugan&author=RF+Hume&publication_year=1996&hl=en""]",,, Evans 1996 {published data only}  ,excluded,CD009925-bbs2-0177, No Down's syndrome pregnancies in population. 
CD009925-bib-0191,"Falcon O, Cavoretto P, Peralta CF, Csapo B, Nicolaides KH. ",Fetal head‐to‐trunk volume ratio in chromosomally abnormal fetuses at 11 + 0 to 13 + 6 weeks of gestation, Ultrasound in Obstetrics & Gynecology ,2005,26,    ,['citation-journal']," Falcon O, Cavoretto P, Peralta CF, Csapo B, Nicolaides KH. Fetal head‐to‐trunk volume ratio in chromosomally abnormal fetuses at 11 + 0 to 13 + 6 weeks of gestation.  Ultrasound in Obstetrics & Gynecology 2005;26(7):755‐60.    Link to article     Google Scholar     ","['https://doi.org/10.1002/uog.1991', 'https://scholar.google.com/scholar_lookup?title=Fetal+head‐to‐trunk+volume+ratio+in+chromosomally+abnormal+fetuses+at+11+++0+to+13+++6+weeks+of+gestation+&author=O+Falcon&author=P+Cavoretto&author=CF+Peralta&author=B+Csapo&author=KH+Nicolaides&publication_year=2005&hl=en']",,https://doi.org/10.1002/uog.1991, Falcon 2005 {published data only}  ,excluded,CD009925-bbs2-0178, Unable to extract useful data. 
CD009925-bib-0192,"Falcon O, Faiola S, Huggon I, Allan L, Nicolaides KH. ",Fetal tricuspid regurgitation at the 11 + 0 to 13 + 6‐week scan: association with chromosomal defects and reproducibility of the method, Ultrasound in Obstetrics & Gynecology ,2006,27,    ,['citation-journal']," Falcon O, Faiola S, Huggon I, Allan L, Nicolaides KH. Fetal tricuspid regurgitation at the 11 + 0 to 13 + 6‐week scan: association with chromosomal defects and reproducibility of the method.  Ultrasound in Obstetrics & Gynecology 2006;27(6):609‐12.    Link to article     Google Scholar     ","['https://doi.org/10.1002/uog.2736', 'https://scholar.google.com/scholar_lookup?title=Fetal+tricuspid+regurgitation+at+the+11+++0+to+13+++6‐week+scan:+association+with+chromosomal+defects+and+reproducibility+of+the+method+&author=O+Falcon&author=S+Faiola&author=I+Huggon&author=L+Allan&author=KH+Nicolaides&publication_year=2006&hl=en']",,https://doi.org/10.1002/uog.2736, Falcon 2006 {published data only}  ,excluded,CD009925-bbs2-0179, Unable to extract useful data. 
CD009925-bib-0193,"Ford C, Moore AJ, Jordan PA, Bartlett WA, Wyldes MP, Jones AF, et al. ",The value of screening for Down's syndrome in a socioeconomically deprived area with a high ethnic population.[see comment], British Journal of Obstetrics & Gynaecology ,1998,105,    ,['citation-journal']," Ford C, Moore AJ, Jordan PA, Bartlett WA, Wyldes MP, Jones AF, et al. The value of screening for Down's syndrome in a socioeconomically deprived area with a high ethnic population.[see comment].  British Journal of Obstetrics & Gynaecology 1998;105(8):855‐9.    Link to article     Google Scholar     ","['https://doi.org/10.1111/j.1471-0528.1998.tb10229.x', ""https://scholar.google.com/scholar_lookup?title=The+value+of+screening+for+Down's+syndrome+in+a+socioeconomically+deprived+area+with+a+high+ethnic+population.[see+comment]+&author=C+Ford&author=AJ+Moore&author=PA+Jordan&author=WA+Bartlett&author=MP+Wyldes&author=AF+Jones&publication_year=1998&hl=en""]",,https://doi.org/10.1111/j.1471-0528.1998.tb10229.x, Ford 1998 {published data only}  ,excluded,CD009925-bbs2-0180, Audit. 
CD009925-bib-0194,"Frishman GN, Canick JA, Hogan JW, Hackett RJ, Kellner LH, Saller DN. ",Serum triple‐marker screening in in vitro fertilization and naturally conceived pregnancies, Obstetrics & Gynecology ,1997,90,    ,['citation-journal']," Frishman GN, Canick JA, Hogan JW, Hackett RJ, Kellner LH, Saller DN. Serum triple‐marker screening in in vitro fertilization and naturally conceived pregnancies.  Obstetrics & Gynecology 1997;90(1):98‐101.    Link to article     Google Scholar     ","['https://doi.org/10.1016/S0029-7844(97)00139-7', 'https://scholar.google.com/scholar_lookup?title=Serum+triple‐marker+screening+in+in+vitro+fertilization+and+naturally+conceived+pregnancies&author=GN+Frishman&author=JA+Canick&author=JW+Hogan&author=RJ+Hackett&author=LH+Kellner&author=DN+Saller&publication_year=1997&hl=en']",,https://doi.org/10.1016/S0029-7844(97)00139-7, Frishman 1997 {published data only}  ,excluded,CD009925-bbs2-0181, No Down's syndrome pregnancies in population. 
CD009925-bib-0195,"Fukada Y, Takizawa M, Amemiya A, Yoda H, Kohno K, Hoshi K. ",Detection of aneuploidy with fetal nuchal translucency and maternal serum markers in Japanese women, Acta Obstetricia et Gynecologica Scandinavica ,2000,79,    ,['citation-journal']," Fukada Y, Takizawa M, Amemiya A, Yoda H, Kohno K, Hoshi K. Detection of aneuploidy with fetal nuchal translucency and maternal serum markers in Japanese women.  Acta Obstetricia et Gynecologica Scandinavica 2000;79(12):1124‐5.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=Detection+of+aneuploidy+with+fetal+nuchal+translucency+and+maternal+serum+markers+in+Japanese+women+&author=Y+Fukada&author=M+Takizawa&author=A+Amemiya&author=H+Yoda&author=K+Kohno&author=K+Hoshi&publication_year=2000&hl=en'],,, Fukada 2000 {published data only}  ,excluded,CD009925-bbs2-0182, Unable to extract useful data. 
CD009925-bib-0196,"Ghidini A, Spong CY, Grier RE, Walker CN, Pezzullo JC. ",Is maternal serum triple screening a better predictor of Down syndrome in female than in male fetuses?, Prenatal Diagnosis ,1998,18,    ,['citation-journal']," Ghidini A, Spong CY, Grier RE, Walker CN, Pezzullo JC. Is maternal serum triple screening a better predictor of Down syndrome in female than in male fetuses?.  Prenatal Diagnosis 1998;18(2):123‐6.    Link to article     Google Scholar     ","['https://doi.org/10.1002/(SICI)1097-0223(199802)18:2<123::AID-PD221>3.0.CO;2-6', 'https://scholar.google.com/scholar_lookup?title=Is+maternal+serum+triple+screening+a+better+predictor+of+Down+syndrome+in+female+than+in+male+fetuses?+&author=A+Ghidini&author=CY+Spong&author=RE+Grier&author=CN+Walker&author=JC+Pezzullo&publication_year=1998&hl=en']",,https://doi.org/10.1002/(SICI)1097-0223(199802)18:2<123::AID-PD221>3.0.CO;2-6, Ghidini 1998 {published data only}  ,excluded,CD009925-bbs2-0183, Comparison of male versus female fetuses. 
CD009925-bib-0197,"Goldie DJ, Astley JP, Beaman JM, Bickley DA, Gunneberg A, Jones SR. ",Screening for Down's syndrome: the first two years experience in Bristol, Journal of Medical Screening ,1995,2,    ,['citation-journal']," Goldie DJ, Astley JP, Beaman JM, Bickley DA, Gunneberg A, Jones SR. Screening for Down's syndrome: the first two years experience in Bristol.  Journal of Medical Screening 1995;2(4):207‐10.    Link to article     Google Scholar     ","['https://doi.org/10.1177/096914139500200407', ""https://scholar.google.com/scholar_lookup?title=Screening+for+Down's+syndrome:+the+first+two+years+experience+in+Bristol&author=DJ+Goldie&author=JP+Astley&author=JM+Beaman&author=DA+Bickley&author=A+Gunneberg&author=SR+Jones&publication_year=1995&hl=en""]",,https://doi.org/10.1177/096914139500200407, Goldie 1995 {published data only}  ,excluded,CD009925-bbs2-0184, Fewer than 80% of study population ahd gestational age confirmed by USS. 
CD009925-bib-0198,"Gonçalves LF, Espinoza J, Lee W, Schoen ML, Devers P, Mazor M, et al. ",Phenotypic characteristics of absent and hypoplastic nasal bones in fetuses with down syndrome: Description by 3‐dimensional ultrasonography and clinical significance, Journal of Ultrasound in Medicine ,2004,23,    ,['citation-journal']," Gonçalves LF, Espinoza J, Lee W, Schoen ML, Devers P, Mazor M, et al. Phenotypic characteristics of absent and hypoplastic nasal bones in fetuses with down syndrome: Description by 3‐dimensional ultrasonography and clinical significance.  Journal of Ultrasound in Medicine 2004;23(12):1619‐27.    Link to article     Google Scholar     ","['https://doi.org/10.7863/jum.2004.23.12.1619', 'https://scholar.google.com/scholar_lookup?title=Phenotypic+characteristics+of+absent+and+hypoplastic+nasal+bones+in+fetuses+with+down+syndrome:+Description+by+3‐dimensional+ultrasonography+and+clinical+significance+&author=LF+Gonçalves&author=J+Espinoza&author=W+Lee&author=ML+Schoen&author=P+Devers&author=M+Mazor&publication_year=2004&hl=en']",,https://doi.org/10.7863/jum.2004.23.12.1619, Gonçalves 2004 {published data only}  ,excluded,CD009925-bbs2-0185, Greater than 14 weeks USS screening. 
CD009925-bib-0199,"Goodburn SF, Yates JR, Raggatt PR, Carr C, Ferguson‐Smith ME, Kershaw AJ, et al. ","Second‐trimester maternal serum screening using alpha‐fetoprotein, human chorionic gonadotrophin, and unconjugated oestriol: experience of a regional programme", Prenatal Diagnosis ,1994,14,    ,['citation-journal']," Goodburn SF, Yates JR, Raggatt PR, Carr C, Ferguson‐Smith ME, Kershaw AJ, et al. Second‐trimester maternal serum screening using alpha‐fetoprotein, human chorionic gonadotrophin, and unconjugated oestriol: experience of a regional programme.  Prenatal Diagnosis 1994;14(5):391‐402.    Link to article     Google Scholar     ","['https://doi.org/10.1002/pd.1970140509', 'https://scholar.google.com/scholar_lookup?title=Second‐trimester+maternal+serum+screening+using+alpha‐fetoprotein,+human+chorionic+gonadotrophin,+and+unconjugated+oestriol:+experience+of+a+regional+programme+&author=SF+Goodburn&author=JR+Yates&author=PR+Raggatt&author=C+Carr&author=ME+Ferguson‐Smith&author=AJ+Kershaw&publication_year=1994&hl=en']",,https://doi.org/10.1002/pd.1970140509, Goodburn 1994 {published data only}  ,excluded,CD009925-bbs2-0186, Likely that fewer than 80% of pregnancies had gestational age estimated by USS. 
CD009925-bib-0200,"Grozdea J, De La Farge F, Bourrouillou G, Calot M, Cambus JP, Valdiguie P. ",Maternal serum urea resistant alkaline phosphatase in Down syndrome pregnancy, Early Human Development ,2002,67,    ,['citation-journal']," Grozdea J, De La Farge F, Bourrouillou G, Calot M, Cambus JP, Valdiguie P. Maternal serum urea resistant alkaline phosphatase in Down syndrome pregnancy.  Early Human Development 2002;67(1‐2):55‐9.    Link to article     Google Scholar     ","['https://doi.org/10.1016/S0378-3782(01)00251-1', 'https://scholar.google.com/scholar_lookup?title=Maternal+serum+urea+resistant+alkaline+phosphatase+in+Down+syndrome+pregnancy&author=J+Grozdea&author=F+Farge&author=G+Bourrouillou&author=M+Calot&author=JP+Cambus&author=P+Valdiguie&publication_year=2002&hl=en']",,https://doi.org/10.1016/S0378-3782(01)00251-1, Grozdea 2002 {published data only}  ,excluded,CD009925-bbs2-0187, Unable to extract useful data. 
CD009925-bib-0201,"Gyselaers WJ, Vereecken AJ, Van Herck EJ, Straetmans DP, Martens GE, De Jonge ET, et al. ",Screening for trisomy 21 in Flanders: a 10 years review of 40.490 pregnancies screened by maternal serum," European Journal of Obstetrics, Gynecology, & Reproductive Biology ",2004,115,    ,['citation-journal']," Gyselaers WJ, Vereecken AJ, Van Herck EJ, Straetmans DP, Martens GE, De Jonge ET, et al. Screening for trisomy 21 in Flanders: a 10 years review of 40.490 pregnancies screened by maternal serum.  European Journal of Obstetrics, Gynecology, & Reproductive Biology 2004;115(2):185‐9.    Link to article     Google Scholar     ","['https://doi.org/10.1016/j.ejogrb.2003.12.014', 'https://scholar.google.com/scholar_lookup?title=Screening+for+trisomy+21+in+Flanders:+a+10+years+review+of+40.490+pregnancies+screened+by+maternal+serum+&author=WJ+Gyselaers&author=AJ+Vereecken&author=EJ+Herck&author=DP+Straetmans&author=GE+Martens&author=ET+Jonge&publication_year=2004&hl=en']",,https://doi.org/10.1016/j.ejogrb.2003.12.014, Gyselaers 2004a {published data only}  ,excluded,CD009925-bbs2-0188, Less than 80% follow‐up. 
CD009925-bib-0202,"Gyselaers WJA, Vereecken AJ, Van Herck, Straetmans DPL, De Jonge, Ombelet WUA, et al. ",Single‐step maternal serum screening for trisomy 21 in the era of combined or integrated screening, Gynecologic and Obstetric Investigation ,2004,58,    ,['citation-journal']," Gyselaers WJA, Vereecken AJ, Van Herck, Straetmans DPL, De Jonge, Ombelet WUA, et al. Single‐step maternal serum screening for trisomy 21 in the era of combined or integrated screening.  Gynecologic and Obstetric Investigation 2004;58(4):221‐4.    Link to article     Google Scholar     ","['https://doi.org/10.1159/000080578', 'https://scholar.google.com/scholar_lookup?title=Single‐step+maternal+serum+screening+for+trisomy+21+in+the+era+of+combined+or+integrated+screening+&author=WJA+Gyselaers&author=AJ+Vereecken&author=Herck+Van&author=DPL+Straetmans&author=Jonge+De&author=WUA+Ombelet&publication_year=2004&hl=en']",,https://doi.org/10.1159/000080578, Gyselaers 2004b {published data only}  ,excluded,CD009925-bbs2-0189, Less than 80% follow‐up. 
CD009925-bib-0203,"Gyselaers WJ, Vereecken AJ, Van Herck EJ, Straetmans DP, Ombelet WU, Nijhuis JG. ","Nuchal translucency thickness measurements for fetal aneuploidy screening: Log NT‐MoM or Delta‐NT, performer‐specific medians and ultrasound training", Journal of Medical Screening ,2006,13,    ,['citation-journal']," Gyselaers WJ, Vereecken AJ, Van Herck EJ, Straetmans DP, Ombelet WU, Nijhuis JG. Nuchal translucency thickness measurements for fetal aneuploidy screening: Log NT‐MoM or Delta‐NT, performer‐specific medians and ultrasound training.  Journal of Medical Screening 2006;13(1):4‐7.    Link to article     Google Scholar     ","['https://doi.org/10.1258/096914106776179755', 'https://scholar.google.com/scholar_lookup?title=Nuchal+translucency+thickness+measurements+for+fetal+aneuploidy+screening:+Log+NT‐MoM+or+Delta‐NT,+performer‐specific+medians+and+ultrasound+training+&author=WJ+Gyselaers&author=AJ+Vereecken&author=EJ+Herck&author=DP+Straetmans&author=WU+Ombelet&author=JG+Nijhuis&publication_year=2006&hl=en']",,https://doi.org/10.1258/096914106776179755, Gyselaers 2006a {published data only}  ,excluded,CD009925-bbs2-0190, Unaffected pregnancies only. 
CD009925-bib-0204,"Gyselaers WJ, Roets ER, Van Holsbeke CD, Vereecken AJ, Van Herck EJ, Straetmans DP, et al. ",Sequential triage in the first trimester may enhance advanced ultrasound scanning in population screening for trisomy 21, Ultrasound in Obstetrics & Gynecology ,2006,27,    ,['citation-journal']," Gyselaers WJ, Roets ER, Van Holsbeke CD, Vereecken AJ, Van Herck EJ, Straetmans DP, et al. Sequential triage in the first trimester may enhance advanced ultrasound scanning in population screening for trisomy 21.  Ultrasound in Obstetrics & Gynecology 2006;27(6):622‐7.    Link to article     Google Scholar     ","['https://doi.org/10.1002/uog.2780', 'https://scholar.google.com/scholar_lookup?title=Sequential+triage+in+the+first+trimester+may+enhance+advanced+ultrasound+scanning+in+population+screening+for+trisomy+21+&author=WJ+Gyselaers&author=ER+Roets&author=CD+Holsbeke&author=AJ+Vereecken&author=EJ+Herck&author=DP+Straetmans&publication_year=2006&hl=en']",,https://doi.org/10.1002/uog.2780, Gyselaers 2006b {published data only}  ,excluded,CD009925-bbs2-0191, Unable to extract useful data. 
CD009925-bib-0205,"Hackshaw AK, Densem J, Wald NJ. ",Repeat maternal serum testing for Down's syndrome screening using multiple markers with special reference to free alpha and free ß‐hCG, Prenatal Diagnosis ,1995,15,    ,['citation-journal']," Hackshaw AK, Densem J, Wald NJ. Repeat maternal serum testing for Down's syndrome screening using multiple markers with special reference to free alpha and free ß‐hCG.  Prenatal Diagnosis 1995;15(12):1125‐30.    Link to article     Google Scholar     ","['https://doi.org/10.1002/pd.1970151208', ""https://scholar.google.com/scholar_lookup?title=Repeat+maternal+serum+testing+for+Down's+syndrome+screening+using+multiple+markers+with+special+reference+to+free+alpha+and+free+ß‐hCG+&author=AK+Hackshaw&author=J+Densem&author=NJ+Wald&publication_year=1995&hl=en""]",,https://doi.org/10.1002/pd.1970151208, Hackshaw 1995 {published data only}  ,excluded,CD009925-bbs2-0192, No Down's syndrome pregnancies in population. 
CD009925-bib-0206,"Hackshaw AK, Wald NJ. ",Repeat testing in antenatal screening for Down syndrome using dimeric inhibin‐A in combination with other maternal serum markers, Prenatal Diagnosis ,2001,21,    ,['citation-journal']," Hackshaw AK, Wald NJ. Repeat testing in antenatal screening for Down syndrome using dimeric inhibin‐A in combination with other maternal serum markers.  Prenatal Diagnosis 2001;21(1):58‐61.    Link to article     Google Scholar     ","['https://doi.org/10.1002/1097-0223(200101)21:1<58::AID-PD964>3.0.CO;2-9', 'https://scholar.google.com/scholar_lookup?title=Repeat+testing+in+antenatal+screening+for+Down+syndrome+using+dimeric+inhibin‐A+in+combination+with+other+maternal+serum+markers+&author=AK+Hackshaw&author=NJ+Wald&publication_year=2001&hl=en']",,https://doi.org/10.1002/1097-0223(200101)21:1<58::AID-PD964>3.0.CO;2-9, Hackshaw 2001 {published data only}  ,excluded,CD009925-bbs2-0193, No Down's syndrome pregnancies in population 
CD009925-bib-0207,"Haddow JE, Palomaki GE, Knight GJ, Williams J, Pulkkinen A, Canick J, et al. ",Prenatal screening for Down's syndrome with use of maternal serum markers, New England Journal of Medicine ,1992,327,    ,['citation-journal']," Haddow JE, Palomaki GE, Knight GJ, Williams J, Pulkkinen A, Canick J, et al. Prenatal screening for Down's syndrome with use of maternal serum markers.  New England Journal of Medicine 1992;327(9):588‐93.    Link to article     Google Scholar     ","['https://doi.org/10.1056/NEJM199208273270902', ""https://scholar.google.com/scholar_lookup?title=Prenatal+screening+for+Down's+syndrome+with+use+of+maternal+serum+markers&author=JE+Haddow&author=GE+Palomaki&author=GJ+Knight&author=J+Williams&author=A+Pulkkinen&author=J+Canick&publication_year=1992&hl=en""]",,https://doi.org/10.1056/NEJM199208273270902, Haddow 1992 {published data only}  ,excluded,CD009925-bbs2-0194, Less than 80% of pregnancies had gestational age confirmed by ultrasound scan. 
CD009925-bib-0208,"Hafner E, Schuchter K, Philipp K. ",Screening for chromosomal abnormalities in an unselected population by fetal nuchal translucency, Ultrasound in Obstetrics & Gynecology ,1995,6,    ,['citation-journal']," Hafner E, Schuchter K, Philipp K. Screening for chromosomal abnormalities in an unselected population by fetal nuchal translucency.  Ultrasound in Obstetrics & Gynecology 1995;6(5):330‐3.    Link to article     Google Scholar     ","['https://doi.org/10.1046/j.1469-0705.1995.06050330.x', 'https://scholar.google.com/scholar_lookup?title=Screening+for+chromosomal+abnormalities+in+an+unselected+population+by+fetal+nuchal+translucency+&author=E+Hafner&author=K+Schuchter&author=K+Philipp&publication_year=1995&hl=en']",,https://doi.org/10.1046/j.1469-0705.1995.06050330.x, Hafner 1995 {published data only}  ,excluded,CD009925-bbs2-0195, Less than 5 Down's pregnancies in study population. 
CD009925-bib-0209,"Hallahan TW, Krantz DA, Tului L, Alberti E, Buchanan PD, Orlandi F, et al. ",Comparison of urinary free ß (hCG) and ß‐core (hCG) in prenatal screening for chromosomal abnormalities, Prenatal Diagnosis ,1998,18,    ,['citation-journal']," Hallahan TW, Krantz DA, Tului L, Alberti E, Buchanan PD, Orlandi F, et al. Comparison of urinary free ß (hCG) and ß‐core (hCG) in prenatal screening for chromosomal abnormalities.  Prenatal Diagnosis 1998;18(9):893‐900.    Link to article     Google Scholar     ","['https://doi.org/10.1002/(SICI)1097-0223(199809)18:9<893::AID-PD362>3.0.CO;2-E', 'https://scholar.google.com/scholar_lookup?title=Comparison+of+urinary+free+ß+(hCG)+and+ß‐core+(hCG)+in+prenatal+screening+for+chromosomal+abnormalities+&author=TW+Hallahan&author=DA+Krantz&author=L+Tului&author=E+Alberti&author=PD+Buchanan&author=F+Orlandi&publication_year=1998&hl=en']",,https://doi.org/10.1002/(SICI)1097-0223(199809)18:9<893::AID-PD362>3.0.CO;2-E, Hallahan 1998 {published data only}  ,excluded,CD009925-bbs2-0196, Gestational age greater than 24 weeks. 
CD009925-bib-0210,"Harrison G, Goldie D. ","Second‐trimester Down's syndrome serum screening: double, triple or quadruple marker testing?", Annals of Clinical Biochemistry ,2006,43,    ,['citation-journal']," Harrison G, Goldie D. Second‐trimester Down's syndrome serum screening: double, triple or quadruple marker testing?.  Annals of Clinical Biochemistry 2006;43(1):67‐72.    Link to article     Google Scholar     ","['https://doi.org/10.1258/000456306775141876', ""https://scholar.google.com/scholar_lookup?title=Second‐trimester+Down's+syndrome+serum+screening:+double,+triple+or+quadruple+marker+testing?+&author=G+Harrison&author=D+Goldie&publication_year=2006&hl=en""]",,https://doi.org/10.1258/000456306775141876, Harrison 2006 {published data only}  ,excluded,CD009925-bbs2-0197, Less than 80% of pregnancies had gestational age confirmed by ultrasound scan. 
CD009925-bib-0211,"Harry WG, Reed KL. ",Nuchal translucency and first‐trimester screening, Journal of the Society for Gynecologic Investigation ,2006,13,    ,['citation-journal']," Harry WG, Reed KL. Nuchal translucency and first‐trimester screening.  Journal of the Society for Gynecologic Investigation 2006;13(3):153‐4.    Link to article     Google Scholar     ","['https://doi.org/10.1016/j.jsgi.2006.03.001', 'https://scholar.google.com/scholar_lookup?title=Nuchal+translucency+and+first‐trimester+screening&author=WG+Harry&author=KL+Reed&publication_year=2006&hl=en']",,https://doi.org/10.1016/j.jsgi.2006.03.001, Harry 2006 {published data only}  ,excluded,CD009925-bbs2-0198, Editorial. 
CD009925-bib-0212,"Hayashi M, Kozu H. ",Maternal urinary ß‐core fragment of hCG/creatinine ratios and fetal chromosomal abnormalities in the second trimester of pregnancy, Prenatal Diagnosis ,1995,15,    ,['citation-journal']," Hayashi M, Kozu H. Maternal urinary ß‐core fragment of hCG/creatinine ratios and fetal chromosomal abnormalities in the second trimester of pregnancy.  Prenatal Diagnosis 1995;15(1):11‐6.    Link to article     Google Scholar     ","['https://doi.org/10.1002/pd.1970150104', 'https://scholar.google.com/scholar_lookup?title=Maternal+urinary+ß‐core+fragment+of+hCG/creatinine+ratios+and+fetal+chromosomal+abnormalities+in+the+second+trimester+of+pregnancy+&author=M+Hayashi&author=H+Kozu&publication_year=1995&hl=en']",,https://doi.org/10.1002/pd.1970150104, Hayashi 1995 {published data only}  ,excluded,CD009925-bbs2-0199, Unable to extract useful data. 
CD009925-bib-0213,"Hayashi M, Kozu H, Takei H. ",Maternal urinary free ß‐subunit of human chorionic gonadotrophin: Creatinine ratios and fetal chromosomal abnormalities in the second trimester of pregnancy, British Journal of Obstetrics and Gynaecology ,1996,103,    ,['citation-journal']," Hayashi M, Kozu H, Takei H. Maternal urinary free ß‐subunit of human chorionic gonadotrophin: Creatinine ratios and fetal chromosomal abnormalities in the second trimester of pregnancy.  British Journal of Obstetrics and Gynaecology 1996;103(6):577‐80.    Link to article     Google Scholar     ","['https://doi.org/10.1111/j.1471-0528.1996.tb09810.x', 'https://scholar.google.com/scholar_lookup?title=Maternal+urinary+free+ß‐subunit+of+human+chorionic+gonadotrophin:+Creatinine+ratios+and+fetal+chromosomal+abnormalities+in+the+second+trimester+of+pregnancy+&author=M+Hayashi&author=H+Kozu&author=H+Takei&publication_year=1996&hl=en']",,https://doi.org/10.1111/j.1471-0528.1996.tb09810.x, Hayashi 1996 {published data only}  ,excluded,CD009925-bbs2-0200, Less than 5 Down's pregnancies in study population. 
CD009925-bib-0214,"Heikkila A, Ryynanen M, Kirkinen P, Saarikoski S. ",Results and views of women in population‐wide pregnancy screening for trisomy 21 in east Finland, Fetal Diagnosis & Therapy ,1997,12,    ,['citation-journal']," Heikkila A, Ryynanen M, Kirkinen P, Saarikoski S. Results and views of women in population‐wide pregnancy screening for trisomy 21 in east Finland.  Fetal Diagnosis & Therapy 1997;12(2):93‐6.    Link to article     Google Scholar     ","['https://doi.org/10.1159/000264439', 'https://scholar.google.com/scholar_lookup?title=Results+and+views+of+women+in+population‐wide+pregnancy+screening+for+trisomy+21+in+east+Finland+&author=A+Heikkila&author=M+Ryynanen&author=P+Kirkinen&author=S+Saarikoski&publication_year=1997&hl=en']",,https://doi.org/10.1159/000264439, Heikkila 1997 {published data only}  ,excluded,CD009925-bbs2-0201, Fewer than 80% of pregnancies had gestational age confirmed by USS. 
CD009925-bib-0215,"Heinonen S, Ryynanen M, Kirkinen P, Hippelainen M, Saarikoski S. ",Effect of in vitro fertilization on human chorionic gonadotropin serum concentrations and Down's syndrome screening, Fertility and Sterility ,1996,66,    ,['citation-journal']," Heinonen S, Ryynanen M, Kirkinen P, Hippelainen M, Saarikoski S. Effect of in vitro fertilization on human chorionic gonadotropin serum concentrations and Down's syndrome screening.  Fertility and Sterility 1996;66(3):398‐403.    Link to article     Google Scholar     ","['https://doi.org/10.1016/S0015-0282(16)58508-2', ""https://scholar.google.com/scholar_lookup?title=Effect+of+in+vitro+fertilization+on+human+chorionic+gonadotropin+serum+concentrations+and+Down's+syndrome+screening+&author=S+Heinonen&author=M+Ryynanen&author=P+Kirkinen&author=M+Hippelainen&author=S+Saarikoski&publication_year=1996&hl=en""]",,https://doi.org/10.1016/S0015-0282(16)58508-2, Heinonen 1996 {published data only}  ,excluded,CD009925-bbs2-0202, No Down's syndrome pregnancies in population. 
CD009925-bib-0216,"Herman A, Weinraub Z, Dreazen E, Arieli S, Rozansky S, Bukovsky I, et al. ",Combined first trimester nuchal translucency and second trimester biochemical screening tests among normal pregnancies, Prenatal Diagnosis. ,2000,20,    ,['citation-journal']," Herman A, Weinraub Z, Dreazen E, Arieli S, Rozansky S, Bukovsky I, et al. Combined first trimester nuchal translucency and second trimester biochemical screening tests among normal pregnancies.  Prenatal Diagnosis. 2000;20(10):781‐4.    Link to article     Google Scholar     ","['https://doi.org/10.1002/1097-0223(200010)20:10<781::AID-PD908>3.0.CO;2-Z', 'https://scholar.google.com/scholar_lookup?title=Combined+first+trimester+nuchal+translucency+and+second+trimester+biochemical+screening+tests+among+normal+pregnancies+&author=A+Herman&author=Z+Weinraub&author=E+Dreazen&author=S+Arieli&author=S+Rozansky&author=I+Bukovsky&publication_year=2000&hl=en']",,https://doi.org/10.1002/1097-0223(200010)20:10<781::AID-PD908>3.0.CO;2-Z, Herman 2000 {published data only}  ,excluded,CD009925-bbs2-0203, No Down's syndrome pregnancies in study population. 
CD009925-bib-0217,"Herman A, Dreazen E, Tovbin Y, Reish O, Bukovsky I, Maymon R. ",Correlation and overlapping between nuchal translucency and triple test among Down syndrome‐affected pregnancies, Fetal Diagnosis and Therapy ,2003,18,    ,['citation-journal']," Herman A, Dreazen E, Tovbin Y, Reish O, Bukovsky I, Maymon R. Correlation and overlapping between nuchal translucency and triple test among Down syndrome‐affected pregnancies.  Fetal Diagnosis and Therapy 2003;18(3):196‐200.    Link to article     Google Scholar     ","['https://doi.org/10.1159/000069377', 'https://scholar.google.com/scholar_lookup?title=Correlation+and+overlapping+between+nuchal+translucency+and+triple+test+among+Down+syndrome‐affected+pregnancies+&author=A+Herman&author=E+Dreazen&author=Y+Tovbin&author=O+Reish&author=I+Bukovsky&author=R+Maymon&publication_year=2003&hl=en']",,https://doi.org/10.1159/000069377, Herman 2003 {published data only}  ,excluded,CD009925-bbs2-0204," Correlation between markers, not evaluation of screening tests. "
CD009925-bib-0218,"Herrou M, Leporrier N, Leymarie P. ",Screening for fetal Down syndrome with maternal serum hCG and oestriol: a prospective study, Prenatal Diagnosis ,1992,12,    ,['citation-journal']," Herrou M, Leporrier N, Leymarie P. Screening for fetal Down syndrome with maternal serum hCG and oestriol: a prospective study.  Prenatal Diagnosis 1992;12(11):887‐92.    Link to article     Google Scholar     ","['https://doi.org/10.1002/pd.1970121106', 'https://scholar.google.com/scholar_lookup?title=Screening+for+fetal+Down+syndrome+with+maternal+serum+hCG+and+oestriol:+a+prospective+study+&author=M+Herrou&author=N+Leporrier&author=P+Leymarie&publication_year=1992&hl=en']",,https://doi.org/10.1002/pd.1970121106, Herrou 1992 {published data only}  ,excluded,CD009925-bbs2-0205, Unable to extract useful data. 
CD009925-bib-0219,"Hershey DW, Crandall BF, Schroth PS. ",Maternal serum alpha‐fetoprotein screening of fetal trisomies, American Journal of Obstetrics & Gynecology ,1985,153,    ,['citation-journal']," Hershey DW, Crandall BF, Schroth PS. Maternal serum alpha‐fetoprotein screening of fetal trisomies.  American Journal of Obstetrics & Gynecology 1985;153(2):224‐5.    Link to article     Google Scholar     ","['https://doi.org/10.1016/0002-9378(85)90119-X', 'https://scholar.google.com/scholar_lookup?title=Maternal+serum+alpha‐fetoprotein+screening+of+fetal+trisomies&author=DW+Hershey&author=BF+Crandall&author=PS+Schroth&publication_year=1985&hl=en']",,https://doi.org/10.1016/0002-9378(85)90119-X, Hershey 1985 {published data only}  ,excluded,CD009925-bbs2-0206, Gestation unclear. 
CD009925-bib-0220,"Hershey DW, Crandall BF, Perdue S. ",Combining maternal age and serum alpha‐fetoprotein to predict the risk of Down syndrome, Obstetrics & Gynecology ,1986,68,    ,['citation-journal']," Hershey DW, Crandall BF, Perdue S. Combining maternal age and serum alpha‐fetoprotein to predict the risk of Down syndrome.  Obstetrics & Gynecology 1986;68(2):177‐80.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=Combining+maternal+age+and+serum+alpha‐fetoprotein+to+predict+the+risk+of+Down+syndrome&author=DW+Hershey&author=BF+Crandall&author=S+Perdue&publication_year=1986&hl=en'],,, Hershey 1986 {published data only}  ,excluded,CD009925-bbs2-0207, Gestation based on LMP. 
CD009925-bib-0221,Hewitt B. ,Nuchal translucency in the first trimester, Australian & New Zealand Journal of Obstetrics & Gynaecology ,1993,33,    ,['citation-journal'], Hewitt B. Nuchal translucency in the first trimester.  Australian & New Zealand Journal of Obstetrics & Gynaecology 1993;33(4):389‐91.    Link to article     Google Scholar     ,"['https://doi.org/10.1111/j.1479-828X.1993.tb02117.x', 'https://scholar.google.com/scholar_lookup?title=Nuchal+translucency+in+the+first+trimester&author=B+Hewitt&publication_year=1993&hl=en']",,https://doi.org/10.1111/j.1479-828X.1993.tb02117.x, Hewitt 1993 {published data only}  ,excluded,CD009925-bbs2-0208, Unable to extract useful data. 
CD009925-bib-0222,"Hogdall CK, Hogdall EV, Arends J, Norgaard‐Pedersen B, Smidt‐Jensen S, Larsen SO. ",CA‐125 as a maternal serum marker for Down's syndrome in the first and second trimesters, Prenatal Diagnosis ,1992,12,    ,['citation-journal']," Hogdall CK, Hogdall EV, Arends J, Norgaard‐Pedersen B, Smidt‐Jensen S, Larsen SO. CA‐125 as a maternal serum marker for Down's syndrome in the first and second trimesters.  Prenatal Diagnosis 1992;12(3):223‐7.    Link to article     Google Scholar     ","['https://doi.org/10.1002/pd.1970120312', ""https://scholar.google.com/scholar_lookup?title=CA‐125+as+a+maternal+serum+marker+for+Down's+syndrome+in+the+first+and+second+trimesters&author=CK+Hogdall&author=EV+Hogdall&author=J+Arends&author=B+Norgaard‐Pedersen&author=S+Smidt‐Jensen&author=SO+Larsen&publication_year=1992&hl=en""]",,https://doi.org/10.1002/pd.1970120312, Hogdall 1992 {published data only}  ,excluded,CD009925-bbs2-0209, Unclear method of determination of gestational age. Unable to extract useful data. 
CD009925-bib-0223,Anon. ,Screening tests in pregnancy, Hong Kong Practitioner ,2001,23,    ,['citation-journal'], Anon. Screening tests in pregnancy.  Hong Kong Practitioner 2001;23(10):461‐5.    Google Scholar     ,['https://scholar.google.com/scholar_lookup?title=Screening+tests+in+pregnancy&author=+Anon&publication_year=2001&hl=en'],,, Hong Kong Practitioner {published data only}  ,excluded,CD009925-bbs2-0210, CME. 
CD009925-bib-0224,"Howe DT, Gornall R, Wellesley D, Boyle T, Barber J. ",Six year survey of screening for Down's syndrome by maternal age and mid‐trimester ultrasound scans, BMJ ,2000,320,    ,['citation-journal']," Howe DT, Gornall R, Wellesley D, Boyle T, Barber J. Six year survey of screening for Down's syndrome by maternal age and mid‐trimester ultrasound scans.  BMJ 2000;320(7235):606‐10.    Link to article     Google Scholar     ","['https://doi.org/10.1136/bmj.320.7235.606', ""https://scholar.google.com/scholar_lookup?title=Six+year+survey+of+screening+for+Down's+syndrome+by+maternal+age+and+mid‐trimester+ultrasound+scans+&author=DT+Howe&author=R+Gornall&author=D+Wellesley&author=T+Boyle&author=J+Barber&publication_year=2000&hl=en""]",,https://doi.org/10.1136/bmj.320.7235.606, Howe 2000 {published data only}  ,excluded,CD009925-bbs2-0211, Second trimester ultrasound scans. 
CD009925-bib-0225,"Hsiao KJ, Lee SY, Chuang HC. ",[Antenatal screening of maternal alpha‐fetoprotein with dried‐blood spot samples on filter paper]. [Chinese], Journal of the Formosan Medical Association ,1991,90,    ,['citation-journal']," Hsiao KJ, Lee SY, Chuang HC. [Antenatal screening of maternal alpha‐fetoprotein with dried‐blood spot samples on filter paper]. [Chinese].  Journal of the Formosan Medical Association 1991;90(6):598‐604.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=[Antenatal+screening+of+maternal+alpha‐fetoprotein+with+dried‐blood+spot+samples+on+filter+paper].+[Chinese]+&author=KJ+Hsiao&author=SY+Lee&author=HC+Chuang&publication_year=1991&hl=en'],,, Hsiao 1991 {published data only}  ,excluded,CD009925-bbs2-0212, Unable to obtain translation. 
CD009925-bib-0226,"Hsieh TT, Hsu JJ, Lo LM, Liou JD, Soong YK. ",Maternal urine alpha‐fetoprotein concentrations between 14 and 21 weeks of gestation, Changgeng Yi Xue Za Zhi ,1999,22,    ,['citation-journal']," Hsieh TT, Hsu JJ, Lo LM, Liou JD, Soong YK. Maternal urine alpha‐fetoprotein concentrations between 14 and 21 weeks of gestation.  Changgeng Yi Xue Za Zhi 1999;22(2):234‐9.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=Maternal+urine+alpha‐fetoprotein+concentrations+between+14+and+21+weeks+of+gestation&author=TT+Hsieh&author=JJ+Hsu&author=LM+Lo&author=JD+Liou&author=YK+Soong&publication_year=1999&hl=en'],,, Hsieh 1999 {published data only}  ,excluded,CD009925-bbs2-0213, No Down's syndrome pregnancies in study population. 
CD009925-bib-0227,"Hsu JJ, Hsieh TT, Soong YK. ","Influence of maternal age and weight on second‐trimester serum alpha‐fetoprotein, total and free ß human chorionic gonadotropin levels", Changgeng Yi Xue Za Zhi. ,1997,20,    ,['citation-journal']," Hsu JJ, Hsieh TT, Soong YK. Influence of maternal age and weight on second‐trimester serum alpha‐fetoprotein, total and free ß human chorionic gonadotropin levels.  Changgeng Yi Xue Za Zhi. 1997;20(3):181‐6.    Google Scholar     ","['https://scholar.google.com/scholar_lookup?title=Influence+of+maternal+age+and+weight+on+second‐trimester+serum+alpha‐fetoprotein,+total+and+free+ß+human+chorionic+gonadotropin+levels+&author=JJ+Hsu&author=TT+Hsieh&author=YK+Soong&publication_year=1997&hl=en']",,, Hsu 1997b {published data only}  ,excluded,CD009925-bbs2-0214, Adjustment factors. 
CD009925-bib-0228,"Hsu JJ, Hsieh TT, Hung TH, Chiang CH. ",Midtrimester maternal serum free ß‐human chorionic gonadotropin levels: normal reference values for Taiwanese women, Changgeng Yi Xue Za Zhi ,1998,21,    ,['citation-journal']," Hsu JJ, Hsieh TT, Hung TH, Chiang CH. Midtrimester maternal serum free ß‐human chorionic gonadotropin levels: normal reference values for Taiwanese women.  Changgeng Yi Xue Za Zhi 1998;21(3):277‐82.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=Midtrimester+maternal+serum+free+ß‐human+chorionic+gonadotropin+levels:+normal+reference+values+for+Taiwanese+women+&author=JJ+Hsu&author=TT+Hsieh&author=TH+Hung&author=CH+Chiang&publication_year=1998&hl=en'],,, Hsu 1998a {published data only}  ,excluded,CD009925-bbs2-0215, No Down's syndrome pregnancies in study population. 
CD009925-bib-0229,"Hsu JJ, Hsieh TT, Hung TH, Chen KC, Soong YK. ",Urine free ß‐human chorionic gonadotropin levels between 14 and 21 weeks of gestation in Taiwanese pregnancies, Changgeng Yi Xue Za Zhi ,1999,22,    ,['citation-journal']," Hsu JJ, Hsieh TT, Hung TH, Chen KC, Soong YK. Urine free ß‐human chorionic gonadotropin levels between 14 and 21 weeks of gestation in Taiwanese pregnancies.  Changgeng Yi Xue Za Zhi 1999;22(1):11‐6.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=Urine+free+ß‐human+chorionic+gonadotropin+levels+between+14+and+21+weeks+of+gestation+in+Taiwanese+pregnancies+&author=JJ+Hsu&author=TT+Hsieh&author=TH+Hung&author=KC+Chen&author=YK+Soong&publication_year=1999&hl=en'],,, Hsu 1999b {published data only}  ,excluded,CD009925-bbs2-0216, No Down's pregnancies. 
CD009925-bib-0230,"Huang T, Summers AM, Wyatt PR, Meier C, Cote GB. ",Maternal serum marker medians in Aboriginal Canadian women, Prenatal Diagnosis ,2003,23,    ,['citation-journal']," Huang T, Summers AM, Wyatt PR, Meier C, Cote GB. Maternal serum marker medians in Aboriginal Canadian women.  Prenatal Diagnosis 2003;23(2):98‐100.    Link to article     Google Scholar     ","['https://doi.org/10.1002/pd.537', 'https://scholar.google.com/scholar_lookup?title=Maternal+serum+marker+medians+in+Aboriginal+Canadian+women&author=T+Huang&author=AM+Summers&author=PR+Wyatt&author=C+Meier&author=GB+Cote&publication_year=2003&hl=en']",,https://doi.org/10.1002/pd.537, Huang 2003 {published data only}  ,excluded,CD009925-bbs2-0217, No Down's syndrome pregnancies in study population. 
CD009925-bib-0231,"Huggon IC, Turan O, Allan LD. ",Doppler assessment of cardiac function at 11‐14 weeks' gestation in fetuses with normal and increased nuchal translucency, Ultrasound in Obstetrics & Gynecology ,2004,24,    ,['citation-journal']," Huggon IC, Turan O, Allan LD. Doppler assessment of cardiac function at 11‐14 weeks' gestation in fetuses with normal and increased nuchal translucency.  Ultrasound in Obstetrics & Gynecology 2004;24(4):390‐8.    Link to article     Google Scholar     ","['https://doi.org/10.1002/uog.1720', ""https://scholar.google.com/scholar_lookup?title=Doppler+assessment+of+cardiac+function+at+11‐14+weeks'+gestation+in+fetuses+with+normal+and+increased+nuchal+translucency+&author=IC+Huggon&author=O+Turan&author=LD+Allan&publication_year=2004&hl=en""]",,https://doi.org/10.1002/uog.1720, Huggon 2004 {published data only}  ,excluded,CD009925-bbs2-0218, Study of cardiac function in pregnancies with normal and abnormal NT results. 
CD009925-bib-0232,"Hui PW, Tang MH, Lam YH, NG EH, Yeung WS, Ho PC. ",Maternal serum hCG and alpha‐fetoprotein levels in pregnancies conceived after IVF or ICSI with fresh and frozen‐thawed embryos, Human Reproduction ,2003,18,    ,['citation-journal']," Hui PW, Tang MH, Lam YH, NG EH, Yeung WS, Ho PC. Maternal serum hCG and alpha‐fetoprotein levels in pregnancies conceived after IVF or ICSI with fresh and frozen‐thawed embryos.  Human Reproduction 2003;18(3):572‐5.    Link to article     Google Scholar     ","['https://doi.org/10.1093/humrep/deg153', 'https://scholar.google.com/scholar_lookup?title=Maternal+serum+hCG+and+alpha‐fetoprotein+levels+in+pregnancies+conceived+after+IVF+or+ICSI+with+fresh+and+frozen‐thawed+embryos+&author=PW+Hui&author=MH+Tang&author=YH+Lam&author=EH+NG&author=WS+Yeung&author=PC+Ho&publication_year=2003&hl=en']",,https://doi.org/10.1093/humrep/deg153, Hui 2003 {published data only}  ,excluded,CD009925-bbs2-0219, No Down's syndrome pregnancies in population. 
CD009925-bib-0233,"Hui PW, Tang MH, Lam YH, Yeung WS, NG EH, Ho PC. ",Nuchal translucency in pregnancies conceived after assisted reproduction technology, Ultrasound in Obstetrics & Gynecology ,2005,25,    ,['citation-journal']," Hui PW, Tang MH, Lam YH, Yeung WS, NG EH, Ho PC. Nuchal translucency in pregnancies conceived after assisted reproduction technology.  Ultrasound in Obstetrics & Gynecology 2005;25(3):234‐8.    Link to article     Google Scholar     ","['https://doi.org/10.1002/uog.1846', 'https://scholar.google.com/scholar_lookup?title=Nuchal+translucency+in+pregnancies+conceived+after+assisted+reproduction+technology&author=PW+Hui&author=MH+Tang&author=YH+Lam&author=WS+Yeung&author=EH+NG&author=PC+Ho&publication_year=2005&hl=en']",,https://doi.org/10.1002/uog.1846, Hui 2005 {published data only}  ,excluded,CD009925-bbs2-0220, No Down's syndrome pregnancies in population. 
CD009925-bib-0234,Hultén M. ,Combined serum and nuchal translucency screening in the first trimester achieves 85% to 90% detection rate for Down and Edward syndromes, Evidence‐Based Healthcare ,2004,8,    ,['citation-journal'], Hultén M. Combined serum and nuchal translucency screening in the first trimester achieves 85% to 90% detection rate for Down and Edward syndromes.  Evidence‐Based Healthcare 2004;8(2):82‐4.    Link to article     Google Scholar     ,"['https://doi.org/10.1016/j.ehbc.2004.02.021', 'https://scholar.google.com/scholar_lookup?title=Combined+serum+and+nuchal+translucency+screening+in+the+first+trimester+achieves+85%+to+90%+detection+rate+for+Down+and+Edward+syndromes+&author=M+Hultén&publication_year=2004&hl=en']",,https://doi.org/10.1016/j.ehbc.2004.02.021, Hultén 2004 {published data only}  ,excluded,CD009925-bbs2-0221, Editorial/commentary. 
CD009925-bib-0235,"Hung JH, Fu CY, Yuan CC, Chen CL, Yang ML, Shu LP, et al. ",Nuchal translucence incorporated into a one‐stage multifactorial screening model for Down syndrome prediction at second‐trimester pregnancy, Ultrasound in Medicine & Biology ,2003,29,    ,['citation-journal']," Hung JH, Fu CY, Yuan CC, Chen CL, Yang ML, Shu LP, et al. Nuchal translucence incorporated into a one‐stage multifactorial screening model for Down syndrome prediction at second‐trimester pregnancy.  Ultrasound in Medicine & Biology 2003;29(12):1667‐74.    Link to article     Google Scholar     ","['https://doi.org/10.1016/S0301-5629(03)01048-2', 'https://scholar.google.com/scholar_lookup?title=Nuchal+translucence+incorporated+into+a+one‐stage+multifactorial+screening+model+for+Down+syndrome+prediction+at+second‐trimester+pregnancy+&author=JH+Hung&author=CY+Fu&author=CC+Yuan&author=CL+Chen&author=ML+Yang&author=LP+Shu&publication_year=2003&hl=en']",,https://doi.org/10.1016/S0301-5629(03)01048-2, Hung 2003 {published data only}  ,excluded,CD009925-bbs2-0222, Modelling. 
CD009925-bib-0236,"Hurley PA, Ward RH, Teisner B, Iles RK, Lucas M, Grudzinskas JG. ",Serum PAPP‐A measurements in first‐trimester screening for Down syndrome, Prenatal Diagnosis ,1993,13,    ,['citation-journal']," Hurley PA, Ward RH, Teisner B, Iles RK, Lucas M, Grudzinskas JG. Serum PAPP‐A measurements in first‐trimester screening for Down syndrome.  Prenatal Diagnosis 1993;13(10):903‐8.    Link to article     Google Scholar     ","['https://doi.org/10.1002/pd.1970131004', 'https://scholar.google.com/scholar_lookup?title=Serum+PAPP‐A+measurements+in+first‐trimester+screening+for+Down+syndrome&author=PA+Hurley&author=RH+Ward&author=B+Teisner&author=RK+Iles&author=M+Lucas&author=JG+Grudzinskas&publication_year=1993&hl=en']",,https://doi.org/10.1002/pd.1970131004, Hurley 1993 {published data only}  ,excluded,CD009925-bbs2-0223, Unable to extract useful data. 
CD009925-bib-0237,"Huttly W, Rudnicka A, Wald NJ. ",Second‐trimester prenatal screening markers for Down syndrome in women with insulin‐dependent diabetes mellitus, Prenatal Diagnosis ,2004,24,    ,['citation-journal']," Huttly W, Rudnicka A, Wald NJ. Second‐trimester prenatal screening markers for Down syndrome in women with insulin‐dependent diabetes mellitus.  Prenatal Diagnosis 2004;24(10):804‐7.    Link to article     Google Scholar     ","['https://doi.org/10.1002/pd.994', 'https://scholar.google.com/scholar_lookup?title=Second‐trimester+prenatal+screening+markers+for+Down+syndrome+in+women+with+insulin‐dependent+diabetes+mellitus+&author=W+Huttly&author=A+Rudnicka&author=NJ+Wald&publication_year=2004&hl=en']",,https://doi.org/10.1002/pd.994, Huttly 2004 {published data only}  ,excluded,CD009925-bbs2-0224, No Down's syndrome pregnancies in population. 
CD009925-bib-0238,"Hwa HL, Yen MF, Hsieh FJ, Ko TM, Chen TH. ",Evaluation of second trimester maternal serum screening for Down's Syndrome using the Spiegelhalter‐Knill‐Jones (S‐KJ) approach, Journal of Perinatal Medicine ,2004,32,    ,['citation-journal']," Hwa HL, Yen MF, Hsieh FJ, Ko TM, Chen TH. Evaluation of second trimester maternal serum screening for Down's Syndrome using the Spiegelhalter‐Knill‐Jones (S‐KJ) approach.  Journal of Perinatal Medicine 2004;32(5):407‐12.    Link to article     Google Scholar     ","['https://doi.org/10.1515/JPM.2004.137', ""https://scholar.google.com/scholar_lookup?title=Evaluation+of+second+trimester+maternal+serum+screening+for+Down's+Syndrome+using+the+Spiegelhalter‐Knill‐Jones+(S‐KJ)+approach+&author=HL+Hwa&author=MF+Yen&author=FJ+Hsieh&author=TM+Ko&author=TH+Chen&publication_year=2004&hl=en""]",,https://doi.org/10.1515/JPM.2004.137, Hwa 2004 {published data only}  ,excluded,CD009925-bbs2-0225, Less than 5 Down's pregnancies in population. 
CD009925-bib-0239,Iles RK. ,Urinary analysis for Down's syndrome: Is the measurement of urinary ß‐core the future of biochemical screening for Down's syndrome, Early Human Development ,1996,47,    ,['citation-journal'], Iles RK. Urinary analysis for Down's syndrome: Is the measurement of urinary ß‐core the future of biochemical screening for Down's syndrome.  Early Human Development 1996;47(Suppl.):S41‐S45.    Link to article     Google Scholar     ,"['https://doi.org/10.1016/S0378-3782(96)01818-X', ""https://scholar.google.com/scholar_lookup?title=Urinary+analysis+for+Down's+syndrome:+Is+the+measurement+of+urinary+ß‐core+the+future+of+biochemical+screening+for+Down's+syndrome+&author=RK+Iles&publication_year=1996&hl=en""]",,https://doi.org/10.1016/S0378-3782(96)01818-X, Iles 1996 {published data only}  ,excluded,CD009925-bbs2-0226, Review. 
CD009925-bib-0240,"Ind TEJ, Iles RK, Cuckle HS, Chard T. ",Second trimester maternal serum placental alkaline phosphatase concentrations in Down's syndrome, Journal of Obstetrics and Gynaecology ,1994,14,    ,['citation-journal']," Ind TEJ, Iles RK, Cuckle HS, Chard T. Second trimester maternal serum placental alkaline phosphatase concentrations in Down's syndrome.  Journal of Obstetrics and Gynaecology 1994;14(5):305‐8.    Link to article     Google Scholar     ","['https://doi.org/10.3109/01443619409027596', ""https://scholar.google.com/scholar_lookup?title=Second+trimester+maternal+serum+placental+alkaline+phosphatase+concentrations+in+Down's+syndrome+&author=TEJ+Ind&author=RK+Iles&author=HS+Cuckle&author=T+Chard&publication_year=1994&hl=en""]",,https://doi.org/10.3109/01443619409027596, Ind 1994 {published data only}  ,excluded,CD009925-bbs2-0227, Unable to extract useful data. 
CD009925-bib-0241,Jean Pierre. ,Fetal nasal bone: Review of first trimester findings, Ultrasound Review of Obstetrics and Gynecology ,2005,5,    ,['citation-journal'], Jean Pierre. Fetal nasal bone: Review of first trimester findings.  Ultrasound Review of Obstetrics and Gynecology 2005;5(2):102‐4.    Link to article     Google Scholar     ,"['https://doi.org/10.3109/14722240500190673', 'https://scholar.google.com/scholar_lookup?title=Fetal+nasal+bone:+Review+of+first+trimester+findings&author=Pierre+Jean&publication_year=2005&hl=en']",,https://doi.org/10.3109/14722240500190673, Jean‐Pierre 2005 {published data only}  ,excluded,CD009925-bbs2-0228, Review article. 
CD009925-bib-0242,"Johnson A, Cowchock FS, Darby M, Wapner R, Jackson LG. ",First‐trimester maternal serum alpha‐fetoprotein and chorionic gonadotropin in aneuploid pregnancies, Prenatal Diagnosis ,1991,11,    ,['citation-journal']," Johnson A, Cowchock FS, Darby M, Wapner R, Jackson LG. First‐trimester maternal serum alpha‐fetoprotein and chorionic gonadotropin in aneuploid pregnancies.  Prenatal Diagnosis 1991;11(7):443‐50.    Link to article     Google Scholar     ","['https://doi.org/10.1002/pd.1970110706', 'https://scholar.google.com/scholar_lookup?title=First‐trimester+maternal+serum+alpha‐fetoprotein+and+chorionic+gonadotropin+in+aneuploid+pregnancies+&author=A+Johnson&author=FS+Cowchock&author=M+Darby&author=R+Wapner&author=LG+Jackson&publication_year=1991&hl=en']",,https://doi.org/10.1002/pd.1970110706, Johnson 1991 {published data only}  ,excluded,CD009925-bbs2-0229, Gestatiojnal age estimated by USS in fewer than 80% of cases. 
CD009925-bib-0243,"Johnson MP, Johnson A, Holzgreve W, Isada NB, Wapner RJ, Treadwell MC, et al. ",First‐trimester simple hygroma: cause and outcome, American Journal of Obstetrics & Gynecology ,1993,168,    ,['citation-journal']," Johnson MP, Johnson A, Holzgreve W, Isada NB, Wapner RJ, Treadwell MC, et al. First‐trimester simple hygroma: cause and outcome.  American Journal of Obstetrics & Gynecology 1993;168(1):156‐61.    Link to article     Google Scholar     ","['https://doi.org/10.1016/S0002-9378(12)90906-0', 'https://scholar.google.com/scholar_lookup?title=First‐trimester+simple+hygroma:+cause+and+outcome&author=MP+Johnson&author=A+Johnson&author=W+Holzgreve&author=NB+Isada&author=RJ+Wapner&author=MC+Treadwell&publication_year=1993&hl=en']",,https://doi.org/10.1016/S0002-9378(12)90906-0, Johnson 1993 {published data only}  ,excluded,CD009925-bbs2-0230, Normal pregnancies only. 
CD009925-bib-0244,"Jorgensen FS, Valentin L, Salvesen KA, Jorgensen C, Jensen FR, Bang J, et al. ",MULTISCAN‐‐a Scandinavian multicenter second trimester obstetric ultrasound and serum screening study, Acta Obstetricia et Gynecologica Scandinavica ,1999,78,    ,['citation-journal']," Jorgensen FS, Valentin L, Salvesen KA, Jorgensen C, Jensen FR, Bang J, et al. MULTISCAN‐‐a Scandinavian multicenter second trimester obstetric ultrasound and serum screening study.  Acta Obstetricia et Gynecologica Scandinavica 1999;78(6):501‐10.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=MULTISCAN‐‐a+Scandinavian+multicenter+second+trimester+obstetric+ultrasound+and+serum+screening+study+&author=FS+Jorgensen&author=L+Valentin&author=KA+Salvesen&author=C+Jorgensen&author=FR+Jensen&author=J+Bang&publication_year=1999&hl=en'],,, Jorgensen 1999 {published data only}  ,excluded,CD009925-bbs2-0231, Gestation greater than 14 weeks for USS. 
CD009925-bib-0245,"Josefsson A, Molander E, Selbing A. ",Nuchal translucency as a screening test for chromosomal abnormalities in a routine first trimester ultrasound examination, Acta Obstetricia et Gynecologica Scandinavica ,1998,77,    ,['citation-journal']," Josefsson A, Molander E, Selbing A. Nuchal translucency as a screening test for chromosomal abnormalities in a routine first trimester ultrasound examination.  Acta Obstetricia et Gynecologica Scandinavica 1998;77(5):497‐9.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=Nuchal+translucency+as+a+screening+test+for+chromosomal+abnormalities+in+a+routine+first+trimester+ultrasound+examination+&author=A+Josefsson&author=E+Molander&author=A+Selbing&publication_year=1998&hl=en'],,, Josefsson 1998 {published data only}  ,excluded,CD009925-bbs2-0232, No Down's syndrome pregnancies in study population. 
CD009925-bib-0246,"Jou HJ, Shih JC, Wu SC, Li TC, Tzeng CY, Hsieh FJ. ",First‐trimester Down's syndrome screening by fetal nuchal translucency measurement in Taiwan, Journal of the Formosan Medical Association ,2001,100,    ,['citation-journal']," Jou HJ, Shih JC, Wu SC, Li TC, Tzeng CY, Hsieh FJ. First‐trimester Down's syndrome screening by fetal nuchal translucency measurement in Taiwan.  Journal of the Formosan Medical Association 2001;100(4):257‐61.    Google Scholar     ","[""https://scholar.google.com/scholar_lookup?title=First‐trimester+Down's+syndrome+screening+by+fetal+nuchal+translucency+measurement+in+Taiwan+&author=HJ+Jou&author=JC+Shih&author=SC+Wu&author=TC+Li&author=CY+Tzeng&author=FJ+Hsieh&publication_year=2001&hl=en""]",,, Jou 2001 {published data only}  ,excluded,CD009925-bbs2-0233, Less than 5 Down's syndrome pregnancies in study population. 
CD009925-bib-0247,"Liu JT, Hao N, Sun NH, Wang FY, Xu YH, Gai MY, et al. ",[Screening by maternal serum markers for Down's syndrome]. [Chinese], Chung‐Kuo i Hsueh Ko Hsueh Yuan Hsueh Pao Acta Academiae Medicinae Sinicae ,2003,25,    ,['citation-journal']," Liu JT, Hao N, Sun NH, Wang FY, Xu YH, Gai MY, et al. [Screening by maternal serum markers for Down's syndrome]. [Chinese].  Chung‐Kuo i Hsueh Ko Hsueh Yuan Hsueh Pao Acta Academiae Medicinae Sinicae 2003;25(2):156‐9.    Google Scholar     ","[""https://scholar.google.com/scholar_lookup?title=[Screening+by+maternal+serum+markers+for+Down's+syndrome].+[Chinese]&author=JT+Liu&author=N+Hao&author=NH+Sun&author=FY+Wang&author=YH+Xu&author=MY+Gai&publication_year=2003&hl=en""]",,, Jun‐Tao 2003 {published data only}  ,excluded,CD009925-bbs2-0234, Unable to obtain translation. 
CD009925-bib-0248,"Kagan KO, Avgidou K, Molina FS, Gajewska K, Nicolaides KH. ",Relation between increased fetal nuchal translucency thickness and chromosomal defects.[see comment], Obstetrics & Gynecology ,2006,107,    ,['citation-journal']," Kagan KO, Avgidou K, Molina FS, Gajewska K, Nicolaides KH. Relation between increased fetal nuchal translucency thickness and chromosomal defects.[see comment].  Obstetrics & Gynecology 2006;107(1):6‐10.    Link to article     Google Scholar     ","['https://doi.org/10.1097/01.AOG.0000191301.63871.c6', 'https://scholar.google.com/scholar_lookup?title=Relation+between+increased+fetal+nuchal+translucency+thickness+and+chromosomal+defects.[see+comment]+&author=KO+Kagan&author=K+Avgidou&author=FS+Molina&author=K+Gajewska&author=KH+Nicolaides&publication_year=2006&hl=en']",,https://doi.org/10.1097/01.AOG.0000191301.63871.c6, Kagan 2006 {published data only}  ,excluded,CD009925-bbs2-0235, Screen positive pregnancies only. 
CD009925-bib-0249,"Kautzmann M, Solis RL, Luberta A, Fernandez JL, Navarro J, Rodriguez L, et al. ",Study of the efficiency of screening for trisomy 21 based on maternal serum levels of AFP and hCG combined with maternal age, Journal of Clinical Ligand Assay ,1995,18,    ,['citation-journal']," Kautzmann M, Solis RL, Luberta A, Fernandez JL, Navarro J, Rodriguez L, et al. Study of the efficiency of screening for trisomy 21 based on maternal serum levels of AFP and hCG combined with maternal age.  Journal of Clinical Ligand Assay 1995;18(3):181‐5.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=Study+of+the+efficiency+of+screening+for+trisomy+21+based+on+maternal+serum+levels+of+AFP+and+hCG+combined+with+maternal+age+&author=M+Kautzmann&author=RL+Solis&author=A+Luberta&author=JL+Fernandez&author=J+Navarro&author=L+Rodriguez&publication_year=1995&hl=en'],,, Kautzmann 1995 {published data only}  ,excluded,CD009925-bbs2-0236, Fewer than 80% pregnancies had gestational age estimated by USS. 
CD009925-bib-0250,Keith D. ,Maternal serum screening for neural tube defects and Down syndrome, Clinical Laboratory Science ,1992,5,    ,['citation-journal'], Keith D. Maternal serum screening for neural tube defects and Down syndrome.  Clinical Laboratory Science 1992;5(5):274‐6.    Google Scholar     ,['https://scholar.google.com/scholar_lookup?title=Maternal+serum+screening+for+neural+tube+defects+and+Down+syndrome&author=D+Keith&publication_year=1992&hl=en'],,, Keith 1992 {published data only}  ,excluded,CD009925-bbs2-0237, Summary article. 
CD009925-bib-0251,"Kelekci S, Yazicioglu HF, Oguz S, Inan I, Yilmaz B, Sonmez S. ",Nasal bone measurement during the 1st trimester: is it useful?, Gynecologic & Obstetric Investigation ,2004,58,    ,['citation-journal']," Kelekci S, Yazicioglu HF, Oguz S, Inan I, Yilmaz B, Sonmez S. Nasal bone measurement during the 1st trimester: is it useful?.  Gynecologic & Obstetric Investigation 2004;58(2):91‐5.    Link to article     Google Scholar     ","['https://doi.org/10.1159/000078499', 'https://scholar.google.com/scholar_lookup?title=Nasal+bone+measurement+during+the+1st+trimester:+is+it+useful?&author=S+Kelekci&author=HF+Yazicioglu&author=S+Oguz&author=I+Inan&author=B+Yilmaz&author=S+Sonmez&publication_year=2004&hl=en']",,https://doi.org/10.1159/000078499, Kelekci 2004 {published data only}  ,excluded,CD009925-bbs2-0238, Less than 5 Down's syndrome pregnancies in population. 
CD009925-bib-0252,"Kellner LH, Weiner Z, Weiss RR, Neuer M, Martin GM, Mueenuddin M, et al. ","Triple marker (alpha‐fetoprotein, unconjugated estriol, human chorionic gonadotropin) versus alpha‐fetoprotein plus free‐ß subunit in second‐trimester maternal serum screening for fetal Down syndrome: a prospective comparison study.[see comment]", American Journal of Obstetrics & Gynecology ,1995,173,    ,['citation-journal']," Kellner LH, Weiner Z, Weiss RR, Neuer M, Martin GM, Mueenuddin M, et al. Triple marker (alpha‐fetoprotein, unconjugated estriol, human chorionic gonadotropin) versus alpha‐fetoprotein plus free‐ß subunit in second‐trimester maternal serum screening for fetal Down syndrome: a prospective comparison study.[see comment].  American Journal of Obstetrics & Gynecology 1995;173(4):1306‐9.    Link to article     Google Scholar     ","['https://doi.org/10.1016/0002-9378(95)91376-9', 'https://scholar.google.com/scholar_lookup?title=Triple+marker+(alpha‐fetoprotein,+unconjugated+estriol,+human+chorionic+gonadotropin)+versus+alpha‐fetoprotein+plus+free‐ß+subunit+in+second‐trimester+maternal+serum+screening+for+fetal+Down+syndrome:+a+prospective+comparison+study.[see+comment]+&author=LH+Kellner&author=Z+Weiner&author=RR+Weiss&author=M+Neuer&author=GM+Martin&author=M+Mueenuddin&publication_year=1995&hl=en']",,https://doi.org/10.1016/0002-9378(95)91376-9, Kellner 1995a {published data only}  ,excluded,CD009925-bbs2-0239, Less than 5 Down's syndrome pregnancies in population. 
CD009925-bib-0253,"Kellner LH, Weiss RR, Weiner Z, Neuer M, Martin GM, Schulman H, et al. ",The advantages of using triple‐marker screening for chromosomal abnormalities, American Journal of Obstetrics & Gynecology ,1995,172,    ,['citation-journal']," Kellner LH, Weiss RR, Weiner Z, Neuer M, Martin GM, Schulman H, et al. The advantages of using triple‐marker screening for chromosomal abnormalities.  American Journal of Obstetrics & Gynecology 1995;172(3):831‐6.    Link to article     Google Scholar     ","['https://doi.org/10.1016/0002-9378(95)90007-1', 'https://scholar.google.com/scholar_lookup?title=The+advantages+of+using+triple‐marker+screening+for+chromosomal+abnormalities&author=LH+Kellner&author=RR+Weiss&author=Z+Weiner&author=M+Neuer&author=GM+Martin&author=H+Schulman&publication_year=1995&hl=en']",,https://doi.org/10.1016/0002-9378(95)90007-1, Kellner 1995b {published data only}  ,excluded,CD009925-bbs2-0240, Less than 80% follow‐up. Unable to ascertain proportion of population with gestational age confirmed by USS.  
CD009925-bib-0254,"Kellner LH, Canick JA, Palomaki GE, Neveux LM, Saller DN, Walker RP, et al. ","Levels of urinary ß‐core fragment, total oestriol, and the ratio of the two in second‐trimester screening for Down syndrome", Prenatal Diagnosis ,1997,17,    ,['citation-journal']," Kellner LH, Canick JA, Palomaki GE, Neveux LM, Saller DN, Walker RP, et al. Levels of urinary ß‐core fragment, total oestriol, and the ratio of the two in second‐trimester screening for Down syndrome.  Prenatal Diagnosis 1997;17(12):1135‐41.    Link to article     Google Scholar     ","['https://doi.org/10.1002/(SICI)1097-0223(199712)17:12<1135::AID-PD217>3.0.CO;2-E', 'https://scholar.google.com/scholar_lookup?title=Levels+of+urinary+ß‐core+fragment,+total+oestriol,+and+the+ratio+of+the+two+in+second‐trimester+screening+for+Down+syndrome+&author=LH+Kellner&author=JA+Canick&author=GE+Palomaki&author=LM+Neveux&author=DN+Saller&author=RP+Walker&publication_year=1997&hl=en']",,https://doi.org/10.1002/(SICI)1097-0223(199712)17:12<1135::AID-PD217>3.0.CO;2-E, Kellner 1997 {published data only}  ,excluded,CD009925-bbs2-0241, Assumption of normal karyotype without reference standard in significant proportion of control pregnancies.  
CD009925-bib-0255,"Knight GJ, Palomaki GE. ",Maternal serum alpha fetoprotein screening for fetal down syndrome, Journal of Clinical Immunoassay ,1990,13,    ,['citation-journal']," Knight GJ, Palomaki GE. Maternal serum alpha fetoprotein screening for fetal down syndrome.  Journal of Clinical Immunoassay 1990;13(1):23‐9.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=Maternal+serum+alpha+fetoprotein+screening+for+fetal+down+syndrome&author=GJ+Knight&author=GE+Palomaki&publication_year=1990&hl=en'],,, Knight 1990 {published data only}  ,excluded,CD009925-bbs2-0242, Review article. 
CD009925-bib-0256,"Knight GJ, Palomaki GE, Neveux LM, Haddow JE, Lambert‐Messerlian GM. ",Clinical validation of a new dimeric inhibin‐A assay suitable for second trimester Down's syndrome screening, Journal of Medical Screening ,2001,8,    ,['citation-journal']," Knight GJ, Palomaki GE, Neveux LM, Haddow JE, Lambert‐Messerlian GM. Clinical validation of a new dimeric inhibin‐A assay suitable for second trimester Down's syndrome screening.  Journal of Medical Screening 2001;8(1):2‐7.    Link to article     Google Scholar     ","['https://doi.org/10.1136/jms.8.1.2', ""https://scholar.google.com/scholar_lookup?title=Clinical+validation+of+a+new+dimeric+inhibin‐A+assay+suitable+for+second+trimester+Down's+syndrome+screening+&author=GJ+Knight&author=GE+Palomaki&author=LM+Neveux&author=JE+Haddow&author=GM+Lambert‐Messerlian&publication_year=2001&hl=en""]",,https://doi.org/10.1136/jms.8.1.2, Knight 2001 {published data only}  ,excluded,CD009925-bbs2-0243, Validation of a specific assay. 
CD009925-bib-0257,"Knight GJ, Palomaki GE, Neveux LM, Smith DE, Kloza EM, Pulkkinen A, et al. ",Integrated serum screening for Down syndrome in primary obstetric practice, Prenatal Diagnosis ,2005,25,    ,['citation-journal']," Knight GJ, Palomaki GE, Neveux LM, Smith DE, Kloza EM, Pulkkinen A, et al. Integrated serum screening for Down syndrome in primary obstetric practice.  Prenatal Diagnosis 2005;25(12):1162‐7.    Link to article     Google Scholar     ","['https://doi.org/10.1002/pd.1305', 'https://scholar.google.com/scholar_lookup?title=Integrated+serum+screening+for+Down+syndrome+in+primary+obstetric+practice&author=GJ+Knight&author=GE+Palomaki&author=LM+Neveux&author=DE+Smith&author=EM+Kloza&author=A+Pulkkinen&publication_year=2005&hl=en']",,https://doi.org/10.1002/pd.1305, Knight 2005 {published data only}  ,excluded,CD009925-bbs2-0244, Less than 80% of pregnancies had gestational age confirmed by ultrasound scan. 
CD009925-bib-0258,Koos BJ. ,First‐trimester screening: Lessons from clinical trials and implementation, Current Opinion in Obstetrics and Gynecology ,2006,18,    ,['citation-journal'], Koos BJ. First‐trimester screening: Lessons from clinical trials and implementation.  Current Opinion in Obstetrics and Gynecology 2006;18(2):152‐5.    Link to article     Google Scholar     ,"['https://doi.org/10.1097/01.gco.0000192966.29449.01', 'https://scholar.google.com/scholar_lookup?title=First‐trimester+screening:+Lessons+from+clinical+trials+and+implementation&author=BJ+Koos&publication_year=2006&hl=en']",,https://doi.org/10.1097/01.gco.0000192966.29449.01, Koos 2006 {published data only}  ,excluded,CD009925-bbs2-0245, Review article. 
CD009925-bib-0259,"Kornman LH, Morssink LP, Beekhuis JR, de Wolf BT, Heringa MP, Mantingh A. ",Nuchal translucency cannot be used as a screening test for chromosomal abnormalities in the first trimester of pregnancy in a routine ultrasound practice.[see comment], Prenatal Diagnosis ,1996,16,    ,['citation-journal']," Kornman LH, Morssink LP, Beekhuis JR, de Wolf BT, Heringa MP, Mantingh A. Nuchal translucency cannot be used as a screening test for chromosomal abnormalities in the first trimester of pregnancy in a routine ultrasound practice.[see comment].  Prenatal Diagnosis 1996;16(9):797‐805.    Link to article     Google Scholar     ","['https://doi.org/10.1002/(SICI)1097-0223(199609)16:9<797::AID-PD948>3.0.CO;2-M', 'https://scholar.google.com/scholar_lookup?title=Nuchal+translucency+cannot+be+used+as+a+screening+test+for+chromosomal+abnormalities+in+the+first+trimester+of+pregnancy+in+a+routine+ultrasound+practice.[see+comment]+&author=LH+Kornman&author=LP+Morssink&author=JR+Beekhuis&author=BT+Wolf&author=MP+Heringa&author=A+Mantingh&publication_year=1996&hl=en']",,https://doi.org/10.1002/(SICI)1097-0223(199609)16:9<797::AID-PD948>3.0.CO;2-M, Kornman 1996 {published data only}  ,excluded,CD009925-bbs2-0246, Less than 5 Down's syndrome pregnancies in population. 
CD009925-bib-0260,"Kornman LH, Morssink LP, Wortelboer MJ, Beekhuis JR, de Wolf BT, Pratt JJ, Mantingh A. ",Maternal urinary ß‐core hCG in chromosomally abnormal pregnancies in the first trimester, Prenatal Diagnosis ,1997,17,    ,['citation-journal']," Kornman LH, Morssink LP, Wortelboer MJ, Beekhuis JR, de Wolf BT, Pratt JJ, Mantingh A. Maternal urinary ß‐core hCG in chromosomally abnormal pregnancies in the first trimester.  Prenatal Diagnosis 1997;17(2):135‐9.    Link to article     Google Scholar     ","['https://doi.org/10.1002/(SICI)1097-0223(199702)17:2<135::AID-PD41>3.0.CO;2-P', 'https://scholar.google.com/scholar_lookup?title=Maternal+urinary+ß‐core+hCG+in+chromosomally+abnormal+pregnancies+in+the+first+trimester&author=LH+Kornman&author=LP+Morssink&author=MJ+Wortelboer&author=JR+Beekhuis&author=BT+Wolf&author=JJ+Pratt&author=A+Mantingh&publication_year=1997&hl=en']",,https://doi.org/10.1002/(SICI)1097-0223(199702)17:2<135::AID-PD41>3.0.CO;2-P, Kornman 1997 {published data only}  ,excluded,CD009925-bbs2-0247, Unable to extract useful information. 
CD009925-bib-0261,"Kramer RL, Yaron Y, O'Brien JE, Critchfield G, Ayoub M, Johnson MP, et al. ",Effect of adjustment of maternal serum alpha‐fetoprotein levels in insulin‐dependent diabetes mellitus, American Journal of Medical Genetics ,1998,75,    ,['citation-journal']," Kramer RL, Yaron Y, O'Brien JE, Critchfield G, Ayoub M, Johnson MP, et al. Effect of adjustment of maternal serum alpha‐fetoprotein levels in insulin‐dependent diabetes mellitus.  American Journal of Medical Genetics 1998;75(2):176‐8.    Link to article     Google Scholar     ","['https://doi.org/10.1002/(SICI)1096-8628(19980113)75:2<176::AID-AJMG10>3.0.CO;2-M', ""https://scholar.google.com/scholar_lookup?title=Effect+of+adjustment+of+maternal+serum+alpha‐fetoprotein+levels+in+insulin‐dependent+diabetes+mellitus+&author=RL+Kramer&author=Y+Yaron&author=JE+O'Brien&author=G+Critchfield&author=M+Ayoub&author=MP+Johnson&publication_year=1998&hl=en""]",,https://doi.org/10.1002/(SICI)1096-8628(19980113)75:2<176::AID-AJMG10>3.0.CO;2-M, Kramer 1998 {published data only}  ,excluded,CD009925-bbs2-0248, No Down's syndrome pregnancies in study population. 
CD009925-bib-0262,"Krantz DA, Larsen JW, Buchanan PD, Macri JN. ",First‐trimester Down syndrome screening: free ß‐human chorionic gonadotropin and pregnancy‐associated plasma protein A, American Journal of Obstetrics & Gynecology ,1996,174,    ,['citation-journal']," Krantz DA, Larsen JW, Buchanan PD, Macri JN. First‐trimester Down syndrome screening: free ß‐human chorionic gonadotropin and pregnancy‐associated plasma protein A.  American Journal of Obstetrics & Gynecology 1996;174(2):612‐6.    Link to article     Google Scholar     ","['https://doi.org/10.1016/S0002-9378(96)70436-2', 'https://scholar.google.com/scholar_lookup?title=First‐trimester+Down+syndrome+screening:+free+ß‐human+chorionic+gonadotropin+and+pregnancy‐associated+plasma+protein+A+&author=DA+Krantz&author=JW+Larsen&author=PD+Buchanan&author=JN+Macri&publication_year=1996&hl=en']",,https://doi.org/10.1016/S0002-9378(96)70436-2, Krantz 1996 {published data only}  ,excluded,CD009925-bbs2-0249, Modelled data. 
CD009925-bib-0263,"Krantz DA, Hallahan TW, Macri VJ, Macri JN. ",Maternal weight and ethnic adjustment within a first‐trimester Down syndrome and trisomy 18 screening program, Prenatal Diagnosis ,2005,25,    ,['citation-journal']," Krantz DA, Hallahan TW, Macri VJ, Macri JN. Maternal weight and ethnic adjustment within a first‐trimester Down syndrome and trisomy 18 screening program.  Prenatal Diagnosis 2005;25(8):635‐40.    Link to article     Google Scholar     ","['https://doi.org/10.1002/pd.1188', 'https://scholar.google.com/scholar_lookup?title=Maternal+weight+and+ethnic+adjustment+within+a+first‐trimester+Down+syndrome+and+trisomy+18+screening+program+&author=DA+Krantz&author=TW+Hallahan&author=VJ+Macri&author=JN+Macri&publication_year=2005&hl=en']",,https://doi.org/10.1002/pd.1188, Krantz 2005 {published data only}  ,excluded,CD009925-bbs2-0250, Adjustment factor. 
CD009925-bib-0264,"Kulch P, Keener S, Matsumoto M, Crandall BF. ",Racial differences in maternal serum human chorionic gonadotropin and unconjugated oestriol levels, Prenatal Diagnosis ,1993,13,    ,['citation-journal']," Kulch P, Keener S, Matsumoto M, Crandall BF. Racial differences in maternal serum human chorionic gonadotropin and unconjugated oestriol levels.  Prenatal Diagnosis 1993;13(3):191‐5.    Link to article     Google Scholar     ","['https://doi.org/10.1002/pd.1970130306', 'https://scholar.google.com/scholar_lookup?title=Racial+differences+in+maternal+serum+human+chorionic+gonadotropin+and+unconjugated+oestriol+levels+&author=P+Kulch&author=S+Keener&author=M+Matsumoto&author=BF+Crandall&publication_year=1993&hl=en']",,https://doi.org/10.1002/pd.1970130306, Kulch 1993 {published data only}  ,excluded,CD009925-bbs2-0251, No Down's cases in population. 
CD009925-bib-0265,"Lai FM, Yeo GS. ","Down syndrome screening in Singapore‐‐the effectiveness of a second trimester serum screening policy modelled on 29,360 pregnancies in KK Women's and Children's Hospital", Singapore Medical Journal ,1998,39,    ,['citation-journal']," Lai FM, Yeo GS. Down syndrome screening in Singapore‐‐the effectiveness of a second trimester serum screening policy modelled on 29,360 pregnancies in KK Women's and Children's Hospital.  Singapore Medical Journal 1998;39(2):69‐75.    Google Scholar     ","[""https://scholar.google.com/scholar_lookup?title=Down+syndrome+screening+in+Singapore‐‐the+effectiveness+of+a+second+trimester+serum+screening+policy+modelled+on+29,360+pregnancies+in+KK+Women's+and+Children's+Hospital+&author=FM+Lai&author=GS+Yeo&publication_year=1998&hl=en""]",,, Lai 1998 {published data only}  ,excluded,CD009925-bbs2-0252, Modelled population.. 
CD009925-bib-0266,"Lai Tsung Hsuan, Chen Su Chee, Tsai Ming Song, Lee Fa Kung, Wei Chi Feng. ",First‐trimester screening for down syndrome in singleton pregnancies achieved by intrauterine insemination, Journal of Assisted Reproduction and Genetics ,2003,20,    ,['citation-journal']," Lai Tsung Hsuan, Chen Su Chee, Tsai Ming Song, Lee Fa Kung, Wei Chi Feng. First‐trimester screening for down syndrome in singleton pregnancies achieved by intrauterine insemination.  Journal of Assisted Reproduction and Genetics 2003;20(8):327‐31.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=First‐trimester+screening+for+down+syndrome+in+singleton+pregnancies+achieved+by+intrauterine+insemination+&author=Hsuan+LaiTsung&author=Chee+ChenSu&author=Song+TsaiMing&author=Kung+LeeFa&author=Feng+WeiChi&publication_year=2003&hl=en'],,, Lai 2003 {published data only}  ,excluded,CD009925-bbs2-0253, No Down's syndrome pregnancies in study population. 
CD009925-bib-0267,"Laigaard J, Cuckle H, Wewer UM, Christiansen M. ",Maternal serum ADAM12 levels in Down and Edwards' syndrome pregnancies at 9‐12 weeks' gestation, Prenatal Diagnosis ,2006,26,    ,['citation-journal']," Laigaard J, Cuckle H, Wewer UM, Christiansen M. Maternal serum ADAM12 levels in Down and Edwards' syndrome pregnancies at 9‐12 weeks' gestation.  Prenatal Diagnosis 2006;26(8):689‐91.    Link to article     Google Scholar     ","['https://doi.org/10.1002/pd.1480', ""https://scholar.google.com/scholar_lookup?title=Maternal+serum+ADAM12+levels+in+Down+and+Edwards'+syndrome+pregnancies+at+9‐12+weeks'+gestation+&author=J+Laigaard&author=H+Cuckle&author=UM+Wewer&author=M+Christiansen&publication_year=2006&hl=en""]",,https://doi.org/10.1002/pd.1480, Laigaard 2006a {published data only}  ,excluded,CD009925-bbs2-0254, Unable to extract useful data. 
CD009925-bib-0268,"Laigaard J, Spencer K, Christiansen M, Cowans NJ, Larsen SO, Pedersen BN, et al. ",ADAM 12 as a first‐trimester maternal serum marker in screening for Down syndrome, Prenatal Diagnosis ,2006,26,    ,['citation-journal']," Laigaard J, Spencer K, Christiansen M, Cowans NJ, Larsen SO, Pedersen BN, et al. ADAM 12 as a first‐trimester maternal serum marker in screening for Down syndrome.  Prenatal Diagnosis 2006;26(10):973‐9.    Link to article     Google Scholar     ","['https://doi.org/10.1002/pd.1540', 'https://scholar.google.com/scholar_lookup?title=ADAM+12+as+a+first‐trimester+maternal+serum+marker+in+screening+for+Down+syndrome&author=J+Laigaard&author=K+Spencer&author=M+Christiansen&author=NJ+Cowans&author=SO+Larsen&author=BN+Pedersen&publication_year=2006&hl=en']",,https://doi.org/10.1002/pd.1540, Laigaard 2006b {published data only}  ,excluded,CD009925-bbs2-0255, Simulation. 
CD009925-bib-0269,"Lam YH, Tang MH, Tang LC, Lee CP, Ho PK. ",Second‐trimester maternal urinary gonadotrophin peptide screening for fetal Down syndrome in Asian women, Prenatal Diagnosis ,1997,17,    ,['citation-journal']," Lam YH, Tang MH, Tang LC, Lee CP, Ho PK. Second‐trimester maternal urinary gonadotrophin peptide screening for fetal Down syndrome in Asian women.  Prenatal Diagnosis 1997;17(12):1101‐6.    Link to article     Google Scholar     ","['https://doi.org/10.1002/(SICI)1097-0223(199712)17:12<1101::AID-PD195>3.0.CO;2-S', 'https://scholar.google.com/scholar_lookup?title=Second‐trimester+maternal+urinary+gonadotrophin+peptide+screening+for+fetal+Down+syndrome+in+Asian+women+&author=YH+Lam&author=MH+Tang&author=LC+Tang&author=CP+Lee&author=PK+Ho&publication_year=1997&hl=en']",,https://doi.org/10.1002/(SICI)1097-0223(199712)17:12<1101::AID-PD195>3.0.CO;2-S, Lam 1997 {published data only}  ,excluded,CD009925-bbs2-0256, Unable to extract useful data. 
CD009925-bib-0270,"Lam YH, Ghosh A, Tang MH, Tang LC, Lee CP, Sin SY, et al. ",Second‐trimester maternal serum alpha‐fetoprotein and human chorionic gonadotrophin screening for Down's syndrome in Hong Kong, Prenatal Diagnosis ,1998,18,    ,['citation-journal']," Lam YH, Ghosh A, Tang MH, Tang LC, Lee CP, Sin SY, et al. Second‐trimester maternal serum alpha‐fetoprotein and human chorionic gonadotrophin screening for Down's syndrome in Hong Kong.  Prenatal Diagnosis 1998;18(6):585‐89.    Link to article     Google Scholar     ","['https://doi.org/10.1002/(SICI)1097-0223(199806)18:6<585::AID-PD305>3.0.CO;2-R', ""https://scholar.google.com/scholar_lookup?title=Second‐trimester+maternal+serum+alpha‐fetoprotein+and+human+chorionic+gonadotrophin+screening+for+Down's+syndrome+in+Hong+Kong+&author=YH+Lam&author=A+Ghosh&author=MH+Tang&author=LC+Tang&author=CP+Lee&author=SY+Sin&publication_year=1998&hl=en""]",,https://doi.org/10.1002/(SICI)1097-0223(199806)18:6<585::AID-PD305>3.0.CO;2-R, Lam 1998 {published data only}  ,excluded,CD009925-bbs2-0257, Fewer than 80% pregnancies had gestational age estimated by USS. 
CD009925-bib-0271,"Lam YH, Yeung WS, Tang MH, NG EH, So WW, Ho PC. ",Maternal serum alpha‐fetoprotein and human chorionic gonadotrophin in pregnancies conceived after intracytoplasmic sperm injection and conventional in‐vitro fertilization, Human Reproduction ,1999,14,    ,['citation-journal']," Lam YH, Yeung WS, Tang MH, NG EH, So WW, Ho PC. Maternal serum alpha‐fetoprotein and human chorionic gonadotrophin in pregnancies conceived after intracytoplasmic sperm injection and conventional in‐vitro fertilization.  Human Reproduction 1999;14(8):2120‐3.    Link to article     Google Scholar     ","['https://doi.org/10.1093/humrep/14.8.2120', 'https://scholar.google.com/scholar_lookup?title=Maternal+serum+alpha‐fetoprotein+and+human+chorionic+gonadotrophin+in+pregnancies+conceived+after+intracytoplasmic+sperm+injection+and+conventional+in‐vitro+fertilization+&author=YH+Lam&author=WS+Yeung&author=MH+Tang&author=EH+NG&author=WW+So&author=PC+Ho&publication_year=1999&hl=en']",,https://doi.org/10.1093/humrep/14.8.2120, Lam 1999a {published data only}  ,excluded,CD009925-bbs2-0258, No Down's syndrome pregnancies in population 
CD009925-bib-0272,"Lam YH, Tang MH. ",Second‐trimester maternal serum inhibin‐A screening for fetal Down syndrome in Asian women, Prenatal Diagnosis. ,1999,19,    ,['citation-journal']," Lam YH, Tang MH. Second‐trimester maternal serum inhibin‐A screening for fetal Down syndrome in Asian women.  Prenatal Diagnosis. 1999;19(5):463‐7.    Link to article     Google Scholar     ","['https://doi.org/10.1002/(SICI)1097-0223(199905)19:5<463::AID-PD574>3.0.CO;2-Q', 'https://scholar.google.com/scholar_lookup?title=Second‐trimester+maternal+serum+inhibin‐A+screening+for+fetal+Down+syndrome+in+Asian+women+&author=YH+Lam&author=MH+Tang&publication_year=1999&hl=en']",,https://doi.org/10.1002/(SICI)1097-0223(199905)19:5<463::AID-PD574>3.0.CO;2-Q, Lam 1999b {published data only}  ,excluded,CD009925-bbs2-0259, Unable to extract useful data 
CD009925-bib-0273,"Lam YH, Tang MH, Lee CP, Sin SY, Tang R, Wong HS, et al. ",Acceptability of serum screening as an alternative to cytogenetic diagnosis of down syndrome among women 35 years or older in Hong Kong, Prenatal Diagnosis. ,2000,20,    ,['citation-journal']," Lam YH, Tang MH, Lee CP, Sin SY, Tang R, Wong HS, et al. Acceptability of serum screening as an alternative to cytogenetic diagnosis of down syndrome among women 35 years or older in Hong Kong.  Prenatal Diagnosis. 2000;20(6):487‐90.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=Acceptability+of+serum+screening+as+an+alternative+to+cytogenetic+diagnosis+of+down+syndrome+among+women+35+years+or+older+in+Hong+Kong+&author=YH+Lam&author=MH+Tang&author=CP+Lee&author=SY+Sin&author=R+Tang&author=HS+Wong&publication_year=2000&hl=en'],,, Lam 2000 {published data only}  ,excluded,CD009925-bbs2-0260, Study of women's decisions about screening. 
CD009925-bib-0274,"Lam YH, Tang MH. ",The effect of fetal gender on second‐trimester maternal serum inhibin‐A concentration, Prenatal Diagnosis ,2001,21,    ,['citation-journal']," Lam YH, Tang MH. The effect of fetal gender on second‐trimester maternal serum inhibin‐A concentration.  Prenatal Diagnosis 2001;21(8):662‐4.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=The+effect+of+fetal+gender+on+second‐trimester+maternal+serum+inhibin‐A+concentration&author=YH+Lam&author=MH+Tang&publication_year=2001&hl=en'],,, Lam 2001 {published data only}  ,excluded,CD009925-bbs2-0261, Male versus female fetuses. 
CD009925-bib-0275,"Lambert‐Messerlian GM, Canick JA, Palomaki GE, Schneyer AL. ","Second trimester levels of maternal serum inhibin A, total inhibin, alpha inhibin precursor, and activin in Down's syndrome pregnancy", Journal of Medical Screening ,1996,3,    ,['citation-journal']," Lambert‐Messerlian GM, Canick JA, Palomaki GE, Schneyer AL. Second trimester levels of maternal serum inhibin A, total inhibin, alpha inhibin precursor, and activin in Down's syndrome pregnancy.  Journal of Medical Screening 1996;3(2):58‐62.    Link to article     Google Scholar     ","['https://doi.org/10.1177/096914139600300202', ""https://scholar.google.com/scholar_lookup?title=Second+trimester+levels+of+maternal+serum+inhibin+A,+total+inhibin,+alpha+inhibin+precursor,+and+activin+in+Down's+syndrome+pregnancy+&author=GM+Lambert‐Messerlian&author=JA+Canick&author=GE+Palomaki&author=AL+Schneyer&publication_year=1996&hl=en""]",,https://doi.org/10.1177/096914139600300202, Lambert‐Messerlian 1996 {published data only}  ,excluded,CD009925-bbs2-0262, Fewer than 80% of pregnancies USS dated. 
CD009925-bib-0276,"Lambert Messerlian, Luisi S, Florio P, Mazza V, Canick JA, Petraglia F. ",Second trimester levels of maternal serum total activin A and placental inhibin/activin alpha and ßA subunit messenger ribonucleic acids in Down syndrome pregnancy, European Journal of Endocrinology ,1998,138,    ,['citation-journal']," Lambert Messerlian, Luisi S, Florio P, Mazza V, Canick JA, Petraglia F. Second trimester levels of maternal serum total activin A and placental inhibin/activin alpha and ßA subunit messenger ribonucleic acids in Down syndrome pregnancy.  European Journal of Endocrinology 1998;138(4):425‐9.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=Second+trimester+levels+of+maternal+serum+total+activin+A+and+placental+inhibin/activin+alpha+and+ßA+subunit+messenger+ribonucleic+acids+in+Down+syndrome+pregnancy+&author=Messerlian+Lambert&author=S+Luisi&author=P+Florio&author=V+Mazza&author=JA+Canick&author=F+Petraglia&publication_year=1998&hl=en'],,, Lambert‐Messerlian 1998 {published data only}  ,excluded,CD009925-bbs2-0263, Unable to extract useful data. 
CD009925-bib-0277,"Lehavi O, Aizenstein O, Evans MI, Yaron Y. ",2nd‐trimester maternal serum human chorionic gonadotropin and alpha‐fetoprotein levels in male and female fetuses with Down syndrome, Fetal Diagnosis & Therapy ,2005,20,    ,['citation-journal']," Lehavi O, Aizenstein O, Evans MI, Yaron Y. 2nd‐trimester maternal serum human chorionic gonadotropin and alpha‐fetoprotein levels in male and female fetuses with Down syndrome.  Fetal Diagnosis & Therapy 2005;20(3):235‐8.    Link to article     Google Scholar     ","['https://doi.org/10.1159/000083911', 'https://scholar.google.com/scholar_lookup?title=2nd‐trimester+maternal+serum+human+chorionic+gonadotropin+and+alpha‐fetoprotein+levels+in+male+and+female+fetuses+with+Down+syndrome+&author=O+Lehavi&author=O+Aizenstein&author=MI+Evans&author=Y+Yaron&publication_year=2005&hl=en']",,https://doi.org/10.1159/000083911, Lehavi 2005 {published data only}  ,excluded,CD009925-bbs2-0264, Down's syndrome pregnancies only. 
CD009925-bib-0278,"Leung TY, Spencer K, Leung TN, Fung TY, Lau TK. ",Higher median levels of free ß‐hCG and PAPP‐A in the first trimester of pregnancy in a Chinese ethnic group. Implication for first trimester combined screening for Down's syndrome in the Chinese population, Fetal Diagnosis & Therapy ,2006,21,    ,['citation-journal']," Leung TY, Spencer K, Leung TN, Fung TY, Lau TK. Higher median levels of free ß‐hCG and PAPP‐A in the first trimester of pregnancy in a Chinese ethnic group. Implication for first trimester combined screening for Down's syndrome in the Chinese population.  Fetal Diagnosis & Therapy 2006;21(1):140‐3.    Link to article     Google Scholar     ","['https://doi.org/10.1159/000089064', ""https://scholar.google.com/scholar_lookup?title=Higher+median+levels+of+free+ß‐hCG+and+PAPP‐A+in+the+first+trimester+of+pregnancy+in+a+Chinese+ethnic+group.+Implication+for+first+trimester+combined+screening+for+Down's+syndrome+in+the+Chinese+population+&author=TY+Leung&author=K+Spencer&author=TN+Leung&author=TY+Fung&author=TK+Lau&publication_year=2006&hl=en""]",,https://doi.org/10.1159/000089064, Leung 2006 {published data only}  ,excluded,CD009925-bbs2-0265, Unable to separate twins from singletons therefore unable to extract useful data. 
CD009925-bib-0279,"Leymarie P, Leporrier N. ",Maternal serum markers and prenatal screening for Down syndrome, Archives Francaises de Pediatrie ,1993,50,    ,['citation-journal']," Leymarie P, Leporrier N. Maternal serum markers and prenatal screening for Down syndrome.  Archives Francaises de Pediatrie 1993;50(5):455‐7.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=Maternal+serum+markers+and+prenatal+screening+for+Down+syndrome&author=P+Leymarie&author=N+Leporrier&publication_year=1993&hl=en'],,, Leymarie 1993 {published data only}  ,excluded,CD009925-bbs2-0266, Appears to be a review article (French). 
CD009925-bib-0280,"Li G, Huang X. ",[Clinical uses of maternal serum markers in the prenatal diagnosis] [Chinese], Chung‐Hua Fu Chan Ko Tsa Chih ,1998,33,    ,['citation-journal']," Li G, Huang X. [Clinical uses of maternal serum markers in the prenatal diagnosis] [Chinese].  Chung‐Hua Fu Chan Ko Tsa Chih 1998;33(4):252‐4.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=[Clinical+uses+of+maternal+serum+markers+in+the+prenatal+diagnosis]+[Chinese]&author=G+Li&author=X+Huang&publication_year=1998&hl=en'],,, Li 1998 {published data only}  ,excluded,CD009925-bbs2-0267, Unable to obtain translation. 
CD009925-bib-0281,"Li W, Zhou Y. ",[Measurement of pregnancy‐associated plasma protein A in maternal peripheral blood and Down syndrome] [Chinese], Chung‐Hua Fu Chan Ko Tsa Chih ,1999,34,    ,['citation-journal']," Li W, Zhou Y. [Measurement of pregnancy‐associated plasma protein A in maternal peripheral blood and Down syndrome] [Chinese].  Chung‐Hua Fu Chan Ko Tsa Chih 1999;34(10):631‐3.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=[Measurement+of+pregnancy‐associated+plasma+protein+A+in+maternal+peripheral+blood+and+Down+syndrome]+[Chinese]+&author=W+Li&author=Y+Zhou&publication_year=1999&hl=en'],,, Li 1999 {published data only}  ,excluded,CD009925-bbs2-0268, Unable to obtain translation. 
CD009925-bib-0282,"Liao S, Wang Y, Ye G. ","[AFP, uE3, ß‐hCG levels applied for prenatal diagnosis of Down's syndrome]. [Chinese]", Chung‐Hua Fu Chan Ko Tsa Chih ,1997,32,    ,['citation-journal']," Liao S, Wang Y, Ye G. [AFP, uE3, ß‐hCG levels applied for prenatal diagnosis of Down's syndrome]. [Chinese].  Chung‐Hua Fu Chan Ko Tsa Chih 1997;32(11):655‐8.    Google Scholar     ","[""https://scholar.google.com/scholar_lookup?title=[AFP,+uE3,+ß‐hCG+levels+applied+for+prenatal+diagnosis+of+Down's+syndrome].+[Chinese]&author=S+Liao&author=Y+Wang&author=G+Ye&publication_year=1997&hl=en""]",,, Liao 1997 {published data only}  ,excluded,CD009925-bbs2-0269, Unable to obtain translation. 
CD009925-bib-0283,"Liao AW, Heath V, Kametas N, Spencer K, Nicolaides KH. ",First‐trimester screening for trisomy 21 in singleton pregnancies achieved by assisted reproduction, Human Reproduction ,2001,16,    ,['citation-journal']," Liao AW, Heath V, Kametas N, Spencer K, Nicolaides KH. First‐trimester screening for trisomy 21 in singleton pregnancies achieved by assisted reproduction.  Human Reproduction 2001;16(7):1501‐4.    Link to article     Google Scholar     ","['https://doi.org/10.1093/humrep/16.7.1501', 'https://scholar.google.com/scholar_lookup?title=First‐trimester+screening+for+trisomy+21+in+singleton+pregnancies+achieved+by+assisted+reproduction+&author=AW+Liao&author=V+Heath&author=N+Kametas&author=K+Spencer&author=KH+Nicolaides&publication_year=2001&hl=en']",,https://doi.org/10.1093/humrep/16.7.1501, Liao 2001 {published data only}  ,excluded,CD009925-bbs2-0270, Unable to extract useful data. 
CD009925-bib-0284,"Lim KI, Pugash D, Dansereau J, Wilson RD. ",Nuchal index: a gestational age independent ultrasound marker for the detection of Down syndrome, Prenatal Diagnosis ,2002,22,    ,['citation-journal']," Lim KI, Pugash D, Dansereau J, Wilson RD. Nuchal index: a gestational age independent ultrasound marker for the detection of Down syndrome.  Prenatal Diagnosis 2002;22(13):1233‐7.    Link to article     Google Scholar     ","['https://doi.org/10.1002/pd.497', 'https://scholar.google.com/scholar_lookup?title=Nuchal+index:+a+gestational+age+independent+ultrasound+marker+for+the+detection+of+Down+syndrome+&author=KI+Lim&author=D+Pugash&author=J+Dansereau&author=RD+Wilson&publication_year=2002&hl=en']",,https://doi.org/10.1002/pd.497, Lim 2002 {published data only}  ,excluded,CD009925-bbs2-0271, Second trimester ultrasound. 
CD009925-bib-0285,"Lippman A, Evans JA. ",Screening for maternal serum alpha‐fetoprotein: what about the low side?, Canadian Medical Association Journal ,1987,136,    ,['citation-journal']," Lippman A, Evans JA. Screening for maternal serum alpha‐fetoprotein: what about the low side?.  Canadian Medical Association Journal 1987;136(8):801‐4.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=Screening+for+maternal+serum+alpha‐fetoprotein:+what+about+the+low+side?&author=A+Lippman&author=JA+Evans&publication_year=1987&hl=en'],,, Lippman 1987 {published data only}  ,excluded,CD009925-bbs2-0272, Editorial. 
CD009925-bib-0286,"Lustig L, Clarke S, Cunningham G, Schonberg R, Tompkinson G. ",California's experience with low MS‐AFP results, American Journal of Medical Genetics ,1988,31,    ,['citation-journal']," Lustig L, Clarke S, Cunningham G, Schonberg R, Tompkinson G. California's experience with low MS‐AFP results.  American Journal of Medical Genetics 1988;31(1):211‐22.    Link to article     Google Scholar     ","['https://doi.org/10.1002/ajmg.1320310128', ""https://scholar.google.com/scholar_lookup?title=California's+experience+with+low+MS‐AFP+results&author=L+Lustig&author=S+Clarke&author=G+Cunningham&author=R+Schonberg&author=G+Tompkinson&publication_year=1988&hl=en""]",,https://doi.org/10.1002/ajmg.1320310128, Lustig 1988 {published data only}  ,excluded,CD009925-bbs2-0273, Gestational age by LMP only. 
CD009925-bib-0287,"MacDonald ML, Wagner RM, Slotnick RN. ","Sensitivity and specificity of screening for Down syndrome with alpha‐fetoprotein, hCG, unconjugated estriol, and maternal age.[see comment]", Obstetrics & Gynecology ,1991,77,    ,['citation-journal']," MacDonald ML, Wagner RM, Slotnick RN. Sensitivity and specificity of screening for Down syndrome with alpha‐fetoprotein, hCG, unconjugated estriol, and maternal age.[see comment].  Obstetrics & Gynecology 1991;77(1):63‐8.    Google Scholar     ","['https://scholar.google.com/scholar_lookup?title=Sensitivity+and+specificity+of+screening+for+Down+syndrome+with+alpha‐fetoprotein,+hCG,+unconjugated+estriol,+and+maternal+age.[see+comment]+&author=ML+MacDonald&author=RM+Wagner&author=RN+Slotnick&publication_year=1991&hl=en']",,, MacDonald 1991 {published data only}  ,excluded,CD009925-bbs2-0274, Fewer than 80% of gestational ages estimated by USS. 
CD009925-bib-0288,"Macintosh MCM, Iles R, Teisner B, Sharma K, Chard T, Grudzinskas J, et al. ","Maternal serum human chorionic gonadotrophin and pregnancy‐associated plasma protein A, markers for fetal Down syndrome at 8‐14 weeks", Prenatal Diagnosis ,1994,14,    ,['citation-journal']," Macintosh MCM, Iles R, Teisner B, Sharma K, Chard T, Grudzinskas J, et al. Maternal serum human chorionic gonadotrophin and pregnancy‐associated plasma protein A, markers for fetal Down syndrome at 8‐14 weeks.  Prenatal Diagnosis 1994;14(3):203‐8.    Link to article     Google Scholar     ","['https://doi.org/10.1002/pd.1970140311', 'https://scholar.google.com/scholar_lookup?title=Maternal+serum+human+chorionic+gonadotrophin+and+pregnancy‐associated+plasma+protein+A,+markers+for+fetal+Down+syndrome+at+8‐14+weeks+&author=MCM+Macintosh&author=R+Iles&author=B+Teisner&author=K+Sharma&author=T+Chard&author=J+Grudzinskas&publication_year=1994&hl=en']",,https://doi.org/10.1002/pd.1970140311, Macintosh 1994 {published data only}  ,excluded,CD009925-bbs2-0275, Unable to extract useful data. 
CD009925-bib-0289,"Macintosh MCM, Nicolaides KH, Noble P, Chard T, Gunn L, Iles R. ",Urinary ß‐core hCG: Screening for aneuploidies in early pregnancy (11‐14 weeks' gestation), Prenatal Diagnosis ,1997,17,    ,['citation-journal']," Macintosh MCM, Nicolaides KH, Noble P, Chard T, Gunn L, Iles R. Urinary ß‐core hCG: Screening for aneuploidies in early pregnancy (11‐14 weeks' gestation).  Prenatal Diagnosis 1997;17(5):401‐5.    Link to article     Google Scholar     ","['https://doi.org/10.1002/(SICI)1097-0223(199705)17:5<401::AID-PD40>3.0.CO;2-M', ""https://scholar.google.com/scholar_lookup?title=Urinary+ß‐core+hCG:+Screening+for+aneuploidies+in+early+pregnancy+(11‐14+weeks'+gestation)&author=MCM+Macintosh&author=KH+Nicolaides&author=P+Noble&author=T+Chard&author=L+Gunn&author=R+Iles&publication_year=1997&hl=en""]",,https://doi.org/10.1002/(SICI)1097-0223(199705)17:5<401::AID-PD40>3.0.CO;2-M, Macintosh 1997 {published data only}  ,excluded,CD009925-bbs2-0276, Unable to extract useful data. 
CD009925-bib-0290,"Macri JN, Kasturi RV, Krantz DA, Cook EJ, Moore ND, Young JA, et al. ",Maternal serum Down syndrome screening: free ß‐protein is a more effective marker than human chorionic gonadotropin.[see comment], American Journal of Obstetrics & Gynecology ,1990,163,    ,['citation-journal']," Macri JN, Kasturi RV, Krantz DA, Cook EJ, Moore ND, Young JA, et al. Maternal serum Down syndrome screening: free ß‐protein is a more effective marker than human chorionic gonadotropin.[see comment].  American Journal of Obstetrics & Gynecology 1990;163(4):1248‐53.    Link to article     Google Scholar     ","['https://doi.org/10.1016/0002-9378(90)90700-H', 'https://scholar.google.com/scholar_lookup?title=Maternal+serum+Down+syndrome+screening:+free+ß‐protein+is+a+more+effective+marker+than+human+chorionic+gonadotropin.[see+comment]+&author=JN+Macri&author=RV+Kasturi&author=DA+Krantz&author=EJ+Cook&author=ND+Moore&author=JA+Young&publication_year=1990&hl=en']",,https://doi.org/10.1016/0002-9378(90)90700-H, Macri 1994 {published data only}  ,excluded,CD009925-bbs2-0277, Likely fewer than 80% evaluated for gestational age by ultrasound examination. 
CD009925-bib-0291,"Macri JN, Spencer K, Garver K, Buchanan PD, Say B, Carpenter NJ, Muller F, Boue A. ",Maternal serum free ß hCG screening: results of studies including 480 cases of Down syndrome.[see comment], Prenatal Diagnosis ,1994,14,    ,['citation-journal']," Macri JN, Spencer K, Garver K, Buchanan PD, Say B, Carpenter NJ, Muller F, Boue A. Maternal serum free ß hCG screening: results of studies including 480 cases of Down syndrome.[see comment].  Prenatal Diagnosis 1994;14(2):97‐103.    Link to article     Google Scholar     ","['https://doi.org/10.1002/pd.1970140204', 'https://scholar.google.com/scholar_lookup?title=Maternal+serum+free+ß+hCG+screening:+results+of+studies+including+480+cases+of+Down+syndrome.[see+comment]+&author=JN+Macri&author=K+Spencer&author=K+Garver&author=PD+Buchanan&author=B+Say&author=NJ+Carpenter&author=F+Muller&author=A+Boue&publication_year=1994&hl=en']",,https://doi.org/10.1002/pd.1970140204, Macri 1994 {published data only}  ,excluded,CD009925-bbs2-0277, Likely fewer than 80% evaluated for gestational age by ultrasound examination. 
CD009925-bib-0292,"Spencer K, Macri JN. ",Early detection of Down's syndrome using free ß human choriogonadotropin, Annals of Clinical Biochemistry ,1992,19,    ,['citation-journal']," Spencer K, Macri JN. Early detection of Down's syndrome using free ß human choriogonadotropin.  Annals of Clinical Biochemistry 1992;19(3):349‐50.    Link to article     Google Scholar     ","['https://doi.org/10.1177/000456329202900319', ""https://scholar.google.com/scholar_lookup?title=Early+detection+of+Down's+syndrome+using+free+ß+human+choriogonadotropin&author=K+Spencer&author=JN+Macri&publication_year=1992&hl=en""]",,https://doi.org/10.1177/000456329202900319, Macri 1994 {published data only}  ,excluded,CD009925-bbs2-0277, Likely fewer than 80% evaluated for gestational age by ultrasound examination. 
CD009925-bib-0293,"Macri JN, Anderson RW, Krantz DA, Larsen JW, Buchanan PD. ",Prenatal maternal dried blood screening with alpha‐fetoprotein and free ß‐human chorionic gonadotropin for open neural tube defect and Down syndrome, American Journal of Obstetrics & Gynecology ,1996,174,    ,['citation-journal']," Macri JN, Anderson RW, Krantz DA, Larsen JW, Buchanan PD. Prenatal maternal dried blood screening with alpha‐fetoprotein and free ß‐human chorionic gonadotropin for open neural tube defect and Down syndrome.  American Journal of Obstetrics & Gynecology 1996;174(2):566‐72.    Link to article     Google Scholar     ","['https://doi.org/10.1016/S0002-9378(96)70429-5', 'https://scholar.google.com/scholar_lookup?title=Prenatal+maternal+dried+blood+screening+with+alpha‐fetoprotein+and+free+ß‐human+chorionic+gonadotropin+for+open+neural+tube+defect+and+Down+syndrome+&author=JN+Macri&author=RW+Anderson&author=DA+Krantz&author=JW+Larsen&author=PD+Buchanan&publication_year=1996&hl=en']",,https://doi.org/10.1016/S0002-9378(96)70429-5, Macri 1996 {published data only}  ,excluded,CD009925-bbs2-0278, Likely fewer than 80% evaluated for gestational age by ultrasound examination. 
CD009925-bib-0294,"Malone FD, D'Alton ME. ",Ultrasound clinics. Fetal nuchal fold translucency screening, Contemporary OB/GYN ,1998,43,    ,['citation-journal']," Malone FD, D'Alton ME. Ultrasound clinics. Fetal nuchal fold translucency screening.  Contemporary OB/GYN 1998;43(3):117‐8.    Google Scholar     ","[""https://scholar.google.com/scholar_lookup?title=Ultrasound+clinics.+Fetal+nuchal+fold+translucency+screening&author=FD+Malone&author=ME+D'Alton&publication_year=1998&hl=en""]",,, Malone 1998 {published data only}  ,excluded,CD009925-bbs2-0279, Review article. 
CD009925-bib-0295,"Malone FD, D'Alton ME. ",First‐trimester sonographic screening for Down syndrome, Obstetrics and Gynecology ,2003,102,    ,['citation-journal']," Malone FD, D'Alton ME. First‐trimester sonographic screening for Down syndrome.  Obstetrics and Gynecology 2003;102(5):1066‐79.    Google Scholar     ","[""https://scholar.google.com/scholar_lookup?title=First‐trimester+sonographic+screening+for+Down+syndrome&author=FD+Malone&author=ME+D'Alton&publication_year=2003&hl=en""]",,, Malone 2003 {published data only}  ,excluded,CD009925-bbs2-0280, Review article. 
CD009925-bib-0296,"Mangione R, Guyon F, Taine L, Wen ZQ, Roux D, Vergnaud A, et al. ",Pregnancy outcome and prognosis in fetuses with increased first‐trimester nuchal translucency, Fetal Diagnosis & Therapy ,2001,16,    ,['citation-journal']," Mangione R, Guyon F, Taine L, Wen ZQ, Roux D, Vergnaud A, et al. Pregnancy outcome and prognosis in fetuses with increased first‐trimester nuchal translucency.  Fetal Diagnosis & Therapy 2001;16(6):360‐3.    Link to article     Google Scholar     ","['https://doi.org/10.1159/000053941', 'https://scholar.google.com/scholar_lookup?title=Pregnancy+outcome+and+prognosis+in+fetuses+with+increased+first‐trimester+nuchal+translucency&author=R+Mangione&author=F+Guyon&author=L+Taine&author=ZQ+Wen&author=D+Roux&author=A+Vergnaud&publication_year=2001&hl=en']",,https://doi.org/10.1159/000053941, Mangione 2001 {published data only}  ,excluded,CD009925-bbs2-0281, Abnormal screening results only. 
CD009925-bib-0297,"Maymon R, Shulman A. ",Comparison of triple serum screening and pregnancy outcome in oocyte donation versus IVF pregnancies, Human Reproduction ,2001,16,    ,['citation-journal']," Maymon R, Shulman A. Comparison of triple serum screening and pregnancy outcome in oocyte donation versus IVF pregnancies.  Human Reproduction 2001;16(4):691‐5.    Link to article     Google Scholar     ","['https://doi.org/10.1093/humrep/16.4.691', 'https://scholar.google.com/scholar_lookup?title=Comparison+of+triple+serum+screening+and+pregnancy+outcome+in+oocyte+donation+versus+IVF+pregnancies+&author=R+Maymon&author=A+Shulman&publication_year=2001&hl=en']",,https://doi.org/10.1093/humrep/16.4.691, Maymon 2001a {published data only}  ,excluded,CD009925-bbs2-0282, No Down's syndrome pregnancies in study population. 
CD009925-bib-0298,"Maymon R, Dreazen E, Buckovsky I, Weinraub Z, Herman A. ",Does a 'notched' nuchal translucency indicate Down syndrome fetuses or other adverse pregnancy outcome?, Prenatal Diagnosis ,2001,21,    ,['citation-journal']," Maymon R, Dreazen E, Buckovsky I, Weinraub Z, Herman A. Does a 'notched' nuchal translucency indicate Down syndrome fetuses or other adverse pregnancy outcome?.  Prenatal Diagnosis 2001;21(5):403‐8.    Link to article     Google Scholar     ","['https://doi.org/10.1002/pd.61', ""https://scholar.google.com/scholar_lookup?title=Does+a+'notched'+nuchal+translucency+indicate+Down+syndrome+fetuses+or+other+adverse+pregnancy+outcome?+&author=R+Maymon&author=E+Dreazen&author=I+Buckovsky&author=Z+Weinraub&author=A+Herman&publication_year=2001&hl=en""]",,https://doi.org/10.1002/pd.61, Maymon 2001b {published data only}  ,excluded,CD009925-bbs2-0283, No normal test results included therefore unable to extract meaningful data. 
CD009925-bib-0299,"Maymon R, Shulman A. ",Serial first‐ and second‐trimester Down's syndrome screening tests among IVF‐versus naturally‐conceived singletons, Human Reproduction ,2002,17,    ,['citation-journal']," Maymon R, Shulman A. Serial first‐ and second‐trimester Down's syndrome screening tests among IVF‐versus naturally‐conceived singletons.  Human Reproduction 2002;17(4):1081‐5.    Link to article     Google Scholar     ","['https://doi.org/10.1093/humrep/17.4.1081', ""https://scholar.google.com/scholar_lookup?title=Serial+first‐+and+second‐trimester+Down's+syndrome+screening+tests+among+IVF‐versus+naturally‐conceived+singletons+&author=R+Maymon&author=A+Shulman&publication_year=2002&hl=en""]",,https://doi.org/10.1093/humrep/17.4.1081, Maymon 2002 {published data only}  ,excluded,CD009925-bbs2-0284, No Down's syndrome pregnancies in study population. 
CD009925-bib-0300,"Maymon R, Shulman A. ",Integrated first‐ and second‐trimester Down syndrome screening test among unaffected IVF pregnancies, Prenatal Diagnosis ,2004,24,    ,['citation-journal']," Maymon R, Shulman A. Integrated first‐ and second‐trimester Down syndrome screening test among unaffected IVF pregnancies.  Prenatal Diagnosis 2004;24(2):125‐9.    Link to article     Google Scholar     ","['https://doi.org/10.1002/pd.809', 'https://scholar.google.com/scholar_lookup?title=Integrated+first‐+and+second‐trimester+Down+syndrome+screening+test+among+unaffected+IVF+pregnancies+&author=R+Maymon&author=A+Shulman&publication_year=2004&hl=en']",,https://doi.org/10.1002/pd.809, Maymon 2004 {published data only}  ,excluded,CD009925-bbs2-0285, No Down's syndrome pregnancies in study population. 
CD009925-bib-0301,"Maymon R, Cuckle H, Jones R, Reish O, Sharony R, Herman A. ",Predicting the result of additional second‐trimester markers from a woman's first‐trimester marker profile: A new concept in Down syndrome screening, Prenatal Diagnosis ,2005,25,    ,['citation-journal']," Maymon R, Cuckle H, Jones R, Reish O, Sharony R, Herman A. Predicting the result of additional second‐trimester markers from a woman's first‐trimester marker profile: A new concept in Down syndrome screening.  Prenatal Diagnosis 2005;25(12):1102‐6.    Link to article     Google Scholar     ","['https://doi.org/10.1002/pd.1256', ""https://scholar.google.com/scholar_lookup?title=Predicting+the+result+of+additional+second‐trimester+markers+from+a+woman's+first‐trimester+marker+profile:+A+new+concept+in+Down+syndrome+screening+&author=R+Maymon&author=H+Cuckle&author=R+Jones&author=O+Reish&author=R+Sharony&author=A+Herman&publication_year=2005&hl=en""]",,https://doi.org/10.1002/pd.1256, Maymon 2005 {published data only}  ,excluded,CD009925-bbs2-0286, Modelled data. 
CD009925-bib-0302,"McDuffie Jr, Haverkamp AD, Stark CF, Haverkamp C, Barth CK. ","Prenatal screening using maternal serum alpha‐fetoprotein, human chorionic gonadotropin, and unconjugated estriol: Two‐year experience in a health maintenance organization", Journal of Maternal‐Fetal Medicine ,1996,5,    ,['citation-journal']," McDuffie Jr, Haverkamp AD, Stark CF, Haverkamp C, Barth CK. Prenatal screening using maternal serum alpha‐fetoprotein, human chorionic gonadotropin, and unconjugated estriol: Two‐year experience in a health maintenance organization.  Journal of Maternal‐Fetal Medicine 1996;5(2):70‐3.    Google Scholar     ","['https://scholar.google.com/scholar_lookup?title=Prenatal+screening+using+maternal+serum+alpha‐fetoprotein,+human+chorionic+gonadotropin,+and+unconjugated+estriol:+Two‐year+experience+in+a+health+maintenance+organization+&author=Jr+McDuffie&author=AD+Haverkamp&author=CF+Stark&author=C+Haverkamp&author=CK+Barth&publication_year=1996&hl=en']",,, McDuffie 1996 {published data only}  ,excluded,CD009925-bbs2-0287, USS dating on screen positive women only. 
CD009925-bib-0303,"Meier C, Huang T, Wyatt PR, Summers AM. ",Accuracy of expected risk of Down syndrome using the second‐trimester triple test, Clinical Chemistry ,2002,48,    ,['citation-journal']," Meier C, Huang T, Wyatt PR, Summers AM. Accuracy of expected risk of Down syndrome using the second‐trimester triple test.  Clinical Chemistry 2002;48(4):653‐5.    Link to article     Google Scholar     ","['https://doi.org/10.1093/clinchem/48.4.653', 'https://scholar.google.com/scholar_lookup?title=Accuracy+of+expected+risk+of+Down+syndrome+using+the+second‐trimester+triple+test&author=C+Meier&author=T+Huang&author=PR+Wyatt&author=AM+Summers&publication_year=2002&hl=en']",,https://doi.org/10.1093/clinchem/48.4.653, Meier 2002 {published data only}  ,excluded,CD009925-bbs2-0288, Observed vs expected cases of Down's syndrome in a population. 
CD009925-bib-0304,"Merkatz IR, Nitowsky HM, Macri JN, Johnson WE. ",An association between low maternal serum alpha‐fetoprotein and fetal chromosomal abnormalities, American Journal of Obstetrics & Gynecology ,1984,148,    ,['citation-journal']," Merkatz IR, Nitowsky HM, Macri JN, Johnson WE. An association between low maternal serum alpha‐fetoprotein and fetal chromosomal abnormalities.  American Journal of Obstetrics & Gynecology 1984;148(7):886‐94.    Link to article     Google Scholar     ","['https://doi.org/10.1016/0002-9378(84)90530-1', 'https://scholar.google.com/scholar_lookup?title=An+association+between+low+maternal+serum+alpha‐fetoprotein+and+fetal+chromosomal+abnormalities+&author=IR+Merkatz&author=HM+Nitowsky&author=JN+Macri&author=WE+Johnson&publication_year=1984&hl=en']",,https://doi.org/10.1016/0002-9378(84)90530-1, Merkatz 1984 {published data only}  ,excluded,CD009925-bbs2-0289, Gestational age not confirmed by ultrasound scan. 
CD009925-bib-0305,Merz E. ,The fetal nasal bone in the first trimester ‐ Precise assessment using 3D sonography, Ultraschall in der Medizin ,2005,26,    ,['citation-journal'], Merz E. The fetal nasal bone in the first trimester ‐ Precise assessment using 3D sonography.  Ultraschall in der Medizin 2005;26(5):365‐6.    Google Scholar     ,['https://scholar.google.com/scholar_lookup?title=The+fetal+nasal+bone+in+the+first+trimester+‐+Precise+assessment+using+3D+sonography&author=E+Merz&publication_year=2005&hl=en'],,, Merz 2005 {published data only}  ,excluded,CD009925-bbs2-0290, Editorial. 
CD009925-bib-0306,"Metzenbauer M, Hafner E, Hoefinger D, Schuchter K, Stangl G, Ogris E, Philipp K. ",Three‐dimensional ultrasound measurement of the placental volume in early pregnancy: method and correlation with biochemical placenta parameters, Placenta ,2001,22,    ,['citation-journal']," Metzenbauer M, Hafner E, Hoefinger D, Schuchter K, Stangl G, Ogris E, Philipp K. Three‐dimensional ultrasound measurement of the placental volume in early pregnancy: method and correlation with biochemical placenta parameters.  Placenta 2001;22(6):602‐5.    Link to article     Google Scholar     ","['https://doi.org/10.1053/plac.2001.0684', 'https://scholar.google.com/scholar_lookup?title=Three‐dimensional+ultrasound+measurement+of+the+placental+volume+in+early+pregnancy:+method+and+correlation+with+biochemical+placenta+parameters+&author=M+Metzenbauer&author=E+Hafner&author=D+Hoefinger&author=K+Schuchter&author=G+Stangl&author=E+Ogris&author=K+Philipp&publication_year=2001&hl=en']",,https://doi.org/10.1053/plac.2001.0684, Metzenbauer 2001 {published data only}  ,excluded,CD009925-bbs2-0291, Normal pregnancies only. 
CD009925-bib-0307,"Metzenbauer M, Hafner E, Schuchter K, Philipp K. ",First‐trimester placental volume as a marker for chromosomal anomalies: preliminary results from an unselected population, Ultrasound in Obstetrics & Gynecology ,2002,19,    ,['citation-journal']," Metzenbauer M, Hafner E, Schuchter K, Philipp K. First‐trimester placental volume as a marker for chromosomal anomalies: preliminary results from an unselected population.  Ultrasound in Obstetrics & Gynecology 2002;19(3):240‐2.    Link to article     Google Scholar     ","['https://doi.org/10.1046/j.1469-0705.2002.00655.x', 'https://scholar.google.com/scholar_lookup?title=First‐trimester+placental+volume+as+a+marker+for+chromosomal+anomalies:+preliminary+results+from+an+unselected+population+&author=M+Metzenbauer&author=E+Hafner&author=K+Schuchter&author=K+Philipp&publication_year=2002&hl=en']",,https://doi.org/10.1046/j.1469-0705.2002.00655.x, Metzenbauer 2002 {published data only}  ,excluded,CD009925-bbs2-0292, Unable to extract useful data. 
CD009925-bib-0308,"Mikic TS, Johnson P. ",Second trimester maternal serum ß human chorionic gonadotrophin and pregnancy outcome, British Journal of Obstetrics & Gynaecology ,1999,106,    ,['citation-journal']," Mikic TS, Johnson P. Second trimester maternal serum ß human chorionic gonadotrophin and pregnancy outcome.  British Journal of Obstetrics & Gynaecology 1999;106(6):598‐600.    Link to article     Google Scholar     ","['https://doi.org/10.1111/j.1471-0528.1999.tb08331.x', 'https://scholar.google.com/scholar_lookup?title=Second+trimester+maternal+serum+ß+human+chorionic+gonadotrophin+and+pregnancy+outcome&author=TS+Mikic&author=P+Johnson&publication_year=1999&hl=en']",,https://doi.org/10.1111/j.1471-0528.1999.tb08331.x, Mikic 1999 {published data only}  ,excluded,CD009925-bbs2-0293, No Down's syndrome pregnancies in study population. 
CD009925-bib-0309,"Miller CH, O'Brien TJ, Chatelain S, Butler BB, Quirk JG. ",Alteration in age‐specific risks for chromosomal trisomy by maternal serum alpha‐fetoprotein and human chorionic gonadotropin screening, Prenatal Diagnosis ,1991,11,    ,['citation-journal']," Miller CH, O'Brien TJ, Chatelain S, Butler BB, Quirk JG. Alteration in age‐specific risks for chromosomal trisomy by maternal serum alpha‐fetoprotein and human chorionic gonadotropin screening.  Prenatal Diagnosis 1991;11(3):153‐8.    Link to article     Google Scholar     ","['https://doi.org/10.1002/pd.1970110304', ""https://scholar.google.com/scholar_lookup?title=Alteration+in+age‐specific+risks+for+chromosomal+trisomy+by+maternal+serum+alpha‐fetoprotein+and+human+chorionic+gonadotropin+screening+&author=CH+Miller&author=TJ+O'Brien&author=S+Chatelain&author=BB+Butler&author=JG+Quirk&publication_year=1991&hl=en""]",,https://doi.org/10.1002/pd.1970110304, Miller 1991 {published data only}  ,excluded,CD009925-bbs2-0294, Unable to extract useful data. 
CD009925-bib-0310,"Milunsky A, Jick SS, Bruell CL, Maclaughlin DS, Tsung Y‐K, Jick H, et al. ",Predictive values relative risks and overall benefits of high and low maternal serum alpha fetoprotein screening in singleton pregnancies ‐ new epidemiological data, American Journal of Obstetrics and Gynecology ,1989,161,    ,['citation-journal']," Milunsky A, Jick SS, Bruell CL, Maclaughlin DS, Tsung Y‐K, Jick H, et al. Predictive values relative risks and overall benefits of high and low maternal serum alpha fetoprotein screening in singleton pregnancies ‐ new epidemiological data.  American Journal of Obstetrics and Gynecology 1989;161(2):291‐7.    Link to article     Google Scholar     ","['https://doi.org/10.1016/0002-9378(89)90501-2', 'https://scholar.google.com/scholar_lookup?title=Predictive+values+relative+risks+and+overall+benefits+of+high+and+low+maternal+serum+alpha+fetoprotein+screening+in+singleton+pregnancies+‐+new+epidemiological+data+&author=A+Milunsky&author=SS+Jick&author=CL+Bruell&author=DS+Maclaughlin&author=Y‐K+Tsung&author=H+Jick&publication_year=1989&hl=en']",,https://doi.org/10.1016/0002-9378(89)90501-2, Milunsky 1989 {published data only}  ,excluded,CD009925-bbs2-0295, Fewer than 80% gestational age estimated by USS. 
CD009925-bib-0311,"Milunsky A, Nebiolo L. ",Maternal serum triple analyte screening and adverse pregnancy outcome, Fetal Diagnosis & Therapy ,1996,11,    ,['citation-journal']," Milunsky A, Nebiolo L. Maternal serum triple analyte screening and adverse pregnancy outcome.  Fetal Diagnosis & Therapy 1996;11(4):249‐53.    Link to article     Google Scholar     ","['https://doi.org/10.1159/000264310', 'https://scholar.google.com/scholar_lookup?title=Maternal+serum+triple+analyte+screening+and+adverse+pregnancy+outcome&author=A+Milunsky&author=L+Nebiolo&publication_year=1996&hl=en']",,https://doi.org/10.1159/000264310, Milunsky 1996 {published data only}  ,excluded,CD009925-bbs2-0296, Fewer than 80% gestational age estimated by USS. 
CD009925-bib-0312,Minobe S. ,[A study on the screening of prenatal trisomy 21 using the fucosylated alpha‐fetoprotein ratio measured by a liquid‐phase binding assay]. [Japanese], Hokkaido Igaku Zasshi ‐ Hokkaido Journal of Medical Science ,2002,77,    ,['citation-journal'], Minobe S. [A study on the screening of prenatal trisomy 21 using the fucosylated alpha‐fetoprotein ratio measured by a liquid‐phase binding assay]. [Japanese].  Hokkaido Igaku Zasshi ‐ Hokkaido Journal of Medical Science 2002;77(6):527‐32.    Google Scholar     ,['https://scholar.google.com/scholar_lookup?title=[A+study+on+the+screening+of+prenatal+trisomy+21+using+the+fucosylated+alpha‐fetoprotein+ratio+measured+by+a+liquid‐phase+binding+assay].+[Japanese]+&author=S+Minobe&publication_year=2002&hl=en'],,, Minobe 2002 {published data only}  ,excluded,CD009925-bbs2-0297, Gestational age greater than specified limits. 
CD009925-bib-0313,"Miyamura T, Saito N, Touno A, Nagata S, Hidaki T, Ishimaru T, et al. ","Multicenter study for maternal serum triple markers to establish Japanese standards: Maternal serum marker study group, Japan Association of Prenatal Diagnostics", Acta Obstetrica et Gynaecologica Japonica ,1999,51,    ,['citation-journal']," Miyamura T, Saito N, Touno A, Nagata S, Hidaki T, Ishimaru T, et al. Multicenter study for maternal serum triple markers to establish Japanese standards: Maternal serum marker study group, Japan Association of Prenatal Diagnostics.  Acta Obstetrica et Gynaecologica Japonica 1999;51(11):1042‐8.    Google Scholar     ","['https://scholar.google.com/scholar_lookup?title=Multicenter+study+for+maternal+serum+triple+markers+to+establish+Japanese+standards:+Maternal+serum+marker+study+group,+Japan+Association+of+Prenatal+Diagnostics+&author=T+Miyamura&author=N+Saito&author=A+Touno&author=S+Nagata&author=T+Hidaki&author=T+Ishimaru&publication_year=1999&hl=en']",,, Miyamura 1999 {published data only}  ,excluded,CD009925-bbs2-0298, Unable to extract useful data. 
CD009925-bib-0314,"Moghadam S, Engel W, Bougoussa M, Hennen G, Igout A, Sancken U. ",Maternal serum placental growth hormone and insulinlike growth factor binding proteins 1 and 3 in pregnancies affected by fetal aneuploidy and other abnormalities: implications for prenatal diagnosis of trisomy 21, Fetal Diagnosis & Therapy ,1998,13,    ,['citation-journal']," Moghadam S, Engel W, Bougoussa M, Hennen G, Igout A, Sancken U. Maternal serum placental growth hormone and insulinlike growth factor binding proteins 1 and 3 in pregnancies affected by fetal aneuploidy and other abnormalities: implications for prenatal diagnosis of trisomy 21.  Fetal Diagnosis & Therapy 1998;13(5):291‐7.    Link to article     Google Scholar     ","['https://doi.org/10.1159/000020856', 'https://scholar.google.com/scholar_lookup?title=Maternal+serum+placental+growth+hormone+and+insulinlike+growth+factor+binding+proteins+1+and+3+in+pregnancies+affected+by+fetal+aneuploidy+and+other+abnormalities:+implications+for+prenatal+diagnosis+of+trisomy+21+&author=S+Moghadam&author=W+Engel&author=M+Bougoussa&author=G+Hennen&author=A+Igout&author=U+Sancken&publication_year=1998&hl=en']",,https://doi.org/10.1159/000020856, Moghadam 1998 {published data only}  ,excluded,CD009925-bbs2-0299, Unable to extract useful data. 
CD009925-bib-0315,"Monni G, Zoppi MA, Ibba RM, Putzolu M, Floris M. ",Nuchal translucency in multiple pregnancies, Croatian Medical Journal ,2000,41,    ,['citation-journal']," Monni G, Zoppi MA, Ibba RM, Putzolu M, Floris M. Nuchal translucency in multiple pregnancies.  Croatian Medical Journal 2000;41(3):266‐9.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=Nuchal+translucency+in+multiple+pregnancies&author=G+Monni&author=MA+Zoppi&author=RM+Ibba&author=M+Putzolu&author=M+Floris&publication_year=2000&hl=en'],,, Monni 2000 {published data only}  ,excluded,CD009925-bbs2-0300, Less than 5 Down's syndrome pregnancies. 
CD009925-bib-0316,"Monni G, Zoppi MA. ",New ultrasonographic markers of aneuploidies: Nasal bones, Ultrasound Review of Obstetrics and Gynecology ,2002,2,    ,['citation-journal']," Monni G, Zoppi MA. New ultrasonographic markers of aneuploidies: Nasal bones.  Ultrasound Review of Obstetrics and Gynecology 2002;2(4):229‐34.    Link to article     Google Scholar     ","['https://doi.org/10.3109/14722240208500480', 'https://scholar.google.com/scholar_lookup?title=New+ultrasonographic+markers+of+aneuploidies:+Nasal+bones&author=G+Monni&author=MA+Zoppi&publication_year=2002&hl=en']",,https://doi.org/10.3109/14722240208500480, Monni 2002 {published data only}  ,excluded,CD009925-bbs2-0301, Review article. 
CD009925-bib-0317,"Mooney RA, Peterson J, French CA, Saller Jr, Arvan DA. ",Effectiveness of combining maternal serum alpha‐fetoprotein and hCG in a second‐trimester screening program for Down syndrome, Obstetrics and Gynecology ,1994,84,    ,['citation-journal']," Mooney RA, Peterson J, French CA, Saller Jr, Arvan DA. Effectiveness of combining maternal serum alpha‐fetoprotein and hCG in a second‐trimester screening program for Down syndrome.  Obstetrics and Gynecology 1994;84(2):298‐303.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=Effectiveness+of+combining+maternal+serum+alpha‐fetoprotein+and+hCG+in+a+second‐trimester+screening+program+for+Down+syndrome+&author=RA+Mooney&author=J+Peterson&author=CA+French&author=Jr+Saller&author=DA+Arvan&publication_year=1994&hl=en'],,, Mooney 1994 {published data only}  ,excluded,CD009925-bbs2-0302, Greater than 24 weeks gestation. 
CD009925-bib-0318,"Muller F, Bussieres L, Pelissier MC, Oury JF, Boue C, Uzan S, et al. ","Do racial differences exist in second‐trimester maternal hCG levels? A study of 23,369 women", Prenatal Diagnosis ,1994,14,    ,['citation-journal']," Muller F, Bussieres L, Pelissier MC, Oury JF, Boue C, Uzan S, et al. Do racial differences exist in second‐trimester maternal hCG levels? A study of 23,369 women.  Prenatal Diagnosis 1994;14(7):633‐6.    Link to article     Google Scholar     ","['https://doi.org/10.1002/pd.1970140721', 'https://scholar.google.com/scholar_lookup?title=Do+racial+differences+exist+in+second‐trimester+maternal+hCG+levels?+A+study+of+23,369+women+&author=F+Muller&author=L+Bussieres&author=MC+Pelissier&author=JF+Oury&author=C+Boue&author=S+Uzan&publication_year=1994&hl=en']",,https://doi.org/10.1002/pd.1970140721, Muller 1994 {published data only}  ,excluded,CD009925-bbs2-0303, No Down's syndrome pregnancies in study population. 
CD009925-bib-0319,"Muller F, Dommergues M, Bussieres L, Aegerter P, Le Fiblec B, Uzan S, et al. ",Prenatal screening for Down syndrome: should first trimester ultrasound replace maternal serum screening?, Early Human Development ,1996,47 Suppl,    ,['citation-journal']," Muller F, Dommergues M, Bussieres L, Aegerter P, Le Fiblec B, Uzan S, et al. Prenatal screening for Down syndrome: should first trimester ultrasound replace maternal serum screening?.  Early Human Development 1996;47 Suppl:S37‐S39.    Link to article     Google Scholar     ","['https://doi.org/10.1016/S0378-3782(96)01817-8', 'https://scholar.google.com/scholar_lookup?title=Prenatal+screening+for+Down+syndrome:+should+first+trimester+ultrasound+replace+maternal+serum+screening?+&author=F+Muller&author=M+Dommergues&author=L+Bussieres&author=P+Aegerter&author=B+Fiblec&author=S+Uzan&publication_year=1996&hl=en']",,https://doi.org/10.1016/S0378-3782(96)01817-8, Muller 1996b {published data only}  ,excluded,CD009925-bbs2-0304, Unable to extract useful data. 
CD009925-bib-0320,"Muller F, Ngo S, Rebiffe M, Oury JF, Uzan S, Satge D. ",Maternal serum s100b protein is ineffective for Down syndrome screening, Prenatal Diagnosis. ,1999,19,    ,['citation-journal']," Muller F, Ngo S, Rebiffe M, Oury JF, Uzan S, Satge D. Maternal serum s100b protein is ineffective for Down syndrome screening.  Prenatal Diagnosis. 1999;19(11):1086.    Link to article     Google Scholar     ","['https://doi.org/10.1002/(SICI)1097-0223(199911)19:11<1086::AID-PD704>3.0.CO;2-T', 'https://scholar.google.com/scholar_lookup?title=Maternal+serum+s100b+protein+is+ineffective+for+Down+syndrome+screening&author=F+Muller&author=S+Ngo&author=M+Rebiffe&author=JF+Oury&author=S+Uzan&author=D+Satge&publication_year=1999&hl=en']",,https://doi.org/10.1002/(SICI)1097-0223(199911)19:11<1086::AID-PD704>3.0.CO;2-T, Muller 1999 {published data only}  ,excluded,CD009925-bbs2-0305, Unable to extract useful data. 
CD009925-bib-0321,"Muller F, Dreux S, Oury JF, Luton D, Uzan S, Uzan M, et al. ",Down syndrome maternal serum marker screening after 18 weeks' gestation, Prenatal Diagnosis ,2002,22,    ,['citation-journal']," Muller F, Dreux S, Oury JF, Luton D, Uzan S, Uzan M, et al. Down syndrome maternal serum marker screening after 18 weeks' gestation.  Prenatal Diagnosis 2002;22(11):1001‐4.    Link to article     Google Scholar     ","['https://doi.org/10.1002/pd.451', ""https://scholar.google.com/scholar_lookup?title=Down+syndrome+maternal+serum+marker+screening+after+18+weeks'+gestation&author=F+Muller&author=S+Dreux&author=JF+Oury&author=D+Luton&author=S+Uzan&author=M+Uzan&publication_year=2002&hl=en""]",,https://doi.org/10.1002/pd.451, Muller 2002a {published data only}  ,excluded,CD009925-bbs2-0306, Getstional age greater than 24 weeks. 
CD009925-bib-0322,"Muller F, Forestier F, Dingeon B, for the ABA Study Group. ","Second trimester trisomy 21 maternal serum marker screening. Results of a countrywide study of 854,902 women", Prenatal Diagnosis ,2002,22,    ,['citation-journal']," Muller F, Forestier F, Dingeon B, for the ABA Study Group. Second trimester trisomy 21 maternal serum marker screening. Results of a countrywide study of 854,902 women.  Prenatal Diagnosis 2002;22(10):925‐9.    Link to article     Google Scholar     ","['https://doi.org/10.1002/pd.438', 'https://scholar.google.com/scholar_lookup?title=Second+trimester+trisomy+21+maternal+serum+marker+screening.+Results+of+a+countrywide+study+of+854,902+women+&author=F+Muller&author=F+Forestier&author=B+Dingeon&publication_year=2002&hl=en']",,https://doi.org/10.1002/pd.438, Muller 2002b {published data only}  ,excluded,CD009925-bbs2-0307, Unable to extract meaningful data ‐ unable to separate double and triple test data. 
CD009925-bib-0323,"Muller F, Dreux S, Lemeur A, Sault C, Desgres J, Bernard MA, et al. ",Medically assisted reproduction and second‐trimester maternal serum marker screening for Down syndrome, Prenatal Diagnosis ,2003,23,    ,['citation-journal']," Muller F, Dreux S, Lemeur A, Sault C, Desgres J, Bernard MA, et al. Medically assisted reproduction and second‐trimester maternal serum marker screening for Down syndrome.  Prenatal Diagnosis 2003;23(13):1073‐6.    Link to article     Google Scholar     ","['https://doi.org/10.1002/pd.756', 'https://scholar.google.com/scholar_lookup?title=Medically+assisted+reproduction+and+second‐trimester+maternal+serum+marker+screening+for+Down+syndrome+&author=F+Muller&author=S+Dreux&author=A+Lemeur&author=C+Sault&author=J+Desgres&author=MA+Bernard&publication_year=2003&hl=en']",,https://doi.org/10.1002/pd.756, Muller 2003 {published data only}  ,excluded,CD009925-bbs2-0308, No Down's syndrome pregnancies in study population. 
CD009925-bib-0324,"Murta CG, Moron AF, Avila MA, Weiner CP. ",Application of ductus venosus Doppler velocimetry for the detection of fetal aneuploidy in the first trimester of pregnancy, Fetal Diagnosis & Therapy ,2002,17,    ,['citation-journal']," Murta CG, Moron AF, Avila MA, Weiner CP. Application of ductus venosus Doppler velocimetry for the detection of fetal aneuploidy in the first trimester of pregnancy.  Fetal Diagnosis & Therapy 2002;17(5):308‐14.    Link to article     Google Scholar     ","['https://doi.org/10.1159/000063185', 'https://scholar.google.com/scholar_lookup?title=Application+of+ductus+venosus+Doppler+velocimetry+for+the+detection+of+fetal+aneuploidy+in+the+first+trimester+of+pregnancy+&author=CG+Murta&author=AF+Moron&author=MA+Avila&author=CP+Weiner&publication_year=2002&hl=en']",,https://doi.org/10.1159/000063185, Murta 2002 {published data only}  ,excluded,CD009925-bbs2-0309, Unable to extract useful data. 
CD009925-bib-0325,"Musone R, Bonafiglia R, Menditto A, Paccone M, Cassese E, Russo G, et al. ",Fetuses with cystic hygroma. A retrospective study, Panminerva Medica ,2000,42,    ,['citation-journal']," Musone R, Bonafiglia R, Menditto A, Paccone M, Cassese E, Russo G, et al. Fetuses with cystic hygroma. A retrospective study.  Panminerva Medica 2000;42(1):39‐43.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=Fetuses+with+cystic+hygroma.+A+retrospective+study&author=R+Musone&author=R+Bonafiglia&author=A+Menditto&author=M+Paccone&author=E+Cassese&author=G+Russo&publication_year=2000&hl=en'],,, Musone 2000 {published data only}  ,excluded,CD009925-bbs2-0310, Unable to extract useful data. 
CD009925-bib-0326,"Musto JD, Pizzolante JM, Chesarone VP, Sassi AM, Sane R. ",Alpha‐fetoprotein: an enhanced‐sensitivity assay for neural tube defect and Down syndrome evaluation, Clinical Chemistry ,1986,32,    ,['citation-journal']," Musto JD, Pizzolante JM, Chesarone VP, Sassi AM, Sane R. Alpha‐fetoprotein: an enhanced‐sensitivity assay for neural tube defect and Down syndrome evaluation.  Clinical Chemistry 1986;32(7):1412.    Link to article     Google Scholar     ","['https://doi.org/10.1093/clinchem/32.7.1412', 'https://scholar.google.com/scholar_lookup?title=Alpha‐fetoprotein:+an+enhanced‐sensitivity+assay+for+neural+tube+defect+and+Down+syndrome+evaluation+&author=JD+Musto&author=JM+Pizzolante&author=VP+Chesarone&author=AM+Sassi&author=R+Sane&publication_year=1986&hl=en']",,https://doi.org/10.1093/clinchem/32.7.1412, Musto 1986 {published data only}  ,excluded,CD009925-bbs2-0311, Fewer than 80% USS dated. 
CD009925-bib-0327,"Myrick JE, Caudill SP, Hubert IL, Robinson MK, Adams MJ, Pueschel SM. ",Identification of haptoglobin alpha‐2FF variants in mid‐trimester maternal serum as potential markers for Down syndrome, Applied & Theoretical Electrophoresis ,1990,1,    ,['citation-journal']," Myrick JE, Caudill SP, Hubert IL, Robinson MK, Adams MJ, Pueschel SM. Identification of haptoglobin alpha‐2FF variants in mid‐trimester maternal serum as potential markers for Down syndrome.  Applied & Theoretical Electrophoresis 1990;1(5):233‐41.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=Identification+of+haptoglobin+alpha‐2FF+variants+in+mid‐trimester+maternal+serum+as+potential+markers+for+Down+syndrome+&author=JE+Myrick&author=SP+Caudill&author=IL+Hubert&author=MK+Robinson&author=MJ+Adams&author=SM+Pueschel&publication_year=1990&hl=en'],,, Myrick 1990 {published data only}  ,excluded,CD009925-bbs2-0312, Unable to extract useful data. 
CD009925-bib-0328,"Neveux LM, Palomaki GE, Larrivee DA, Knight GJ, Haddow JE. ",Refinements in managing maternal weight adjustment for interpreting prenatal screening results, Prenatal Diagnosis ,1996,16,    ,['citation-journal']," Neveux LM, Palomaki GE, Larrivee DA, Knight GJ, Haddow JE. Refinements in managing maternal weight adjustment for interpreting prenatal screening results.  Prenatal Diagnosis 1996;16(12):1115‐9.    Link to article     Google Scholar     ","['https://doi.org/10.1002/(SICI)1097-0223(199612)16:12<1115::AID-PD3>3.0.CO;2-6', 'https://scholar.google.com/scholar_lookup?title=Refinements+in+managing+maternal+weight+adjustment+for+interpreting+prenatal+screening+results+&author=LM+Neveux&author=GE+Palomaki&author=DA+Larrivee&author=GJ+Knight&author=JE+Haddow&publication_year=1996&hl=en']",,https://doi.org/10.1002/(SICI)1097-0223(199612)16:12<1115::AID-PD3>3.0.CO;2-6, Neveux 1996a {published data only}  ,excluded,CD009925-bbs2-0313, No Down's syndrome pregnancies in population. 
CD009925-bib-0329,"Neveux LM, Palomaki GE, Knight GJ, Haddow JE. ",Multiple marker screening for Down syndrome in twin pregnancies, Prenatal Diagnosis ,1996,16,    ,['citation-journal']," Neveux LM, Palomaki GE, Knight GJ, Haddow JE. Multiple marker screening for Down syndrome in twin pregnancies.  Prenatal Diagnosis 1996;16(1):29‐34.    Link to article     Google Scholar     ","['https://doi.org/10.1002/(SICI)1097-0223(199601)16:1<29::AID-PD801>3.0.CO;2-K', 'https://scholar.google.com/scholar_lookup?title=Multiple+marker+screening+for+Down+syndrome+in+twin+pregnancies&author=LM+Neveux&author=GE+Palomaki&author=GJ+Knight&author=JE+Haddow&publication_year=1996&hl=en']",,https://doi.org/10.1002/(SICI)1097-0223(199601)16:1<29::AID-PD801>3.0.CO;2-K, Neveux 1996b {published data only}  ,excluded,CD009925-bbs2-0314, Unable to extract useful data. 
CD009925-bib-0330,"Ng EK, El‐Sheikhah A, Chiu RW, Chan KC, Hogg M, Bindra R, et al. ",Evaluation of human chorionic gonadotropin ß‐subunit mRNA concentrations in maternal serum in aneuploid pregnancies: a feasibility study, Clinical Chemistry ,2004,50,    ,['citation-journal']," Ng EK, El‐Sheikhah A, Chiu RW, Chan KC, Hogg M, Bindra R, et al. Evaluation of human chorionic gonadotropin ß‐subunit mRNA concentrations in maternal serum in aneuploid pregnancies: a feasibility study.  Clinical Chemistry 2004;50(6):1055‐7.    Link to article     Google Scholar     ","['https://doi.org/10.1373/clinchem.2004.031260', 'https://scholar.google.com/scholar_lookup?title=Evaluation+of+human+chorionic+gonadotropin+ß‐subunit+mRNA+concentrations+in+maternal+serum+in+aneuploid+pregnancies:+a+feasibility+study+&author=EK+Ng&author=A+El‐Sheikhah&author=RW+Chiu&author=KC+Chan&author=M+Hogg&author=R+Bindra&publication_year=2004&hl=en']",,https://doi.org/10.1373/clinchem.2004.031260, Ng 2004 {published data only}  ,excluded,CD009925-bbs2-0315, Unable to extract useful data. 
CD009925-bib-0331,"Nicolaides KH, ZAR G, Snijders RJM, Gosden CM. ",Fetal nuchal oedema associated malformations and chromosomal defects, Fetal Diagnosis and Therapy ,1992,7,    ,['citation-journal']," Nicolaides KH, ZAR G, Snijders RJM, Gosden CM. Fetal nuchal oedema associated malformations and chromosomal defects.  Fetal Diagnosis and Therapy 1992;7(2):123‐31.    Link to article     Google Scholar     ","['https://doi.org/10.1159/000263659', 'https://scholar.google.com/scholar_lookup?title=Fetal+nuchal+oedema+associated+malformations+and+chromosomal+defects&author=KH+Nicolaides&author=G+ZAR&author=RJM+Snijders&author=CM+Gosden&publication_year=1992&hl=en']",,https://doi.org/10.1159/000263659, Nicolaides 1992 {published data only}  ,excluded,CD009925-bbs2-0316, Study of outcomes of abnormal NT results. 
CD009925-bib-0332,"Nicolaides KH, Cicero S, Liao AW. ",One‐stop clinic for assessment of risk of chromosomal defects at 12 weeks of gestation, Prenatal and Neonatal Medicine ,2000,5,    ,['citation-journal']," Nicolaides KH, Cicero S, Liao AW. One‐stop clinic for assessment of risk of chromosomal defects at 12 weeks of gestation.  Prenatal and Neonatal Medicine 2000;5(3):145‐54.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=One‐stop+clinic+for+assessment+of+risk+of+chromosomal+defects+at+12+weeks+of+gestation&author=KH+Nicolaides&author=S+Cicero&author=AW+Liao&publication_year=2000&hl=en'],,, Nicolaides 2000 {published data only}  ,excluded,CD009925-bbs2-0317, Review article. 
CD009925-bib-0333,Nicolaides KH. ,Nuchal translucency and other first‐trimester sonographic markers of chromosomal abnormalities, American Journal of Obstetrics and Gynecology ,2004,191,    ,['citation-journal'], Nicolaides KH. Nuchal translucency and other first‐trimester sonographic markers of chromosomal abnormalities.  American Journal of Obstetrics and Gynecology 2004;191(1):45‐67.    Link to article     Google Scholar     ,"['https://doi.org/10.1016/j.ajog.2004.03.090', 'https://scholar.google.com/scholar_lookup?title=Nuchal+translucency+and+other+first‐trimester+sonographic+markers+of+chromosomal+abnormalities&author=KH+Nicolaides&publication_year=2004&hl=en']",,https://doi.org/10.1016/j.ajog.2004.03.090, Nicolaides 2004 {published data only}  ,excluded,CD009925-bbs2-0318, Review article. 
CD009925-bib-0334,"Nicolaides KH, Wegrzyn P. ",[First trimester diagnosis of chromosomal defects][Polish]," Ginekologia Polska.76(1):1‐8, ",2005,76,    ,['citation-journal']," Nicolaides KH, Wegrzyn P. [First trimester diagnosis of chromosomal defects][Polish].  Ginekologia Polska.76(1):1‐8, 2005;76(1):1‐8.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=[First+trimester+diagnosis+of+chromosomal+defects][Polish]&author=KH+Nicolaides&author=P+Wegrzyn&publication_year=2005&hl=en'],,, Nicolaides 2005a {published data only}  ,excluded,CD009925-bbs2-0319, Unable to obtain translation ‐ appears to be a review article. 
CD009925-bib-0335,"Nicolaides KH, Wegrzyn P. ",[Sonographic features of chromosomal defects at 11(+0) to 13(+6) weeks of gestation] [Polish], Ginekologia Polska ,2005,76,    ,['citation-journal']," Nicolaides KH, Wegrzyn P. [Sonographic features of chromosomal defects at 11(+0) to 13(+6) weeks of gestation] [Polish].  Ginekologia Polska 2005;76(6):423‐30.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=[Sonographic+features+of+chromosomal+defects+at+11(+0)+to+13(+6)+weeks+of+gestation]+[Polish]+&author=KH+Nicolaides&author=P+Wegrzyn&publication_year=2005&hl=en'],,, Nicolaides 2005b {published data only}  ,excluded,CD009925-bbs2-0320, Unable to obtain translation ‐ appears to be a review article. 
CD009925-bib-0336,"Nicolaides KH, Wegrzyn P. ",[Increased nuchal translucency with normal karyotype]. [Polish], Ginekologia Polska ,2005,76,    ,['citation-journal']," Nicolaides KH, Wegrzyn P. [Increased nuchal translucency with normal karyotype]. [Polish].  Ginekologia Polska 2005;76(8):593‐601.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=[Increased+nuchal+translucency+with+normal+karyotype].+[Polish]&author=KH+Nicolaides&author=P+Wegrzyn&publication_year=2005&hl=en'],,, Nicolaides 2005c {published data only}  ,excluded,CD009925-bbs2-0321, Unable to obtain translation ‐ appears to be a review article. 
CD009925-bib-0337,"Nicolaides KH, Wegrzyn P. ",[Fetal nuchal translucency]. [Polish], Ginekologia Polska ,2005,76,    ,['citation-journal']," Nicolaides KH, Wegrzyn P. [Fetal nuchal translucency]. [Polish].  Ginekologia Polska 2005;76(3):179‐86.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=[Fetal+nuchal+translucency].+[Polish]&author=KH+Nicolaides&author=P+Wegrzyn&publication_year=2005&hl=en'],,, Nicolaides 2005d {published data only}  ,excluded,CD009925-bbs2-0322, Unable to obtain translation ‐ appears to be a review article. 
CD009925-bib-0338,"Nicolaides KH, Wegrzyn P. ",[Fetal nuchal translucency thickness and risk for chromosomal defects]. [Polish]," Ginekologia Polska.76(4):257‐63, ",2005,76,    ,['citation-journal']," Nicolaides KH, Wegrzyn P. [Fetal nuchal translucency thickness and risk for chromosomal defects]. [Polish].  Ginekologia Polska.76(4):257‐63, 2005;76(4):257‐63.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=[Fetal+nuchal+translucency+thickness+and+risk+for+chromosomal+defects].+[Polish]&author=KH+Nicolaides&author=P+Wegrzyn&publication_year=2005&hl=en'],,, Nicolaides 2005e {published data only}  ,excluded,CD009925-bbs2-0323, Unable to obtain translation ‐ appears to be a review article. 
CD009925-bib-0339,Nicolaides Kypros H. ,First‐trimester screening for chromosomal abnormalities, Seminars in Perinatology (Philadelphia) ,2005,29,    ,['citation-journal'], Nicolaides Kypros H. First‐trimester screening for chromosomal abnormalities.  Seminars in Perinatology (Philadelphia) 2005;29(4):190‐4.    Link to article     Google Scholar     ,"['https://doi.org/10.1053/j.semperi.2005.06.001', 'https://scholar.google.com/scholar_lookup?title=First‐trimester+screening+for+chromosomal+abnormalities&author=H+NicolaidesKypros&publication_year=2005&hl=en']",,https://doi.org/10.1053/j.semperi.2005.06.001, Nicolaides 2005f {published data only}  ,excluded,CD009925-bbs2-0324, Review article. 
CD009925-bib-0340,"Niemimaa M, Heinonen S, Seppala M, Hippelainen M, Martikainen H, Ryynanen M. ",First‐trimester screening for Down's syndrome in in vitro fertilization pregnancies, Fertility & Sterility ,2001,76,    ,['citation-journal']," Niemimaa M, Heinonen S, Seppala M, Hippelainen M, Martikainen H, Ryynanen M. First‐trimester screening for Down's syndrome in in vitro fertilization pregnancies.  Fertility & Sterility 2001;76(6):1282‐3.    Link to article     Google Scholar     ","['https://doi.org/10.1016/S0015-0282(01)02871-0', ""https://scholar.google.com/scholar_lookup?title=First‐trimester+screening+for+Down's+syndrome+in+in+vitro+fertilization+pregnancies&author=M+Niemimaa&author=S+Heinonen&author=M+Seppala&author=M+Hippelainen&author=H+Martikainen&author=M+Ryynanen&publication_year=2001&hl=en""]",,https://doi.org/10.1016/S0015-0282(01)02871-0, Niemimaa 2001 {published data only}  ,excluded,CD009925-bbs2-0325, No Down's pregnancies in study population. 
CD009925-bib-0341,"Niemimaa M, Suonpaa M, Heinonen S, Seppala M, Bloigu R, Ryynanen M. ",Maternal serum human chorionic gonadotrophin and pregnancy‐associated plasma protein A in twin pregnancies in the first trimester, Prenatal Diagnosis ,2002,22,    ,['citation-journal']," Niemimaa M, Suonpaa M, Heinonen S, Seppala M, Bloigu R, Ryynanen M. Maternal serum human chorionic gonadotrophin and pregnancy‐associated plasma protein A in twin pregnancies in the first trimester.  Prenatal Diagnosis 2002;22(3):183‐5.    Link to article     Google Scholar     ","['https://doi.org/10.1002/pd.286', 'https://scholar.google.com/scholar_lookup?title=Maternal+serum+human+chorionic+gonadotrophin+and+pregnancy‐associated+plasma+protein+A+in+twin+pregnancies+in+the+first+trimester+&author=M+Niemimaa&author=M+Suonpaa&author=S+Heinonen&author=M+Seppala&author=R+Bloigu&author=M+Ryynanen&publication_year=2002&hl=en']",,https://doi.org/10.1002/pd.286, Niemimaa 2002 {published data only}  ,excluded,CD009925-bbs2-0326, No Down's syndrome pregnancies in population. 
CD009925-bib-0342,"Niemimaa M, Heinonen S, Seppala M, Ryynanen M. ","The influence of smoking on the pregnancy‐associated plasma protein A, free ß human chorionic gonadotrophin and nuchal translucency", BJOG ,2003,110,    ,['citation-journal']," Niemimaa M, Heinonen S, Seppala M, Ryynanen M. The influence of smoking on the pregnancy‐associated plasma protein A, free ß human chorionic gonadotrophin and nuchal translucency.  BJOG 2003;110(7):664‐7.    Google Scholar     ","['https://scholar.google.com/scholar_lookup?title=The+influence+of+smoking+on+the+pregnancy‐associated+plasma+protein+A,+free+ß+human+chorionic+gonadotrophin+and+nuchal+translucency+&author=M+Niemimaa&author=S+Heinonen&author=M+Seppala&author=M+Ryynanen&publication_year=2003&hl=en']",,, Niemimaa 2003 {published data only}  ,excluded,CD009925-bbs2-0327, No Down's syndrome pregnancies in population. 
CD009925-bib-0343,"Noble PL, Snijders RJ, Abraha HD, Sherwood RA, Nicolaides KH. ",Maternal serum free ß‐hCG at 10 to 14 weeks of gestation in trisomic twin pregnancies, British Journal of Obstetrics & Gynaecology ,1997,104,    ,['citation-journal']," Noble PL, Snijders RJ, Abraha HD, Sherwood RA, Nicolaides KH. Maternal serum free ß‐hCG at 10 to 14 weeks of gestation in trisomic twin pregnancies.  British Journal of Obstetrics & Gynaecology 1997;104(6):741‐3.    Link to article     Google Scholar     ","['https://doi.org/10.1111/j.1471-0528.1997.tb11989.x', 'https://scholar.google.com/scholar_lookup?title=Maternal+serum+free+ß‐hCG+at+10+to+14+weeks+of+gestation+in+trisomic+twin+pregnancies&author=PL+Noble&author=RJ+Snijders&author=HD+Abraha&author=RA+Sherwood&author=KH+Nicolaides&publication_year=1997&hl=en']",,https://doi.org/10.1111/j.1471-0528.1997.tb11989.x, Noble 1997 {published data only}  ,excluded,CD009925-bbs2-0328, Unable to extract useful data. 
CD009925-bib-0344,"Norgaard Pedersen, Larsen SO, Arends J, Svenstrup B, Tabor A. ",Maternal serum markers in screening for Down syndrome, Clinical Genetics ,1990,37,    ,['citation-journal']," Norgaard Pedersen, Larsen SO, Arends J, Svenstrup B, Tabor A. Maternal serum markers in screening for Down syndrome.  Clinical Genetics 1990;37(1):35‐43.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=Maternal+serum+markers+in+screening+for+Down+syndrome&author=Pedersen+Norgaard&author=SO+Larsen&author=J+Arends&author=B+Svenstrup&author=A+Tabor&publication_year=1990&hl=en'],,, Norgaard 1990 {published data only}  ,excluded,CD009925-bbs2-0329, Less than 80% of gestational ages confirmed by USS. 
CD009925-bib-0345,"Norton ME, Golbus MS. ",Maternal serum CA 125 for aneuploidy detection in early pregnancy, Prenatal Diagnosis ,1992,12,    ,['citation-journal']," Norton ME, Golbus MS. Maternal serum CA 125 for aneuploidy detection in early pregnancy.  Prenatal Diagnosis 1992;12(9):779‐81.    Link to article     Google Scholar     ","['https://doi.org/10.1002/pd.1970120911', 'https://scholar.google.com/scholar_lookup?title=Maternal+serum+CA+125+for+aneuploidy+detection+in+early+pregnancy&author=ME+Norton&author=MS+Golbus&publication_year=1992&hl=en']",,https://doi.org/10.1002/pd.1970120911, Norton 1992 {published data only}  ,excluded,CD009925-bbs2-0330, Unable to extract useful data. 
CD009925-bib-0346,"Brien JE, Dvorin E, Yaron Y, Ayoub M, Johnson MP, Hume RF, et al. ","Differential increases in AFP, hCG, and uE3 in twin pregnancies: Impact on attempts to quantify Down syndrome screening calculations", American Journal of Medical Genetics ,1997,73,    ,['citation-journal']," Brien JE, Dvorin E, Yaron Y, Ayoub M, Johnson MP, Hume RF, et al. Differential increases in AFP, hCG, and uE3 in twin pregnancies: Impact on attempts to quantify Down syndrome screening calculations.  American Journal of Medical Genetics 1997;73(2):109‐12.    Link to article     Google Scholar     ","['https://doi.org/10.1002/(SICI)1096-8628(19971212)73:2<109::AID-AJMG1>3.0.CO;2-P', 'https://scholar.google.com/scholar_lookup?title=Differential+increases+in+AFP,+hCG,+and+uE3+in+twin+pregnancies:+Impact+on+attempts+to+quantify+Down+syndrome+screening+calculations+&author=JE+Brien&author=E+Dvorin&author=Y+Yaron&author=M+Ayoub&author=MP+Johnson&author=RF+Hume&publication_year=1997&hl=en']",,https://doi.org/10.1002/(SICI)1096-8628(19971212)73:2<109::AID-AJMG1>3.0.CO;2-P, O'Brien 1997a {published data only}  ,excluded,CD009925-bbs2-0331, No Down's syndrome pregnancies in population. 
CD009925-bib-0347,"Brien JE, Dvorin E, Drugan A, Johnson MP, Yaron Y, Evans MI. ","Race‐ethnicity‐specific variation in multiple‐marker biochemical screening: Alpha‐fetoprotein, hCG, and estriol", Obstetrics and Gynecology ,1997,89,    ,['citation-journal']," Brien JE, Dvorin E, Drugan A, Johnson MP, Yaron Y, Evans MI. Race‐ethnicity‐specific variation in multiple‐marker biochemical screening: Alpha‐fetoprotein, hCG, and estriol.  Obstetrics and Gynecology 1997;89(3):355‐8.    Google Scholar     ","['https://scholar.google.com/scholar_lookup?title=Race‐ethnicity‐specific+variation+in+multiple‐marker+biochemical+screening:+Alpha‐fetoprotein,+hCG,+and+estriol+&author=JE+Brien&author=E+Dvorin&author=A+Drugan&author=MP+Johnson&author=Y+Yaron&author=MI+Evans&publication_year=1997&hl=en']",,, O'Brien 1997b {published data only}  ,excluded,CD009925-bbs2-0332, No Down's syndrome pregnancies in population. 
CD009925-bib-0348,"Odibo AO, Sehdev HM, Dunn L, McDonald R, Macones GA. ",The association between fetal nasal bone hypoplasia and aneuploidy, Obstetrics & Gynecology ,2004,104,    ,['citation-journal']," Odibo AO, Sehdev HM, Dunn L, McDonald R, Macones GA. The association between fetal nasal bone hypoplasia and aneuploidy.  Obstetrics & Gynecology 2004;104(6):1229‐33.    Link to article     Google Scholar     ","['https://doi.org/10.1097/01.AOG.0000148848.49752.37', 'https://scholar.google.com/scholar_lookup?title=The+association+between+fetal+nasal+bone+hypoplasia+and+aneuploidy&author=AO+Odibo&author=HM+Sehdev&author=L+Dunn&author=R+McDonald&author=GA+Macones&publication_year=2004&hl=en']",,https://doi.org/10.1097/01.AOG.0000148848.49752.37, Odibo 2004 {published data only}  ,excluded,CD009925-bbs2-0333, Gestational age of greater than 14 weeks in USS population. 
CD009925-bib-0349,"Ognibene A, Ciuti R, Tozzi P, Messeri G. ",Maternal serum superoxide dismutase (SOD): a possible marker for screening Down syndrome affected pregnancies.[see comment], Prenatal Diagnosis. ,1999,19,    ,['citation-journal']," Ognibene A, Ciuti R, Tozzi P, Messeri G. Maternal serum superoxide dismutase (SOD): a possible marker for screening Down syndrome affected pregnancies.[see comment].  Prenatal Diagnosis. 1999;19(11):1058‐60.    Link to article     Google Scholar     ","['https://doi.org/10.1002/(SICI)1097-0223(199911)19:11<1058::AID-PD685>3.0.CO;2-S', 'https://scholar.google.com/scholar_lookup?title=Maternal+serum+superoxide+dismutase+(SOD):+a+possible+marker+for+screening+Down+syndrome+affected+pregnancies.[see+comment]+&author=A+Ognibene&author=R+Ciuti&author=P+Tozzi&author=G+Messeri&publication_year=1999&hl=en']",,https://doi.org/10.1002/(SICI)1097-0223(199911)19:11<1058::AID-PD685>3.0.CO;2-S, Ognibene 1999 {published data only}  ,excluded,CD009925-bbs2-0334, Unable to extract useful data. 
CD009925-bib-0350,"Olajide F, Kitau MJ, Chard T. ",Maternal serum AFP levels in the first trimester of pregnancy," European Journal of Obstetrics, Gynecology, & Reproductive Biology ",1989,30,    ,['citation-journal']," Olajide F, Kitau MJ, Chard T. Maternal serum AFP levels in the first trimester of pregnancy.  European Journal of Obstetrics, Gynecology, & Reproductive Biology 1989;30(2):123‐8.    Link to article     Google Scholar     ","['https://doi.org/10.1016/0028-2243(89)90058-0', 'https://scholar.google.com/scholar_lookup?title=Maternal+serum+AFP+levels+in+the+first+trimester+of+pregnancy&author=F+Olajide&author=MJ+Kitau&author=T+Chard&publication_year=1989&hl=en']",,https://doi.org/10.1016/0028-2243(89)90058-0, Olajide 1989 {published data only}  ,excluded,CD009925-bbs2-0335, Unable to extract useful data. 
CD009925-bib-0351,"Onda T, Kitagawa M, Takeda O, Sago H, Kubonoya K, Iinuma K, et al. ",Triple marker screening in native Japanese women, Prenatal Diagnosis ,1996,16,    ,['citation-journal']," Onda T, Kitagawa M, Takeda O, Sago H, Kubonoya K, Iinuma K, et al. Triple marker screening in native Japanese women.  Prenatal Diagnosis 1996;16(8):713‐7.    Link to article     Google Scholar     ","['https://doi.org/10.1002/(SICI)1097-0223(199608)16:8<713::AID-PD933>3.0.CO;2-X', 'https://scholar.google.com/scholar_lookup?title=Triple+marker+screening+in+native+Japanese+women&author=T+Onda&author=M+Kitagawa&author=O+Takeda&author=H+Sago&author=K+Kubonoya&author=K+Iinuma&publication_year=1996&hl=en']",,https://doi.org/10.1002/(SICI)1097-0223(199608)16:8<713::AID-PD933>3.0.CO;2-X, Onda 1996 {published data only}  ,excluded,CD009925-bbs2-0336, Unable to extract useful data 
CD009925-bib-0352,"Onda T, Tanaka T, Takeda O, Kitagawa M, Kuwabara Y, Yamamoto H, et al. ",Agreement between predicted risk and prevalence of Down syndrome in second‐trimester triple‐marker screening in Japan, Prenatal Diagnosis ,1998,18,    ,['citation-journal']," Onda T, Tanaka T, Takeda O, Kitagawa M, Kuwabara Y, Yamamoto H, et al. Agreement between predicted risk and prevalence of Down syndrome in second‐trimester triple‐marker screening in Japan.  Prenatal Diagnosis 1998;18(9):956‐8.    Link to article     Google Scholar     ","['https://doi.org/10.1002/(SICI)1097-0223(199809)18:9<956::AID-PD370>3.0.CO;2-R', 'https://scholar.google.com/scholar_lookup?title=Agreement+between+predicted+risk+and+prevalence+of+Down+syndrome+in+second‐trimester+triple‐marker+screening+in+Japan+&author=T+Onda&author=T+Tanaka&author=O+Takeda&author=M+Kitagawa&author=Y+Kuwabara&author=H+Yamamoto&publication_year=1998&hl=en']",,https://doi.org/10.1002/(SICI)1097-0223(199809)18:9<956::AID-PD370>3.0.CO;2-R, Onda 1998 {published data only}  ,excluded,CD009925-bbs2-0337, Unable to extract useful data. 
CD009925-bib-0353,"Onda T, Tanaka T, Yoshida K, Nakamura Y, Kudo R, Yamamoto H, et al. ","Triple marker screening for trisomy 21, trisomy 18 and open neural tube defects in singleton pregnancies of native Japanese pregnant women", Journal of Obstetrics & Gynaecology Research ,2000,26,    ,['citation-journal']," Onda T, Tanaka T, Yoshida K, Nakamura Y, Kudo R, Yamamoto H, et al. Triple marker screening for trisomy 21, trisomy 18 and open neural tube defects in singleton pregnancies of native Japanese pregnant women.  Journal of Obstetrics & Gynaecology Research 2000;26(6):441‐7.    Link to article     Google Scholar     ","['https://doi.org/10.1111/j.1447-0756.2000.tb01355.x', 'https://scholar.google.com/scholar_lookup?title=Triple+marker+screening+for+trisomy+21,+trisomy+18+and+open+neural+tube+defects+in+singleton+pregnancies+of+native+Japanese+pregnant+women+&author=T+Onda&author=T+Tanaka&author=K+Yoshida&author=Y+Nakamura&author=R+Kudo&author=H+Yamamoto&publication_year=2000&hl=en']",,https://doi.org/10.1111/j.1447-0756.2000.tb01355.x, Onda 2000 {published data only}  ,excluded,CD009925-bbs2-0338, Less than 80% follow‐up. 
CD009925-bib-0354,"Orlandi F, Rossi C, Allegra A, Krantz D, Hallahan T, Orlandi E, et al. ","First trimester screening with free ß‐hCG, PAPP‐A and nuchal translucency in pregnancies conceived with assisted reproduction", Prenatal Diagnosis ,2002,22,    ,['citation-journal']," Orlandi F, Rossi C, Allegra A, Krantz D, Hallahan T, Orlandi E, et al. First trimester screening with free ß‐hCG, PAPP‐A and nuchal translucency in pregnancies conceived with assisted reproduction.  Prenatal Diagnosis 2002;22(8):718‐21.    Link to article     Google Scholar     ","['https://doi.org/10.1002/pd.390', 'https://scholar.google.com/scholar_lookup?title=First+trimester+screening+with+free+ß‐hCG,+PAPP‐A+and+nuchal+translucency+in+pregnancies+conceived+with+assisted+reproduction+&author=F+Orlandi&author=C+Rossi&author=A+Allegra&author=D+Krantz&author=T+Hallahan&author=E+Orlandi&publication_year=2002&hl=en']",,https://doi.org/10.1002/pd.390, Orlandi 2002 {published data only}  ,excluded,CD009925-bbs2-0339, No Down's syndrome pregnancies in study population 
CD009925-bib-0355,"Páez L, Peña E, González F, Bello F, Bellorín J, Espinoza F, et al. ","Plasma protein ""A"" and chorionic gonadotropin at first trimester pregnancy", Informe Medico ,2004,6,    ,['citation-journal']," Páez L, Peña E, González F, Bello F, Bellorín J, Espinoza F, et al. Plasma protein ""A"" and chorionic gonadotropin at first trimester pregnancy.  Informe Medico 2004;6(2):99‐109.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=Plasma+protein+'],,, Páez 2004 {published data only}  ,excluded,CD009925-bbs2-0340, Unable to obtain translation. 
CD009925-bib-0356,"Palka G, Guanciali Franchi P, Papponetti M, Marcuccitti J, Morizio E, Calabrese G, et al. ",Prenatal diagnosis using the triple test, Minerva Ginecologica ,1998,50,    ,['citation-journal']," Palka G, Guanciali Franchi P, Papponetti M, Marcuccitti J, Morizio E, Calabrese G, et al. Prenatal diagnosis using the triple test.  Minerva Ginecologica 1998;50(10):411‐5.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=Prenatal+diagnosis+using+the+triple+test&author=G+Palka&author=P+GuancialiFranchi&author=M+Papponetti&author=J+Marcuccitti&author=E+Morizio&author=G+Calabrese&publication_year=1998&hl=en'],,, Palka 1998 {published data only}  ,excluded,CD009925-bbs2-0341, Twin data used in calculation of the median. 
CD009925-bib-0357,"Palomaki GE, Williams J, Haddow JE. ",Combining maternal serum alpha‐fetoprotein measurements and age to screen for Down syndrome in pregnant women under age 35, American Journal of Obstetrics and Gynecology ,1989,160,    ,['citation-journal']," Palomaki GE, Williams J, Haddow JE. Combining maternal serum alpha‐fetoprotein measurements and age to screen for Down syndrome in pregnant women under age 35.  American Journal of Obstetrics and Gynecology 1989;160(3):575‐81.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=Combining+maternal+serum+alpha‐fetoprotein+measurements+and+age+to+screen+for+Down+syndrome+in+pregnant+women+under+age+35+&author=GE+Palomaki&author=J+Williams&author=JE+Haddow&publication_year=1989&hl=en'],,, Palomaki 1989 {published data only}  ,excluded,CD009925-bbs2-0342, Fewer than 80% USS dated. 
CD009925-bib-0358,"Palomaki GE, Knight GJ, Haddow JE, Canick JA, Wald NJ, Kennard A. ","Cigarette smoking and levels of maternal serum alpha‐fetoprotein, unconjugated estriol, and hCG: Impact on Down syndrome screening", Obstetrics and Gynecology ,1993,81,    ,['citation-journal']," Palomaki GE, Knight GJ, Haddow JE, Canick JA, Wald NJ, Kennard A. Cigarette smoking and levels of maternal serum alpha‐fetoprotein, unconjugated estriol, and hCG: Impact on Down syndrome screening.  Obstetrics and Gynecology 1993;81(5):675‐8.    Google Scholar     ","['https://scholar.google.com/scholar_lookup?title=Cigarette+smoking+and+levels+of+maternal+serum+alpha‐fetoprotein,+unconjugated+estriol,+and+hCG:+Impact+on+Down+syndrome+screening+&author=GE+Palomaki&author=GJ+Knight&author=JE+Haddow&author=JA+Canick&author=NJ+Wald&author=A+Kennard&publication_year=1993&hl=en']",,, Palomaki 1993 {published data only}  ,excluded,CD009925-bbs2-0343, No Down's syndrome pregnancies in population. 
CD009925-bib-0359,"Palomaki GE, Knight GJ, Haddow JE. ",Human chorionic gonadotropin and unconjugated oestriol measurements in insulin‐dependent diabetic pregnant women being screened for fetal Down syndrome, Prenatal Diagnosis ,1994,14,    ,['citation-journal']," Palomaki GE, Knight GJ, Haddow JE. Human chorionic gonadotropin and unconjugated oestriol measurements in insulin‐dependent diabetic pregnant women being screened for fetal Down syndrome.  Prenatal Diagnosis 1994;14(1):65‐8.    Link to article     Google Scholar     ","['https://doi.org/10.1002/pd.1970140112', 'https://scholar.google.com/scholar_lookup?title=Human+chorionic+gonadotropin+and+unconjugated+oestriol+measurements+in+insulin‐dependent+diabetic+pregnant+women+being+screened+for+fetal+Down+syndrome+&author=GE+Palomaki&author=GJ+Knight&author=JE+Haddow&publication_year=1994&hl=en']",,https://doi.org/10.1002/pd.1970140112, Palomaki 1994 {published data only}  ,excluded,CD009925-bbs2-0344, No Down's syndrome pregnancies in population. 
CD009925-bib-0360,"Palomaki GE, Neveux LM, Haddow JE. ",Can reliable Down's syndrome detection rates be determined from prenatal screening intervention trials?, Journal of Medical Screening ,1996,3,    ,['citation-journal']," Palomaki GE, Neveux LM, Haddow JE. Can reliable Down's syndrome detection rates be determined from prenatal screening intervention trials?.  Journal of Medical Screening 1996;3(1):12‐7.    Link to article     Google Scholar     ","['https://doi.org/10.1177/096914139600300105', ""https://scholar.google.com/scholar_lookup?title=Can+reliable+Down's+syndrome+detection+rates+be+determined+from+prenatal+screening+intervention+trials?+&author=GE+Palomaki&author=LM+Neveux&author=JE+Haddow&publication_year=1996&hl=en""]",,https://doi.org/10.1177/096914139600300105, Palomaki 1996 {published data only}  ,excluded,CD009925-bbs2-0345, Meta‐analysis. 
CD009925-bib-0361,"Palomaki GE, Knight GJ, Neveux LM, Pandian R, Haddow JE. ",Maternal serum invasive trophoblast antigen and first‐trimester Down syndrome screening, Clinical Chemistry ,2005,51,    ,['citation-journal']," Palomaki GE, Knight GJ, Neveux LM, Pandian R, Haddow JE. Maternal serum invasive trophoblast antigen and first‐trimester Down syndrome screening.  Clinical Chemistry 2005;51(8):1499‐504.    Link to article     Google Scholar     ","['https://doi.org/10.1373/clinchem.2005.050567', 'https://scholar.google.com/scholar_lookup?title=Maternal+serum+invasive+trophoblast+antigen+and+first‐trimester+Down+syndrome+screening&author=GE+Palomaki&author=GJ+Knight&author=LM+Neveux&author=R+Pandian&author=JE+Haddow&publication_year=2005&hl=en']",,https://doi.org/10.1373/clinchem.2005.050567, Palomaki 2005 {published data only}  ,excluded,CD009925-bbs2-0346, Unable to extract meaningful data. 
CD009925-bib-0362,"Panburana P, Ajjimakorn S, Tungkajiwangoon P. ",First trimester Down Syndrome screening by nuchal translucency in a Thai population, International Journal of Gynaecology & Obstetrics ,2001,75,    ,['citation-journal']," Panburana P, Ajjimakorn S, Tungkajiwangoon P. First trimester Down Syndrome screening by nuchal translucency in a Thai population.  International Journal of Gynaecology & Obstetrics 2001;75(3):311‐2.    Link to article     Google Scholar     ","['https://doi.org/10.1016/S0020-7292(01)00482-9', 'https://scholar.google.com/scholar_lookup?title=First+trimester+Down+Syndrome+screening+by+nuchal+translucency+in+a+Thai+population&author=P+Panburana&author=S+Ajjimakorn&author=P+Tungkajiwangoon&publication_year=2001&hl=en']",,https://doi.org/10.1016/S0020-7292(01)00482-9, Panburana 2001 {published data only}  ,excluded,CD009925-bbs2-0347, Less than 5 Down's syndrome pregnancies in population. 
CD009925-bib-0363,"Pandya PP, Brizot ML, Kuhn P, Snijders RJ, Nicolaides KH. ",First‐trimester fetal nuchal translucency thickness and risk for trisomies, Obstetrics & Gynecology ,1994,84,    ,['citation-journal']," Pandya PP, Brizot ML, Kuhn P, Snijders RJ, Nicolaides KH. First‐trimester fetal nuchal translucency thickness and risk for trisomies.  Obstetrics & Gynecology 1994;84(3):420‐3.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=First‐trimester+fetal+nuchal+translucency+thickness+and+risk+for+trisomies&author=PP+Pandya&author=ML+Brizot&author=P+Kuhn&author=RJ+Snijders&author=KH+Nicolaides&publication_year=1994&hl=en'],,, Pandya 1994 {published data only}  ,excluded,CD009925-bbs2-0348, Study of outcomes of abnormal NT results. 
CD009925-bib-0364,"Pandya PP, Santiago C, Snijders RJM, Nicolaides KH. ",First trimester fetal nuchal translucency, Current Opinion in Obstetrics and Gynecology ,1995,7,    ,['citation-journal']," Pandya PP, Santiago C, Snijders RJM, Nicolaides KH. First trimester fetal nuchal translucency.  Current Opinion in Obstetrics and Gynecology 1995;7(2):95‐102.    Link to article     Google Scholar     ","['https://doi.org/10.1097/00001703-199504000-00004', 'https://scholar.google.com/scholar_lookup?title=First+trimester+fetal+nuchal+translucency&author=PP+Pandya&author=C+Santiago&author=RJM+Snijders&author=KH+Nicolaides&publication_year=1995&hl=en']",,https://doi.org/10.1097/00001703-199504000-00004, Pandya 1995 {published data only}  ,excluded,CD009925-bbs2-0349, Review article. 
CD009925-bib-0365,"Paul C, Krampl E, Skentou C, Jurkovic D, Nicolaides KH. ",Measurement of fetal nuchal translucency thickness by three‐dimensional ultrasound, Ultrasound in Obstetrics & Gynecology ,2001,18,    ,['citation-journal']," Paul C, Krampl E, Skentou C, Jurkovic D, Nicolaides KH. Measurement of fetal nuchal translucency thickness by three‐dimensional ultrasound.  Ultrasound in Obstetrics & Gynecology 2001;18(5):481‐4.    Link to article     Google Scholar     ","['https://doi.org/10.1046/j.0960-7692.2001.00547.x', 'https://scholar.google.com/scholar_lookup?title=Measurement+of+fetal+nuchal+translucency+thickness+by+three‐dimensional+ultrasound&author=C+Paul&author=E+Krampl&author=C+Skentou&author=D+Jurkovic&author=KH+Nicolaides&publication_year=2001&hl=en']",,https://doi.org/10.1046/j.0960-7692.2001.00547.x, Paul 2001 {published data only}  ,excluded,CD009925-bbs2-0350, Unable to extract useful data. 
CD009925-bib-0366,"Peralta CF, Falcon O, Wegrzyn P, Faro C, Nicolaides KH. ",Assessment of the gap between the fetal nasal bones at 11 to 13 + 6 weeks of gestation by three‐dimensional ultrasound, Ultrasound in Obstetrics & Gynecology ,2005,25,    ,['citation-journal']," Peralta CF, Falcon O, Wegrzyn P, Faro C, Nicolaides KH. Assessment of the gap between the fetal nasal bones at 11 to 13 + 6 weeks of gestation by three‐dimensional ultrasound.  Ultrasound in Obstetrics & Gynecology 2005;25(5):464‐7.    Link to article     Google Scholar     ","['https://doi.org/10.1002/uog.1885', 'https://scholar.google.com/scholar_lookup?title=Assessment+of+the+gap+between+the+fetal+nasal+bones+at+11+to+13+++6+weeks+of+gestation+by+three‐dimensional+ultrasound+&author=CF+Peralta&author=O+Falcon&author=P+Wegrzyn&author=C+Faro&author=KH+Nicolaides&publication_year=2005&hl=en']",,https://doi.org/10.1002/uog.1885, Peralta 2005 {published data only}  ,excluded,CD009925-bbs2-0351, Unable to extract useful data. 
CD009925-bib-0367,"Perenc M, Dudarewicz L, Kaluzewski B. ",Analysis of triple test results in 27 cases of twin pregnancies, Acta Geneticae Medicae et Gemellologiae ,1998,47,    ,['citation-journal']," Perenc M, Dudarewicz L, Kaluzewski B. Analysis of triple test results in 27 cases of twin pregnancies.  Acta Geneticae Medicae et Gemellologiae 1998;47(3‐4):249‐54.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=Analysis+of+triple+test+results+in+27+cases+of+twin+pregnancies&author=M+Perenc&author=L+Dudarewicz&author=B+Kaluzewski&publication_year=1998&hl=en'],,, Perenc 1998 {published data only}  ,excluded,CD009925-bbs2-0352, No Down's syndrome pregnancies in study population. 
CD009925-bib-0368,"Perheentupa A, Ruokonen A, Tuomivaara L, Ryynänen M, Martikainen H. ",Maternal serum (ß)‐HCG and (alpha)‐fetoprotein concentrations in singleton pregnancies following assisted reproduction, Human Reproduction ,2002,17,    ,['citation-journal']," Perheentupa A, Ruokonen A, Tuomivaara L, Ryynänen M, Martikainen H. Maternal serum (ß)‐HCG and (alpha)‐fetoprotein concentrations in singleton pregnancies following assisted reproduction.  Human Reproduction 2002;17(3):794‐7.    Link to article     Google Scholar     ","['https://doi.org/10.1093/humrep/17.3.794', 'https://scholar.google.com/scholar_lookup?title=Maternal+serum+(ß)‐HCG+and+(alpha)‐fetoprotein+concentrations+in+singleton+pregnancies+following+assisted+reproduction+&author=A+Perheentupa&author=A+Ruokonen&author=L+Tuomivaara&author=M+Ryynänen&author=H+Martikainen&publication_year=2002&hl=en']",,https://doi.org/10.1093/humrep/17.3.794, Perheentupa 2002 {published data only}  ,excluded,CD009925-bbs2-0353, No Down's syndrome pregnancies in population. 
CD009925-bib-0369,"Perona M, Mancini G, Dall'Amico D, Guaraldo V, Carbonara A. ",Influence of smoking habits on Down's syndrome risk evaluation at mid‐trimester through biochemical screening, International Journal of Clinical & Laboratory Research ,1998,28,    ,['citation-journal']," Perona M, Mancini G, Dall'Amico D, Guaraldo V, Carbonara A. Influence of smoking habits on Down's syndrome risk evaluation at mid‐trimester through biochemical screening.  International Journal of Clinical & Laboratory Research 1998;28(3):179‐82.    Link to article     Google Scholar     ","['https://doi.org/10.1007/s005990050040', ""https://scholar.google.com/scholar_lookup?title=Influence+of+smoking+habits+on+Down's+syndrome+risk+evaluation+at+mid‐trimester+through+biochemical+screening+&author=M+Perona&author=G+Mancini&author=D+Dall'Amico&author=V+Guaraldo&author=A+Carbonara&publication_year=1998&hl=en""]",,https://doi.org/10.1007/s005990050040, Perona 1998 {published data only}  ,excluded,CD009925-bbs2-0354, Smokers versus non smokers. 
CD009925-bib-0370,"Petervari L, Varga A, Tanko A, Szabo L, Godo G. ",[Significance of nuchal edema in fetuses of pregnant women under 35 years of age]. [Hungarian], Orvosi Hetilap ,2000,141,    ,['citation-journal']," Petervari L, Varga A, Tanko A, Szabo L, Godo G. [Significance of nuchal edema in fetuses of pregnant women under 35 years of age]. [Hungarian].  Orvosi Hetilap 2000;141(8):399‐402.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=[Significance+of+nuchal+edema+in+fetuses+of+pregnant+women+under+35+years+of+age].+[Hungarian]+&author=L+Petervari&author=A+Varga&author=A+Tanko&author=L+Szabo&author=G+Godo&publication_year=2000&hl=en'],,, Petervari 2000 {published data only}  ,excluded,CD009925-bbs2-0355, Unable to extract useful data. 
CD009925-bib-0371,"Petrocik E, Wassman ER, Kelly JC. ",Prenatal screening for Down syndrome with maternal serum human chorionic gonadotropin levels.[see comment], American Journal of Obstetrics & Gynecology ,1989,161,    ,['citation-journal']," Petrocik E, Wassman ER, Kelly JC. Prenatal screening for Down syndrome with maternal serum human chorionic gonadotropin levels.[see comment].  American Journal of Obstetrics & Gynecology 1989;161(5):1168‐73.    Link to article     Google Scholar     ","['https://doi.org/10.1016/0002-9378(89)90657-1', 'https://scholar.google.com/scholar_lookup?title=Prenatal+screening+for+Down+syndrome+with+maternal+serum+human+chorionic+gonadotropin+levels.[see+comment]+&author=E+Petrocik&author=ER+Wassman&author=JC+Kelly&publication_year=1989&hl=en']",,https://doi.org/10.1016/0002-9378(89)90657-1, Petrocik 1989 {published data only}  ,excluded,CD009925-bbs2-0356, Likely fewer than 80% USS dated. 
CD009925-bib-0372,"Phillips OP, Elias S, Shulman LP, Andersen RN, Morgan CD, Simpson JL. ","Maternal serum screening for fetal Down syndrome in women less than 35 years of age using alpha‐fetoprotein, hCG, and unconjugated estriol: a prospective 2‐year study", Obstetrics & Gynecology ,1992,80,    ,['citation-journal']," Phillips OP, Elias S, Shulman LP, Andersen RN, Morgan CD, Simpson JL. Maternal serum screening for fetal Down syndrome in women less than 35 years of age using alpha‐fetoprotein, hCG, and unconjugated estriol: a prospective 2‐year study.  Obstetrics & Gynecology 1992;80(3):353‐8.    Google Scholar     ","['https://scholar.google.com/scholar_lookup?title=Maternal+serum+screening+for+fetal+Down+syndrome+in+women+less+than+35+years+of+age+using+alpha‐fetoprotein,+hCG,+and+unconjugated+estriol:+a+prospective+2‐year+study+&author=OP+Phillips&author=S+Elias&author=LP+Shulman&author=RN+Andersen&author=CD+Morgan&author=JL+Simpson&publication_year=1992&hl=en']",,, Phillips 1992 {published data only}  ,excluded,CD009925-bbs2-0357, Gestational age confirmed by USS in less than 80% of population. 
CD009925-bib-0373,"Phillips OP, Shulman LP, Elias S, Simpson JL. ","Maternal serum screening for fetal Down syndrome using alpha‐ fetoprotein, human chorionic gonadotrophin, and unconjugated estriol in adolescents", Adolescent and Pediatric Gynecology ,1993,6,    ,['citation-journal']," Phillips OP, Shulman LP, Elias S, Simpson JL. Maternal serum screening for fetal Down syndrome using alpha‐ fetoprotein, human chorionic gonadotrophin, and unconjugated estriol in adolescents.  Adolescent and Pediatric Gynecology 1993;6(2):91‐4.    Link to article     Google Scholar     ","['https://doi.org/10.1016/S0932-8610(12)80224-6', 'https://scholar.google.com/scholar_lookup?title=Maternal+serum+screening+for+fetal+Down+syndrome+using+alpha‐+fetoprotein,+human+chorionic+gonadotrophin,+and+unconjugated+estriol+in+adolescents+&author=OP+Phillips&author=LP+Shulman&author=S+Elias&author=JL+Simpson&publication_year=1993&hl=en']",,https://doi.org/10.1016/S0932-8610(12)80224-6, Phillips 1993 {published data only}  ,excluded,CD009925-bbs2-0358, Gestational age confirmed by USS in less than 80% of population. 
CD009925-bib-0374,"Pinette MG, Egan JF, Wax JR, Blackstone J, Cartin A, Benn PA. ",Combined sonographic and biochemical markers for Down syndrome screening, Journal of Ultrasound in Medicine ,2003,22,    ,['citation-journal']," Pinette MG, Egan JF, Wax JR, Blackstone J, Cartin A, Benn PA. Combined sonographic and biochemical markers for Down syndrome screening.  Journal of Ultrasound in Medicine 2003;22(11):1185‐90.    Link to article     Google Scholar     ","['https://doi.org/10.7863/jum.2003.22.11.1185', 'https://scholar.google.com/scholar_lookup?title=Combined+sonographic+and+biochemical+markers+for+Down+syndrome+screening&author=MG+Pinette&author=JF+Egan&author=JR+Wax&author=J+Blackstone&author=A+Cartin&author=PA+Benn&publication_year=2003&hl=en']",,https://doi.org/10.7863/jum.2003.22.11.1185, Pinette 2003 {published data only}  ,excluded,CD009925-bbs2-0359, Women screened prior to recruitment. 
CD009925-bib-0375,"Platt LD, Greene N, Johnson A, Zachary J, Thom E, Krantz D, et al. ",Sequential pathways of testing after first‐trimester screening for trisomy 21, Obstetrics and Gynecology ,2004,104,    ,['citation-journal']," Platt LD, Greene N, Johnson A, Zachary J, Thom E, Krantz D, et al. Sequential pathways of testing after first‐trimester screening for trisomy 21.  Obstetrics and Gynecology 2004;104(4):661‐6.    Link to article     Google Scholar     ","['https://doi.org/10.1097/01.AOG.0000139832.79658.b9', 'https://scholar.google.com/scholar_lookup?title=Sequential+pathways+of+testing+after+first‐trimester+screening+for+trisomy+21&author=LD+Platt&author=N+Greene&author=A+Johnson&author=J+Zachary&author=E+Thom&author=D+Krantz&publication_year=2004&hl=en']",,https://doi.org/10.1097/01.AOG.0000139832.79658.b9, Platt 2004 {published data only}  ,excluded,CD009925-bbs2-0360, Unable to extract useful data. 
CD009925-bib-0376,"Podobnik M, Singer Z, Podobnik Sarkanji, Bulic M. ",First trimester diagnosis of cystic hygromata using transvaginal ultrasound and cytogenetic evaluation, Journal of Perinatal Medicine ,1995,23,    ,['citation-journal']," Podobnik M, Singer Z, Podobnik Sarkanji, Bulic M. First trimester diagnosis of cystic hygromata using transvaginal ultrasound and cytogenetic evaluation.  Journal of Perinatal Medicine 1995;23(4):283‐91.    Link to article     Google Scholar     ","['https://doi.org/10.1515/jpme.1995.23.4.283', 'https://scholar.google.com/scholar_lookup?title=First+trimester+diagnosis+of+cystic+hygromata+using+transvaginal+ultrasound+and+cytogenetic+evaluation+&author=M+Podobnik&author=Z+Singer&author=Sarkanji+Podobnik&author=M+Bulic&publication_year=1995&hl=en']",,https://doi.org/10.1515/jpme.1995.23.4.283, Podobnik 1995 {published data only}  ,excluded,CD009925-bbs2-0361, Abnormal results only. 
CD009925-bib-0377,"Prefumo F, Thilaganathan B. ",Agreement between predicted risk and prevalence of Down syndrome in first trimester nuchal translucency screening, Prenatal Diagnosis ,2002,22,    ,['citation-journal']," Prefumo F, Thilaganathan B. Agreement between predicted risk and prevalence of Down syndrome in first trimester nuchal translucency screening.  Prenatal Diagnosis 2002;22(10):917‐8.    Link to article     Google Scholar     ","['https://doi.org/10.1002/pd.432', 'https://scholar.google.com/scholar_lookup?title=Agreement+between+predicted+risk+and+prevalence+of+Down+syndrome+in+first+trimester+nuchal+translucency+screening+&author=F+Prefumo&author=B+Thilaganathan&publication_year=2002&hl=en']",,https://doi.org/10.1002/pd.432, Prefumo 2002 {published data only}  ,excluded,CD009925-bbs2-0362, Comparison of prevalence and predicition. 
CD009925-bib-0378,"Prefumo F, Sairam S, Bhide A, Penna L, Hollis B, Thilaganathan B. ",Maternal ethnic origin and fetal nasal bones at 11‐14 weeks of gestation, BJOG: An International Journal of Obstetrics & Gynaecology. ,2004,111,    ,['citation-journal']," Prefumo F, Sairam S, Bhide A, Penna L, Hollis B, Thilaganathan B. Maternal ethnic origin and fetal nasal bones at 11‐14 weeks of gestation.  BJOG: An International Journal of Obstetrics & Gynaecology. 2004;111(2):109‐12.    Link to article     Google Scholar     ","['https://doi.org/10.1046/j.1471-0528.2003.00025.x-i1', 'https://scholar.google.com/scholar_lookup?title=Maternal+ethnic+origin+and+fetal+nasal+bones+at+11‐14+weeks+of+gestation&author=F+Prefumo&author=S+Sairam&author=A+Bhide&author=L+Penna&author=B+Hollis&author=B+Thilaganathan&publication_year=2004&hl=en']",,https://doi.org/10.1046/j.1471-0528.2003.00025.x-i1, Prefumo 2004 {published data only}  ,excluded,CD009925-bbs2-0363, Comparison of a marker in women of different ethnic origins. 
CD009925-bib-0379,"Price KM, Van Lith JM, Silman R, Mantingh A, Grudzinskas JG. ",First trimester maternal serum concentrations of fetal antigen 2 in normal pregnancies and those affected by trisomy 21, Human Reproduction ,1998,13,    ,['citation-journal']," Price KM, Van Lith JM, Silman R, Mantingh A, Grudzinskas JG. First trimester maternal serum concentrations of fetal antigen 2 in normal pregnancies and those affected by trisomy 21.  Human Reproduction 1998;13(6):1706‐8.    Link to article     Google Scholar     ","['https://doi.org/10.1093/humrep/13.6.1706', 'https://scholar.google.com/scholar_lookup?title=First+trimester+maternal+serum+concentrations+of+fetal+antigen+2+in+normal+pregnancies+and+those+affected+by+trisomy+21+&author=KM+Price&author=JM+Lith&author=R+Silman&author=A+Mantingh&author=JG+Grudzinskas&publication_year=1998&hl=en']",,https://doi.org/10.1093/humrep/13.6.1706, Price 1998 {published data only}  ,excluded,CD009925-bbs2-0364, Unable to extract useful data. 
CD009925-bib-0380,"Raty R, Virtanen A, Koskinen P, Laitinen P, Forsstrom J, Salonen R, et al. ",Maternal midtrimester serum AFP and free ß‐hCG levels in in vitro fertilization twin pregnancies, Prenatal Diagnosis ,2000,20,    ,['citation-journal']," Raty R, Virtanen A, Koskinen P, Laitinen P, Forsstrom J, Salonen R, et al. Maternal midtrimester serum AFP and free ß‐hCG levels in in vitro fertilization twin pregnancies.  Prenatal Diagnosis 2000;20(3):221‐3.    Link to article     Google Scholar     ","['https://doi.org/10.1002/(SICI)1097-0223(200003)20:3<221::AID-PD787>3.0.CO;2-S', 'https://scholar.google.com/scholar_lookup?title=Maternal+midtrimester+serum+AFP+and+free+ß‐hCG+levels+in+in+vitro+fertilization+twin+pregnancies+&author=R+Raty&author=A+Virtanen&author=P+Koskinen&author=P+Laitinen&author=J+Forsstrom&author=R+Salonen&publication_year=2000&hl=en']",,https://doi.org/10.1002/(SICI)1097-0223(200003)20:3<221::AID-PD787>3.0.CO;2-S, Raty 2000 {published data only}  ,excluded,CD009925-bbs2-0365, No Down's syndrome pregnancies in population. 
CD009925-bib-0381,"Räty R, Virtanen A, Koskinen P, Anttila L, Forsström J, Laitinen P, et al. ","Serum free (ß)‐HCG and alpha‐fetoprotein levels in IVF, ICSI and frozen embryo transfer pregnancies in maternal mid‐trimester serum screening for Down's syndrome", Human Reproduction ,2002,17,    ,['citation-journal']," Räty R, Virtanen A, Koskinen P, Anttila L, Forsström J, Laitinen P, et al. Serum free (ß)‐HCG and alpha‐fetoprotein levels in IVF, ICSI and frozen embryo transfer pregnancies in maternal mid‐trimester serum screening for Down's syndrome.  Human Reproduction 2002;17(2):481‐4.    Link to article     Google Scholar     ","['https://doi.org/10.1093/humrep/17.2.481', ""https://scholar.google.com/scholar_lookup?title=Serum+free+(ß)‐HCG+and+alpha‐fetoprotein+levels+in+IVF,+ICSI+and+frozen+embryo+transfer+pregnancies+in+maternal+mid‐trimester+serum+screening+for+Down's+syndrome+&author=R+Räty&author=A+Virtanen&author=P+Koskinen&author=L+Anttila&author=J+Forsström&author=P+Laitinen&publication_year=2002&hl=en""]",,https://doi.org/10.1093/humrep/17.2.481, Räty 2002 {published data only}  ,excluded,CD009925-bbs2-0366, No Down's pregnancies in population. 
CD009925-bib-0382,"Rembouskos G, Cicero S, Longo D, Vandecruys H, Nicolaides KH. ",Assessment of the fetal nasal bone at 11‐14 weeks of gestation by three‐dimensional ultrasound, Ultrasound in Obstetrics & Gynecology ,2004,23,    ,['citation-journal']," Rembouskos G, Cicero S, Longo D, Vandecruys H, Nicolaides KH. Assessment of the fetal nasal bone at 11‐14 weeks of gestation by three‐dimensional ultrasound.  Ultrasound in Obstetrics & Gynecology 2004;23(3):232‐6.    Link to article     Google Scholar     ","['https://doi.org/10.1002/uog.952', 'https://scholar.google.com/scholar_lookup?title=Assessment+of+the+fetal+nasal+bone+at+11‐14+weeks+of+gestation+by+three‐dimensional+ultrasound+&author=G+Rembouskos&author=S+Cicero&author=D+Longo&author=H+Vandecruys&author=KH+Nicolaides&publication_year=2004&hl=en']",,https://doi.org/10.1002/uog.952, Rembouskos 2004 {published data only}  ,excluded,CD009925-bbs2-0367, Unable to extract useful data. 
CD009925-bib-0383,"Ren S‐G, Braunstein GD. ",Human chorionic gonadotropin, Seminars in Reproductive Endocrinology ,1992,10,    ,['citation-journal']," Ren S‐G, Braunstein GD. Human chorionic gonadotropin.  Seminars in Reproductive Endocrinology 1992;10(2):95‐105.    Link to article     Google Scholar     ","['https://doi.org/10.1055/s-2007-1018865', 'https://scholar.google.com/scholar_lookup?title=Human+chorionic+gonadotropin&author=S‐G+Ren&author=GD+Braunstein&publication_year=1992&hl=en']",,https://doi.org/10.1055/s-2007-1018865, Ren 1992 {published data only}  ,excluded,CD009925-bbs2-0368, Review article. 
CD009925-bib-0384,"Renier MA, Vereecken A, Van Herck E, Straetmans D, Ramaekers P, Buytaert P. ",Second trimester maternal dimeric inhibin‐A in the multiple‐marker screening test for Down's syndrome, Human Reproduction ,1998,13,    ,['citation-journal']," Renier MA, Vereecken A, Van Herck E, Straetmans D, Ramaekers P, Buytaert P. Second trimester maternal dimeric inhibin‐A in the multiple‐marker screening test for Down's syndrome.  Human Reproduction 1998;13(3):744‐8.    Link to article     Google Scholar     ","['https://doi.org/10.1093/humrep/13.3.744', ""https://scholar.google.com/scholar_lookup?title=Second+trimester+maternal+dimeric+inhibin‐A+in+the+multiple‐marker+screening+test+for+Down's+syndrome+&author=MA+Renier&author=A+Vereecken&author=E+Herck&author=D+Straetmans&author=P+Ramaekers&author=P+Buytaert&publication_year=1998&hl=en""]",,https://doi.org/10.1093/humrep/13.3.744, Renier 1998 {published data only}  ,excluded,CD009925-bbs2-0369, Method of ascertainment of gestational age unclear. Twin gestations included in general population.  
CD009925-bib-0385,"Resta RG, Nyberg D. ",The role of ultrasound in screening for Down syndrome, Birth Defects: Original Article Series ,1990,26,    ,['citation-journal']," Resta RG, Nyberg D. The role of ultrasound in screening for Down syndrome.  Birth Defects: Original Article Series 1990;26(3):104.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=The+role+of+ultrasound+in+screening+for+Down+syndrome&author=RG+Resta&author=D+Nyberg&publication_year=1990&hl=en'],,, Resta 1990 {published data only}  ,excluded,CD009925-bbs2-0370, Second trimester USS. 
CD009925-bib-0386,"Reynders CS, Pauker SP, Benacerraf BR. ",First trimester isolated fetal nuchal lucency: significance and outcome, Journal of Ultrasound in Medicine ,1997,16,    ,['citation-journal']," Reynders CS, Pauker SP, Benacerraf BR. First trimester isolated fetal nuchal lucency: significance and outcome.  Journal of Ultrasound in Medicine 1997;16(2):101‐5.    Link to article     Google Scholar     ","['https://doi.org/10.7863/jum.1997.16.2.101', 'https://scholar.google.com/scholar_lookup?title=First+trimester+isolated+fetal+nuchal+lucency:+significance+and+outcome&author=CS+Reynders&author=SP+Pauker&author=BR+Benacerraf&publication_year=1997&hl=en']",,https://doi.org/10.7863/jum.1997.16.2.101, Reynders 1997 {published data only}  ,excluded,CD009925-bbs2-0371, Fewer than 5 Down's cases. 
CD009925-bib-0387,"Reynolds TM, Penney MD. ",The mathematical basis of multivariate risk screening: with special reference to screening for Down's syndrome associated pregnancy, Annals of Clinical Biochemistry ,1989,27,    ,['citation-journal']," Reynolds TM, Penney MD. The mathematical basis of multivariate risk screening: with special reference to screening for Down's syndrome associated pregnancy.  Annals of Clinical Biochemistry 1989;27(5):452‐8.    Link to article     Google Scholar     ","['https://doi.org/10.1177/000456329002700506', ""https://scholar.google.com/scholar_lookup?title=The+mathematical+basis+of+multivariate+risk+screening:+with+special+reference+to+screening+for+Down's+syndrome+associated+pregnancy+&author=TM+Reynolds&author=MD+Penney&publication_year=1989&hl=en""]",,https://doi.org/10.1177/000456329002700506, Reynolds 1989 {published data only}  ,excluded,CD009925-bbs2-0372, Explanation of mathematical techniques. 
CD009925-bib-0388,"Reynolds TM, Schaeffer HJ, Schlensker S. ","Estimation of Down's syndrome risks in the first trimester of pregnancy: Experience of testing with PAPP‐A, total hCG and free ß‐ hCG levels in maternal blood samples in a German population", Clinical Laboratory ,1999,45,    ,['citation-journal']," Reynolds TM, Schaeffer HJ, Schlensker S. Estimation of Down's syndrome risks in the first trimester of pregnancy: Experience of testing with PAPP‐A, total hCG and free ß‐ hCG levels in maternal blood samples in a German population.  Clinical Laboratory 1999;45(1‐2):49‐53.    Google Scholar     ","[""https://scholar.google.com/scholar_lookup?title=Estimation+of+Down's+syndrome+risks+in+the+first+trimester+of+pregnancy:+Experience+of+testing+with+PAPP‐A,+total+hCG+and+free+ß‐+hCG+levels+in+maternal+blood+samples+in+a+German+population+&author=TM+Reynolds&author=HJ+Schaeffer&author=S+Schlensker&publication_year=1999&hl=en""]",,, Reynolds 1999 {published data only}  ,excluded,CD009925-bbs2-0373, Unable to extract useful data. 
CD009925-bib-0389,"Ribbert LS, Kornman LH, de Wolf BT, Simons AH, Jansen CA, Beekhuis JR, Mantingh A. ",Maternal serum screening for fetal Down syndrome in IVF pregnancies, Prenatal Diagnosis ,1996,16,    ,['citation-journal']," Ribbert LS, Kornman LH, de Wolf BT, Simons AH, Jansen CA, Beekhuis JR, Mantingh A. Maternal serum screening for fetal Down syndrome in IVF pregnancies.  Prenatal Diagnosis 1996;16(1):35‐8.    Link to article     Google Scholar     ","['https://doi.org/10.1002/(SICI)1097-0223(199601)16:1<35::AID-PD805>3.0.CO;2-9', 'https://scholar.google.com/scholar_lookup?title=Maternal+serum+screening+for+fetal+Down+syndrome+in+IVF+pregnancies&author=LS+Ribbert&author=LH+Kornman&author=BT+Wolf&author=AH+Simons&author=CA+Jansen&author=JR+Beekhuis&author=A+Mantingh&publication_year=1996&hl=en']",,https://doi.org/10.1002/(SICI)1097-0223(199601)16:1<35::AID-PD805>3.0.CO;2-9, Ribbert 1996 {published data only}  ,excluded,CD009925-bbs2-0374, No Down's syndrome pregnancies in study population. 
CD009925-bib-0390,"Rice JD, McIntosh SF, Halstead AC. ",Second‐trimester maternal serum screening for Down syndrome in in vitro fertilization pregnancies, Prenatal Diagnosis ,2005,25,    ,['citation-journal']," Rice JD, McIntosh SF, Halstead AC. Second‐trimester maternal serum screening for Down syndrome in in vitro fertilization pregnancies.  Prenatal Diagnosis 2005;25(3):234‐8.    Link to article     Google Scholar     ","['https://doi.org/10.1002/pd.1116', 'https://scholar.google.com/scholar_lookup?title=Second‐trimester+maternal+serum+screening+for+Down+syndrome+in+in+vitro+fertilization+pregnancies+&author=JD+Rice&author=SF+McIntosh&author=AC+Halstead&publication_year=2005&hl=en']",,https://doi.org/10.1002/pd.1116, Rice 2005 {published data only}  ,excluded,CD009925-bbs2-0375, Down's syndrome pregnancies excluded from study. 
CD009925-bib-0391,"Rich N, Boots L, Davis R, Finley S. ",Efficiency of maternal serum hCG AFP and free estriol in the identification of trisomy 21 and other complications of pregnancy, Journal of the Alabama Academy of Science ,1991,62,    ,['citation-journal']," Rich N, Boots L, Davis R, Finley S. Efficiency of maternal serum hCG AFP and free estriol in the identification of trisomy 21 and other complications of pregnancy.  Journal of the Alabama Academy of Science 1991;62(2‐3):135.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=Efficiency+of+maternal+serum+hCG+AFP+and+free+estriol+in+the+identification+of+trisomy+21+and+other+complications+of+pregnancy+&author=N+Rich&author=L+Boots&author=R+Davis&author=S+Finley&publication_year=1991&hl=en'],,, Rich 1991 {published data only}  ,excluded,CD009925-bbs2-0376, Unable to extract useful data. 
CD009925-bib-0392,"Roberts LJ, Bewley S, Mackinson AM, Rodeck CH. ",First trimester fetal nuchal translucency: problems with screening the general population. 1, British Journal of Obstetrics & Gynaecology ,1995,102,    ,['citation-journal']," Roberts LJ, Bewley S, Mackinson AM, Rodeck CH. First trimester fetal nuchal translucency: problems with screening the general population. 1.  British Journal of Obstetrics & Gynaecology 1995;102(5):381‐5.    Link to article     Google Scholar     ","['https://doi.org/10.1111/j.1471-0528.1995.tb11289.x', 'https://scholar.google.com/scholar_lookup?title=First+trimester+fetal+nuchal+translucency:+problems+with+screening+the+general+population.+1+&author=LJ+Roberts&author=S+Bewley&author=AM+Mackinson&author=CH+Rodeck&publication_year=1995&hl=en']",,https://doi.org/10.1111/j.1471-0528.1995.tb11289.x, Roberts 1995 {published data only}  ,excluded,CD009925-bbs2-0377, No Down's syndrome pregnancies in study population. 
CD009925-bib-0393,Robertson EF. ,Maternal serum screening for neural tube defects and Down's syndrome.[see comment], Medical Journal of Australia ,1991,155,    ,['citation-journal'], Robertson EF. Maternal serum screening for neural tube defects and Down's syndrome.[see comment].  Medical Journal of Australia 1991;155(2):67‐8.    Link to article     Google Scholar     ,"['https://doi.org/10.5694/j.1326-5377.1991.tb142124.x', ""https://scholar.google.com/scholar_lookup?title=Maternal+serum+screening+for+neural+tube+defects+and+Down's+syndrome.[see+comment]&author=EF+Robertson&publication_year=1991&hl=en""]",,https://doi.org/10.5694/j.1326-5377.1991.tb142124.x, Robertson 1991 {published data only}  ,excluded,CD009925-bbs2-0378, Editorial. 
CD009925-bib-0394,"Rode L, Wojdemann KR, Shalmi AC, Larsen SO, Sundberg K, Norgaard‐Pedersen B, et al. ",Combined first‐ and second‐trimester screening for Down syndrome: an evaluation of proMBP as a marker, Prenatal Diagnosis ,2003,23,    ,['citation-journal']," Rode L, Wojdemann KR, Shalmi AC, Larsen SO, Sundberg K, Norgaard‐Pedersen B, et al. Combined first‐ and second‐trimester screening for Down syndrome: an evaluation of proMBP as a marker.  Prenatal Diagnosis 2003;23(7):593‐8.    Link to article     Google Scholar     ","['https://doi.org/10.1002/pd.648', 'https://scholar.google.com/scholar_lookup?title=Combined+first‐+and+second‐trimester+screening+for+Down+syndrome:+an+evaluation+of+proMBP+as+a+marker+&author=L+Rode&author=KR+Wojdemann&author=AC+Shalmi&author=SO+Larsen&author=K+Sundberg&author=B+Norgaard‐Pedersen&publication_year=2003&hl=en']",,https://doi.org/10.1002/pd.648, Rode 2003 {published data only}  ,excluded,CD009925-bbs2-0379, No Down's pregnancies. 
CD009925-bib-0395,Ronge R. ,Combined first trimester screening for Down's syndrome is superior to quadruple test, Geburtshilfe und Frauenheilkunde ,2006,66,    ,['citation-journal'], Ronge R. Combined first trimester screening for Down's syndrome is superior to quadruple test.  Geburtshilfe und Frauenheilkunde 2006;66(4):332.    Google Scholar     ,"[""https://scholar.google.com/scholar_lookup?title=Combined+first+trimester+screening+for+Down's+syndrome+is+superior+to+quadruple+test&author=R+Ronge&publication_year=2006&hl=en""]",,, Ronge 2006 {published data only}  ,excluded,CD009925-bbs2-0380, Editorial ‐ summary of FASTER results. 
CD009925-bib-0396,"Rose NC, Mennuti MT. ",Multiple marker screening for women 35 and older, Contemporary OB/GYN ,1995,40,    ,['citation-journal']," Rose NC, Mennuti MT. Multiple marker screening for women 35 and older.  Contemporary OB/GYN 1995;40(9):55‐6.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=Multiple+marker+screening+for+women+35+and+older&author=NC+Rose&author=MT+Mennuti&publication_year=1995&hl=en'],,, Rose 1995 {published data only}  ,excluded,CD009925-bbs2-0381, Review article. 
CD009925-bib-0397,"Ross HL, Elias S. ",Maternal serum screening for fetal genetic disorders, Obstetrics & Gynecology Clinics of North America ,1997,24,    ,['citation-journal']," Ross HL, Elias S. Maternal serum screening for fetal genetic disorders.  Obstetrics & Gynecology Clinics of North America 1997;24(1):33‐47.    Link to article     Google Scholar     ","['https://doi.org/10.1016/S0889-8545(05)70288-6', 'https://scholar.google.com/scholar_lookup?title=Maternal+serum+screening+for+fetal+genetic+disorders&author=HL+Ross&author=S+Elias&publication_year=1997&hl=en']",,https://doi.org/10.1016/S0889-8545(05)70288-6, Ross 1997 {published data only}  ,excluded,CD009925-bbs2-0382, Review article. 
CD009925-bib-0398,"Rotmensch S, Liberati M, Kardana A, Copel JA, Ben‐Rafael Z, Cole LA. ",Nicked free ß‐subunit of human chorionic gonadotropin: A potential new marker for Down syndrome screening, American Journal of Obstetrics and Gynecology ,1996,174,    ,['citation-journal']," Rotmensch S, Liberati M, Kardana A, Copel JA, Ben‐Rafael Z, Cole LA. Nicked free ß‐subunit of human chorionic gonadotropin: A potential new marker for Down syndrome screening.  American Journal of Obstetrics and Gynecology 1996;174(2):609‐11.    Link to article     Google Scholar     ","['https://doi.org/10.1016/S0002-9378(96)70435-0', 'https://scholar.google.com/scholar_lookup?title=Nicked+free+ß‐subunit+of+human+chorionic+gonadotropin:+A+potential+new+marker+for+Down+syndrome+screening+&author=S+Rotmensch&author=M+Liberati&author=A+Kardana&author=JA+Copel&author=Z+Ben‐Rafael&author=LA+Cole&publication_year=1996&hl=en']",,https://doi.org/10.1016/S0002-9378(96)70435-0, Rotmensch 1996 {published data only}  ,excluded,CD009925-bbs2-0383, Unable to extract useful data. 
CD009925-bib-0399,"Rotmensch S, Celentano C, Shalev J, Vishne TH, Lipitz S, Ben‐Rafael Z, et al. ",Midtrimester maternal serum screening after multifetal pregnancy reduction in pregnancies conceived by in vitro fertilization, Journal of Assisted Reproduction and Genetics ,1999,16,    ,['citation-journal']," Rotmensch S, Celentano C, Shalev J, Vishne TH, Lipitz S, Ben‐Rafael Z, et al. Midtrimester maternal serum screening after multifetal pregnancy reduction in pregnancies conceived by in vitro fertilization.  Journal of Assisted Reproduction and Genetics 1999;16(1):8‐12.    Link to article     Google Scholar     ","['https://doi.org/10.1023/A:1022585326896', 'https://scholar.google.com/scholar_lookup?title=Midtrimester+maternal+serum+screening+after+multifetal+pregnancy+reduction+in+pregnancies+conceived+by+in+vitro+fertilization+&author=S+Rotmensch&author=C+Celentano&author=J+Shalev&author=TH+Vishne&author=S+Lipitz&author=Z+Ben‐Rafael&publication_year=1999&hl=en']",,https://doi.org/10.1023/A:1022585326896, Rotmensch 1999 {published data only}  ,excluded,CD009925-bbs2-0384, No Down's syndrome pregnancies in study population. 
CD009925-bib-0400,"Rozenberg P, Bussieres L, Chevret S, Bernard JP, Malagrida L, Cuckle H, et al. ",Screening for Down syndrome using first‐trimester combined screening followed by second‐trimester ultrasound examination in an unselected population, American Journal of Obstetrics & Gynecology ,2006,195,    ,['citation-journal']," Rozenberg P, Bussieres L, Chevret S, Bernard JP, Malagrida L, Cuckle H, et al. Screening for Down syndrome using first‐trimester combined screening followed by second‐trimester ultrasound examination in an unselected population.  American Journal of Obstetrics & Gynecology 2006;195(5):1379‐87.    Link to article     Google Scholar     ","['https://doi.org/10.1016/j.ajog.2006.02.046', 'https://scholar.google.com/scholar_lookup?title=Screening+for+Down+syndrome+using+first‐trimester+combined+screening+followed+by+second‐trimester+ultrasound+examination+in+an+unselected+population+&author=P+Rozenberg&author=L+Bussieres&author=S+Chevret&author=JP+Bernard&author=L+Malagrida&author=H+Cuckle&publication_year=2006&hl=en']",,https://doi.org/10.1016/j.ajog.2006.02.046, Rozenberg 2006 {published data only}  ,excluded,CD009925-bbs2-0385, USS greater than 14 weeks gestation. 
CD009925-bib-0401,"Rudnicka AR, Wald NJ, Huttly W, Hackshaw AK. ",Influence of maternal smoking on the birth prevalence of Down syndrome and on second trimester screening performance, Prenatal Diagnosis ,2002,22,    ,['citation-journal']," Rudnicka AR, Wald NJ, Huttly W, Hackshaw AK. Influence of maternal smoking on the birth prevalence of Down syndrome and on second trimester screening performance.  Prenatal Diagnosis 2002;22(10):893‐7.    Link to article     Google Scholar     ","['https://doi.org/10.1002/pd.440', 'https://scholar.google.com/scholar_lookup?title=Influence+of+maternal+smoking+on+the+birth+prevalence+of+Down+syndrome+and+on+second+trimester+screening+performance+&author=AR+Rudnicka&author=NJ+Wald&author=W+Huttly&author=AK+Hackshaw&publication_year=2002&hl=en']",,https://doi.org/10.1002/pd.440, Rudnicka 2002 {published data only}  ,excluded,CD009925-bbs2-0386, No Down's syndrome pregnancies in population. 
CD009925-bib-0402,"Ryall RG, Staples AJ, Robertson EF, Pollard AC. ",Improved performance in a prenatal screening programme for Down's syndrome incorporating serum‐free hCG subunit analyses, Prenatal Diagnosis ,1992,12,    ,['citation-journal']," Ryall RG, Staples AJ, Robertson EF, Pollard AC. Improved performance in a prenatal screening programme for Down's syndrome incorporating serum‐free hCG subunit analyses.  Prenatal Diagnosis 1992;12(4):251‐61.    Link to article     Google Scholar     ","['https://doi.org/10.1002/pd.1970120404', ""https://scholar.google.com/scholar_lookup?title=Improved+performance+in+a+prenatal+screening+programme+for+Down's+syndrome+incorporating+serum‐free+hCG+subunit+analyses+&author=RG+Ryall&author=AJ+Staples&author=EF+Robertson&author=AC+Pollard&publication_year=1992&hl=en""]",,https://doi.org/10.1002/pd.1970120404, Ryall 1992 {published data only}  ,excluded,CD009925-bbs2-0387, Unable to determine method of confirmation of gestational age. 
CD009925-bib-0403,"Ryall RG, Callen D, Cocciolone R, Duvnjak A, Esca R, Frantzis N, et al. ",Karyotypes found in the population declared at increased risk of Down syndrome following maternal serum screening, Prenatal Diagnosis ,2001,21,    ,['citation-journal']," Ryall RG, Callen D, Cocciolone R, Duvnjak A, Esca R, Frantzis N, et al. Karyotypes found in the population declared at increased risk of Down syndrome following maternal serum screening.  Prenatal Diagnosis 2001;21(7):553‐7.    Link to article     Google Scholar     ","['https://doi.org/10.1002/pd.108', 'https://scholar.google.com/scholar_lookup?title=Karyotypes+found+in+the+population+declared+at+increased+risk+of+Down+syndrome+following+maternal+serum+screening+&author=RG+Ryall&author=D+Callen&author=R+Cocciolone&author=A+Duvnjak&author=R+Esca&author=N+Frantzis&publication_year=2001&hl=en']",,https://doi.org/10.1002/pd.108, Ryall 2001 {published data only}  ,excluded,CD009925-bbs2-0388, High‐risk results only included (i.e. no screen negative group for comparison). 
CD009925-bib-0404,"Sabriá J, Cabrero D, Bach C. ",Aneuploidy screening: Ultrasound versus biochemistry, Ultrasound Review of Obstetrics and Gynecology ,2002,2,    ,['citation-journal']," Sabriá J, Cabrero D, Bach C. Aneuploidy screening: Ultrasound versus biochemistry.  Ultrasound Review of Obstetrics and Gynecology 2002;2(4):221‐8.    Link to article     Google Scholar     ","['https://doi.org/10.3109/14722240208500490', 'https://scholar.google.com/scholar_lookup?title=Aneuploidy+screening:+Ultrasound+versus+biochemistry&author=J+Sabriá&author=D+Cabrero&author=C+Bach&publication_year=2002&hl=en']",,https://doi.org/10.3109/14722240208500490, Sabriá 2002 {published data only}  ,excluded,CD009925-bbs2-0389, Unable to ascertain hjow numbers calculated and from which populations. 
CD009925-bib-0405,"Sacchini C, El‐Sheikhah A, Cicero S, Rembouskos G, Nicolaides KH. ",Ear length in trisomy 21 fetuses at 11‐14 weeks of gestation, Ultrasound in Obstetrics & Gynecology ,2003,22,    ,['citation-journal']," Sacchini C, El‐Sheikhah A, Cicero S, Rembouskos G, Nicolaides KH. Ear length in trisomy 21 fetuses at 11‐14 weeks of gestation.  Ultrasound in Obstetrics & Gynecology 2003;22(5):460‐3.    Link to article     Google Scholar     ","['https://doi.org/10.1002/uog.903', 'https://scholar.google.com/scholar_lookup?title=Ear+length+in+trisomy+21+fetuses+at+11‐14+weeks+of+gestation&author=C+Sacchini&author=A+El‐Sheikhah&author=S+Cicero&author=G+Rembouskos&author=KH+Nicolaides&publication_year=2003&hl=en']",,https://doi.org/10.1002/uog.903, Sacchini 2003 {published data only}  ,excluded,CD009925-bbs2-0390, Unable to extract useful data. 
CD009925-bib-0406,"Saller DN, Canick JA, Kellner LH, Rose NC, Garza J, French CA, et al. ",Maternal serum analyte levels in pregnancies with fetal Down syndrome resulting from translocations, American Journal of Obstetrics & Gynecology ,1997,177,    ,['citation-journal']," Saller DN, Canick JA, Kellner LH, Rose NC, Garza J, French CA, et al. Maternal serum analyte levels in pregnancies with fetal Down syndrome resulting from translocations.  American Journal of Obstetrics & Gynecology 1997;177(4):879‐81.    Link to article     Google Scholar     ","['https://doi.org/10.1016/S0002-9378(97)70287-4', 'https://scholar.google.com/scholar_lookup?title=Maternal+serum+analyte+levels+in+pregnancies+with+fetal+Down+syndrome+resulting+from+translocations+&author=DN+Saller&author=JA+Canick&author=LH+Kellner&author=NC+Rose&author=J+Garza&author=CA+French&publication_year=1997&hl=en']",,https://doi.org/10.1016/S0002-9378(97)70287-4, Saller 1997 {published data only}  ,excluded,CD009925-bbs2-0391, Down's syndrome secondary to Robertsonian translocation only. No controls. 
CD009925-bib-0407,"Salomon LJ, Bernard JP, Taupin P, Benard C, Ville Y. ",Relationship between nuchal translucency at 11‐14 weeks and nuchal fold at 20‐24 weeks of gestation, Ultrasound in Obstetrics & Gynecology ,2001,18,    ,['citation-journal']," Salomon LJ, Bernard JP, Taupin P, Benard C, Ville Y. Relationship between nuchal translucency at 11‐14 weeks and nuchal fold at 20‐24 weeks of gestation.  Ultrasound in Obstetrics & Gynecology 2001;18(6):636‐7.    Link to article     Google Scholar     ","['https://doi.org/10.1046/j.0960-7692.2001.00582.x', 'https://scholar.google.com/scholar_lookup?title=Relationship+between+nuchal+translucency+at+11‐14+weeks+and+nuchal+fold+at+20‐24+weeks+of+gestation+&author=LJ+Salomon&author=JP+Bernard&author=P+Taupin&author=C+Benard&author=Y+Ville&publication_year=2001&hl=en']",,https://doi.org/10.1046/j.0960-7692.2001.00582.x, Salomon 2001 {published data only}  ,excluded,CD009925-bbs2-0392, No Down's syndrome pregnancies in population. 
CD009925-bib-0408,"Salonen R, Turpeinen U, Kurki L, Lappalainen M, Ammala P, Hiilesmaa V, et al. ",Maternal serum screening for Down's syndrome on population basis, Acta Obstetricia et Gynecologica Scandinavica ,1997,76,    ,['citation-journal']," Salonen R, Turpeinen U, Kurki L, Lappalainen M, Ammala P, Hiilesmaa V, et al. Maternal serum screening for Down's syndrome on population basis.  Acta Obstetricia et Gynecologica Scandinavica 1997;76(9):817‐21.    Link to article     Google Scholar     ","['https://doi.org/10.3109/00016349709024358', ""https://scholar.google.com/scholar_lookup?title=Maternal+serum+screening+for+Down's+syndrome+on+population+basis&author=R+Salonen&author=U+Turpeinen&author=L+Kurki&author=M+Lappalainen&author=P+Ammala&author=V+Hiilesmaa&publication_year=1997&hl=en""]",,https://doi.org/10.3109/00016349709024358, Salonen 1997 {published data only}  ,excluded,CD009925-bbs2-0393, Fewer than 80% had gestational age estimated by USS. 
CD009925-bib-0409,"Saltvedt S, Almstrom H, Kublickas M, Valentin L, Bottinga R, Bui TH, et al. ","Screening for Down syndrome based on maternal age or fetal nuchal translucency: a randomized controlled trial in 39,572 pregnancies", Ultrasound in Obstetrics & Gynecology ,2005,25,    ,['citation-journal']," Saltvedt S, Almstrom H, Kublickas M, Valentin L, Bottinga R, Bui TH, et al. Screening for Down syndrome based on maternal age or fetal nuchal translucency: a randomized controlled trial in 39,572 pregnancies.  Ultrasound in Obstetrics & Gynecology 2005;25(6):537‐45.    Link to article     Google Scholar     ","['https://doi.org/10.1002/uog.1917', 'https://scholar.google.com/scholar_lookup?title=Screening+for+Down+syndrome+based+on+maternal+age+or+fetal+nuchal+translucency:+a+randomized+controlled+trial+in+39,572+pregnancies+&author=S+Saltvedt&author=H+Almstrom&author=M+Kublickas&author=L+Valentin&author=R+Bottinga&author=TH+Bui&publication_year=2005&hl=en']",,https://doi.org/10.1002/uog.1917, Saltvedt 2005 {published data only}  ,excluded,CD009925-bbs2-0394, Gestation greater than 14 weeks for nuchal scanning. 
CD009925-bib-0410,"Saridogan E, Djahanbakhch O, Naftalin AA. ",Screening for Down's syndrome: experience in an inner city health district, British Journal of Obstetrics & Gynaecology ,1996,103,    ,['citation-journal']," Saridogan E, Djahanbakhch O, Naftalin AA. Screening for Down's syndrome: experience in an inner city health district.  British Journal of Obstetrics & Gynaecology 1996;103(12):1205‐11.    Link to article     Google Scholar     ","['https://doi.org/10.1111/j.1471-0528.1996.tb09630.x', ""https://scholar.google.com/scholar_lookup?title=Screening+for+Down's+syndrome:+experience+in+an+inner+city+health+district&author=E+Saridogan&author=O+Djahanbakhch&author=AA+Naftalin&publication_year=1996&hl=en""]",,https://doi.org/10.1111/j.1471-0528.1996.tb09630.x, Saridogan 1996 {published data only}  ,excluded,CD009925-bbs2-0395, Down's syndrome and Edward's syndrome affected pregnancies only. 
CD009925-bib-0411,"Savoldelli G, Binkert F, Achermann J, Schmid W. ",Ultrasound screening for chromosomal anomalies in the first trimester of pregnancy, Prenatal Diagnosis ,1993,13,    ,['citation-journal']," Savoldelli G, Binkert F, Achermann J, Schmid W. Ultrasound screening for chromosomal anomalies in the first trimester of pregnancy.  Prenatal Diagnosis 1993;13(6):513‐8.    Link to article     Google Scholar     ","['https://doi.org/10.1002/pd.1970130613', 'https://scholar.google.com/scholar_lookup?title=Ultrasound+screening+for+chromosomal+anomalies+in+the+first+trimester+of+pregnancy&author=G+Savoldelli&author=F+Binkert&author=J+Achermann&author=W+Schmid&publication_year=1993&hl=en']",,https://doi.org/10.1002/pd.1970130613, Savoldelli 1993 {published data only}  ,excluded,CD009925-bbs2-0396, Unable to extract useful data. 
CD009925-bib-0412,"Schiott KM, Christiansen M, Petersen OB, Sorensen TL, Uldbjerg N. ","The ""Consecutive Combined Test""‐‐using double test from week 8 + 0 and nuchal translucency scan, for first trimester screening for Down syndrome", Prenatal Diagnosis ,2006,26,    ,['citation-journal']," Schiott KM, Christiansen M, Petersen OB, Sorensen TL, Uldbjerg N. The ""Consecutive Combined Test""‐‐using double test from week 8 + 0 and nuchal translucency scan, for first trimester screening for Down syndrome.  Prenatal Diagnosis 2006;26(12):1105‐9.    Link to article     Google Scholar     ","['https://doi.org/10.1002/pd.1487', 'https://scholar.google.com/scholar_lookup?title=The+']",,https://doi.org/10.1002/pd.1487, Schiott 2006 {published data only}  ,excluded,CD009925-bbs2-0397, Unable to extract useful data. 
CD009925-bib-0413,"Schuchter K, Wald N, Hackshaw AK, Hafner E, Liebhart E. ",The distribution of nuchal translucency at 10‐13 weeks of pregnancy, Prenatal Diagnosi ,1998,18,    ,['citation-journal']," Schuchter K, Wald N, Hackshaw AK, Hafner E, Liebhart E. The distribution of nuchal translucency at 10‐13 weeks of pregnancy.  Prenatal Diagnosi 1998;18(3):281‐6.    Link to article     Google Scholar     ","['https://doi.org/10.1002/(SICI)1097-0223(199803)18:3<281::AID-PD306>3.0.CO;2-6', 'https://scholar.google.com/scholar_lookup?title=The+distribution+of+nuchal+translucency+at+10‐13+weeks+of+pregnancy&author=K+Schuchter&author=N+Wald&author=AK+Hackshaw&author=E+Hafner&author=E+Liebhart&publication_year=1998&hl=en']",,https://doi.org/10.1002/(SICI)1097-0223(199803)18:3<281::AID-PD306>3.0.CO;2-6, Schuchter 1998 {published data only}  ,excluded,CD009925-bbs2-0398, No Down's pregnancies in study population. 
CD009925-bib-0414,"Scott F, Boogert A, Smart S, Anderson J. ",Maternal serum screening and routine 18‐week ultrasound in the detection of all chromosomal abnormalities, Australian & New Zealand Journal of Obstetrics & Gynaecology ,1995,35,    ,['citation-journal']," Scott F, Boogert A, Smart S, Anderson J. Maternal serum screening and routine 18‐week ultrasound in the detection of all chromosomal abnormalities.  Australian & New Zealand Journal of Obstetrics & Gynaecology 1995;35(2):165‐8.    Link to article     Google Scholar     ","['https://doi.org/10.1111/j.1479-828X.1995.tb01860.x', 'https://scholar.google.com/scholar_lookup?title=Maternal+serum+screening+and+routine+18‐week+ultrasound+in+the+detection+of+all+chromosomal+abnormalities+&author=F+Scott&author=A+Boogert&author=S+Smart&author=J+Anderson&publication_year=1995&hl=en']",,https://doi.org/10.1111/j.1479-828X.1995.tb01860.x, Scott 1995 {published data only}  ,excluded,CD009925-bbs2-0399, Less than 5 Down's syndrome pregnancies in study population. 
CD009925-bib-0415,"Seeds JW, Watson WJ. ",Ultrasound and maternal serum alpha‐fetoprotein screening: A complementary relationship, Ultrasound Quarterly ,1990,8,    ,['citation-journal']," Seeds JW, Watson WJ. Ultrasound and maternal serum alpha‐fetoprotein screening: A complementary relationship.  Ultrasound Quarterly 1990;8(2):145‐66.    Link to article     Google Scholar     ","['https://doi.org/10.1097/00013644-199000820-00003', 'https://scholar.google.com/scholar_lookup?title=Ultrasound+and+maternal+serum+alpha‐fetoprotein+screening:+A+complementary+relationship&author=JW+Seeds&author=WJ+Watson&publication_year=1990&hl=en']",,https://doi.org/10.1097/00013644-199000820-00003, Seeds 1990 {published data only}  ,excluded,CD009925-bbs2-0400, Review article. 
CD009925-bib-0416,"Seki K, Mitsui C, Nagata I. ",Measurement of urinary free ß‐human chorionic gonadotropin by immunoradiometric assay, Gynecologic and Obstetric Investigation ,1995,40,    ,['citation-journal']," Seki K, Mitsui C, Nagata I. Measurement of urinary free ß‐human chorionic gonadotropin by immunoradiometric assay.  Gynecologic and Obstetric Investigation 1995;40(3):162‐7.    Link to article     Google Scholar     ","['https://doi.org/10.1159/000292328', 'https://scholar.google.com/scholar_lookup?title=Measurement+of+urinary+free+ß‐human+chorionic+gonadotropin+by+immunoradiometric+assay&author=K+Seki&author=C+Mitsui&author=I+Nagata&publication_year=1995&hl=en']",,https://doi.org/10.1159/000292328, Seki 1995 {published data only}  ,excluded,CD009925-bbs2-0401, No Down's syndrome pregnancies in study population. 
CD009925-bib-0417,"Shenhav S, Gemer O, Sherman DJ, Peled R, Segal S. ",Midtrimester triple‐test levels in women with chronic hypertension and altered renal function, Prenatal Diagnosis ,2003,23,    ,['citation-journal']," Shenhav S, Gemer O, Sherman DJ, Peled R, Segal S. Midtrimester triple‐test levels in women with chronic hypertension and altered renal function.  Prenatal Diagnosis 2003;23(2):166‐7.    Link to article     Google Scholar     ","['https://doi.org/10.1002/pd.564', 'https://scholar.google.com/scholar_lookup?title=Midtrimester+triple‐test+levels+in+women+with+chronic+hypertension+and+altered+renal+function+&author=S+Shenhav&author=O+Gemer&author=DJ+Sherman&author=R+Peled&author=S+Segal&publication_year=2003&hl=en']",,https://doi.org/10.1002/pd.564, Shenhav 2003 {published data only}  ,excluded,CD009925-bbs2-0402, No Down's syndrome pregnancies. 
CD009925-bib-0418,"Shintaku Y, Takabayashi T, Sasaki H, Ozawa N, Shinkawa O, Hamazaki Y, et al. ",[Screening for chromosomal anomalies with maternal serum alpha‐fetoprotein]. [Japanese], Nippon Sanka Fujinka Gakkai Zasshi ‐ Acta Obstetrica et Gynaecologica Japonica ,1989,41,    ,['citation-journal']," Shintaku Y, Takabayashi T, Sasaki H, Ozawa N, Shinkawa O, Hamazaki Y, et al. [Screening for chromosomal anomalies with maternal serum alpha‐fetoprotein]. [Japanese].  Nippon Sanka Fujinka Gakkai Zasshi ‐ Acta Obstetrica et Gynaecologica Japonica 1989;41(2):185‐90.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=[Screening+for+chromosomal+anomalies+with+maternal+serum+alpha‐fetoprotein].+[Japanese]&author=Y+Shintaku&author=T+Takabayashi&author=H+Sasaki&author=N+Ozawa&author=O+Shinkawa&author=Y+Hamazaki&publication_year=1989&hl=en'],,, Shintaku 1989 {published data only}  ,excluded,CD009925-bbs2-0403, Unable to extract useful data. 
CD009925-bib-0419,"Shulman A, Maymon R. ",Mid‐gestation Down syndrome screening test and pregnancy outcome among unstimulated assisted‐conception pregnancies, Prenatal Diagnosis ,2003,23,    ,['citation-journal']," Shulman A, Maymon R. Mid‐gestation Down syndrome screening test and pregnancy outcome among unstimulated assisted‐conception pregnancies.  Prenatal Diagnosis 2003;23(8):625‐8.    Link to article     Google Scholar     ","['https://doi.org/10.1002/pd.650', 'https://scholar.google.com/scholar_lookup?title=Mid‐gestation+Down+syndrome+screening+test+and+pregnancy+outcome+among+unstimulated+assisted‐conception+pregnancies+&author=A+Shulman&author=R+Maymon&publication_year=2003&hl=en']",,https://doi.org/10.1002/pd.650, Shulman 2003 {published data only}  ,excluded,CD009925-bbs2-0404, No Down's syndrome pregnancies in population. 
CD009925-bib-0420,Simon‐Bouy B. ,[Markers for trisomy 21][French], Fertilite Contraception Sexualite ,1999,27,    ,['citation-journal'], Simon‐Bouy B. [Markers for trisomy 21][French].  Fertilite Contraception Sexualite 1999;27(9):289‐91.    Google Scholar     ,['https://scholar.google.com/scholar_lookup?title=[Markers+for+trisomy+21][French]&author=B+Simon‐Bouy&publication_year=1999&hl=en'],,, Simon‐Bouy 1999 {published data only}  ,excluded,CD009925-bbs2-0405, Review article. 
CD009925-bib-0421,"Simpson JL, Baum LD, Marder R, Elias S, Ober C, Martin AO. ",Maternal serum alpha‐fetoprotein screening: low and high values for detection of genetic abnormalities, American Journal of Obstetrics & Gynecology ,1986,155,    ,['citation-journal']," Simpson JL, Baum LD, Marder R, Elias S, Ober C, Martin AO. Maternal serum alpha‐fetoprotein screening: low and high values for detection of genetic abnormalities.  American Journal of Obstetrics & Gynecology 1986;155(3):593‐7.    Link to article     Google Scholar     ","['https://doi.org/10.1016/0002-9378(86)90285-1', 'https://scholar.google.com/scholar_lookup?title=Maternal+serum+alpha‐fetoprotein+screening:+low+and+high+values+for+detection+of+genetic+abnormalities+&author=JL+Simpson&author=LD+Baum&author=R+Marder&author=S+Elias&author=C+Ober&author=AO+Martin&publication_year=1986&hl=en']",,https://doi.org/10.1016/0002-9378(86)90285-1, Simpson 1986 {published data only}  ,excluded,CD009925-bbs2-0406, Gestational age confirmed by USS in less than 80% of population. 
CD009925-bib-0422,"Smith C, Grube GL, Wilson S. ",Maternal serum alpha‐fetoprotein screening and the role of ultrasound, Journal of Diagnostic Medical Sonography ,1990,6,    ,['citation-journal']," Smith C, Grube GL, Wilson S. Maternal serum alpha‐fetoprotein screening and the role of ultrasound.  Journal of Diagnostic Medical Sonography 1990;6(6):312‐6.    Link to article     Google Scholar     ","['https://doi.org/10.1177/875647939000600602', 'https://scholar.google.com/scholar_lookup?title=Maternal+serum+alpha‐fetoprotein+screening+and+the+role+of+ultrasound&author=C+Smith&author=GL+Grube&author=S+Wilson&publication_year=1990&hl=en']",,https://doi.org/10.1177/875647939000600602, Smith 1990 {published data only}  ,excluded,CD009925-bbs2-0407, Analysis of screen positive results. 
CD009925-bib-0423,"Smith ER, Petersen J, Okorodudu AO, Bissell MG. ",Does the addition of unconjugated estriol in maternal serum screening improve the detection of trisomy 21? A meta‐analysis, Clinical Laboratory Management Review ,1996,10,    ,['citation-journal']," Smith ER, Petersen J, Okorodudu AO, Bissell MG. Does the addition of unconjugated estriol in maternal serum screening improve the detection of trisomy 21? A meta‐analysis.  Clinical Laboratory Management Review 1996;10(2):176‐81.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=Does+the+addition+of+unconjugated+estriol+in+maternal+serum+screening+improve+the+detection+of+trisomy+21?+A+meta‐analysis+&author=ER+Smith&author=J+Petersen&author=AO+Okorodudu&author=MG+Bissell&publication_year=1996&hl=en'],,, Smith 1996 {published data only}  ,excluded,CD009925-bbs2-0408, Review/meta‐analysis. 
CD009925-bib-0424,"Smith NC, Hau C. ",A six year study of the antenatal detection of fetal abnormality in six Scottish health boards, British Journal of Obstetrics & Gynaecology ,1999,106,    ,['citation-journal']," Smith NC, Hau C. A six year study of the antenatal detection of fetal abnormality in six Scottish health boards.  British Journal of Obstetrics & Gynaecology 1999;106(3):206‐12.    Link to article     Google Scholar     ","['https://doi.org/10.1111/j.1471-0528.1999.tb08232.x', 'https://scholar.google.com/scholar_lookup?title=A+six+year+study+of+the+antenatal+detection+of+fetal+abnormality+in+six+Scottish+health+boards+&author=NC+Smith&author=C+Hau&publication_year=1999&hl=en']",,https://doi.org/10.1111/j.1471-0528.1999.tb08232.x, Smith 1999 {published data only}  ,excluded,CD009925-bbs2-0409, Unable to extract useful data. 
CD009925-bib-0425,"Smith‐Bindman R, Hosmer W, Feldstein VA, Deeks JJ, Goldberg JD. ",Second‐trimester ultrasound to detect fetuses with Down syndrome: a meta‐analysis.[see comment], JAMA ,2001,285,    ,['citation-journal']," Smith‐Bindman R, Hosmer W, Feldstein VA, Deeks JJ, Goldberg JD. Second‐trimester ultrasound to detect fetuses with Down syndrome: a meta‐analysis.[see comment].  JAMA 2001;285(8):1044‐55.    Link to article     Google Scholar     ","['https://doi.org/10.1001/jama.285.8.1044', 'https://scholar.google.com/scholar_lookup?title=Second‐trimester+ultrasound+to+detect+fetuses+with+Down+syndrome:+a+meta‐analysis.[see+comment]+&author=R+Smith‐Bindman&author=W+Hosmer&author=VA+Feldstein&author=JJ+Deeks&author=JD+Goldberg&publication_year=2001&hl=en']",,https://doi.org/10.1001/jama.285.8.1044, Smith‐Bindman 2001 {published data only}  ,excluded,CD009925-bbs2-0410, Meta‐analysis of second trimester ultrasound markers. 
CD009925-bib-0426,"Smith‐Bindman R, Chu P, Bacchetti P, Waters JJ, Mutton D, Alberman E. ",Prenatal screening for Down syndrome in England and Wales and population‐based birth outcomes, American Journal of Obstetrics & Gynecology ,2003,187,    ,['citation-journal']," Smith‐Bindman R, Chu P, Bacchetti P, Waters JJ, Mutton D, Alberman E. Prenatal screening for Down syndrome in England and Wales and population‐based birth outcomes.  American Journal of Obstetrics & Gynecology 2003;187(4):980‐5.    Link to article     Google Scholar     ","['https://doi.org/10.1067/S0002-9378(03)00721-X', 'https://scholar.google.com/scholar_lookup?title=Prenatal+screening+for+Down+syndrome+in+England+and+Wales+and+population‐based+birth+outcomes+&author=R+Smith‐Bindman&author=P+Chu&author=P+Bacchetti&author=JJ+Waters&author=D+Mutton&author=E+Alberman&publication_year=2003&hl=en']",,https://doi.org/10.1067/S0002-9378(03)00721-X, Smith‐Bindman 2003 {published data only}  ,excluded,CD009925-bbs2-0411," Population study, not examining DTA. "
CD009925-bib-0427,"Snijders RJM, Sebire NJ, Nicolaides KH. ",Maternal age and gestational age‐specific risk for chromosomal defects, Fetal Diagnosis and Therapy ,1995,10,    ,['citation-journal']," Snijders RJM, Sebire NJ, Nicolaides KH. Maternal age and gestational age‐specific risk for chromosomal defects.  Fetal Diagnosis and Therapy 1995;10(6):356‐67.    Link to article     Google Scholar     ","['https://doi.org/10.1159/000264259', 'https://scholar.google.com/scholar_lookup?title=Maternal+age+and+gestational+age‐specific+risk+for+chromosomal+defects&author=RJM+Snijders&author=NJ+Sebire&author=KH+Nicolaides&publication_year=1995&hl=en']",,https://doi.org/10.1159/000264259, Snijders 1995 {published data only}  ,excluded,CD009925-bbs2-0412," Study of prevalence, not screening. "
CD009925-bib-0428,"Snijders RJM, Sundberg K, Holzgreve W, Henry G, Nicolaides KH. ",Maternal age‐ and gestation‐specific risk for trisomy 21, Ultrasound in Obstetrics and Gynecology ,1999,13,    ,['citation-journal']," Snijders RJM, Sundberg K, Holzgreve W, Henry G, Nicolaides KH. Maternal age‐ and gestation‐specific risk for trisomy 21.  Ultrasound in Obstetrics and Gynecology 1999;13(3):167‐70.    Link to article     Google Scholar     ","['https://doi.org/10.1046/j.1469-0705.1999.13030167.x', 'https://scholar.google.com/scholar_lookup?title=Maternal+age‐+and+gestation‐specific+risk+for+trisomy+21&author=RJM+Snijders&author=K+Sundberg&author=W+Holzgreve&author=G+Henry&author=KH+Nicolaides&publication_year=1999&hl=en']",,https://doi.org/10.1046/j.1469-0705.1999.13030167.x, Snijders 1999 {published data only}  ,excluded,CD009925-bbs2-0413," Study of prevalence, not screening. "
CD009925-bib-0429,"Soergel P, Pruggmayer M, Schwerdtfeger R, Muhlhaus K, Scharf A. ","Screening for trisomy 21 with maternal age, fetal nuchal translucency and maternal serum biochemistry at 11‐14 weeks: a regional experience from Germany", Fetal Diagnosis & Therapy ,2006,21,    ,['citation-journal']," Soergel P, Pruggmayer M, Schwerdtfeger R, Muhlhaus K, Scharf A. Screening for trisomy 21 with maternal age, fetal nuchal translucency and maternal serum biochemistry at 11‐14 weeks: a regional experience from Germany.  Fetal Diagnosis & Therapy 2006;21(3):264‐8.    Link to article     Google Scholar     ","['https://doi.org/10.1159/000091353', 'https://scholar.google.com/scholar_lookup?title=Screening+for+trisomy+21+with+maternal+age,+fetal+nuchal+translucency+and+maternal+serum+biochemistry+at+11‐14+weeks:+a+regional+experience+from+Germany+&author=P+Soergel&author=M+Pruggmayer&author=R+Schwerdtfeger&author=K+Muhlhaus&author=A+Scharf&publication_year=2006&hl=en']",,https://doi.org/10.1159/000091353, Soergel 2006 {published data only}  ,excluded,CD009925-bbs2-0414, Less than 80% follow‐up. 
CD009925-bib-0430,"Sokol AI, Kramer RL, Yaron Y, O'Brien JE, Muller F, Johnson MP, et al. ",Age‐specific variation in aneuploidy incidence among biochemical screening programs, American Journal of Obstetrics & Gynecology ,1998,179,    ,['citation-journal']," Sokol AI, Kramer RL, Yaron Y, O'Brien JE, Muller F, Johnson MP, et al. Age‐specific variation in aneuploidy incidence among biochemical screening programs.  American Journal of Obstetrics & Gynecology 1998;179(4):971‐3.    Link to article     Google Scholar     ","['https://doi.org/10.1016/S0002-9378(98)70199-1', ""https://scholar.google.com/scholar_lookup?title=Age‐specific+variation+in+aneuploidy+incidence+among+biochemical+screening+programs&author=AI+Sokol&author=RL+Kramer&author=Y+Yaron&author=JE+O'Brien&author=F+Muller&author=MP+Johnson&publication_year=1998&hl=en""]",,https://doi.org/10.1016/S0002-9378(98)70199-1, Sokol 1998 {published data only}  ,excluded,CD009925-bbs2-0415, Observation of Down's prevalence stratified by age. 
CD009925-bib-0431,Sonek JD. ,Nasal bone evaluation with ultrasonography: A marker for fetal aneuploidy, Ultrasound in Obstetrics and Gynecology ,2003,22,    ,['citation-journal'], Sonek JD. Nasal bone evaluation with ultrasonography: A marker for fetal aneuploidy.  Ultrasound in Obstetrics and Gynecology 2003;22(1):11‐5.    Link to article     Google Scholar     ,"['https://doi.org/10.1002/uog.182', 'https://scholar.google.com/scholar_lookup?title=Nasal+bone+evaluation+with+ultrasonography:+A+marker+for+fetal+aneuploidy&author=JD+Sonek&publication_year=2003&hl=en']",,https://doi.org/10.1002/uog.182, Sonek 2003 {published data only}  ,excluded,CD009925-bbs2-0416, Editorial. 
CD009925-bib-0432,"Spencer K, Carpenter P. ",Screening for Down's syndrome using serum alpha fetoprotein: a retrospective study indicating caution, British Medical Journal Clinical Research Education ,1985,290,    ,['citation-journal']," Spencer K, Carpenter P. Screening for Down's syndrome using serum alpha fetoprotein: a retrospective study indicating caution.  British Medical Journal Clinical Research Education 1985;290(6486):1940‐3.    Link to article     Google Scholar     ","['https://doi.org/10.1136/bmj.290.6486.1940', ""https://scholar.google.com/scholar_lookup?title=Screening+for+Down's+syndrome+using+serum+alpha+fetoprotein:+a+retrospective+study+indicating+caution+&author=K+Spencer&author=P+Carpenter&publication_year=1985&hl=en""]",,https://doi.org/10.1136/bmj.290.6486.1940, Spencer 1985 {published data only}  ,excluded,CD009925-bbs2-0417, Fewer than 80% USS dated. 
CD009925-bib-0433,Spencer K. ,Evaluation of an assay of the free ß‐subunit of choriogonadotropin and its potential value in screening for Down's syndrome, Clinical Chemistry ,1991,37,    ,['citation-journal'], Spencer K. Evaluation of an assay of the free ß‐subunit of choriogonadotropin and its potential value in screening for Down's syndrome.  Clinical Chemistry 1991;37(6):809‐14.    Link to article     Google Scholar     ,"['https://doi.org/10.1093/clinchem/37.6.809', ""https://scholar.google.com/scholar_lookup?title=Evaluation+of+an+assay+of+the+free+ß‐subunit+of+choriogonadotropin+and+its+potential+value+in+screening+for+Down's+syndrome+&author=K+Spencer&publication_year=1991&hl=en""]",,https://doi.org/10.1093/clinchem/37.6.809, Spencer 1991a {published data only}  ,excluded,CD009925-bbs2-0418, Likely fewer than 80% USS dated. 
CD009925-bib-0434,Spencer K. ,Maternal serum CA125 is not a second trimester marker for Down's syndrome, Annals of Clinical Biochemistry ,1991,28,    ,['citation-journal'], Spencer K. Maternal serum CA125 is not a second trimester marker for Down's syndrome.  Annals of Clinical Biochemistry 1991;28(3):299‐300.    Link to article     Google Scholar     ,"['https://doi.org/10.1177/000456329102800318', ""https://scholar.google.com/scholar_lookup?title=Maternal+serum+CA125+is+not+a+second+trimester+marker+for+Down's+syndrome&author=K+Spencer&publication_year=1991&hl=en""]",,https://doi.org/10.1177/000456329102800318, Spencer 1991b {published data only}  ,excluded,CD009925-bbs2-0419, Unable to extract useful data. 
CD009925-bib-0435,"Spencer K, Coombes EJ, Mallard AS, Ward AM. ",Free ß human choriogonadotropin in Down's syndrome screening: a multicentre study of its role compared with other biochemical markers.[see comment], Annals of Clinical Biochemistry ,1992,29,    ,['citation-journal']," Spencer K, Coombes EJ, Mallard AS, Ward AM. Free ß human choriogonadotropin in Down's syndrome screening: a multicentre study of its role compared with other biochemical markers.[see comment].  Annals of Clinical Biochemistry 1992;29(5):506‐18.    Link to article     Google Scholar     ","['https://doi.org/10.1177/000456329202900504', ""https://scholar.google.com/scholar_lookup?title=Free+ß+human+choriogonadotropin+in+Down's+syndrome+screening:+a+multicentre+study+of+its+role+compared+with+other+biochemical+markers.[see+comment]+&author=K+Spencer&author=EJ+Coombes&author=AS+Mallard&author=AM+Ward&publication_year=1992&hl=en""]",,https://doi.org/10.1177/000456329202900504, Spencer 1992 {published data only}  ,excluded,CD009925-bbs2-0420, Unable to extract useful data. 
CD009925-bib-0436,"Spencer K, Carpenter P. ",Prospective study of prenatal screening for Down's syndrome with free ß human chorionic gonadotrophin.[see comment], BMJ ,1993,307,    ,['citation-journal']," Spencer K, Carpenter P. Prospective study of prenatal screening for Down's syndrome with free ß human chorionic gonadotrophin.[see comment].  BMJ 1993;307(6907):764‐9.    Link to article     Google Scholar     ","['https://doi.org/10.1136/bmj.307.6907.764', ""https://scholar.google.com/scholar_lookup?title=Prospective+study+of+prenatal+screening+for+Down's+syndrome+with+free+ß+human+chorionic+gonadotrophin.[see+comment]+&author=K+Spencer&author=P+Carpenter&publication_year=1993&hl=en""]",,https://doi.org/10.1136/bmj.307.6907.764, Spencer 1993a {published data only}  ,excluded,CD009925-bbs2-0421, Fewer than 80% USS dated. 
CD009925-bib-0437,"Spencer K, Macri JN, Carpenter P, Anderson R, Krantz DA. ","Stability of intact chorionic gonadotropin (hCG) in serum, liquid whole blood, and dried whole‐blood filter‐paper spots: impact on screening for Down syndrome by measurement of free ß‐hCG subunit", Clinical Chemistry ,1993,39,    ,['citation-journal']," Spencer K, Macri JN, Carpenter P, Anderson R, Krantz DA. Stability of intact chorionic gonadotropin (hCG) in serum, liquid whole blood, and dried whole‐blood filter‐paper spots: impact on screening for Down syndrome by measurement of free ß‐hCG subunit.  Clinical Chemistry 1993;39(6):1064‐8.    Link to article     Google Scholar     ","['https://doi.org/10.1093/clinchem/39.6.1064', 'https://scholar.google.com/scholar_lookup?title=Stability+of+intact+chorionic+gonadotropin+(hCG)+in+serum,+liquid+whole+blood,+and+dried+whole‐blood+filter‐paper+spots:+impact+on+screening+for+Down+syndrome+by+measurement+of+free+ß‐hCG+subunit+&author=K+Spencer&author=JN+Macri&author=P+Carpenter&author=R+Anderson&author=DA+Krantz&publication_year=1993&hl=en']",,https://doi.org/10.1093/clinchem/39.6.1064, Spencer 1993b {published data only}  ,excluded,CD009925-bbs2-0422, No Down's pregnancies in study population. 
CD009925-bib-0438,"Spencer K, Wood PJ, Anthony FW. ",Elevated levels of maternal serum inhibin immunoreactivity in second trimester pregnancies affected by Down's syndrome, Annals of Clinical Biochemistry ,1993,30,    ,['citation-journal']," Spencer K, Wood PJ, Anthony FW. Elevated levels of maternal serum inhibin immunoreactivity in second trimester pregnancies affected by Down's syndrome.  Annals of Clinical Biochemistry 1993;30(Pt 2):219‐20.    Link to article     Google Scholar     ","['https://doi.org/10.1177/000456329303000226', ""https://scholar.google.com/scholar_lookup?title=Elevated+levels+of+maternal+serum+inhibin+immunoreactivity+in+second+trimester+pregnancies+affected+by+Down's+syndrome+&author=K+Spencer&author=PJ+Wood&author=FW+Anthony&publication_year=1993&hl=en""]",,https://doi.org/10.1177/000456329303000226, Spencer 1993c {published data only}  ,excluded,CD009925-bbs2-0423, Unable to extract useful data. 
CD009925-bib-0439,"Spencer K, Macri JN, Anderson RW, Aitken DA, Berry E, Crossley JA, et al. ",Dual analyte immunoassay in neural tube defect and Down's syndrome screening: results of a multicentre clinical trial, Annals of Clinical Biochemistry ,1993,30,    ,['citation-journal']," Spencer K, Macri JN, Anderson RW, Aitken DA, Berry E, Crossley JA, et al. Dual analyte immunoassay in neural tube defect and Down's syndrome screening: results of a multicentre clinical trial.  Annals of Clinical Biochemistry 1993;30(4):394‐401.    Link to article     Google Scholar     ","['https://doi.org/10.1177/000456329303000408', ""https://scholar.google.com/scholar_lookup?title=Dual+analyte+immunoassay+in+neural+tube+defect+and+Down's+syndrome+screening:+results+of+a+multicentre+clinical+trial+&author=K+Spencer&author=JN+Macri&author=RW+Anderson&author=DA+Aitken&author=E+Berry&author=JA+Crossley&publication_year=1993&hl=en""]",,https://doi.org/10.1177/000456329303000408, Spencer 1993d {published data only}  ,excluded,CD009925-bbs2-0424, Fewer than 80% of pregnancies had gestational age confirmed by USS. 
CD009925-bib-0440,Spencer K. ,Free alpha‐subunit of human chorionic gonadotropin in Down syndrome, American Journal of Obstetrics and Gynecology ,1993,168,    ,['citation-journal'], Spencer K. Free alpha‐subunit of human chorionic gonadotropin in Down syndrome.  American Journal of Obstetrics and Gynecology 1993;168(1):132‐5.    Link to article     Google Scholar     ,"['https://doi.org/10.1016/S0002-9378(12)90901-1', 'https://scholar.google.com/scholar_lookup?title=Free+alpha‐subunit+of+human+chorionic+gonadotropin+in+Down+syndrome&author=K+Spencer&publication_year=1993&hl=en']",,https://doi.org/10.1016/S0002-9378(12)90901-1, Spencer 1993e {published data only}  ,excluded,CD009925-bbs2-0425, Unable to extract useful data. 
CD009925-bib-0441,Spencer K. ,The influence of gravidity on Down's syndrome screening with free ß hCG, Prenatal Diagnosis ,1995,15,    ,['citation-journal'], Spencer K. The influence of gravidity on Down's syndrome screening with free ß hCG.  Prenatal Diagnosis 1995;15(1):87‐9.    Link to article     Google Scholar     ,"['https://doi.org/10.1002/pd.1970150119', ""https://scholar.google.com/scholar_lookup?title=The+influence+of+gravidity+on+Down's+syndrome+screening+with+free+ß+hCG&author=K+Spencer&publication_year=1995&hl=en""]",,https://doi.org/10.1002/pd.1970150119, Spencer 1995 {published data only}  ,excluded,CD009925-bbs2-0426, No Down's pregnancies in population. 
CD009925-bib-0442,"Spencer K, Wallace EM, Ritoe S. ",Second‐trimester dimeric inhibin‐A in Down's syndrome screening, Prenatal Diagnosis ,1996,16,    ,['citation-journal']," Spencer K, Wallace EM, Ritoe S. Second‐trimester dimeric inhibin‐A in Down's syndrome screening.  Prenatal Diagnosis 1996;16(12):1101‐10.    Link to article     Google Scholar     ","['https://doi.org/10.1002/(SICI)1097-0223(199612)16:12<1101::AID-PD5>3.0.CO;2-7', ""https://scholar.google.com/scholar_lookup?title=Second‐trimester+dimeric+inhibin‐A+in+Down's+syndrome+screening&author=K+Spencer&author=EM+Wallace&author=S+Ritoe&publication_year=1996&hl=en""]",,https://doi.org/10.1002/(SICI)1097-0223(199612)16:12<1101::AID-PD5>3.0.CO;2-7, Spencer 1996a {published data only}  ,excluded,CD009925-bbs2-0427, Fewer than 80% of pregnancies had gestational age confirmed by USS. 
CD009925-bib-0443,"Spencer K, Noble P, Snijders RJ, Nicolaides KH. ","First‐trimester urine free ß hCG, ß core, and total oestriol in pregnancies affected by Down's syndrome: implications for first‐trimester screening with nuchal translucency and serum free ß hCG", Prenatal Diagnosis ,1997,17,    ,['citation-journal']," Spencer K, Noble P, Snijders RJ, Nicolaides KH. First‐trimester urine free ß hCG, ß core, and total oestriol in pregnancies affected by Down's syndrome: implications for first‐trimester screening with nuchal translucency and serum free ß hCG.  Prenatal Diagnosis 1997;17(6):525‐38.    Link to article     Google Scholar     ","['https://doi.org/10.1002/(SICI)1097-0223(199706)17:6<525::AID-PD105>3.0.CO;2-I', ""https://scholar.google.com/scholar_lookup?title=First‐trimester+urine+free+ß+hCG,+ß+core,+and+total+oestriol+in+pregnancies+affected+by+Down's+syndrome:+implications+for+first‐trimester+screening+with+nuchal+translucency+and+serum+free+ß+hCG+&author=K+Spencer&author=P+Noble&author=RJ+Snijders&author=KH+Nicolaides&publication_year=1997&hl=en""]",,https://doi.org/10.1002/(SICI)1097-0223(199706)17:6<525::AID-PD105>3.0.CO;2-I, Spencer 1997 {published data only}  ,excluded,CD009925-bbs2-0428," Statistical modelling, aneuploid pregnancies only in study population. "
CD009925-bib-0444,Spencer K. ,The influence of smoking on maternal serum AFP and free ß hCG levels and the impact on screening for Down syndrome, Prenatal Diagnosis ,1998,18,    ,['citation-journal'], Spencer K. The influence of smoking on maternal serum AFP and free ß hCG levels and the impact on screening for Down syndrome.  Prenatal Diagnosis 1998;18(3):225‐34.    Link to article     Google Scholar     ,"['https://doi.org/10.1002/(SICI)1097-0223(199803)18:3<225::AID-PD239>3.0.CO;2-B', 'https://scholar.google.com/scholar_lookup?title=The+influence+of+smoking+on+maternal+serum+AFP+and+free+ß+hCG+levels+and+the+impact+on+screening+for+Down+syndrome+&author=K+Spencer&publication_year=1998&hl=en']",,https://doi.org/10.1002/(SICI)1097-0223(199803)18:3<225::AID-PD239>3.0.CO;2-B, Spencer 1998a {published data only}  ,excluded,CD009925-bbs2-0429, No Down's pregnancies in population. 
CD009925-bib-0445,"Spencer K, Carpenter P. ",Is prostate‐specific antigen a marker for pregnancies affected by Down syndrome?, Clinical Chemistry ,1998,44,    ,['citation-journal']," Spencer K, Carpenter P. Is prostate‐specific antigen a marker for pregnancies affected by Down syndrome?.  Clinical Chemistry 1998;44(11):2362‐5.    Link to article     Google Scholar     ","['https://doi.org/10.1093/clinchem/44.11.2362', 'https://scholar.google.com/scholar_lookup?title=Is+prostate‐specific+antigen+a+marker+for+pregnancies+affected+by+Down+syndrome?&author=K+Spencer&author=P+Carpenter&publication_year=1998&hl=en']",,https://doi.org/10.1093/clinchem/44.11.2362, Spencer 1998b {published data only}  ,excluded,CD009925-bbs2-0430, Unable to extract useful data. 
CD009925-bib-0446,Spencer K. ,Second trimester prenatal screening for Down's syndrome using alpha‐fetoprotein and free ß hCG: a seven year review, British Journal of Obstetrics & Gynaecology ,1999,106,    ,['citation-journal'], Spencer K. Second trimester prenatal screening for Down's syndrome using alpha‐fetoprotein and free ß hCG: a seven year review.  British Journal of Obstetrics & Gynaecology 1999;106(12):1287‐93.    Link to article     Google Scholar     ,"['https://doi.org/10.1111/j.1471-0528.1999.tb08183.x', ""https://scholar.google.com/scholar_lookup?title=Second+trimester+prenatal+screening+for+Down's+syndrome+using+alpha‐fetoprotein+and+free+ß+hCG:+a+seven+year+review+&author=K+Spencer&publication_year=1999&hl=en""]",,https://doi.org/10.1111/j.1471-0528.1999.tb08183.x, Spencer 1999a {published data only}  ,excluded,CD009925-bbs2-0431, Review. 
CD009925-bib-0447,Spencer K. ,Accuracy of Down's syndrome risks produced in a prenatal screening program, Annals of Clinical Biochemistry ,1999,36,    ,['citation-journal'], Spencer K. Accuracy of Down's syndrome risks produced in a prenatal screening program.  Annals of Clinical Biochemistry 1999;36(1):101‐3.    Link to article     Google Scholar     ,"['https://doi.org/10.1177/000456329903600115', ""https://scholar.google.com/scholar_lookup?title=Accuracy+of+Down's+syndrome+risks+produced+in+a+prenatal+screening+program&author=K+Spencer&publication_year=1999&hl=en""]",,https://doi.org/10.1177/000456329903600115, Spencer 1999b {published data only}  ,excluded,CD009925-bbs2-0432, Statistical methods paper. 
CD009925-bib-0448,"Spencer K, Berry E, Crossley JA, Aitken DA, Nicolaides KH. ",Is maternal serum total hCG a marker of trisomy 21 in the first trimester of pregnancy?, Prenatal Diagnosis. ,2000,20,    ,['citation-journal']," Spencer K, Berry E, Crossley JA, Aitken DA, Nicolaides KH. Is maternal serum total hCG a marker of trisomy 21 in the first trimester of pregnancy?.  Prenatal Diagnosis. 2000;20(4):311‐7.    Link to article     Google Scholar     ","['https://doi.org/10.1002/(SICI)1097-0223(200004)20:4<311::AID-PD809>3.0.CO;2-P', 'https://scholar.google.com/scholar_lookup?title=Is+maternal+serum+total+hCG+a+marker+of+trisomy+21+in+the+first+trimester+of+pregnancy?&author=K+Spencer&author=E+Berry&author=JA+Crossley&author=DA+Aitken&author=KH+Nicolaides&publication_year=2000&hl=en']",,https://doi.org/10.1002/(SICI)1097-0223(200004)20:4<311::AID-PD809>3.0.CO;2-P, Spencer 2000a {published data only}  ,excluded,CD009925-bbs2-0433, Examination of median shifts rather than an evaluation of screening. 
CD009925-bib-0449,Spencer K. ,"Screening for trisomy 21 in twin pregnancies in the first trimester using free ß‐hCG and PAPP‐A, combined with fetal nuchal translucency thickness", Prenatal Diagnosis. ,2000,20,    ,['citation-journal']," Spencer K. Screening for trisomy 21 in twin pregnancies in the first trimester using free ß‐hCG and PAPP‐A, combined with fetal nuchal translucency thickness.  Prenatal Diagnosis. 2000;20(2):91‐5.    Link to article     Google Scholar     ","['https://doi.org/10.1002/(SICI)1097-0223(200002)20:2<91::AID-PD759>3.0.CO;2-X', 'https://scholar.google.com/scholar_lookup?title=Screening+for+trisomy+21+in+twin+pregnancies+in+the+first+trimester+using+free+ß‐hCG+and+PAPP‐A,+combined+with+fetal+nuchal+translucency+thickness+&author=K+Spencer&publication_year=2000&hl=en']",,https://doi.org/10.1002/(SICI)1097-0223(200002)20:2<91::AID-PD759>3.0.CO;2-X, Spencer 2000b {published data only}  ,excluded,CD009925-bbs2-0434, No Down's syndrome pregnancies in population. 
CD009925-bib-0450,Spencer K. ,The influence of smoking on maternal serum PAPP‐A and free ß hCG levels in the first trimester of pregnancy, Prenatal Diagnosis. ,1999,19,    ,['citation-journal'], Spencer K. The influence of smoking on maternal serum PAPP‐A and free ß hCG levels in the first trimester of pregnancy.  Prenatal Diagnosis. 1999;19(11):1065‐6.    Link to article     Google Scholar     ,"['https://doi.org/10.1002/(SICI)1097-0223(199911)19:11<1065::AID-PD695>3.0.CO;2-R', 'https://scholar.google.com/scholar_lookup?title=The+influence+of+smoking+on+maternal+serum+PAPP‐A+and+free+ß+hCG+levels+in+the+first+trimester+of+pregnancy+&author=K+Spencer&publication_year=1999&hl=en']",,https://doi.org/10.1002/(SICI)1097-0223(199911)19:11<1065::AID-PD695>3.0.CO;2-R, Spencer 2000c {published data only}  ,excluded,CD009925-bbs2-0435, No Down's syndrome pregnancies in population. 
CD009925-bib-0451,"Spencer K, Ong CY, Liao AW, Nicolaides KH. ",The influence of parity and gravidity on first trimester markers of chromosomal abnormality, Prenatal Diagnosis ,2000,20,    ,['citation-journal']," Spencer K, Ong CY, Liao AW, Nicolaides KH. The influence of parity and gravidity on first trimester markers of chromosomal abnormality.  Prenatal Diagnosis 2000;20(10):792‐4.    Link to article     Google Scholar     ","['https://doi.org/10.1002/1097-0223(200010)20:10<792::AID-PD914>3.0.CO;2-5', 'https://scholar.google.com/scholar_lookup?title=The+influence+of+parity+and+gravidity+on+first+trimester+markers+of+chromosomal+abnormality&author=K+Spencer&author=CY+Ong&author=AW+Liao&author=KH+Nicolaides&publication_year=2000&hl=en']",,https://doi.org/10.1002/1097-0223(200010)20:10<792::AID-PD914>3.0.CO;2-5, Spencer 2000d {published data only}  ,excluded,CD009925-bbs2-0436, No Down's cases. 
CD009925-bib-0452,Spencer K. ,The influence of fetal sex in screening for Down syndrome in the second trimester using AFP and free ß‐hCG, Prenatal Diagnosis ,2000,20,    ,['citation-journal'], Spencer K. The influence of fetal sex in screening for Down syndrome in the second trimester using AFP and free ß‐hCG.  Prenatal Diagnosis 2000;20(8):648‐51.    Link to article     Google Scholar     ,"['https://doi.org/10.1002/1097-0223(200008)20:8<648::AID-PD869>3.0.CO;2-L', 'https://scholar.google.com/scholar_lookup?title=The+influence+of+fetal+sex+in+screening+for+Down+syndrome+in+the+second+trimester+using+AFP+and+free+ß‐hCG+&author=K+Spencer&publication_year=2000&hl=en']",,https://doi.org/10.1002/1097-0223(200008)20:8<648::AID-PD869>3.0.CO;2-L, Spencer 2000e {published data only}  ,excluded,CD009925-bbs2-0437, Male versus female fetuses. 
CD009925-bib-0453,"Spencer K, Ong CY, Liao AW, Nicolaides KH. ",The influence of ethnic origin on first trimester biochemical markers of chromosomal abnormalities, Prenatal Diagnosis ,2000,20,    ,['citation-journal']," Spencer K, Ong CY, Liao AW, Nicolaides KH. The influence of ethnic origin on first trimester biochemical markers of chromosomal abnormalities.  Prenatal Diagnosis 2000;20(6):491‐4.    Link to article     Google Scholar     ","['https://doi.org/10.1002/1097-0223(200006)20:6<491::AID-PD844>3.0.CO;2-3', 'https://scholar.google.com/scholar_lookup?title=The+influence+of+ethnic+origin+on+first+trimester+biochemical+markers+of+chromosomal+abnormalities+&author=K+Spencer&author=CY+Ong&author=AW+Liao&author=KH+Nicolaides&publication_year=2000&hl=en']",,https://doi.org/10.1002/1097-0223(200006)20:6<491::AID-PD844>3.0.CO;2-3, Spencer 2000f {published data only}  ,excluded,CD009925-bbs2-0438, No Down's cases in population. 
CD009925-bib-0454,"Spencer K, Tul N, Nicolaides KH. ",Maternal serum free ß‐hCG and PAPP‐A in fetal sex chromosome defects in the first trimester, Prenatal Diagnosis. ,2000,20,    ,['citation-journal']," Spencer K, Tul N, Nicolaides KH. Maternal serum free ß‐hCG and PAPP‐A in fetal sex chromosome defects in the first trimester.  Prenatal Diagnosis. 2000;20(5):390‐4.    Link to article     Google Scholar     ","['https://doi.org/10.1002/(SICI)1097-0223(200005)20:5<390::AID-PD824>3.0.CO;2-B', 'https://scholar.google.com/scholar_lookup?title=Maternal+serum+free+ß‐hCG+and+PAPP‐A+in+fetal+sex+chromosome+defects+in+the+first+trimester+&author=K+Spencer&author=N+Tul&author=KH+Nicolaides&publication_year=2000&hl=en']",,https://doi.org/10.1002/(SICI)1097-0223(200005)20:5<390::AID-PD824>3.0.CO;2-B, Spencer 2000g {published data only}  ,excluded,CD009925-bbs2-0439, No Down's pregnancies in population. 
CD009925-bib-0455,Spencer K. ,Second‐trimester prenatal screening for Down syndrome and the relationship of maternal serum biochemical markers to pregnancy complications with adverse outcome, Prenatal Diagnosis. ,2000,20,    ,['citation-journal'], Spencer K. Second‐trimester prenatal screening for Down syndrome and the relationship of maternal serum biochemical markers to pregnancy complications with adverse outcome.  Prenatal Diagnosis. 2000;20(8):652‐6.    Link to article     Google Scholar     ,"['https://doi.org/10.1002/1097-0223(200008)20:8<652::AID-PD882>3.0.CO;2-6', 'https://scholar.google.com/scholar_lookup?title=Second‐trimester+prenatal+screening+for+Down+syndrome+and+the+relationship+of+maternal+serum+biochemical+markers+to+pregnancy+complications+with+adverse+outcome+&author=K+Spencer&publication_year=2000&hl=en']",,https://doi.org/10.1002/1097-0223(200008)20:8<652::AID-PD882>3.0.CO;2-6, Spencer 2000h {published data only}  ,excluded,CD009925-bbs2-0440, No Down's pregnancies in population. 
CD009925-bib-0456,"Spencer K, Ong CY, Liao AW, Papademetriou D, Nicolaides KH. ","The influence of fetal sex in screening for trisomy 21 by fetal nuchal translucency, maternal serum free ß‐hCG and PAPP‐A at 10‐14 weeks of gestation", Prenatal Diagnosis. ,2000,20,    ,['citation-journal']," Spencer K, Ong CY, Liao AW, Papademetriou D, Nicolaides KH. The influence of fetal sex in screening for trisomy 21 by fetal nuchal translucency, maternal serum free ß‐hCG and PAPP‐A at 10‐14 weeks of gestation.  Prenatal Diagnosis. 2000;20(8):673‐5.    Link to article     Google Scholar     ","['https://doi.org/10.1002/1097-0223(200008)20:8<673::AID-PD880>3.0.CO;2-5', 'https://scholar.google.com/scholar_lookup?title=The+influence+of+fetal+sex+in+screening+for+trisomy+21+by+fetal+nuchal+translucency,+maternal+serum+free+ß‐hCG+and+PAPP‐A+at+10‐14+weeks+of+gestation+&author=K+Spencer&author=CY+Ong&author=AW+Liao&author=D+Papademetriou&author=KH+Nicolaides&publication_year=2000&hl=en']",,https://doi.org/10.1002/1097-0223(200008)20:8<673::AID-PD880>3.0.CO;2-5, Spencer 2000i {published data only}  ,excluded,CD009925-bbs2-0441, Comparsison of fetal sex. 
CD009925-bib-0457,Spencer K. ,Age related detection and false positive rates when screening for Down's syndrome in the first trimester using fetal nuchal translucency and maternal serum free ßhCG and PAPP‐A, BJOG: An International Journal of Obstetrics & Gynaecology ,2001,108,    ,['citation-journal'], Spencer K. Age related detection and false positive rates when screening for Down's syndrome in the first trimester using fetal nuchal translucency and maternal serum free ßhCG and PAPP‐A.  BJOG: An International Journal of Obstetrics & Gynaecology 2001;108(10):1043‐6.    Google Scholar     ,"[""https://scholar.google.com/scholar_lookup?title=Age+related+detection+and+false+positive+rates+when+screening+for+Down's+syndrome+in+the+first+trimester+using+fetal+nuchal+translucency+and+maternal+serum+free+ßhCG+and+PAPP‐A+&author=K+Spencer&publication_year=2001&hl=en""]",,, Spencer 2001 {published data only}  ,excluded,CD009925-bbs2-0442, No Down's syndrome pregnancies in population. 
CD009925-bib-0458,"Spencer K, Liao AW, Ong CY, Geerts L, Nicolaides KH. ",First trimester maternal serum placenta growth factor (PIGF)concentrations in pregnancies with fetal trisomy 21 or trisomy 18, Prenatal Diagnosis ,2001,21,    ,['citation-journal']," Spencer K, Liao AW, Ong CY, Geerts L, Nicolaides KH. First trimester maternal serum placenta growth factor (PIGF)concentrations in pregnancies with fetal trisomy 21 or trisomy 18.  Prenatal Diagnosis 2001;21(9):718‐22.    Link to article     Google Scholar     ","['https://doi.org/10.1002/pd.148', 'https://scholar.google.com/scholar_lookup?title=First+trimester+maternal+serum+placenta+growth+factor+(PIGF)concentrations+in+pregnancies+with+fetal+trisomy+21+or+trisomy+18+&author=K+Spencer&author=AW+Liao&author=CY+Ong&author=L+Geerts&author=KH+Nicolaides&publication_year=2001&hl=en']",,https://doi.org/10.1002/pd.148, Spencer 2001a {published data only}  ,excluded,CD009925-bbs2-0443, Unable to extract useful data. 
CD009925-bib-0459,"Spencer K, Liao AW, Ong CY, Geerts L, Nicolaides KH. ",Maternal serum levels of dimeric Inhibin A in pregnancies affected by trisomy 21 in the first trimester, Prenatal Diagnosis ,2001,21,    ,['citation-journal']," Spencer K, Liao AW, Ong CY, Geerts L, Nicolaides KH. Maternal serum levels of dimeric Inhibin A in pregnancies affected by trisomy 21 in the first trimester.  Prenatal Diagnosis 2001;21(6):441‐4.    Link to article     Google Scholar     ","['https://doi.org/10.1002/pd.98', 'https://scholar.google.com/scholar_lookup?title=Maternal+serum+levels+of+dimeric+Inhibin+A+in+pregnancies+affected+by+trisomy+21+in+the+first+trimester+&author=K+Spencer&author=AW+Liao&author=CY+Ong&author=L+Geerts&author=KH+Nicolaides&publication_year=2001&hl=en']",,https://doi.org/10.1002/pd.98, Spencer 2001b {published data only}  ,excluded,CD009925-bbs2-0444, Unable to extract useful data. 
CD009925-bib-0460,"Spencer K, Liao AW, Skentou H, Ong CY, Nicolaides KH. ",Maternal serum levels of total activin‐A in first‐trimester trisomy 21 pregnancies, Prenatal Diagnosis ,2001,21,    ,['citation-journal']," Spencer K, Liao AW, Skentou H, Ong CY, Nicolaides KH. Maternal serum levels of total activin‐A in first‐trimester trisomy 21 pregnancies.  Prenatal Diagnosis 2001;21(4):270‐3.    Link to article     Google Scholar     ","['https://doi.org/10.1002/pd.53', 'https://scholar.google.com/scholar_lookup?title=Maternal+serum+levels+of+total+activin‐A+in+first‐trimester+trisomy+21+pregnancies&author=K+Spencer&author=AW+Liao&author=H+Skentou&author=CY+Ong&author=KH+Nicolaides&publication_year=2001&hl=en']",,https://doi.org/10.1002/pd.53, Spencer 2001c {published data only}  ,excluded,CD009925-bbs2-0445, Unable to extract useful data. 
CD009925-bib-0461,Spencer K. ,Screening for trisomy 21 in twin pregnancies in the first trimester: does chorionicity impact on maternal serum free ß‐hCG or PAPP‐A levels?, Prenatal Diagnosis ,2001,21,    ,['citation-journal'], Spencer K. Screening for trisomy 21 in twin pregnancies in the first trimester: does chorionicity impact on maternal serum free ß‐hCG or PAPP‐A levels?.  Prenatal Diagnosis 2001;21(9):715‐7.    Link to article     Google Scholar     ,"['https://doi.org/10.1002/pd.152', 'https://scholar.google.com/scholar_lookup?title=Screening+for+trisomy+21+in+twin+pregnancies+in+the+first+trimester:+does+chorionicity+impact+on+maternal+serum+free+ß‐hCG+or+PAPP‐A+levels?+&author=K+Spencer&publication_year=2001&hl=en']",,https://doi.org/10.1002/pd.152, Spencer 2001d {published data only}  ,excluded,CD009925-bbs2-0446, No Down's syndrome pregnancies in population. 
CD009925-bib-0462,"Spencer K, Nicolaides KH. ","A first trimester trisomy 13/trisomy 18 risk algorithm combining fetal nuchal translucency thickness, maternal serum free ß‐hCG and PAPP‐A", Prenatal Diagnosis ,2002,22,    ,['citation-journal']," Spencer K, Nicolaides KH. A first trimester trisomy 13/trisomy 18 risk algorithm combining fetal nuchal translucency thickness, maternal serum free ß‐hCG and PAPP‐A.  Prenatal Diagnosis 2002;22(10):877‐9.    Link to article     Google Scholar     ","['https://doi.org/10.1002/pd.420', 'https://scholar.google.com/scholar_lookup?title=A+first+trimester+trisomy+13/trisomy+18+risk+algorithm+combining+fetal+nuchal+translucency+thickness,+maternal+serum+free+ß‐hCG+and+PAPP‐A+&author=K+Spencer&author=KH+Nicolaides&publication_year=2002&hl=en']",,https://doi.org/10.1002/pd.420, Spencer 2002a {published data only}  ,excluded,CD009925-bbs2-0447, No Down's pregnancies. 
CD009925-bib-0463,Spencer K. ,Accuracy of Down syndrome risks produced in a first‐trimester screening programme incorporating fetal nuchal translucency thickness and maternal serum biochemistry, Prenatal Diagnosis ,2002,22,    ,['citation-journal'], Spencer K. Accuracy of Down syndrome risks produced in a first‐trimester screening programme incorporating fetal nuchal translucency thickness and maternal serum biochemistry.  Prenatal Diagnosis 2002;22(3):244‐6.    Link to article     Google Scholar     ,"['https://doi.org/10.1002/pd.312', 'https://scholar.google.com/scholar_lookup?title=Accuracy+of+Down+syndrome+risks+produced+in+a+first‐trimester+screening+programme+incorporating+fetal+nuchal+translucency+thickness+and+maternal+serum+biochemistry+&author=K+Spencer&publication_year=2002&hl=en']",,https://doi.org/10.1002/pd.312, Spencer 2002b {published data only}  ,excluded,CD009925-bbs2-0448, Risk validation study. 
CD009925-bib-0464,"Spencer K, Cuckle HS. ",Screening for chromosomal anomalies in the first trimester: does repeat maternal serum screening improve detection rates?, Prenatal Diagnosis ,2002,22,    ,['citation-journal']," Spencer K, Cuckle HS. Screening for chromosomal anomalies in the first trimester: does repeat maternal serum screening improve detection rates?.  Prenatal Diagnosis 2002;22(10):903‐6.    Link to article     Google Scholar     ","['https://doi.org/10.1002/pd.441', 'https://scholar.google.com/scholar_lookup?title=Screening+for+chromosomal+anomalies+in+the+first+trimester:+does+repeat+maternal+serum+screening+improve+detection+rates?+&author=K+Spencer&author=HS+Cuckle&publication_year=2002&hl=en']",,https://doi.org/10.1002/pd.441, Spencer 2002c {published data only}  ,excluded,CD009925-bbs2-0449, No Down's syndrome pregnancies in population. 
CD009925-bib-0465,"Spencer K, Crossley JA, Aitken DA, Nix AB, Dunstan FD, Williams K. ",Temporal changes in maternal serum biochemical markers of trisomy 21 across the first and second trimester of pregnancy, Annals of Clinical Biochemistry ,2002,39,    ,['citation-journal']," Spencer K, Crossley JA, Aitken DA, Nix AB, Dunstan FD, Williams K. Temporal changes in maternal serum biochemical markers of trisomy 21 across the first and second trimester of pregnancy.  Annals of Clinical Biochemistry 2002;39(6):567‐76.    Link to article     Google Scholar     ","['https://doi.org/10.1177/000456320203900604', 'https://scholar.google.com/scholar_lookup?title=Temporal+changes+in+maternal+serum+biochemical+markers+of+trisomy+21+across+the+first+and+second+trimester+of+pregnancy+&author=K+Spencer&author=JA+Crossley&author=DA+Aitken&author=AB+Nix&author=FD+Dunstan&author=K+Williams&publication_year=2002&hl=en']",,https://doi.org/10.1177/000456320203900604, Spencer 2002d {published data only}  ,excluded,CD009925-bbs2-0450," Demonstration of median changes with time, rather than evaluation of screening. "
CD009925-bib-0466,"Spencer K, Crossley JA, Aitken DA, Nix AB, Dunstan FD, Williams K. ",The effect of temporal variation in biochemical markers of trisomy 21 across the first and second trimesters of pregnancy on the estimation of individual patient‐specific risks and detection rates for Down's syndrome, Annals of Clinical Biochemistry ,2003,40,    ,['citation-journal']," Spencer K, Crossley JA, Aitken DA, Nix AB, Dunstan FD, Williams K. The effect of temporal variation in biochemical markers of trisomy 21 across the first and second trimesters of pregnancy on the estimation of individual patient‐specific risks and detection rates for Down's syndrome.  Annals of Clinical Biochemistry 2003;40(3):219‐31.    Link to article     Google Scholar     ","['https://doi.org/10.1258/000456303321610501', ""https://scholar.google.com/scholar_lookup?title=The+effect+of+temporal+variation+in+biochemical+markers+of+trisomy+21+across+the+first+and+second+trimesters+of+pregnancy+on+the+estimation+of+individual+patient‐specific+risks+and+detection+rates+for+Down's+syndrome+&author=K+Spencer&author=JA+Crossley&author=DA+Aitken&author=AB+Nix&author=FD+Dunstan&author=K+Williams&publication_year=2003&hl=en""]",,https://doi.org/10.1258/000456303321610501, Spencer 2003a {published data only}  ,excluded,CD009925-bbs2-0451, No Down's pregnancies in population. 
CD009925-bib-0467,Spencer K. ,The influence of different sample collection types on the levels of markers used for Down's syndrome screening as measured by the Kryptor Immunosassay system, Annals of Clinical Biochemistry ,2003,40,    ,['citation-journal'], Spencer K. The influence of different sample collection types on the levels of markers used for Down's syndrome screening as measured by the Kryptor Immunosassay system.  Annals of Clinical Biochemistry 2003;40(2):166‐8.    Link to article     Google Scholar     ,"['https://doi.org/10.1258/000456303763046102', ""https://scholar.google.com/scholar_lookup?title=The+influence+of+different+sample+collection+types+on+the+levels+of+markers+used+for+Down's+syndrome+screening+as+measured+by+the+Kryptor+Immunosassay+system+&author=K+Spencer&publication_year=2003&hl=en""]",,https://doi.org/10.1258/000456303763046102, Spencer 2003b {published data only}  ,excluded,CD009925-bbs2-0452, No Down's pregnancies in population. 
CD009925-bib-0468,"Spencer K, Bindra R, Nicolaides KH. ",Maternal weight correction of maternal serum PAPP‐A and free ß‐hCG MoM when screening for trisomy 21 in the first trimester of pregnancy, Prenatal Diagnosis ,2003,23,    ,['citation-journal']," Spencer K, Bindra R, Nicolaides KH. Maternal weight correction of maternal serum PAPP‐A and free ß‐hCG MoM when screening for trisomy 21 in the first trimester of pregnancy.  Prenatal Diagnosis 2003;23(10):851‐5.    Link to article     Google Scholar     ","['https://doi.org/10.1002/pd.708', 'https://scholar.google.com/scholar_lookup?title=Maternal+weight+correction+of+maternal+serum+PAPP‐A+and+free+ß‐hCG+MoM+when+screening+for+trisomy+21+in+the+first+trimester+of+pregnancy+&author=K+Spencer&author=R+Bindra&author=KH+Nicolaides&publication_year=2003&hl=en']",,https://doi.org/10.1002/pd.708, Spencer 2003c {published data only}  ,excluded,CD009925-bbs2-0453, Calculation of weight correction factor. 
CD009925-bib-0469,"Spencer K, Nicolaides KH. ",Screening for trisomy 21 in twins using first trimester ultrasound and maternal serum biochemistry in a one‐stop clinic: a review of three years experience, BJOG: An International Journal of Obstetrics & Gynaecology ,2003,110,    ,['citation-journal']," Spencer K, Nicolaides KH. Screening for trisomy 21 in twins using first trimester ultrasound and maternal serum biochemistry in a one‐stop clinic: a review of three years experience.  BJOG: An International Journal of Obstetrics & Gynaecology 2003;110(3):279‐80.    Link to article     Google Scholar     ","['https://doi.org/10.1046/j.1471-0528.2003.02222.x', 'https://scholar.google.com/scholar_lookup?title=Screening+for+trisomy+21+in+twins+using+first+trimester+ultrasound+and+maternal+serum+biochemistry+in+a+one‐stop+clinic:+a+review+of+three+years+experience+&author=K+Spencer&author=KH+Nicolaides&publication_year=2003&hl=en']",,https://doi.org/10.1046/j.1471-0528.2003.02222.x, Spencer 2003d {published data only}  ,excluded,CD009925-bbs2-0454, Fewer than 5 Down's syndrome pregnancies. 
CD009925-bib-0470,"Spencer K, Bindra R, Cacho AM, Nicolaides KH. ",The impact of correcting for smoking status when screening for chromosomal anomalies using maternal serum biochemistry and fetal nuchal translucency thickness in the first trimester of pregnancy, Prenatal Diagnosis ,2004,24,    ,['citation-journal']," Spencer K, Bindra R, Cacho AM, Nicolaides KH. The impact of correcting for smoking status when screening for chromosomal anomalies using maternal serum biochemistry and fetal nuchal translucency thickness in the first trimester of pregnancy.  Prenatal Diagnosis 2004;24(3):169‐73.    Link to article     Google Scholar     ","['https://doi.org/10.1002/pd.819', 'https://scholar.google.com/scholar_lookup?title=The+impact+of+correcting+for+smoking+status+when+screening+for+chromosomal+anomalies+using+maternal+serum+biochemistry+and+fetal+nuchal+translucency+thickness+in+the+first+trimester+of+pregnancy+&author=K+Spencer&author=R+Bindra&author=AM+Cacho&author=KH+Nicolaides&publication_year=2004&hl=en']",,https://doi.org/10.1002/pd.819, Spencer 2004 {published data only}  ,excluded,CD009925-bbs2-0455, Calculation of smoking correction factor. 
CD009925-bib-0471,"Spencer K, Cicero S, Atzei A, Otigbah C, Nicolaides KH. ",The influence of maternal insulin‐dependent diabetes on fetal nuchal translucency thickness and first‐trimester maternal serum biochemical markers of aneuploidy, Prenatal Diagnosis ,2005,25,    ,['citation-journal']," Spencer K, Cicero S, Atzei A, Otigbah C, Nicolaides KH. The influence of maternal insulin‐dependent diabetes on fetal nuchal translucency thickness and first‐trimester maternal serum biochemical markers of aneuploidy.  Prenatal Diagnosis 2005;25(10):927‐9.    Link to article     Google Scholar     ","['https://doi.org/10.1002/pd.1229', 'https://scholar.google.com/scholar_lookup?title=The+influence+of+maternal+insulin‐dependent+diabetes+on+fetal+nuchal+translucency+thickness+and+first‐trimester+maternal+serum+biochemical+markers+of+aneuploidy+&author=K+Spencer&author=S+Cicero&author=A+Atzei&author=C+Otigbah&author=KH+Nicolaides&publication_year=2005&hl=en']",,https://doi.org/10.1002/pd.1229, Spencer 2005a {published data only}  ,excluded,CD009925-bbs2-0456, No Down's pregnancies. 
CD009925-bib-0472,"Spencer K, Heath V, El‐Sheikhah A, Ong CY, Nicolaides KH. ","Ethnicity and the need for correction of biochemical and ultrasound markers of chromosomal anomalies in the first trimester: a study of Oriental, Asian and Afro‐Caribbean populations", Prenatal Diagnosis ,2005,25,    ,['citation-journal']," Spencer K, Heath V, El‐Sheikhah A, Ong CY, Nicolaides KH. Ethnicity and the need for correction of biochemical and ultrasound markers of chromosomal anomalies in the first trimester: a study of Oriental, Asian and Afro‐Caribbean populations.  Prenatal Diagnosis 2005;25(5):365‐9.    Link to article     Google Scholar     ","['https://doi.org/10.1002/pd.1153', 'https://scholar.google.com/scholar_lookup?title=Ethnicity+and+the+need+for+correction+of+biochemical+and+ultrasound+markers+of+chromosomal+anomalies+in+the+first+trimester:+a+study+of+Oriental,+Asian+and+Afro‐Caribbean+populations+&author=K+Spencer&author=V+Heath&author=A+El‐Sheikhah&author=CY+Ong&author=KH+Nicolaides&publication_year=2005&hl=en']",,https://doi.org/10.1002/pd.1153, Spencer 2005b {published data only}  ,excluded,CD009925-bbs2-0457, No Down's pregnancies. 
CD009925-bib-0473,Spencer K. ,First trimester maternal serum screening for Down's syndrome: an evaluation of the DPC Immulite 2000 free ß‐hCG and pregnancy‐associated plasma protein‐A assays.[see comment], Annals of Clinical Biochemistry ,2005,42,    ,['citation-journal'], Spencer K. First trimester maternal serum screening for Down's syndrome: an evaluation of the DPC Immulite 2000 free ß‐hCG and pregnancy‐associated plasma protein‐A assays.[see comment].  Annals of Clinical Biochemistry 2005;42(1):30‐40.    Link to article     Google Scholar     ,"['https://doi.org/10.1258/0004563053026880', ""https://scholar.google.com/scholar_lookup?title=First+trimester+maternal+serum+screening+for+Down's+syndrome:+an+evaluation+of+the+DPC+Immulite+2000+free+ß‐hCG+and+pregnancy‐associated+plasma+protein‐A+assays.[see+comment]+&author=K+Spencer&publication_year=2005&hl=en""]",,https://doi.org/10.1258/0004563053026880, Spencer 2005c {published data only}  ,excluded,CD009925-bbs2-0458, Comparison of two different assays ‐ not actual screening evaluation. 
CD009925-bib-0474,"Spong CY, Ghidini A, Stanley‐Christian H, Meck JM, Seydel FD, Pezzullo JC. ",Risk of abnormal triple screen for Down syndrome is significantly higher in women with female fetuses, Prenatal Diagnosis. ,1999,19,    ,['citation-journal']," Spong CY, Ghidini A, Stanley‐Christian H, Meck JM, Seydel FD, Pezzullo JC. Risk of abnormal triple screen for Down syndrome is significantly higher in women with female fetuses.  Prenatal Diagnosis. 1999;19(4):337‐9.    Link to article     Google Scholar     ","['https://doi.org/10.1002/(SICI)1097-0223(199904)19:4<337::AID-PD553>3.0.CO;2-4', 'https://scholar.google.com/scholar_lookup?title=Risk+of+abnormal+triple+screen+for+Down+syndrome+is+significantly+higher+in+women+with+female+fetuses+&author=CY+Spong&author=A+Ghidini&author=H+Stanley‐Christian&author=JM+Meck&author=FD+Seydel&author=JC+Pezzullo&publication_year=1999&hl=en']",,https://doi.org/10.1002/(SICI)1097-0223(199904)19:4<337::AID-PD553>3.0.CO;2-4, Spong 1999 {published data only}  ,excluded,CD009925-bbs2-0459, Comparison of male and female fetuses. 
CD009925-bib-0475,Stevens SL. ,The use of nuchal lucency as a screening tool in first trimester sonography, Journal of Diagnostic Medical Sonography ,1998,14,    ,['citation-journal'], Stevens SL. The use of nuchal lucency as a screening tool in first trimester sonography.  Journal of Diagnostic Medical Sonography 1998;14(6):251‐4.    Link to article     Google Scholar     ,"['https://doi.org/10.1177/875647939801400603', 'https://scholar.google.com/scholar_lookup?title=The+use+of+nuchal+lucency+as+a+screening+tool+in+first+trimester+sonography&author=SL+Stevens&publication_year=1998&hl=en']",,https://doi.org/10.1177/875647939801400603, Stevens 1998 {published data only}  ,excluded,CD009925-bbs2-0460, Literature review. 
CD009925-bib-0476,Stoll C. ,A new approach of prenatal prevention of constitutional disabilities ‐ the study of markers of maternal serum, Journal de Medecine de Strasbourg ,1992,23,    ,['citation-journal'], Stoll C. A new approach of prenatal prevention of constitutional disabilities ‐ the study of markers of maternal serum.  Journal de Medecine de Strasbourg 1992;23(1):25‐7.    Google Scholar     ,['https://scholar.google.com/scholar_lookup?title=A+new+approach+of+prenatal+prevention+of+constitutional+disabilities+‐+the+study+of+markers+of+maternal+serum+&author=C+Stoll&publication_year=1992&hl=en'],,, Stoll 1992 {published data only}  ,excluded,CD009925-bbs2-0461, Review article. 
CD009925-bib-0477,"Su YN, Hsu JJ, Lee CN, Cheng WF, Kung CC, Hsieh FJ. ",Raised maternal serum placenta growth factor concentration during the second trimester is associated with Down syndrome, Prenatal Diagnosis ,2002,22,    ,['citation-journal']," Su YN, Hsu JJ, Lee CN, Cheng WF, Kung CC, Hsieh FJ. Raised maternal serum placenta growth factor concentration during the second trimester is associated with Down syndrome.  Prenatal Diagnosis 2002;22(1):8‐12.    Link to article     Google Scholar     ","['https://doi.org/10.1002/pd.218', 'https://scholar.google.com/scholar_lookup?title=Raised+maternal+serum+placenta+growth+factor+concentration+during+the+second+trimester+is+associated+with+Down+syndrome+&author=YN+Su&author=JJ+Hsu&author=CN+Lee&author=WF+Cheng&author=CC+Kung&author=FJ+Hsieh&publication_year=2002&hl=en']",,https://doi.org/10.1002/pd.218, Su 2002a {published data only}  ,excluded,CD009925-bbs2-0462, Unable to extract useful data. 
CD009925-bib-0478,Suchet IB. ,Ultrasonography of the fetal neck in the first and second trimesters. Part 2. Anomalies of the posterior nuchal region, Canadian Association of Radiologists Journal ,1995,46,    ,['citation-journal'], Suchet IB. Ultrasonography of the fetal neck in the first and second trimesters. Part 2. Anomalies of the posterior nuchal region.  Canadian Association of Radiologists Journal 1995;46(5):344‐52.    Google Scholar     ,['https://scholar.google.com/scholar_lookup?title=Ultrasonography+of+the+fetal+neck+in+the+first+and+second+trimesters.+Part+2.+Anomalies+of+the+posterior+nuchal+region+&author=IB+Suchet&publication_year=1995&hl=en'],,, Suchet 1995 {published data only}  ,excluded,CD009925-bbs2-0463, Review article. 
CD009925-bib-0479,"Suchy SF, Yeager MT. ",Down syndrome screening in women under 35 with maternal serum hCG, Obstetrics & Gynecology ,1990,76,    ,['citation-journal']," Suchy SF, Yeager MT. Down syndrome screening in women under 35 with maternal serum hCG.  Obstetrics & Gynecology 1990;76(1):20‐4.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=Down+syndrome+screening+in+women+under+35+with+maternal+serum+hCG&author=SF+Suchy&author=MT+Yeager&publication_year=1990&hl=en'],,, Suchy 1990 {published data only}  ,excluded,CD009925-bbs2-0464, Unable to ascertain method of confirmation of gestational age. 
CD009925-bib-0480,"Summers AM, Farrell SA, Huang T, Meier C, Wyatt PR. ",Maternal serum screening in Ontario using the triple marker test, Journal of Medical Screening ,2003,10,    ,['citation-journal']," Summers AM, Farrell SA, Huang T, Meier C, Wyatt PR. Maternal serum screening in Ontario using the triple marker test.  Journal of Medical Screening 2003;10(3):107‐11.    Link to article     Google Scholar     ","['https://doi.org/10.1177/096914130301000302', 'https://scholar.google.com/scholar_lookup?title=Maternal+serum+screening+in+Ontario+using+the+triple+marker+test&author=AM+Summers&author=SA+Farrell&author=T+Huang&author=C+Meier&author=PR+Wyatt&publication_year=2003&hl=en']",,https://doi.org/10.1177/096914130301000302, Summers 2003a {published data only}  ,excluded,CD009925-bbs2-0465, Only 55% gestational ages estimated by USS. 
CD009925-bib-0481,"Summers AM, Huang T, Meier C, Wyatt PR. ",The implications of a false positive second‐trimester serum screen for Down syndrome, Obstetrics & Gynecology ,2003,101,    ,['citation-journal']," Summers AM, Huang T, Meier C, Wyatt PR. The implications of a false positive second‐trimester serum screen for Down syndrome.  Obstetrics & Gynecology 2003;101(6):1301‐6.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=The+implications+of+a+false+positive+second‐trimester+serum+screen+for+Down+syndrome&author=AM+Summers&author=T+Huang&author=C+Meier&author=PR+Wyatt&publication_year=2003&hl=en'],,, Summers 2003b {published data only}  ,excluded,CD009925-bbs2-0466, No Down's syndrome pregnancies in study population. 
CD009925-bib-0482,"Suntharasaj T, Ratanasiri T, Chanprapaph P, Kengpol C, Kor‐anantakul O, Leetanaporn R, et al. ",Variability of nuchal translucency measurement: a multicenter study in Thailand, Gynecologic & Obstetric Investigation ,2005,60,    ,['citation-journal']," Suntharasaj T, Ratanasiri T, Chanprapaph P, Kengpol C, Kor‐anantakul O, Leetanaporn R, et al. Variability of nuchal translucency measurement: a multicenter study in Thailand.  Gynecologic & Obstetric Investigation 2005;60(4):201‐5.    Link to article     Google Scholar     ","['https://doi.org/10.1159/000087206', 'https://scholar.google.com/scholar_lookup?title=Variability+of+nuchal+translucency+measurement:+a+multicenter+study+in+Thailand&author=T+Suntharasaj&author=T+Ratanasiri&author=P+Chanprapaph&author=C+Kengpol&author=O+Kor‐anantakul&author=R+Leetanaporn&publication_year=2005&hl=en']",,https://doi.org/10.1159/000087206, Suntharasaj 2005 {published data only}  ,excluded,CD009925-bbs2-0467, Examination of inter‐observer variation in NT scanning. 
CD009925-bib-0483,"Sutton JM, Cole LA. ",Sialic acid‐deficient invasive trophoblast antigen (sd‐ITA): a new urinary variant for gestational Down syndrome screening, Prenatal Diagnosis ,2004,24,    ,['citation-journal']," Sutton JM, Cole LA. Sialic acid‐deficient invasive trophoblast antigen (sd‐ITA): a new urinary variant for gestational Down syndrome screening.  Prenatal Diagnosis 2004;24(3):194‐7.    Link to article     Google Scholar     ","['https://doi.org/10.1002/pd.836', 'https://scholar.google.com/scholar_lookup?title=Sialic+acid‐deficient+invasive+trophoblast+antigen+(sd‐ITA):+a+new+urinary+variant+for+gestational+Down+syndrome+screening+&author=JM+Sutton&author=LA+Cole&publication_year=2004&hl=en']",,https://doi.org/10.1002/pd.836, Sutton 2004 {published data only}  ,excluded,CD009925-bbs2-0468, Unable to extract useful data. 
CD009925-bib-0484,"Suzuki Y, Takada J, Iwaki T, Isaka K, Takayama M. ",Screening for trisomy 21 in the first trimester by measurement of serum PAPP‐A and free ß‐hCG, Acta Obstetrica et Gynaecologica Japonica ,1998,50,    ,['citation-journal']," Suzuki Y, Takada J, Iwaki T, Isaka K, Takayama M. Screening for trisomy 21 in the first trimester by measurement of serum PAPP‐A and free ß‐hCG.  Acta Obstetrica et Gynaecologica Japonica 1998;50(1):37‐40.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=Screening+for+trisomy+21+in+the+first+trimester+by+measurement+of+serum+PAPP‐A+and+free+ß‐hCG+&author=Y+Suzuki&author=J+Takada&author=T+Iwaki&author=K+Isaka&author=M+Takayama&publication_year=1998&hl=en'],,, Suzuki 1998 {published data only}  ,excluded,CD009925-bbs2-0469, Unable to extract useful data. 
CD009925-bib-0485,"Tabor A, Larsen SO, Nielsen J, Nielsen J, Philip J, Pilgaard B, et al. ",Screening for Down's syndrome using an iso‐risk curve based on maternal age and serum alpha‐fetoprotein level, British Journal of Obstetrics & Gynaecology ,1987,94,    ,['citation-journal']," Tabor A, Larsen SO, Nielsen J, Nielsen J, Philip J, Pilgaard B, et al. Screening for Down's syndrome using an iso‐risk curve based on maternal age and serum alpha‐fetoprotein level.  British Journal of Obstetrics & Gynaecology 1987;94(7):636‐42.    Link to article     Google Scholar     ","['https://doi.org/10.1111/j.1471-0528.1987.tb03167.x', ""https://scholar.google.com/scholar_lookup?title=Screening+for+Down's+syndrome+using+an+iso‐risk+curve+based+on+maternal+age+and+serum+alpha‐fetoprotein+level+&author=A+Tabor&author=SO+Larsen&author=J+Nielsen&author=J+Nielsen&author=J+Philip&author=B+Pilgaard&publication_year=1987&hl=en""]",,https://doi.org/10.1111/j.1471-0528.1987.tb03167.x, Tabor 1987 {published data only}  ,excluded,CD009925-bbs2-0470, Geststional age not confirmed by USS. 
CD009925-bib-0486,"Tanski S, Rosengren SS, Benn PA. ",Predictive value of the triple screening test for the phenotype of Down syndrome, American Journal of Medical Genetics ,1999,85,    ,['citation-journal']," Tanski S, Rosengren SS, Benn PA. Predictive value of the triple screening test for the phenotype of Down syndrome.  American Journal of Medical Genetics 1999;85(2):123‐6.    Link to article     Google Scholar     ","['https://doi.org/10.1002/(SICI)1096-8628(19990716)85:2<123::AID-AJMG5>3.0.CO;2-M', 'https://scholar.google.com/scholar_lookup?title=Predictive+value+of+the+triple+screening+test+for+the+phenotype+of+Down+syndrome&author=S+Tanski&author=SS+Rosengren&author=PA+Benn&publication_year=1999&hl=en']",,https://doi.org/10.1002/(SICI)1096-8628(19990716)85:2<123::AID-AJMG5>3.0.CO;2-M, Tanski 1999 {published data only}  ,excluded,CD009925-bbs2-0471, Information on screen positive pregnancies only. 
CD009925-bib-0487,"Thilaganathan B, Khare M, Williams B, Wathen NC. ",Influence of ethnic origin on nuchal translucency screening for Down's syndrome, Ultrasound in Obstetrics & Gynecology ,1998,12,    ,['citation-journal']," Thilaganathan B, Khare M, Williams B, Wathen NC. Influence of ethnic origin on nuchal translucency screening for Down's syndrome.  Ultrasound in Obstetrics & Gynecology 1998;12(2):112‐4.    Link to article     Google Scholar     ","['https://doi.org/10.1046/j.1469-0705.1998.12020112.x', ""https://scholar.google.com/scholar_lookup?title=Influence+of+ethnic+origin+on+nuchal+translucency+screening+for+Down's+syndrome&author=B+Thilaganathan&author=M+Khare&author=B+Williams&author=NC+Wathen&publication_year=1998&hl=en""]",,https://doi.org/10.1046/j.1469-0705.1998.12020112.x, Thilaganathan 1998 {published data only}  ,excluded,CD009925-bbs2-0472, No Down's syndrome pregnancies in study population. 
CD009925-bib-0488,Thilaganathan B. ,First‐trimester nuchal translucency and maternal serum biochemical screening for Down's syndrome: A happy union?, Ultrasound in Obstetrics and Gynecology ,1999,13,    ,['citation-journal'], Thilaganathan B. First‐trimester nuchal translucency and maternal serum biochemical screening for Down's syndrome: A happy union?.  Ultrasound in Obstetrics and Gynecology 1999;13(4):229‐30.    Link to article     Google Scholar     ,"['https://doi.org/10.1046/j.1469-0705.1999.13040229.x', ""https://scholar.google.com/scholar_lookup?title=First‐trimester+nuchal+translucency+and+maternal+serum+biochemical+screening+for+Down's+syndrome:+A+happy+union?+&author=B+Thilaganathan&publication_year=1999&hl=en""]",,https://doi.org/10.1046/j.1469-0705.1999.13040229.x, Thilaganathan 1999 {published data only}  ,excluded,CD009925-bbs2-0473, Editorial. 
CD009925-bib-0489,"Tislaric D, Brajenovic‐Milic B, Ristic S, Latin V, Zuvic‐Butorac M, Bacic J, et al. ",The influence of smoking and parity on serum markers for Down's syndrome screening, Fetal Diagnosis & Therapy ,2002,17,    ,['citation-journal']," Tislaric D, Brajenovic‐Milic B, Ristic S, Latin V, Zuvic‐Butorac M, Bacic J, et al. The influence of smoking and parity on serum markers for Down's syndrome screening.  Fetal Diagnosis & Therapy 2002;17(1):17‐21.    Link to article     Google Scholar     ","['https://doi.org/10.1159/000047999', ""https://scholar.google.com/scholar_lookup?title=The+influence+of+smoking+and+parity+on+serum+markers+for+Down's+syndrome+screening&author=D+Tislaric&author=B+Brajenovic‐Milic&author=S+Ristic&author=V+Latin&author=M+Zuvic‐Butorac&author=J+Bacic&publication_year=2002&hl=en""]",,https://doi.org/10.1159/000047999, Tislaric 2002 {published data only}  ,excluded,CD009925-bbs2-0474, No Down's syndrome pregnancies in population. 
CD009925-bib-0490,"Torok O, Veress L, Szabo M, Zsupan I, Buczko Z, Bolodar A, et al. ",[Biochemical and ultrasonic screening of chromosomal aneuploidies in the second trimester of pregnancy]. [Hungarian], Orvosi Hetilap ,1997,138,    ,['citation-journal']," Torok O, Veress L, Szabo M, Zsupan I, Buczko Z, Bolodar A, et al. [Biochemical and ultrasonic screening of chromosomal aneuploidies in the second trimester of pregnancy]. [Hungarian].  Orvosi Hetilap 1997;138(3):123‐7.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=[Biochemical+and+ultrasonic+screening+of+chromosomal+aneuploidies+in+the+second+trimester+of+pregnancy].+[Hungarian]+&author=O+Torok&author=L+Veress&author=M+Szabo&author=I+Zsupan&author=Z+Buczko&author=A+Bolodar&publication_year=1997&hl=en'],,, Torok 1997 {published data only}  ,excluded,CD009925-bbs2-0475, Unable to extract useful data. 
CD009925-bib-0491,"Tsai MS, Huang YY, Hwa KY, Cheng CC, Lee FK. ","Combined measurement of fetal nuchal translucency, maternal serum free ß‐hCG, and pregnancy‐associated plasma protein A for first‐trimester Down's syndrome screening", Journal of the Formosan Medical Association ,2001,100,    ,['citation-journal']," Tsai MS, Huang YY, Hwa KY, Cheng CC, Lee FK. Combined measurement of fetal nuchal translucency, maternal serum free ß‐hCG, and pregnancy‐associated plasma protein A for first‐trimester Down's syndrome screening.  Journal of the Formosan Medical Association 2001;100(5):319‐25.    Google Scholar     ","[""https://scholar.google.com/scholar_lookup?title=Combined+measurement+of+fetal+nuchal+translucency,+maternal+serum+free+ß‐hCG,+and+pregnancy‐associated+plasma+protein+A+for+first‐trimester+Down's+syndrome+screening+&author=MS+Tsai&author=YY+Huang&author=KY+Hwa&author=CC+Cheng&author=FK+Lee&publication_year=2001&hl=en""]",,, Tsai 2001 {published data only}  ,excluded,CD009925-bbs2-0476, Less than 5 Down's syndrome pregnancies in study population. 
CD009925-bib-0492,"Valerio D, Aiello R, Altieri V, Fagnoni P. ","Maternal serum screening of fetal chromosomal abnormalities by AFP, UE3, hCG and free‐ß hCG. Prospective and retrospective results", Minerva Ginecologica ,1996,48,    ,['citation-journal']," Valerio D, Aiello R, Altieri V, Fagnoni P. Maternal serum screening of fetal chromosomal abnormalities by AFP, UE3, hCG and free‐ß hCG. Prospective and retrospective results.  Minerva Ginecologica 1996;48(5):169‐73.    Google Scholar     ","['https://scholar.google.com/scholar_lookup?title=Maternal+serum+screening+of+fetal+chromosomal+abnormalities+by+AFP,+UE3,+hCG+and+free‐ß+hCG.+Prospective+and+retrospective+results+&author=D+Valerio&author=R+Aiello&author=V+Altieri&author=P+Fagnoni&publication_year=1996&hl=en']",,, Valerio 1996 {published data only}  ,excluded,CD009925-bbs2-0477, Fewer than 80% pregnancies had gestational age estimated by USS. 
CD009925-bib-0493,"Van Blerk M, Smitz J, De Catte L, Kumps C, Van der Elst J, Van Steirteghem AC. ",Second‐trimester cancer antigen 125 and Down's syndrome.[see comment], Prenatal Diagnosis ,1992,12,    ,['citation-journal']," Van Blerk M, Smitz J, De Catte L, Kumps C, Van der Elst J, Van Steirteghem AC. Second‐trimester cancer antigen 125 and Down's syndrome.[see comment].  Prenatal Diagnosis 1992;12(12):1062‐6.    Link to article     Google Scholar     ","['https://doi.org/10.1002/pd.1970121213', ""https://scholar.google.com/scholar_lookup?title=Second‐trimester+cancer+antigen+125+and+Down's+syndrome.[see+comment]&author=M+Blerk&author=J+Smitz&author=L+Catte&author=C+Kumps&author=J+Elst&author=AC+Steirteghem&publication_year=1992&hl=en""]",,https://doi.org/10.1002/pd.1970121213, Van Blerk 1992 {published data only}  ,excluded,CD009925-bbs2-0478, Unable to extract useful data. 
CD009925-bib-0494,"Van Heesch, Schielen PCJ I, Wildhagen MF, Den Hollander, Steegers EAP, Wildschut HIJ. ",Combined first trimester screening for trisomy 21: Lack of agreement between risk calculation methods, Journal of Perinatal Medicine ,2006,34,    ,['citation-journal']," Van Heesch, Schielen PCJ I, Wildhagen MF, Den Hollander, Steegers EAP, Wildschut HIJ. Combined first trimester screening for trisomy 21: Lack of agreement between risk calculation methods.  Journal of Perinatal Medicine 2006;34(2):162‐5.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=Combined+first+trimester+screening+for+trisomy+21:+Lack+of+agreement+between+risk+calculation+methods+&author=Heesch+Van&author=I+SchielenPCJ&author=MF+Wildhagen&author=Hollander+Den&author=EAP+Steegers&author=HIJ+Wildschut&publication_year=2006&hl=en'],,," Van Heesch, 2006 {published data only}  ",excluded,CD009925-bbs2-0479, No Down's syndrome pregnancies in study population. Software comparison study. 
CD009925-bib-0495,"Van Lith JM, Mantingh A, Beekhuis JR, De Bruijn HW, Breed AS. ",First trimester CA 125 and Down's syndrome, British Journal of Obstetrics & Gynaecology ,1991,98,    ,['citation-journal']," Van Lith JM, Mantingh A, Beekhuis JR, De Bruijn HW, Breed AS. First trimester CA 125 and Down's syndrome.  British Journal of Obstetrics & Gynaecology 1991;98(5):493‐4.    Link to article     Google Scholar     ","['https://doi.org/10.1111/j.1471-0528.1991.tb10351.x', ""https://scholar.google.com/scholar_lookup?title=First+trimester+CA+125+and+Down's+syndrome&author=JM+Lith&author=A+Mantingh&author=JR+Beekhuis&author=HW+Bruijn&author=AS+Breed&publication_year=1991&hl=en""]",,https://doi.org/10.1111/j.1471-0528.1991.tb10351.x, Van Lith 1991 {published data only}  ,excluded,CD009925-bbs2-0480, Unable to extract useful data. 
CD009925-bib-0496,"Van Lith, Mantingh A, De Bruijn. ",Maternal serum CA 125 levels in pregnancies with chromosomally‐normal and ‐abnormal fetuses. Dutch Working Party on Prenatal Diagnosis, Prenatal Diagnosis ,1993,13,    ,['citation-journal']," Van Lith, Mantingh A, De Bruijn. Maternal serum CA 125 levels in pregnancies with chromosomally‐normal and ‐abnormal fetuses. Dutch Working Party on Prenatal Diagnosis.  Prenatal Diagnosis 1993;13(12):1123‐31.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=Maternal+serum+CA+125+levels+in+pregnancies+with+chromosomally‐normal+and+‐abnormal+fetuses.+Dutch+Working+Party+on+Prenatal+Diagnosis+&author=Lith+Van&author=A+Mantingh&author=Bruijn+De&publication_year=1993&hl=en'],,, Van Lith 1993 {published data only}  ,excluded,CD009925-bbs2-0481, Unable to extract useful data. 
CD009925-bib-0497,"Van Lith, Mantingh A, Pratt JJ. ",First‐trimester maternal serum immunoreactive inhibin in chromosomally normal and abnormal pregnancies. Dutch Working Party on Prenatal Diagnosis, Obstetrics and Gynecology ,1994,83,    ,['citation-journal']," Van Lith, Mantingh A, Pratt JJ. First‐trimester maternal serum immunoreactive inhibin in chromosomally normal and abnormal pregnancies. Dutch Working Party on Prenatal Diagnosis.  Obstetrics and Gynecology 1994;83(5 Pt 1):661‐4.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=First‐trimester+maternal+serum+immunoreactive+inhibin+in+chromosomally+normal+and+abnormal+pregnancies.+Dutch+Working+Party+on+Prenatal+Diagnosis+&author=Lith+Van&author=A+Mantingh&author=JJ+Pratt&publication_year=1994&hl=en'],,, Van Lith 1994 {published data only}  ,excluded,CD009925-bbs2-0482, Unable to extract useful data. 
CD009925-bib-0498,"Veress L, Szabo M, Horvath K, Polgar K, Papp Z. ",[Low maternal serum alpha‐fetoprotein concentration and Down syndrome]. [Hungarian], Orvosi Hetilap ,1986,127,    ,['citation-journal']," Veress L, Szabo M, Horvath K, Polgar K, Papp Z. [Low maternal serum alpha‐fetoprotein concentration and Down syndrome]. [Hungarian].  Orvosi Hetilap 1986;127(20):1232‐3.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=[Low+maternal+serum+alpha‐fetoprotein+concentration+and+Down+syndrome].+[Hungarian]&author=L+Veress&author=M+Szabo&author=K+Horvath&author=K+Polgar&author=Z+Papp&publication_year=1986&hl=en'],,, Veress 1986 {published data only}  ,excluded,CD009925-bbs2-0483, Unable to extract useful data. 
CD009925-bib-0499,"Veress L, Szabo M, Polgar K, Takacs L, Papp Z. ",[Prenatal screening for Down's syndrome by measuring the AFP concentration in the maternal serum]. [Hungarian], Orvosi Hetilap ,1988,129,    ,['citation-journal']," Veress L, Szabo M, Polgar K, Takacs L, Papp Z. [Prenatal screening for Down's syndrome by measuring the AFP concentration in the maternal serum]. [Hungarian].  Orvosi Hetilap 1988;129(31):1677.    Google Scholar     ","[""https://scholar.google.com/scholar_lookup?title=[Prenatal+screening+for+Down's+syndrome+by+measuring+the+AFP+concentration+in+the+maternal+serum].+[Hungarian]+&author=L+Veress&author=M+Szabo&author=K+Polgar&author=L+Takacs&author=Z+Papp&publication_year=1988&hl=en""]",,, Veress 1988 {published data only}  ,excluded,CD009925-bbs2-0484, Unable to extract useful data. 
CD009925-bib-0500,"Vintzileos A, Walters C, Yeo L. ",Absent nasal bone in the prenatal detection of fetuses with trisomy 21 in a high‐risk population, Obstetrics & Gynecology ,2003,101,    ,['citation-journal']," Vintzileos A, Walters C, Yeo L. Absent nasal bone in the prenatal detection of fetuses with trisomy 21 in a high‐risk population.  Obstetrics & Gynecology 2003;101(5):905‐8.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=Absent+nasal+bone+in+the+prenatal+detection+of+fetuses+with+trisomy+21+in+a+high‐risk+population+&author=A+Vintzileos&author=C+Walters&author=L+Yeo&publication_year=2003&hl=en'],,, Vintzileos 2003 {published data only}  ,excluded,CD009925-bbs2-0485, Second trimester USS. 
CD009925-bib-0501,"Wald NJ, Cuckle HS, Densem JW, Nanchahal K, Royston P, Chard T, et al. ",Maternal serum screening for Down's syndrome in early pregnancy, BMJ ,1988,297,    ,['citation-journal']," Wald NJ, Cuckle HS, Densem JW, Nanchahal K, Royston P, Chard T, et al. Maternal serum screening for Down's syndrome in early pregnancy.  BMJ 1988;297(6653):883‐7.    Link to article     Google Scholar     ","['https://doi.org/10.1136/bmj.297.6653.883', ""https://scholar.google.com/scholar_lookup?title=Maternal+serum+screening+for+Down's+syndrome+in+early+pregnancy&author=NJ+Wald&author=HS+Cuckle&author=JW+Densem&author=K+Nanchahal&author=P+Royston&author=T+Chard&publication_year=1988&hl=en""]",,https://doi.org/10.1136/bmj.297.6653.883, Wald 1988a {published data only}  ,excluded,CD009925-bbs2-0486, Less than 80% had gestational age confirmed by ultrasound. 
CD009925-bib-0502,"Wald NJ, Cuckle HS, Densem JW, Nanchahal K, Canick JA, Haddow JE, et al. ",Maternal serum unconjugated oestriol as an antenatal screening test for Down's syndrome, British Journal of Obstetrics & Gynaecology ,1988,95,    ,['citation-journal']," Wald NJ, Cuckle HS, Densem JW, Nanchahal K, Canick JA, Haddow JE, et al. Maternal serum unconjugated oestriol as an antenatal screening test for Down's syndrome.  British Journal of Obstetrics & Gynaecology 1988;95(4):334‐41.    Link to article     Google Scholar     ","['https://doi.org/10.1111/j.1471-0528.1988.tb06602.x', ""https://scholar.google.com/scholar_lookup?title=Maternal+serum+unconjugated+oestriol+as+an+antenatal+screening+test+for+Down's+syndrome&author=NJ+Wald&author=HS+Cuckle&author=JW+Densem&author=K+Nanchahal&author=JA+Canick&author=JE+Haddow&publication_year=1988&hl=en""]",,https://doi.org/10.1111/j.1471-0528.1988.tb06602.x, Wald 1988b {published data only}  ,excluded,CD009925-bbs2-0487, Gestational age not confirmed by USS. 
CD009925-bib-0503,"Wald N, Cuckle H, Wu TS, George L. ",Maternal serum unconjugated oestriol and human chorionic gonadotrophin levels in twin pregnancies: implications for screening for Down's syndrome, British Journal of Obstetrics & Gynaecology ,1991,98,    ,['citation-journal']," Wald N, Cuckle H, Wu TS, George L. Maternal serum unconjugated oestriol and human chorionic gonadotrophin levels in twin pregnancies: implications for screening for Down's syndrome.  British Journal of Obstetrics & Gynaecology 1991;98(9):905‐8.    Link to article     Google Scholar     ","['https://doi.org/10.1111/j.1471-0528.1991.tb13513.x', ""https://scholar.google.com/scholar_lookup?title=Maternal+serum+unconjugated+oestriol+and+human+chorionic+gonadotrophin+levels+in+twin+pregnancies:+implications+for+screening+for+Down's+syndrome+&author=N+Wald&author=H+Cuckle&author=TS+Wu&author=L+George&publication_year=1991&hl=en""]",,https://doi.org/10.1111/j.1471-0528.1991.tb13513.x, Wald 1991 {published data only}  ,excluded,CD009925-bbs2-0488, No Down's pregnancies in study. 
CD009925-bib-0504,"Wald NJ, Kennard A, Densem JW, Cuckle HS, Chard T, Butler L. ",Antenatal maternal serum screening for Down's syndrome: results of a demonstration project.[see comment], BMJ ,1992,305,    ,['citation-journal']," Wald NJ, Kennard A, Densem JW, Cuckle HS, Chard T, Butler L. Antenatal maternal serum screening for Down's syndrome: results of a demonstration project.[see comment].  BMJ 1992;305(6850):391‐4.    Link to article     Google Scholar     ","['https://doi.org/10.1136/bmj.305.6850.391', ""https://scholar.google.com/scholar_lookup?title=Antenatal+maternal+serum+screening+for+Down's+syndrome:+results+of+a+demonstration+project.[see+comment]+&author=NJ+Wald&author=A+Kennard&author=JW+Densem&author=HS+Cuckle&author=T+Chard&author=L+Butler&publication_year=1992&hl=en""]",,https://doi.org/10.1136/bmj.305.6850.391, Wald 1992a {published data only}  ,excluded,CD009925-bbs2-0489, Less than 80% had gestational age confirmed by ultrasound. 
CD009925-bib-0505,"Wald NJ, Cuckle HS, Densem JW, Stone RB. ",Maternal serum unconjugated oestriol and human chorionic gonadotrophin levels in pregnancies with insulin‐dependent diabetes: implications for screening for Down's syndrome, British Journal of Obstetrics & Gynaecology ,1992,99,    ,['citation-journal']," Wald NJ, Cuckle HS, Densem JW, Stone RB. Maternal serum unconjugated oestriol and human chorionic gonadotrophin levels in pregnancies with insulin‐dependent diabetes: implications for screening for Down's syndrome.  British Journal of Obstetrics & Gynaecology 1992;99(1):51‐3.    Link to article     Google Scholar     ","['https://doi.org/10.1111/j.1471-0528.1992.tb14392.x', ""https://scholar.google.com/scholar_lookup?title=Maternal+serum+unconjugated+oestriol+and+human+chorionic+gonadotrophin+levels+in+pregnancies+with+insulin‐dependent+diabetes:+implications+for+screening+for+Down's+syndrome+&author=NJ+Wald&author=HS+Cuckle&author=JW+Densem&author=RB+Stone&publication_year=1992&hl=en""]",,https://doi.org/10.1111/j.1471-0528.1992.tb14392.x, Wald 1992b {published data only}  ,excluded,CD009925-bbs2-0490, No Down's pregnancies in study. 
CD009925-bib-0506,"Wald NJ, Cuckle HS, Densem JW, Kennard A, Smith D. ",Maternal serum screening for Down's syndrome: the effect of routine ultrasound scan determination of gestational age and adjustment for maternal weight.[see comment], British Journal of Obstetrics & Gynaecology ,1992,99,    ,['citation-journal']," Wald NJ, Cuckle HS, Densem JW, Kennard A, Smith D. Maternal serum screening for Down's syndrome: the effect of routine ultrasound scan determination of gestational age and adjustment for maternal weight.[see comment].  British Journal of Obstetrics & Gynaecology 1992;99(2):144‐9.    Link to article     Google Scholar     ","['https://doi.org/10.1111/j.1471-0528.1992.tb14474.x', ""https://scholar.google.com/scholar_lookup?title=Maternal+serum+screening+for+Down's+syndrome:+the+effect+of+routine+ultrasound+scan+determination+of+gestational+age+and+adjustment+for+maternal+weight.[see+comment]+&author=NJ+Wald&author=HS+Cuckle&author=JW+Densem&author=A+Kennard&author=D+Smith&publication_year=1992&hl=en""]",,https://doi.org/10.1111/j.1471-0528.1992.tb14474.x, Wald 1992c {published data only}  ,excluded,CD009925-bbs2-0491, No Down's pregnancies in study. 
CD009925-bib-0507,"Wald N, Densem J, Stone R, Cheng R. ",The use of free ß‐hCG in antenatal screening for Down's syndrome.[see comment], British Journal of Obstetrics & Gynaecology ,1993,100,    ,['citation-journal']," Wald N, Densem J, Stone R, Cheng R. The use of free ß‐hCG in antenatal screening for Down's syndrome.[see comment].  British Journal of Obstetrics & Gynaecology 1993;100(6):550‐7.    Link to article     Google Scholar     ","['https://doi.org/10.1111/j.1471-0528.1993.tb15307.x', ""https://scholar.google.com/scholar_lookup?title=The+use+of+free+ß‐hCG+in+antenatal+screening+for+Down's+syndrome.[see+comment]&author=N+Wald&author=J+Densem&author=R+Stone&author=R+Cheng&publication_year=1993&hl=en""]",,https://doi.org/10.1111/j.1471-0528.1993.tb15307.x, Wald 1993 {published data only}  ,excluded,CD009925-bbs2-0492, No USS dating. 
CD009925-bib-0508,"Wald NJ, Densem JW. ",Maternal serum free alpha‐human chorionic gonadotrophin levels in twin pregnancies: implications for screening for Down's syndrome, Prenatal Diagnosis ,1994,14,    ,['citation-journal']," Wald NJ, Densem JW. Maternal serum free alpha‐human chorionic gonadotrophin levels in twin pregnancies: implications for screening for Down's syndrome.  Prenatal Diagnosis 1994;14(8):717‐9.    Link to article     Google Scholar     ","['https://doi.org/10.1002/pd.1970140811', ""https://scholar.google.com/scholar_lookup?title=Maternal+serum+free+alpha‐human+chorionic+gonadotrophin+levels+in+twin+pregnancies:+implications+for+screening+for+Down's+syndrome+&author=NJ+Wald&author=JW+Densem&publication_year=1994&hl=en""]",,https://doi.org/10.1002/pd.1970140811, Wald 1994a {published data only}  ,excluded,CD009925-bbs2-0493, No Down's syndrome pregnancies in population. 
CD009925-bib-0509,"Wald NJ, Watt HC. ",Choice of serum markers in antenatal screening for Down's syndrome, Journal of Medical Screening ,1994,1,    ,['citation-journal']," Wald NJ, Watt HC. Choice of serum markers in antenatal screening for Down's syndrome.  Journal of Medical Screening 1994;1(2):117‐20.    Link to article     Google Scholar     ","['https://doi.org/10.1177/096914139400100211', ""https://scholar.google.com/scholar_lookup?title=Choice+of+serum+markers+in+antenatal+screening+for+Down's+syndrome&author=NJ+Wald&author=HC+Watt&publication_year=1994&hl=en""]",,https://doi.org/10.1177/096914139400100211, Wald 1994b {published data only}  ,excluded,CD009925-bbs2-0494, Review article. 
CD009925-bib-0510,"Wald NJ, Watt HC. ",Serum markers for Down's syndrome in relation to number of previous births and maternal age, Prenatal Diagnosis ,1996,16,    ,['citation-journal']," Wald NJ, Watt HC. Serum markers for Down's syndrome in relation to number of previous births and maternal age.  Prenatal Diagnosis 1996;16(8):699‐703.    Link to article     Google Scholar     ","['https://doi.org/10.1002/(SICI)1097-0223(199608)16:8<699::AID-PD919>3.0.CO;2-P', ""https://scholar.google.com/scholar_lookup?title=Serum+markers+for+Down's+syndrome+in+relation+to+number+of+previous+births+and+maternal+age+&author=NJ+Wald&author=HC+Watt&publication_year=1996&hl=en""]",,https://doi.org/10.1002/(SICI)1097-0223(199608)16:8<699::AID-PD919>3.0.CO;2-P, Wald 1996a {published data only}  ,excluded,CD009925-bbs2-0495, No Down's pregnancies. 
CD009925-bib-0511,"Wald NJ, George L, Smith D, Densem JW, Petterson K. ",Serum screening for Down's syndrome between 8 and 14 weeks of pregnancy. International Prenatal Screening Research Group.[see comment], British Journal of Obstetrics & Gynaecology. ,1996,103,    ,['citation-journal']," Wald NJ, George L, Smith D, Densem JW, Petterson K. Serum screening for Down's syndrome between 8 and 14 weeks of pregnancy. International Prenatal Screening Research Group.[see comment].  British Journal of Obstetrics & Gynaecology. 1996;103(5):407‐12.    Link to article     Google Scholar     ","['https://doi.org/10.1111/j.1471-0528.1996.tb09765.x', ""https://scholar.google.com/scholar_lookup?title=Serum+screening+for+Down's+syndrome+between+8+and+14+weeks+of+pregnancy.+International+Prenatal+Screening+Research+Group.[see+comment]+&author=NJ+Wald&author=L+George&author=D+Smith&author=JW+Densem&author=K+Petterson&publication_year=1996&hl=en""]",,https://doi.org/10.1111/j.1471-0528.1996.tb09765.x, Wald 1996b {published data only}  ,excluded,CD009925-bbs2-0496, Dated by LMP. 
CD009925-bib-0512,"Wald NJ, Watt HC, George L. ",Maternal serum inhibin‐A in pregnancies with insulin‐dependent diabetes mellitus: implications for screening for Down's syndrome, Prenatal Diagnosis ,1996,16,    ,['citation-journal']," Wald NJ, Watt HC, George L. Maternal serum inhibin‐A in pregnancies with insulin‐dependent diabetes mellitus: implications for screening for Down's syndrome.  Prenatal Diagnosis 1996;16(10):923‐6.    Link to article     Google Scholar     ","['https://doi.org/10.1002/(SICI)1097-0223(199610)16:10<923::AID-PD970>3.0.CO;2-A', ""https://scholar.google.com/scholar_lookup?title=Maternal+serum+inhibin‐A+in+pregnancies+with+insulin‐dependent+diabetes+mellitus:+implications+for+screening+for+Down's+syndrome+&author=NJ+Wald&author=HC+Watt&author=L+George&publication_year=1996&hl=en""]",,https://doi.org/10.1002/(SICI)1097-0223(199610)16:10<923::AID-PD970>3.0.CO;2-A, Wald 1996d {published data only}  ,excluded,CD009925-bbs2-0497, No Down's syndrome pregnancies in population. 
CD009925-bib-0513,"Wald NJ, Densem JW, George L, Muttukrishna S, Knight PG. ",Prenatal screening for Down's syndrome using inhibin‐A as a serum marker., Prenatal Diagnosis ,1996,16,    ,['citation-journal']," Wald NJ, Densem JW, George L, Muttukrishna S, Knight PG. Prenatal screening for Down's syndrome using inhibin‐A as a serum marker..  Prenatal Diagnosis 1996;16(2):143‐53.    Link to article     Google Scholar     ","['https://doi.org/10.1002/(SICI)1097-0223(199602)16:2<143::AID-PD825>3.0.CO;2-F', ""https://scholar.google.com/scholar_lookup?title=Prenatal+screening+for+Down's+syndrome+using+inhibin‐A+as+a+serum+marker.&author=NJ+Wald&author=JW+Densem&author=L+George&author=S+Muttukrishna&author=PG+Knight&publication_year=1996&hl=en""]",,https://doi.org/10.1002/(SICI)1097-0223(199602)16:2<143::AID-PD825>3.0.CO;2-F, Wald 1996e {published data only}  ,excluded,CD009925-bbs2-0498, Gestational age greater than 24 weeks. 
CD009925-bib-0514,"Wald NJ, Hackshaw AK. ",Combining ultrasound and biochemistry in first‐trimester screening for Down's syndrome.[see comment], Prenatal Diagnosis ,1997,17,    ,['citation-journal']," Wald NJ, Hackshaw AK. Combining ultrasound and biochemistry in first‐trimester screening for Down's syndrome.[see comment].  Prenatal Diagnosis 1997;17(9):821‐9.    Link to article     Google Scholar     ","['https://doi.org/10.1002/(SICI)1097-0223(199709)17:9<821::AID-PD154>3.0.CO;2-5', ""https://scholar.google.com/scholar_lookup?title=Combining+ultrasound+and+biochemistry+in+first‐trimester+screening+for+Down's+syndrome.[see+comment]+&author=NJ+Wald&author=AK+Hackshaw&publication_year=1997&hl=en""]",,https://doi.org/10.1002/(SICI)1097-0223(199709)17:9<821::AID-PD154>3.0.CO;2-5, Wald 1997 {published data only}  ,excluded,CD009925-bbs2-0499, Data modelled on 3 separate populations of women. 
CD009925-bib-0515,"Wald NJ, Watt HC, Haddow JE, Knight GJ. ",Screening for Down syndrome at 14 weeks of pregnancy, Prenatal Diagnosis ,1998,18,    ,['citation-journal']," Wald NJ, Watt HC, Haddow JE, Knight GJ. Screening for Down syndrome at 14 weeks of pregnancy.  Prenatal Diagnosis 1998;18(3):291‐3.    Link to article     Google Scholar     ","['https://doi.org/10.1002/(SICI)1097-0223(199803)18:3<291::AID-PD244>3.0.CO;2-8', 'https://scholar.google.com/scholar_lookup?title=Screening+for+Down+syndrome+at+14+weeks+of+pregnancy&author=NJ+Wald&author=HC+Watt&author=JE+Haddow&author=GJ+Knight&publication_year=1998&hl=en']",,https://doi.org/10.1002/(SICI)1097-0223(199803)18:3<291::AID-PD244>3.0.CO;2-8, Wald 1998 {published data only}  ,excluded,CD009925-bbs2-0500, Unable to extract useful data. 
CD009925-bib-0516,"Wald NJ, Hackshaw AK, Diamandis EP, Melegos DN. ",Maternal serum prostate‐specific antigen and Down syndrome in the first and second trimesters of pregnancy, Prenatal Diagnosis ,1999,19,    ,['citation-journal']," Wald NJ, Hackshaw AK, Diamandis EP, Melegos DN. Maternal serum prostate‐specific antigen and Down syndrome in the first and second trimesters of pregnancy.  Prenatal Diagnosis 1999;19(7):674‐6.    Link to article     Google Scholar     ","['https://doi.org/10.1002/(SICI)1097-0223(199907)19:7<674::AID-PD590>3.0.CO;2-M', 'https://scholar.google.com/scholar_lookup?title=Maternal+serum+prostate‐specific+antigen+and+Down+syndrome+in+the+first+and+second+trimesters+of+pregnancy+&author=NJ+Wald&author=AK+Hackshaw&author=EP+Diamandis&author=DN+Melegos&publication_year=1999&hl=en']",,https://doi.org/10.1002/(SICI)1097-0223(199907)19:7<674::AID-PD590>3.0.CO;2-M, Wald 1999a {published data only}  ,excluded,CD009925-bbs2-0501, Unable to extract useful data. 
CD009925-bib-0517,"Wald NJ, Watt HC, Norgaard Pederson, Christiansen M. ",SP1 in pregnancies with Down syndrome in the first trimester of pregnancy, Prenatal Diagnosis ,1999,19,    ,['citation-journal']," Wald NJ, Watt HC, Norgaard Pederson, Christiansen M. SP1 in pregnancies with Down syndrome in the first trimester of pregnancy.  Prenatal Diagnosis 1999;19(6):517‐20.    Link to article     Google Scholar     ","['https://doi.org/10.1002/(SICI)1097-0223(199906)19:6<517::AID-PD591>3.0.CO;2-2', 'https://scholar.google.com/scholar_lookup?title=SP1+in+pregnancies+with+Down+syndrome+in+the+first+trimester+of+pregnancy&author=NJ+Wald&author=HC+Watt&author=Pederson+Norgaard&author=M+Christiansen&publication_year=1999&hl=en']",,https://doi.org/10.1002/(SICI)1097-0223(199906)19:6<517::AID-PD591>3.0.CO;2-2, Wald 1999b {published data only}  ,excluded,CD009925-bbs2-0502, Gestational age not confirmed by USS. 
CD009925-bib-0518,"Wald NJ, White N, Morris JK, Huttly WJ, Canick JA. ",Serum markers for Down's syndrome in women who have had in vitro fertilisation: implications for antenatal screening, British Journal of Obstetrics & Gynaecology ,1999,106,    ,['citation-journal']," Wald NJ, White N, Morris JK, Huttly WJ, Canick JA. Serum markers for Down's syndrome in women who have had in vitro fertilisation: implications for antenatal screening.  British Journal of Obstetrics & Gynaecology 1999;106(12):1304‐6.    Link to article     Google Scholar     ","['https://doi.org/10.1111/j.1471-0528.1999.tb08186.x', ""https://scholar.google.com/scholar_lookup?title=Serum+markers+for+Down's+syndrome+in+women+who+have+had+in+vitro+fertilisation:+implications+for+antenatal+screening+&author=NJ+Wald&author=N+White&author=JK+Morris&author=WJ+Huttly&author=JA+Canick&publication_year=1999&hl=en""]",,https://doi.org/10.1111/j.1471-0528.1999.tb08186.x, Wald 1999c {published data only}  ,excluded,CD009925-bbs2-0503, No Down's syndrome pregnancies. 
CD009925-bib-0519,"Wald NJ, Watt HC, Hackshaw AK. ",Integrated screening for Down's syndrome on the basis of tests performed during the first and second trimesters.[see comment], New England Journal of Medicine ,1999,341,    ,['citation-journal']," Wald NJ, Watt HC, Hackshaw AK. Integrated screening for Down's syndrome on the basis of tests performed during the first and second trimesters.[see comment].  New England Journal of Medicine 1999;341(7):461‐7.    Link to article     Google Scholar     ","['https://doi.org/10.1056/NEJM199908123410701', ""https://scholar.google.com/scholar_lookup?title=Integrated+screening+for+Down's+syndrome+on+the+basis+of+tests+performed+during+the+first+and+second+trimesters.[see+comment]+&author=NJ+Wald&author=HC+Watt&author=AK+Hackshaw&publication_year=1999&hl=en""]",,https://doi.org/10.1056/NEJM199908123410701, Wald 1999d {published data only}  ,excluded,CD009925-bbs2-0504," Modelled on several studies, some of which have no USS dating. "
CD009925-bib-0520,"Wald NJ, Rish S, Hackshaw AK. ",Combining nuchal translucency and serum markers in prenatal screening for Down syndrome in twin pregnancies, Prenatal Diagnosis ,2003,23,    ,['citation-journal']," Wald NJ, Rish S, Hackshaw AK. Combining nuchal translucency and serum markers in prenatal screening for Down syndrome in twin pregnancies.  Prenatal Diagnosis 2003;23(7):588‐92.    Link to article     Google Scholar     ","['https://doi.org/10.1002/pd.627', 'https://scholar.google.com/scholar_lookup?title=Combining+nuchal+translucency+and+serum+markers+in+prenatal+screening+for+Down+syndrome+in+twin+pregnancies+&author=NJ+Wald&author=S+Rish&author=AK+Hackshaw&publication_year=2003&hl=en']",,https://doi.org/10.1002/pd.627, Wald 2003b {published data only}  ,excluded,CD009925-bbs2-0505, No cases. 
CD009925-bib-0521,"Wald NJ, Huttly WJ, Hackshaw AK. ",Antenatal screening for Down's syndrome with the quadruple test.[see comment], Lancet ,2003,361,    ,['citation-journal']," Wald NJ, Huttly WJ, Hackshaw AK. Antenatal screening for Down's syndrome with the quadruple test.[see comment].  Lancet 2003;361(9360):835‐6.    Link to article     Google Scholar     ","['https://doi.org/10.1016/S0140-6736(03)12680-3', ""https://scholar.google.com/scholar_lookup?title=Antenatal+screening+for+Down's+syndrome+with+the+quadruple+test.[see+comment]&author=NJ+Wald&author=WJ+Huttly&author=AK+Hackshaw&publication_year=2003&hl=en""]",,https://doi.org/10.1016/S0140-6736(03)12680-3, Wald 2003c {published data only}  ,excluded,CD009925-bbs2-0506, Less than 80% had gestational age confirmed by USS. 
CD009925-bib-0522,"Wald NJ, Rudnicka AR, Bestwick JP. ",Sequential and contingent prenatal screening for Down syndrome, Prenatal Diagnosis ,2006,26,    ,['citation-journal']," Wald NJ, Rudnicka AR, Bestwick JP. Sequential and contingent prenatal screening for Down syndrome.  Prenatal Diagnosis 2006;26(9):769‐77.    Link to article     Google Scholar     ","['https://doi.org/10.1002/pd.1498', 'https://scholar.google.com/scholar_lookup?title=Sequential+and+contingent+prenatal+screening+for+Down+syndrome&author=NJ+Wald&author=AR+Rudnicka&author=JP+Bestwick&publication_year=2006&hl=en']",,https://doi.org/10.1002/pd.1498, Wald 2006 {published data only}  ,excluded,CD009925-bbs2-0507, Modelled on SURRUS data. 
CD009925-bib-0523,"Wallace EM, Harkness LM, Burns S, Liston WA. ",Evaluation of maternal serum immunoreactive Inhibin Aas a first trimester marker of Down's syndrome, Clinical Endocrinology ,1994,41,    ,['citation-journal']," Wallace EM, Harkness LM, Burns S, Liston WA. Evaluation of maternal serum immunoreactive Inhibin Aas a first trimester marker of Down's syndrome.  Clinical Endocrinology 1994;41(4):483‐6.    Link to article     Google Scholar     ","['https://doi.org/10.1111/j.1365-2265.1994.tb02579.x', ""https://scholar.google.com/scholar_lookup?title=Evaluation+of+maternal+serum+immunoreactive+Inhibin+Aas+a+first+trimester+marker+of+Down's+syndrome+&author=EM+Wallace&author=LM+Harkness&author=S+Burns&author=WA+Liston&publication_year=1994&hl=en""]",,https://doi.org/10.1111/j.1365-2265.1994.tb02579.x, Wallace 1994 {published data only}  ,excluded,CD009925-bbs2-0508, Unable to extract useful data. 
CD009925-bib-0524,"Wallace EM, Crossley JA, Ritoe SC, Groome NP, Aitken DA. ",Maternal serum inhibin‐A in pregnancies complicated by insulin dependent diabetes mellitus, British Journal of Obstetrics & Gynaecology ,1997,104,    ,['citation-journal']," Wallace EM, Crossley JA, Ritoe SC, Groome NP, Aitken DA. Maternal serum inhibin‐A in pregnancies complicated by insulin dependent diabetes mellitus.  British Journal of Obstetrics & Gynaecology 1997;104(8):946‐8.    Link to article     Google Scholar     ","['https://doi.org/10.1111/j.1471-0528.1997.tb14356.x', 'https://scholar.google.com/scholar_lookup?title=Maternal+serum+inhibin‐A+in+pregnancies+complicated+by+insulin+dependent+diabetes+mellitus+&author=EM+Wallace&author=JA+Crossley&author=SC+Ritoe&author=NP+Groome&author=DA+Aitken&publication_year=1997&hl=en']",,https://doi.org/10.1111/j.1471-0528.1997.tb14356.x, Wallace 1997 {published data only}  ,excluded,CD009925-bbs2-0509, No Down's syndrome pregnancies in study population. 
CD009925-bib-0525,Ward A. ,Nuchal translucency measurement,,2005,,    ,['citation-other'], Ward A. Nuchal translucency measurement. Synergy (http://www.highbeam.com/doc/1P3‐866108421.html) (accessed 2007)2005.    Google Scholar     ,['https://scholar.google.com/scholar_lookup?title=Nuchal+translucency+measurement&author=A+Ward&publication_year=2005&hl=en'],,, Ward 2005 {published data only}  ,excluded,CD009925-bbs2-0510, Review article. 
CD009925-bib-0526,"Watt HC, Wald NJ, Smith D, Kennard A, Densem J. ",Effect of allowing for ethnic group in prenatal screening for Down's syndrome, Prenatal Diagnosis ,1996,16,    ,['citation-journal']," Watt HC, Wald NJ, Smith D, Kennard A, Densem J. Effect of allowing for ethnic group in prenatal screening for Down's syndrome.  Prenatal Diagnosis 1996;16(8):691‐8.    Link to article     Google Scholar     ","['https://doi.org/10.1002/(SICI)1097-0223(199608)16:8<691::AID-PD946>3.0.CO;2-2', ""https://scholar.google.com/scholar_lookup?title=Effect+of+allowing+for+ethnic+group+in+prenatal+screening+for+Down's+syndrome&author=HC+Watt&author=NJ+Wald&author=D+Smith&author=A+Kennard&author=J+Densem&publication_year=1996&hl=en""]",,https://doi.org/10.1002/(SICI)1097-0223(199608)16:8<691::AID-PD946>3.0.CO;2-2, Watt 1996a {published data only}  ,excluded,CD009925-bbs2-0511, No Donw's syndrome pregnancies in study population. 
CD009925-bib-0527,"Watt HC, Wald NJ, George L. ",Maternal serum inhibin‐A levels in twin pregnancies: implications for screening for Down's syndrome, Prenatal Diagnosis ,1996,16,    ,['citation-journal']," Watt HC, Wald NJ, George L. Maternal serum inhibin‐A levels in twin pregnancies: implications for screening for Down's syndrome.  Prenatal Diagnosis 1996;16(10):927‐9.    Link to article     Google Scholar     ","['https://doi.org/10.1002/(SICI)1097-0223(199610)16:10<927::AID-PD972>3.0.CO;2-0', ""https://scholar.google.com/scholar_lookup?title=Maternal+serum+inhibin‐A+levels+in+twin+pregnancies:+implications+for+screening+for+Down's+syndrome+&author=HC+Watt&author=NJ+Wald&author=L+George&publication_year=1996&hl=en""]",,https://doi.org/10.1002/(SICI)1097-0223(199610)16:10<927::AID-PD972>3.0.CO;2-0, Watt 1996b {published data only}  ,excluded,CD009925-bbs2-0512, No Down's syndrome pregnancies in study population. 
CD009925-bib-0528,"Weinans MJN, Pratt JJ, De Wolf, Mantingh A. ",First‐trimester maternal serum human thyroid‐stimulating hormone in chromosomally normal and Down syndrome pregnancies, Prenatal Diagnosis ,2001,21,    ,['citation-journal']," Weinans MJN, Pratt JJ, De Wolf, Mantingh A. First‐trimester maternal serum human thyroid‐stimulating hormone in chromosomally normal and Down syndrome pregnancies.  Prenatal Diagnosis 2001;21(9):723‐5.    Link to article     Google Scholar     ","['https://doi.org/10.1002/pd.130', 'https://scholar.google.com/scholar_lookup?title=First‐trimester+maternal+serum+human+thyroid‐stimulating+hormone+in+chromosomally+normal+and+Down+syndrome+pregnancies+&author=MJN+Weinans&author=JJ+Pratt&author=Wolf+De&author=A+Mantingh&publication_year=2001&hl=en']",,https://doi.org/10.1002/pd.130, Weinans 2001 {published data only}  ,excluded,CD009925-bbs2-0513, Unable to extract useful data. 
CD009925-bib-0529,"Weinans MJN, Kooij L, Müller MA, Bilardo KM, Van Lith, Tymstra T. ",A comparison of the impact of screen‐positive results obtained from ultrasound and biochemical screening for Down syndrome in the first trimester: A pilot study, Prenatal Diagnosis ,2004,24,    ,['citation-journal']," Weinans MJN, Kooij L, Müller MA, Bilardo KM, Van Lith, Tymstra T. A comparison of the impact of screen‐positive results obtained from ultrasound and biochemical screening for Down syndrome in the first trimester: A pilot study.  Prenatal Diagnosis 2004;24(5):347‐51.    Link to article     Google Scholar     ","['https://doi.org/10.1002/pd.872', 'https://scholar.google.com/scholar_lookup?title=A+comparison+of+the+impact+of+screen‐positive+results+obtained+from+ultrasound+and+biochemical+screening+for+Down+syndrome+in+the+first+trimester:+A+pilot+study+&author=MJN+Weinans&author=L+Kooij&author=MA+Müller&author=KM+Bilardo&author=Lith+Van&author=T+Tymstra&publication_year=2004&hl=en']",,https://doi.org/10.1002/pd.872, Weinans 2004 {published data only}  ,excluded,CD009925-bbs2-0514, Study of women's views on screening. 
CD009925-bib-0530,"Welborn JL, Timm NS. ",Trisomy 21 and cystic hygromas in early gestational age fetuses, American Journal of Perinatology ,1994,11,    ,['citation-journal']," Welborn JL, Timm NS. Trisomy 21 and cystic hygromas in early gestational age fetuses.  American Journal of Perinatology 1994;11(1):19‐20.    Link to article     Google Scholar     ","['https://doi.org/10.1055/s-2007-994526', 'https://scholar.google.com/scholar_lookup?title=Trisomy+21+and+cystic+hygromas+in+early+gestational+age+fetuses&author=JL+Welborn&author=NS+Timm&publication_year=1994&hl=en']",,https://doi.org/10.1055/s-2007-994526, Welborn 1994 {published data only}  ,excluded,CD009925-bbs2-0515, Abnormal results only (cystic hygroma). 
CD009925-bib-0531,"Wenstrom KD, Williamson RA, Grant SS, Hudson JD, Getchell JP. ",Evaluation of multiple‐marker screening for Down syndrome in a statewide population, American Journal of Obstetrics and Gynecology ,1993,169,    ,['citation-journal']," Wenstrom KD, Williamson RA, Grant SS, Hudson JD, Getchell JP. Evaluation of multiple‐marker screening for Down syndrome in a statewide population.  American Journal of Obstetrics and Gynecology 1993;169(4):793‐7.    Link to article     Google Scholar     ","['https://doi.org/10.1016/0002-9378(93)90007-6', 'https://scholar.google.com/scholar_lookup?title=Evaluation+of+multiple‐marker+screening+for+Down+syndrome+in+a+statewide+population&author=KD+Wenstrom&author=RA+Williamson&author=SS+Grant&author=JD+Hudson&author=JP+Getchell&publication_year=1993&hl=en']",,https://doi.org/10.1016/0002-9378(93)90007-6, Wenstrom 1993 {published data only}  ,excluded,CD009925-bbs2-0516, Less than 80% of pregnancies had gestational age confirmed by USS. 
CD009925-bib-0532,"Wenstrom KD, Owen J, Boots L, Ethier M. ",The influence of maternal weight on human chorionic gonadotropin in the multiple‐marker screening test for fetal Down syndrome, American Journal of Obstetrics & Gynecology ,1995,173,    ,['citation-journal']," Wenstrom KD, Owen J, Boots L, Ethier M. The influence of maternal weight on human chorionic gonadotropin in the multiple‐marker screening test for fetal Down syndrome.  American Journal of Obstetrics & Gynecology 1995;173(4):1297‐300.    Link to article     Google Scholar     ","['https://doi.org/10.1016/0002-9378(95)91374-2', 'https://scholar.google.com/scholar_lookup?title=The+influence+of+maternal+weight+on+human+chorionic+gonadotropin+in+the+multiple‐marker+screening+test+for+fetal+Down+syndrome+&author=KD+Wenstrom&author=J+Owen&author=L+Boots&author=M+Ethier&publication_year=1995&hl=en']",,https://doi.org/10.1016/0002-9378(95)91374-2, Wenstrom 1995a {published data only}  ,excluded,CD009925-bbs2-0517, Adjustment factors. 
CD009925-bib-0533,"Wenstrom KD, Desai R, Owen J, Dubard MB, Boots L. ",Comparison of multiple‐marker screening with amniocentesis for the detection of fetal aneuploidy in women greater than or equal35 years old, American Journal of Obstetrics and Gynecology ,1995,173,    ,['citation-journal']," Wenstrom KD, Desai R, Owen J, Dubard MB, Boots L. Comparison of multiple‐marker screening with amniocentesis for the detection of fetal aneuploidy in women greater than or equal35 years old.  American Journal of Obstetrics and Gynecology 1995;173(4):1287‐92.    Link to article     Google Scholar     ","['https://doi.org/10.1016/0002-9378(95)91372-6', 'https://scholar.google.com/scholar_lookup?title=Comparison+of+multiple‐marker+screening+with+amniocentesis+for+the+detection+of+fetal+aneuploidy+in+women+greater+than+or+equal35+years+old+&author=KD+Wenstrom&author=R+Desai&author=J+Owen&author=MB+Dubard&author=L+Boots&publication_year=1995&hl=en']",,https://doi.org/10.1016/0002-9378(95)91372-6, Wenstrom 1995b {published data only}  ,excluded,CD009925-bbs2-0518, Less than 80% of pregnancies had gestational age confirmed by USS. 
CD009925-bib-0534,"Whitlow BJ, Lazanakis ML, Kadir RA, Chatzipapas I, Economides DL. ","The significance of choroid plexus cysts, echogenic heart foci and renal pyelectasis in the first trimester", Ultrasound in Obstetrics & Gynecology ,1998,12,    ,['citation-journal']," Whitlow BJ, Lazanakis ML, Kadir RA, Chatzipapas I, Economides DL. The significance of choroid plexus cysts, echogenic heart foci and renal pyelectasis in the first trimester.  Ultrasound in Obstetrics & Gynecology 1998;12(6):385‐90.    Link to article     Google Scholar     ","['https://doi.org/10.1046/j.1469-0705.1998.12060385.x', 'https://scholar.google.com/scholar_lookup?title=The+significance+of+choroid+plexus+cysts,+echogenic+heart+foci+and+renal+pyelectasis+in+the+first+trimester+&author=BJ+Whitlow&author=ML+Lazanakis&author=RA+Kadir&author=I+Chatzipapas&author=DL+Economides&publication_year=1998&hl=en']",,https://doi.org/10.1046/j.1469-0705.1998.12060385.x, Whitlow 1998a {published data only}  ,excluded,CD009925-bbs2-0519, Unable to extract useful data. 
CD009925-bib-0535,"Whitlow BJ, Economides DL. ",First trimester detection of fetal abnormalities in an unselected population, Contemporary Reviews in Obstetrics and Gynaecology ,1998,10,    ,['citation-journal']," Whitlow BJ, Economides DL. First trimester detection of fetal abnormalities in an unselected population.  Contemporary Reviews in Obstetrics and Gynaecology 1998;10(4):245‐53.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=First+trimester+detection+of+fetal+abnormalities+in+an+unselected+population&author=BJ+Whitlow&author=DL+Economides&publication_year=1998&hl=en'],,, Whitlow 1998b {published data only}  ,excluded,CD009925-bbs2-0520, Unable to extract useful data. 
CD009925-bib-0536,"Whitlow BJ, Chatzipapas IK, Lazanakis ML, Kadir RA, Economides DL. ",The value of sonography in early pregnancy for the detection of fetal abnormalities in an unselected population, British Journal of Obstetrics & Gynaecology ,1999,106,    ,['citation-journal']," Whitlow BJ, Chatzipapas IK, Lazanakis ML, Kadir RA, Economides DL. The value of sonography in early pregnancy for the detection of fetal abnormalities in an unselected population.  British Journal of Obstetrics & Gynaecology 1999;106(9):929‐36.    Link to article     Google Scholar     ","['https://doi.org/10.1111/j.1471-0528.1999.tb08432.x', 'https://scholar.google.com/scholar_lookup?title=The+value+of+sonography+in+early+pregnancy+for+the+detection+of+fetal+abnormalities+in+an+unselected+population+&author=BJ+Whitlow&author=IK+Chatzipapas&author=ML+Lazanakis&author=RA+Kadir&author=DL+Economides&publication_year=1999&hl=en']",,https://doi.org/10.1111/j.1471-0528.1999.tb08432.x, Whitlow 1999 {published data only}  ,excluded,CD009925-bbs2-0521, Unable to extract useful data. 
CD009925-bib-0537,Williamson R. ,Expanded maternal serum alpha fetoprotein screening, Iowa Medicine ,1994,84,    ,['citation-journal'], Williamson R. Expanded maternal serum alpha fetoprotein screening.  Iowa Medicine 1994;84(9):397‐400.    Google Scholar     ,['https://scholar.google.com/scholar_lookup?title=Expanded+maternal+serum+alpha+fetoprotein+screening&author=R+Williamson&publication_year=1994&hl=en'],,, Williamson 1994 {published data only}  ,excluded,CD009925-bbs2-0522, Likely fewer than 80% USS dated. 
CD009925-bib-0538,Wilson K. ,New first‐trimester prenatal screening for down syndrome, Laboratory Medicine ,2000,31,    ,['citation-journal'], Wilson K. New first‐trimester prenatal screening for down syndrome.  Laboratory Medicine 2000;31(11):591.    Google Scholar     ,['https://scholar.google.com/scholar_lookup?title=New+first‐trimester+prenatal+screening+for+down+syndrome&author=K+Wilson&publication_year=2000&hl=en'],,, Wilson 2000 {published data only}  ,excluded,CD009925-bbs2-0523, Review. 
CD009925-bib-0539,"Wojdemann KR, Larsen SO, Shalmi A, Sundberg K, Christiansen M, Tabor A. ",First trimester screening for Down syndrome and assisted reproduction: no basis for concern, Prenatal Diagnosis ,2001,21,    ,['citation-journal']," Wojdemann KR, Larsen SO, Shalmi A, Sundberg K, Christiansen M, Tabor A. First trimester screening for Down syndrome and assisted reproduction: no basis for concern.  Prenatal Diagnosis 2001;21(7):563‐5.    Link to article     Google Scholar     ","['https://doi.org/10.1002/pd.124', 'https://scholar.google.com/scholar_lookup?title=First+trimester+screening+for+Down+syndrome+and+assisted+reproduction:+no+basis+for+concern+&author=KR+Wojdemann&author=SO+Larsen&author=A+Shalmi&author=K+Sundberg&author=M+Christiansen&author=A+Tabor&publication_year=2001&hl=en']",,https://doi.org/10.1002/pd.124, Wojdemann 2001 {published data only}  ,excluded,CD009925-bbs2-0524, No Down's syndrome pregnancies in study population. 
CD009925-bib-0540,"Wong SF, Choi H, Ho LC. ",Nasal bone hypoplasia: is it a common finding amongst chromosomally normal fetuses of southern Chinese women?, Gynecologic & Obstetric Investigation ,2003,56,    ,['citation-journal']," Wong SF, Choi H, Ho LC. Nasal bone hypoplasia: is it a common finding amongst chromosomally normal fetuses of southern Chinese women?.  Gynecologic & Obstetric Investigation 2003;56(2):99‐101.    Link to article     Google Scholar     ","['https://doi.org/10.1159/000072994', 'https://scholar.google.com/scholar_lookup?title=Nasal+bone+hypoplasia:+is+it+a+common+finding+amongst+chromosomally+normal+fetuses+of+southern+Chinese+women?+&author=SF+Wong&author=H+Choi&author=LC+Ho&publication_year=2003&hl=en']",,https://doi.org/10.1159/000072994, Wong 2003 {published data only}  ,excluded,CD009925-bbs2-0525, Less than 5 Down's syndrome pregnancies in population. 
CD009925-bib-0541,"Wright D, Bradbury I, Cuckle H, Gardosi J, Tonks A, Standing S, et al. ",Three‐stage contingent screening for Down syndrome, Prenatal Diagnosis ,2006,26,    ,['citation-journal']," Wright D, Bradbury I, Cuckle H, Gardosi J, Tonks A, Standing S, et al. Three‐stage contingent screening for Down syndrome.  Prenatal Diagnosis 2006;26(6):528‐34.    Link to article     Google Scholar     ","['https://doi.org/10.1002/pd.1451', 'https://scholar.google.com/scholar_lookup?title=Three‐stage+contingent+screening+for+Down+syndrome&author=D+Wright&author=I+Bradbury&author=H+Cuckle&author=J+Gardosi&author=A+Tonks&author=S+Standing&publication_year=2006&hl=en']",,https://doi.org/10.1002/pd.1451, Wright 2006 {published data only}  ,excluded,CD009925-bbs2-0526, Mathematical model. 
CD009925-bib-0542,"Yagel S, Anteby EY, Hochner‐Celnikier D, Ariel I, Chaap T, Ben Neriah Z. ","The role of midtrimester targeted fetal organ screening combined with the ""triple test"" and maternal age in the diagnosis of trisomy 21: a retrospective study", American Journal of Obstetrics & Gynecology ,1998,178,    ,['citation-journal']," Yagel S, Anteby EY, Hochner‐Celnikier D, Ariel I, Chaap T, Ben Neriah Z. The role of midtrimester targeted fetal organ screening combined with the ""triple test"" and maternal age in the diagnosis of trisomy 21: a retrospective study.  American Journal of Obstetrics & Gynecology 1998;178(1):40‐4.    Link to article     Google Scholar     ","['https://doi.org/10.1016/S0002-9378(98)70623-4', 'https://scholar.google.com/scholar_lookup?title=The+role+of+midtrimester+targeted+fetal+organ+screening+combined+with+the+']",,https://doi.org/10.1016/S0002-9378(98)70623-4, Yagel 1998 {published data only}  ,excluded,CD009925-bbs2-0527, Second trimester USS. 
CD009925-bib-0543,"Yamamoto R, Azuma M, Kishida T, Yamada H, Satomura S, Fujimoto S. ",Total alpha‐fetoprotein and Lens culinaris agglutinin‐reactive alpha‐fetoprotein in fetal chromosomal abnormalities, BJOG: An International Journal of Obstetrics & Gynaecology. ,2001,108,    ,['citation-journal']," Yamamoto R, Azuma M, Kishida T, Yamada H, Satomura S, Fujimoto S. Total alpha‐fetoprotein and Lens culinaris agglutinin‐reactive alpha‐fetoprotein in fetal chromosomal abnormalities.  BJOG: An International Journal of Obstetrics & Gynaecology. 2001;108(11):1154‐8.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=Total+alpha‐fetoprotein+and+Lens+culinaris+agglutinin‐reactive+alpha‐fetoprotein+in+fetal+chromosomal+abnormalities+&author=R+Yamamoto&author=M+Azuma&author=T+Kishida&author=H+Yamada&author=S+Satomura&author=S+Fujimoto&publication_year=2001&hl=en'],,, Yamamoto 2001a {published data only}  ,excluded,CD009925-bbs2-0528, Unable to extract useful data. 
CD009925-bib-0544,"Yamamoto R, Azuma M, Hoshi N, Kishida T, Satomura S, Fujimoto S. ","Lens culinaris agglutinin‐reactive alpha‐fetoprotein, an alternative variant to alpha‐fetoprotein in prenatal screening for Down's syndrome", Human Reproduction ,2001,16,    ,['citation-journal']," Yamamoto R, Azuma M, Hoshi N, Kishida T, Satomura S, Fujimoto S. Lens culinaris agglutinin‐reactive alpha‐fetoprotein, an alternative variant to alpha‐fetoprotein in prenatal screening for Down's syndrome.  Human Reproduction 2001;16(11):2438‐44.    Link to article     Google Scholar     ","['https://doi.org/10.1093/humrep/16.11.2438', ""https://scholar.google.com/scholar_lookup?title=Lens+culinaris+agglutinin‐reactive+alpha‐fetoprotein,+an+alternative+variant+to+alpha‐fetoprotein+in+prenatal+screening+for+Down's+syndrome+&author=R+Yamamoto&author=M+Azuma&author=N+Hoshi&author=T+Kishida&author=S+Satomura&author=S+Fujimoto&publication_year=2001&hl=en""]",,https://doi.org/10.1093/humrep/16.11.2438, Yamamoto 2001b {published data only}  ,excluded,CD009925-bbs2-0529, Method of determination of gestational age unclear. 
CD009925-bib-0545,"Yamamoto R, Azuma M, Wakui Y, Kishida T, Yamada H, Okuyama K, et al. ",Alpha‐fetoprotein microheterogeneity: a potential biochemical marker for Down's syndrome, Clinica Chimica Acta ,2001,304,    ,['citation-journal']," Yamamoto R, Azuma M, Wakui Y, Kishida T, Yamada H, Okuyama K, et al. Alpha‐fetoprotein microheterogeneity: a potential biochemical marker for Down's syndrome.  Clinica Chimica Acta 2001;304(1‐2):137‐41.    Link to article     Google Scholar     ","['https://doi.org/10.1016/S0009-8981(00)00381-8', ""https://scholar.google.com/scholar_lookup?title=Alpha‐fetoprotein+microheterogeneity:+a+potential+biochemical+marker+for+Down's+syndrome&author=R+Yamamoto&author=M+Azuma&author=Y+Wakui&author=T+Kishida&author=H+Yamada&author=K+Okuyama&publication_year=2001&hl=en""]",,https://doi.org/10.1016/S0009-8981(00)00381-8, Yamamoto 2001c {published data only}  ,excluded,CD009925-bbs2-0530, Unable to extact useful data. 
CD009925-bib-0546,"Yaron Y, Wolman I, Kupferminc MJ, Ochshorn Y, Many A, Orr Urtreger. ",Effect of fetal gender on first trimester markers and on Down syndrome screening, Prenatal Diagnosis ,2001,21,    ,['citation-journal']," Yaron Y, Wolman I, Kupferminc MJ, Ochshorn Y, Many A, Orr Urtreger. Effect of fetal gender on first trimester markers and on Down syndrome screening.  Prenatal Diagnosis 2001;21(12):1027‐30.    Link to article     Google Scholar     ","['https://doi.org/10.1002/pd.178', 'https://scholar.google.com/scholar_lookup?title=Effect+of+fetal+gender+on+first+trimester+markers+and+on+Down+syndrome+screening&author=Y+Yaron&author=I+Wolman&author=MJ+Kupferminc&author=Y+Ochshorn&author=A+Many&author=Urtreger+Orr&publication_year=2001&hl=en']",,https://doi.org/10.1002/pd.178, Yaron 2001 {published data only}  ,excluded,CD009925-bbs2-0531, Male versus female fetuses. 
CD009925-bib-0547,"Ye G, Liao S, Zhao X. ","The possibility of prenatal screening for fetal abnormalities in second‐trimester pregnancies by measuring AFP, ß‐HCG and uE‐3 levels", Xi'an Yike Daxue Xuebao ,1995,16,    ,['citation-journal']," Ye G, Liao S, Zhao X. The possibility of prenatal screening for fetal abnormalities in second‐trimester pregnancies by measuring AFP, ß‐HCG and uE‐3 levels.  Xi'an Yike Daxue Xuebao 1995;16(4):408‐11.    Google Scholar     ","['https://scholar.google.com/scholar_lookup?title=The+possibility+of+prenatal+screening+for+fetal+abnormalities+in+second‐trimester+pregnancies+by+measuring+AFP,+ß‐HCG+and+uE‐3+levels+&author=G+Ye&author=S+Liao&author=X+Zhao&publication_year=1995&hl=en']",,, Ye 1995 {published data only}  ,excluded,CD009925-bbs2-0532, Unable to obtain translation. 
CD009925-bib-0548,"Yoshida K, Kuwabara Y, Tanaka T, Onda T, Kudo R, Yamamoto H, et al. ",Dimeric Inhibin A as a fourth marker for Down's syndrome maternal serum screening in native Japanese women, Journal of Obstetrics and Gynaecology Research ,2000,26,    ,['citation-journal']," Yoshida K, Kuwabara Y, Tanaka T, Onda T, Kudo R, Yamamoto H, et al. Dimeric Inhibin A as a fourth marker for Down's syndrome maternal serum screening in native Japanese women.  Journal of Obstetrics and Gynaecology Research 2000;26(3):171‐4.    Link to article     Google Scholar     ","['https://doi.org/10.1111/j.1447-0756.2000.tb01306.x', ""https://scholar.google.com/scholar_lookup?title=Dimeric+Inhibin+A+as+a+fourth+marker+for+Down's+syndrome+maternal+serum+screening+in+native+Japanese+women+&author=K+Yoshida&author=Y+Kuwabara&author=T+Tanaka&author=T+Onda&author=R+Kudo&author=H+Yamamoto&publication_year=2000&hl=en""]",,https://doi.org/10.1111/j.1447-0756.2000.tb01306.x, Yoshida 2000 {published data only}  ,excluded,CD009925-bbs2-0533, Fewer than 80% pregnancies had gestational age estimated by USS. 
CD009925-bib-0549,"Zeitune M, Aitken DA, Crossley JA, Yates JR, Cooke A, Ferguson‐Smith MA. ",Estimating the risk of a fetal autosomal trisomy at mid‐trimester using maternal serum alpha‐fetoprotein and age: A retrospective study of 142 pregnancies, Prenatal Diagnosis ,1991,11,    ,['citation-journal']," Zeitune M, Aitken DA, Crossley JA, Yates JR, Cooke A, Ferguson‐Smith MA. Estimating the risk of a fetal autosomal trisomy at mid‐trimester using maternal serum alpha‐fetoprotein and age: A retrospective study of 142 pregnancies.  Prenatal Diagnosis 1991;11(11):847‐57.    Link to article     Google Scholar     ","['https://doi.org/10.1002/pd.1970111106', 'https://scholar.google.com/scholar_lookup?title=Estimating+the+risk+of+a+fetal+autosomal+trisomy+at+mid‐trimester+using+maternal+serum+alpha‐fetoprotein+and+age:+A+retrospective+study+of+142+pregnancies+&author=M+Zeitune&author=DA+Aitken&author=JA+Crossley&author=JR+Yates&author=A+Cooke&author=MA+Ferguson‐Smith&publication_year=1991&hl=en']",,https://doi.org/10.1002/pd.1970111106, Zeitune 1991 {published data only}  ,excluded,CD009925-bbs2-0534, Only aneuploid pregnancies included in study. 
CD009925-bib-0550,"Zelop CM, Milewski E, Brault K, Benn P, Borgida AF, Egan JFX. ",Variation of fetal nasal bone length in second‐trimester fetuses according to race and ethnicity, Journal of Ultrasound in Medicine ,2005,24,    ,['citation-journal']," Zelop CM, Milewski E, Brault K, Benn P, Borgida AF, Egan JFX. Variation of fetal nasal bone length in second‐trimester fetuses according to race and ethnicity.  Journal of Ultrasound in Medicine 2005;24(11):1487‐9.    Link to article     Google Scholar     ","['https://doi.org/10.7863/jum.2005.24.11.1487', 'https://scholar.google.com/scholar_lookup?title=Variation+of+fetal+nasal+bone+length+in+second‐trimester+fetuses+according+to+race+and+ethnicity+&author=CM+Zelop&author=E+Milewski&author=K+Brault&author=P+Benn&author=AF+Borgida&author=JFX+Egan&publication_year=2005&hl=en']",,https://doi.org/10.7863/jum.2005.24.11.1487, Zelop 2005 {published data only}  ,excluded,CD009925-bbs2-0535, No Down's cases in population. 
CD009925-bib-0551,"Zhao Xiaolan, Ye Guoling, Liu Qi. ",Using maternal serum PAPP‐A and other pregnancy‐associated proteins in screening for fetal abnormalities, Xi'an Yike Daxue Xuebao ,1998,19,    ,['citation-journal']," Zhao Xiaolan, Ye Guoling, Liu Qi. Using maternal serum PAPP‐A and other pregnancy‐associated proteins in screening for fetal abnormalities.  Xi'an Yike Daxue Xuebao 1998;19(1):94‐6, 110.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=Using+maternal+serum+PAPP‐A+and+other+pregnancy‐associated+proteins+in+screening+for+fetal+abnormalities+&author=Xiaolan+Zhao&author=Guoling+Ye&author=Qi+Liu&publication_year=1998&hl=en'],,, Zhao 1998 {published data only}  ,excluded,CD009925-bbs2-0536, Unable to obtain translation. 
CD009925-bib-0552,"Zoppi MA, Ibba RM, Floris M, Manca F, Axiana C, Monni G. ",Changes in nuchal translucency thickness in normal and abnormal karyotype fetuses, BJOG: An International Journal of Obstetrics & Gynaecology. ,2003,110,    ,['citation-journal']," Zoppi MA, Ibba RM, Floris M, Manca F, Axiana C, Monni G. Changes in nuchal translucency thickness in normal and abnormal karyotype fetuses.  BJOG: An International Journal of Obstetrics & Gynaecology. 2003;110(6):584‐8.    Link to article     Google Scholar     ","['https://doi.org/10.1046/j.1471-0528.2003.02180.x', 'https://scholar.google.com/scholar_lookup?title=Changes+in+nuchal+translucency+thickness+in+normal+and+abnormal+karyotype+fetuses&author=MA+Zoppi&author=RM+Ibba&author=M+Floris&author=F+Manca&author=C+Axiana&author=G+Monni&publication_year=2003&hl=en']",,https://doi.org/10.1046/j.1471-0528.2003.02180.x, Zoppi 2003 {published data only}  ,excluded,CD009925-bbs2-0537, Inappropriate study design. 
CD009925-bib-0553,"Alfirevic Z, Sundberg K, Brigham S. ",Amniocentesis and chorionic villus sampling for prenatal diagnosis, Cochrane Database of Systematic Reviews ,2003,,    ,['citation-journal']," Alfirevic Z, Sundberg K, Brigham S. Amniocentesis and chorionic villus sampling for prenatal diagnosis.  Cochrane Database of Systematic Reviews 2003, Issue 3. [DOI: 10.1002/14651858.CD003252]    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=Amniocentesis+and+chorionic+villus+sampling+for+prenatal+diagnosis&author=Z+Alfirevic&author=K+Sundberg&author=S+Brigham&publication_year=2003&hl=en'],,, Alfirevic 2003 ,additional,CD009925-bbs2-0538,
CD009925-bib-0554,"Alfirevic Z, Neilson JP. ",Antenatal screening for Down's syndrome, BMJ ,2004,9,    ,['citation-journal']," Alfirevic Z, Neilson JP. Antenatal screening for Down's syndrome.  BMJ 2004;9(329(7470)):811‐2.    Link to article     Google Scholar     ","['https://doi.org/10.1136/bmj.329.7470.811', ""https://scholar.google.com/scholar_lookup?title=Antenatal+screening+for+Down's+syndrome&author=Z+Alfirevic&author=JP+Neilson&publication_year=2004&hl=en""]",,https://doi.org/10.1136/bmj.329.7470.811, Alfirevic 2004 ,additional,CD009925-bbs2-0539,
CD009925-bib-0555,"Alldred SK, Deeks JJ, Neilson JP, Alfirevic Z. ",Antenatal screening for Down's syndrome: generic protocol (Protocol), Cochrane Database of Systematic Reviews ,2010,,    ,['citation-journal']," Alldred SK, Deeks JJ, Neilson JP, Alfirevic Z. Antenatal screening for Down's syndrome: generic protocol (Protocol).  Cochrane Database of Systematic Reviews 2010, Issue 4. [DOI: 10.1002/14651858.CD007384.pub2]    Link to article     Google Scholar     ","['https://doi.org/10.1002/14651858.CD007384.pub2', ""https://scholar.google.com/scholar_lookup?title=Antenatal+screening+for+Down's+syndrome:+generic+protocol+(Protocol)&author=SK+Alldred&author=JJ+Deeks&author=JP+Neilson&author=Z+Alfirevic&publication_year=2010&hl=en""]",,https://doi.org/10.1002/14651858.CD007384.pub2, Alldred 2010 ,additional,CD009925-bbs2-0540,
CD009925-bib-0556,"Bersinger NA, Zakher A, Huber U, Pescia G, Schneider H. ",A sensitive enzyme immunoassay for pregnancy‐associated plasma protein A (PAPP‐A): a possible first trimester method of screening for Down syndrome and other trisomies, Archives of Gynecology and Obstetrics ,1995,256,    ,['citation-journal']," Bersinger NA, Zakher A, Huber U, Pescia G, Schneider H. A sensitive enzyme immunoassay for pregnancy‐associated plasma protein A (PAPP‐A): a possible first trimester method of screening for Down syndrome and other trisomies.  Archives of Gynecology and Obstetrics 1995;256(4):185‐92.    Link to article     Google Scholar     ","['https://doi.org/10.1007/s004040050089', 'https://scholar.google.com/scholar_lookup?title=A+sensitive+enzyme+immunoassay+for+pregnancy‐associated+plasma+protein+A+(PAPP‐A):+a+possible+first+trimester+method+of+screening+for+Down+syndrome+and+other+trisomies+&author=NA+Bersinger&author=A+Zakher&author=U+Huber&author=G+Pescia&author=H+Schneider&publication_year=1995&hl=en']",,https://doi.org/10.1007/s004040050089, Bersinger 1995 ,additional,CD009925-bbs2-0541,
CD009925-bib-0557,"Bogart MH, Pandian MR, Jones OW. ",Abnormal maternal serum chorionic gonadotropin levels in pregnancies with fetal chromosome abnormalities, Prenatal Diagnosis ,1987,7,    ,['citation-journal']," Bogart MH, Pandian MR, Jones OW. Abnormal maternal serum chorionic gonadotropin levels in pregnancies with fetal chromosome abnormalities.  Prenatal Diagnosis 1987;7(9):623‐30.    Link to article     Google Scholar     ","['https://doi.org/10.1002/pd.1970070904', 'https://scholar.google.com/scholar_lookup?title=Abnormal+maternal+serum+chorionic+gonadotropin+levels+in+pregnancies+with+fetal+chromosome+abnormalities+&author=MH+Bogart&author=MR+Pandian&author=OW+Jones&publication_year=1987&hl=en']",,https://doi.org/10.1002/pd.1970070904, Bogart 1987 ,additional,CD009925-bbs2-0542,
CD009925-bib-0558,"Cuckle HS, Holding S, Jones R, Wallace EM, Groome NP. ",Maternal serum dimeric inhibin A in second‐trimester Down's syndrome pregnancies,,1995,,    ,['citation-other']," Cuckle HS, Holding S, Jones R, Wallace EM, Groome NP. Maternal serum dimeric inhibin A in second‐trimester Down's syndrome pregnancies. Prenatal Diagnosis1995; Vol. 15, issue 4:385‐6.    Google Scholar     ","[""https://scholar.google.com/scholar_lookup?title=Maternal+serum+dimeric+inhibin+A+in+second‐trimester+Down's+syndrome+pregnancies&author=HS+Cuckle&author=S+Holding&author=R+Jones&author=EM+Wallace&author=NP+Groome&publication_year=1995&hl=en""]",,, Cuckle 1995 ,additional,CD009925-bbs2-0543,
CD009925-bib-0559,"Macri JN, Kasturi RV, Krantz DA, Cook EJ, Moore ND, Young JA, et al. ",Maternal serum Down syndrome screening: free beta‐protein is a more effective marker than human chorionic gonadotropin, American Journal of Obstetrics and Gynecology ,1990,163,    ,['citation-journal']," Macri JN, Kasturi RV, Krantz DA, Cook EJ, Moore ND, Young JA, et al. Maternal serum Down syndrome screening: free beta‐protein is a more effective marker than human chorionic gonadotropin.  American Journal of Obstetrics and Gynecology 1990;163(4 Pt 1):1248‐53.    Link to article     Google Scholar     ","['https://doi.org/10.1016/0002-9378(90)90700-H', 'https://scholar.google.com/scholar_lookup?title=Maternal+serum+Down+syndrome+screening:+free+beta‐protein+is+a+more+effective+marker+than+human+chorionic+gonadotropin+&author=JN+Macri&author=RV+Kasturi&author=DA+Krantz&author=EJ+Cook&author=ND+Moore&author=JA+Young&publication_year=1990&hl=en']",,https://doi.org/10.1016/0002-9378(90)90700-H, Macri 1990 ,additional,CD009925-bbs2-0544,
CD009925-bib-0560,"Macri JN, Spencer K, Aitken D, Garver K, Buchanan PD, Muller F, et al. ",First‐trimester free beta (hCG) screening for Down syndrome, Prenatal Diagnosis ,1993,13,    ,['citation-journal']," Macri JN, Spencer K, Aitken D, Garver K, Buchanan PD, Muller F, et al. First‐trimester free beta (hCG) screening for Down syndrome.  Prenatal Diagnosis 1993;13(7):557‐62.    Link to article     Google Scholar     ","['https://doi.org/10.1002/pd.1970130704', 'https://scholar.google.com/scholar_lookup?title=First‐trimester+free+beta+(hCG)+screening+for+Down+syndrome&author=JN+Macri&author=K+Spencer&author=D+Aitken&author=K+Garver&author=PD+Buchanan&author=F+Muller&publication_year=1993&hl=en']",,https://doi.org/10.1002/pd.1970130704, Macri 1993 ,additional,CD009925-bbs2-0545,
CD009925-bib-0561,"Mol BW, Lijmer JG, Van der Meulen J, Pajkrt E, Bilardo CM, Bossuyt PM. ",Effect of study design on the association between nuchal translucency measurement and Down syndrome, Obstetrics and Gynecology ,1999,94,    ,['citation-journal']," Mol BW, Lijmer JG, Van der Meulen J, Pajkrt E, Bilardo CM, Bossuyt PM. Effect of study design on the association between nuchal translucency measurement and Down syndrome.  Obstetrics and Gynecology 1999;94(5 Pt 2):864‐9..    PubMed     Google Scholar     ","['https://www.ncbi.nlm.nih.gov/pubmed/10546775', 'https://scholar.google.com/scholar_lookup?title=Effect+of+study+design+on+the+association+between+nuchal+translucency+measurement+and+Down+syndrome+&author=BW+Mol&author=JG+Lijmer&author=J+Meulen&author=E+Pajkrt&author=CM+Bilardo&author=PM+Bossuyt&publication_year=1999&hl=en']",10546775,, Mol 1999 ,additional,CD009925-bbs2-0546,
CD009925-bib-0562,Penrose LS. ,The relative effects of parental and maternal age in mongolism, Journal of Genetics ,1933,27,    ,['citation-journal'], Penrose LS. The relative effects of parental and maternal age in mongolism.  Journal of Genetics 1933;27:219‐24.    Link to article     Google Scholar     ,"['https://doi.org/10.1007/BF02984413', 'https://scholar.google.com/scholar_lookup?title=The+relative+effects+of+parental+and+maternal+age+in+mongolism&author=LS+Penrose&publication_year=1933&hl=en']",,https://doi.org/10.1007/BF02984413, Penrose 1933 ,additional,CD009925-bbs2-0547,
CD009925-bib-0563,"Steele MW, Breg WR. ",Chromosome analysis of human amniotic‐fluid cells, Lancet ,1966,i,    ,['citation-journal']," Steele MW, Breg WR. Chromosome analysis of human amniotic‐fluid cells.  Lancet 1966;i:383‐5.    Link to article     Google Scholar     ","['https://doi.org/10.1016/S0140-6736(66)91387-0', 'https://scholar.google.com/scholar_lookup?title=Chromosome+analysis+of+human+amniotic‐fluid+cells&author=MW+Steele&author=WR+Breg&publication_year=1966&hl=en']",,https://doi.org/10.1016/S0140-6736(66)91387-0, Steele 1966 ,additional,CD009925-bbs2-0548,
CD009925-bib-0564,"Vaklenti C, Schutta E.J, Kehaty T. ",Prenatal diagnosis of Down's syndrome, Lancet ,1968,ii,    ,['citation-journal']," Vaklenti C, Schutta E.J, Kehaty T. Prenatal diagnosis of Down's syndrome.  Lancet 1968;ii:220.    Google Scholar     ","[""https://scholar.google.com/scholar_lookup?title=Prenatal+diagnosis+of+Down's+syndrome&author=C+Vaklenti&author=E.J+Schutta&author=T+Kehaty&publication_year=1968&hl=en""]",,, Vaklenti 1968 ,additional,CD009925-bbs2-0549,
CD009925-bib-0565,"Wallace EM, Grant VE, Swanston IA, Groome NP. ",Evaluation of maternal serum dimeric inhibin A as a first‐trimester marker of Down's syndrome, Prenatal Diagnosis ,1995,15,    ,['citation-journal']," Wallace EM, Grant VE, Swanston IA, Groome NP. Evaluation of maternal serum dimeric inhibin A as a first‐trimester marker of Down's syndrome.  Prenatal Diagnosis 1995;15(4):359‐62.    Link to article     Google Scholar     ","['https://doi.org/10.1002/pd.1970150410', ""https://scholar.google.com/scholar_lookup?title=Evaluation+of+maternal+serum+dimeric+inhibin+A+as+a+first‐trimester+marker+of+Down's+syndrome+&author=EM+Wallace&author=VE+Grant&author=IA+Swanston&author=NP+Groome&publication_year=1995&hl=en""]",,https://doi.org/10.1002/pd.1970150410, Wallace 1995 ,additional,CD009925-bbs2-0550,
CD009925-bib-0566,"Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J. ",The development of QUADAS:  A tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews, BMC Medical Research Methodology ,2003,3,    ,['citation-journal']," Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J. The development of QUADAS:  A tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews.  BMC Medical Research Methodology 2003;3:25.    Link to article     Google Scholar     ","['https://doi.org/10.1186/1471-2288-3-25', 'https://scholar.google.com/scholar_lookup?title=The+development+of+QUADAS:\xa0+A+tool+for+the+quality+assessment+of+studies+of+diagnostic+accuracy+included+in+systematic+reviews+&author=P+Whiting&author=AW+Rutjes&author=JB+Reitsma&author=PM+Bossuyt&author=J+Kleijnen&publication_year=2003&hl=en']",,https://doi.org/10.1186/1471-2288-3-25, Whiting 2003 ,additional,CD009925-bbs2-0551,
